Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACY1,Aminoacylase-1,29478,-0.175673937054251,0.00435837852708465,-0.184216358967337,-0.167131515141165,0
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADIPOQ,Adiponectin,24966,0.23629261695412,0.00469054055374702,0.227099157468776,0.245486076439464,0
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AGRP,Agouti-related protein,29786,-0.215655425092454,0.00362926899280467,-0.222768792318351,-0.208542057866557,0
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,APOF,Apolipoprotein F,24951,0.0790433329579697,0.00175665574376183,0.0756002877001965,0.0824863782157429,0
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,29218,-0.105714918990546,0.00207047233137477,-0.10977304476004,-0.101656793221051,0
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C9,Complement component C9,24951,0.172427876962891,0.00372562556134965,0.165125650862646,0.179730103063137,0
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCN1,CCN family member 1,29301,-0.239568603435818,0.00530165238799321,-0.249959842116284,-0.229177364755351,0
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CES1,Liver carboxylesterase 1,29489,-0.258943393472469,0.00566462254886008,-0.270046053668235,-0.247840733276704,0
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CPM,Carboxypeptidase M,29584,-0.10033729875785,0.00241620985057204,-0.105073070064972,-0.0956015274507291,0
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGF21,Fibroblast growth factor 21,29674,-0.329234824733908,0.00838430089295107,-0.345668054484092,-0.312801594983724,0
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,29566,0.128906223561538,0.00226059365663864,0.124475459994526,0.13333698712855,0
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FURIN,Furin,29566,-0.0989477039858119,0.00236273040300668,-0.103578655575705,-0.0943167523959189,0
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GCG,Pro-glucagon,28797,-0.53832071474708,0.00847268570623396,-0.554927178731298,-0.521714250762861,0
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GPR37,Prosaposin receptor GPR37,28916,-0.20813201039793,0.00465112765030178,-0.217248220592522,-0.199015800203339,0
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,29761,0.397617852174229,0.00854546479606876,0.380868741173934,0.414366963174524,0
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGSF9,Protein turtle homolog A,24922,-0.331797729071519,0.0056662830621977,-0.342903643873427,-0.320691814269612,0
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,INHBC,Inhibin beta C chain,29443,-0.128026085800222,0.00290380542508352,-0.133717544433386,-0.122334627167059,0
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LDLR,Low-density lipoprotein receptor,29500,-0.248297736678394,0.00354376017915205,-0.255243506629532,-0.241351966727256,0
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LPL,Lipoprotein lipase,29478,0.165868089183891,0.00327424905799815,0.159450561030215,0.172285617337567,0
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAMDC4,Apical endosomal glycoprotein,24793,-0.16570016539784,0.003910152827524,-0.173364064939787,-0.158036265855893,0
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MFGE8,Lactadherin,29443,-0.220312762087394,0.00291284150017866,-0.226021931427744,-0.214603592747044,0
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,24381,0.0900649438125736,0.00215967418274991,0.0858319824143838,0.0942979052107634,0
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NPY,Pro-neuropeptide Y,29725,-0.281323999430371,0.00449065869723791,-0.290125690476957,-0.272522308383785,0
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OXT,Oxytocin-neurophysin 1,29694,-0.413642731565007,0.00980453256789937,-0.432859615398089,-0.394425847731924,0
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,29443,0.100989574971048,0.00223538451007465,0.0966082213313021,0.105370928610795,0
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLTP,Phospholipid transfer protein,29702,0.106633682455921,0.00253126951533035,0.101672394205873,0.111594970705968,0
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PON3,Serum paraoxonase/lactonase 3,29581,0.111489590994151,0.00195486110186123,0.107658063234503,0.115321118753799,0
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRAP1,Proline-rich acidic protein 1,24938,-0.173244355527171,0.00276641184745968,-0.178666522748192,-0.16782218830615,0
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRSS8,Prostasin,29347,-0.160978261558154,0.00282745881905759,-0.166520080843507,-0.155436442272801,0
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PYY,Peptide YY,24111,-0.309636651733616,0.00679995664574284,-0.322964566759272,-0.29630873670796,0
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,29628,-0.141091463975251,0.0033288030274383,-0.14761591790903,-0.134567010041472,0
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RTN4R,Reticulon-4 receptor,29725,-0.097011343191706,0.00238971364290796,-0.101695181931806,-0.0923275044516064,0
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLC39A5,Zinc transporter ZIP5,29434,-0.160095094263782,0.00375964837473944,-0.167464005078271,-0.152726183449292,0
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TMPRSS15,Enteropeptidase,29349,-0.292285610592241,0.00633618467986538,-0.304704532564777,-0.279866688619705,0
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EPHA1,Ephrin type-A receptor 1,29536,-0.0916122911181688,0.00235785102319126,-0.0962336791236237,-0.0869909031127139,1.11253692925362e-308
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,28916,-0.230086928238821,0.00592314157325504,-0.241696285722401,-0.218477570755241,1.11253692925364e-308
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTH,Parathyroid hormone,24195,-0.222302222515742,0.00573546309094704,-0.233543730173998,-0.211060714857486,1.11253692928842e-308
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,UPB1,Beta-ureidopropionase,24922,-0.249429139338101,0.00648109198863578,-0.262132079635827,-0.236726199040375,1.11253732805365e-308
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,29725,-0.0881595083886836,0.00232762817509613,-0.092721659611872,-0.0835973571654952,1.30257483567448e-306
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GHR,Growth hormone receptor,24381,-0.0771816854403732,0.00203843542995064,-0.0811770188830765,-0.07318635199767,6.95918436377682e-305
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD4,T-cell surface glycoprotein CD4,29383,-0.080014302862313,0.00212095164501902,-0.0841713680865503,-0.0758572376380758,3.47225519622592e-304
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MVK,Mevalonate kinase,28931,-0.212710456075845,0.00564431583095697,-0.223773315104521,-0.201647597047169,1.87699356650921e-303
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL16,C-C motif chemokine 16,29820,-0.138305040092885,0.00371088359150824,-0.145578371932241,-0.131031708253528,3.36409900006199e-297
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DSG2,Desmoglein-2,29443,0.0703032851221973,0.00191706171656387,0.0665458441577321,0.0740607260866625,6.15495961305808e-288
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD300LG,CMRF35-like molecule 9,29443,0.0970390414334472,0.0026666040391191,0.0918124975167738,0.102265585350121,1.17810143996486e-283
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINF1,Pigment epithelium-derived factor,24579,-0.0671519560384759,0.00185796936123004,-0.0707935759864868,-0.063510336090465,9.59466156856981e-279
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLUL1,Clusterin-like protein 1,29435,0.115564872986027,0.00320646077234905,0.109280209872222,0.121849536099831,2.16459605210521e-278
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,29379,-0.137148376788945,0.00383545845606386,-0.14466587536283,-0.12963087821506,3.80401054653584e-274
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,29036,-0.370101927680394,0.0104758177327116,-0.390634530436509,-0.349569324924279,9.91974653930893e-268
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL27,C-C motif chemokine 27,29478,-0.153942044053556,0.00435938050609767,-0.162486429845508,-0.145397658261605,1.42686450459506e-267
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GSTA1,Glutathione S-transferase A1,29426,-0.211301680501419,0.00598813024566428,-0.223038415782921,-0.199564945219917,3.52966594170764e-267
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,29349,-0.170781538044933,0.00484005377224739,-0.180268043438538,-0.161295032651328,3.86408701460483e-267
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NHLRC3,NHL repeat-containing protein 3,23825,-0.080609604704681,0.00228659009200052,-0.085091321285002,-0.0761278881243599,2.0155268140224e-265
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,24845,-0.190992029712461,0.00542346297026005,-0.201622017134171,-0.180362042290752,3.78012155380202e-265
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RBP5,Retinol-binding protein 5,29349,-0.139246675477147,0.00399445109538477,-0.147075799624101,-0.131417551330193,6.38849499444789e-261
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,F9,Coagulation factor IX,29545,-0.044948427236486,0.00129425489469196,-0.0474851668300822,-0.0424116876428897,4.69616270789467e-259
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SHBG,Sex hormone-binding globulin,24951,0.127629196530974,0.00367986809907144,0.120416655056794,0.134841738005154,1.8460593055593e-257
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",28774,-0.130241397993142,0.00376373691142131,-0.137618322339528,-0.122864473646756,4.11638900799487e-257
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LGALS4,Galectin-4,29454,-0.134539586583726,0.00388888420525353,-0.142161799626023,-0.126917373541429,4.13429502349176e-257
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTSD,Cathepsin D,27442,-0.100079902933301,0.00289146906601275,-0.105747182302686,-0.0944126235639164,5.62841474879443e-257
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,28931,-0.135410337550775,0.00392854747838734,-0.143110290608414,-0.127710384493136,3.52418036448779e-255
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPY,Pancreatic prohormone,29400,-0.247543521041408,0.00724654034456374,-0.261746740116753,-0.233340301966063,7.66452834873848e-251
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACE2,Angiotensin-converting enzyme 2,28916,-0.125232244479009,0.00368202823610649,-0.132449019821778,-0.118015469136241,1.20070922087338e-248
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,F7,Coagulation factor VII,29544,-0.0741960644003049,0.002182657862289,-0.0784740738103913,-0.0699180549902184,1.73045061292072e-248
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,29820,0.0825156698999578,0.00243052110142537,0.0777518485411641,0.0872794912587515,6.5399859234659e-248
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL17RB,Interleukin-17 receptor B,29034,0.129783148748408,0.00382229685113512,0.122291446920184,0.137274850576633,7.53716556216913e-248
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AMBP,Protein AMBP,29683,-0.0485798491522041,0.0014331561669548,-0.0513888352394355,-0.0457708630649727,3.84245578618405e-247
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,29478,-0.073025674211353,0.00217112820353469,-0.077281085490281,-0.068770262932425,2.09777070689168e-243
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,28797,-0.151625222772512,0.00451945487503579,-0.160483354327582,-0.142767091217442,4.25223862081641e-242
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,29655,-0.0750773536309786,0.00223915535189636,-0.0794660981206955,-0.0706886091412617,6.02022305269829e-242
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,29757,0.148294044923384,0.00443565258168238,0.139600165863286,0.156987923983481,1.33422554628635e-240
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,29349,-0.189350506737005,0.00566902494200332,-0.200461795623331,-0.178239217850678,4.21768209215139e-240
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,24804,-0.202364817493921,0.00607429028934564,-0.214270426461038,-0.190459208526803,4.15706080829925e-238
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,29218,-0.0778487754530176,0.00234121592849465,-0.0824375586728671,-0.0732599922331681,5.37845668295739e-238
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,APOD,Apolipoprotein D,23787,0.103183869245857,0.00310048535505048,0.0971069179499584,0.109260820541756,2.09657587034126e-237
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,APOM,Apolipoprotein M,29545,0.0656447769925169,0.00197946663331407,0.0617650223912213,0.0695245315938124,8.2243719408195e-237
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,28797,-0.139653069682647,0.0042231194066623,-0.147930383719705,-0.131375755645589,2.14288230760293e-235
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NTRK3,NT-3 growth factor receptor,29694,0.0510530403507762,0.00154581687518593,0.0480232392754118,0.0540828414261406,6.08974618116775e-235
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CA14,Carbonic anhydrase 14,29725,0.0837324182574684,0.00253978172534027,0.0787544460758015,0.0887103904391353,3.85393872437848e-234
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MCAM,Cell surface glycoprotein MUC18,29594,0.077516773714552,0.00237518929401405,0.0728614026982845,0.0821721447308196,1.50067194493813e-229
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GSTA3,Glutathione S-transferase A3,28797,-0.177763620860486,0.00546720042803276,-0.188479333699431,-0.167047908021542,8.81987238791251e-228
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AFM,Afamin,24966,-0.0452431959141772,0.00139117323799524,-0.0479698954606478,-0.0425164963677065,2.92178856020011e-227
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,29100,-0.109402435450549,0.00338031718679021,-0.116027857136658,-0.10277701376444,8.81244410307954e-226
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GLA,Alpha-galactosidase A,24329,-0.0862795987880432,0.00268913107733095,-0.0915502956996119,-0.0810089018764746,2.95873832686055e-221
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,29566,-0.0816875446002701,0.00256159455052955,-0.086708269919308,-0.0766668192812322,1.97793011590424e-219
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,28797,-0.187158468788227,0.00586967467614066,-0.198663031153463,-0.175653906422992,2.77029569316904e-219
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,29349,-0.197421306422128,0.00620263445849035,-0.209578469960769,-0.185264142883487,1.36727624302819e-218
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL23,C-C motif chemokine 23,29581,-0.0943227440383119,0.00296909810106352,-0.100142176316396,-0.0885033117602274,8.23462932358283e-218
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MUC13,Mucin-13,28774,-0.116675436233845,0.00367932003976225,-0.123886903511779,-0.109463968955911,5.97141539203336e-217
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,29349,-0.0719665423644395,0.00227046840483687,-0.0764166604379198,-0.0675164242909593,7.86636256211348e-217
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HGF,Hepatocyte growth factor,29786,-0.0768206663973399,0.0024577198775021,-0.081637797357244,-0.0720035354374357,4.66545760107124e-211
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PGF,Placenta growth factor,29786,-0.0585178465109512,0.00187506281977153,-0.0621929696377034,-0.054842723384199,2.02013510250647e-210
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,29559,-0.0517871347254694,0.00167251316540617,-0.0550652605296655,-0.0485090089212733,3.4242459005012e-207
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,29349,-0.233704254549363,0.00755763444958025,-0.24851721807054,-0.218891291028185,1.22556621674485e-206
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MME,Neprilysin,29349,-0.177087833595922,0.00573736747319742,-0.188333073843389,-0.165842593348455,6.80683342215739e-206
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",29349,-0.17910246921873,0.00580955219707594,-0.190489191524999,-0.167715746912461,2.04209214937364e-205
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TTR,Transthyretin,24707,-0.0559357793340748,0.00181474086638998,-0.0594926714321992,-0.0523788872359504,9.72950967617994e-205
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CKB,Creatine kinase B-type,24938,0.130336378605296,0.00423404123202134,0.122037657790534,0.138635099420058,2.94816736453452e-204
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCLY,Selenocysteine lyase,29632,-0.10596732305103,0.00346232222697069,-0.112753474615893,-0.0991811714861676,1.46869014341851e-202
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GUSB,Beta-glucuronidase,29604,-0.130329427669993,0.00426906882597201,-0.138696802568898,-0.121962052771088,1.4549751713417e-201
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FAM20A,Pseudokinase FAM20A,24922,-0.0619257164581018,0.00203047158151957,-0.0659054407578801,-0.0579459921583234,1.34197489709078e-200
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRIP2,Cysteine-rich protein 2,29218,-0.0788037026531798,0.00259339574713488,-0.0838867583175642,-0.0737206469887955,1.07606575606687e-199
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,29725,-0.0731369572634417,0.00244724945002992,-0.0779335661855004,-0.0683403483413831,2.23062920625785e-193
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,24381,-0.0800171241095453,0.00269054458131024,-0.0852905914889134,-0.0747436567301772,6.00037245324515e-191
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NFASC,Neurofascin,29786,-0.0601567937740699,0.00202957607714806,-0.0641347628852801,-0.0561788246628597,2.66150985175221e-190
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NRP1,Neuropilin-1,29628,0.0580289346295029,0.00199101502341785,0.0541265451836039,0.0619313240754018,3.82181726430354e-184
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,28916,-0.114433301958672,0.00393684411329329,-0.122149516420727,-0.106717087496618,4.03489876231788e-183
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GIP,Gastric inhibitory polypeptide,24240,-0.106613817382055,0.00367077441178845,-0.11380853522916,-0.0994190995349492,2.44261396454179e-182
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CNTN3,Contactin-3,29443,-0.0667295429953945,0.00230973293564859,-0.0712566195492657,-0.0622024664415232,5.29606852700577e-181
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,28967,-0.0907649399018937,0.00314400253749053,-0.0969271848753752,-0.0846026949284123,1.06025601959767e-180
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HJV,Hemojuvelin,24867,-0.0916815393322913,0.00317648209996729,-0.0979074442482272,-0.0854556344163554,3.30668563433303e-180
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCG2,Secretogranin-2,29559,-0.0672166717663774,0.00233651445339233,-0.0717962400950264,-0.0626371034377285,1.62096582337471e-179
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,29566,-0.0452988377336911,0.00158048518823704,-0.0483965887026357,-0.0422010867647465,3.18968960883755e-178
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,F11R,Junctional adhesion molecule A,29443,-0.115241618055952,0.00402096040213369,-0.123122700444134,-0.10736053566777,3.36841915899409e-178
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,29545,0.0602078613967348,0.00210954441054218,0.0560731543520721,0.0643425684413975,9.23687058524601e-177
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPIND1,Heparin cofactor 2,24914,-0.0577307075819655,0.00202352508002554,-0.0616968167388156,-0.0537645984251155,3.41913011727959e-176
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTSO,Cathepsin O,29786,-0.0617714569750083,0.00217411861556432,-0.0660327294615143,-0.0575101844885022,3.12970829946766e-175
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NOMO1,Nodal modulator 1,29443,-0.0476173474227429,0.00168486569192136,-0.0509196841789087,-0.044315010666577,2.11840756251262e-173
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL18R1,Interleukin-18 receptor 1,29786,-0.0663238632705518,0.00235078948798034,-0.0709314106669933,-0.0617163158741103,7.55324758628374e-173
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLAT,Tissue-type plasminogen activator,29736,-0.101102540185794,0.00360019494403123,-0.108158922276095,-0.0940461580954929,2.77193158535741e-171
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NPPC,C-type natriuretic peptide,29434,-0.0962943035015713,0.0034294927644695,-0.103016109319931,-0.089572497683211,3.27792900150328e-171
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MTSS1,Protein MTSS 1,24805,-0.22323969662196,0.00796848055838986,-0.238857918516404,-0.207621474727516,4.70898521011559e-170
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,24381,-0.0995798657003944,0.00355464103258062,-0.106546962124252,-0.0926127692765364,5.41221164747448e-170
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AGR3,Anterior gradient protein 3,28764,-0.119264983716118,0.00426820307451352,-0.127630661742165,-0.110899305690072,1.49752262836068e-169
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AMOT,Angiomotin,24381,-0.0807946848281128,0.00289720023151398,-0.0864731972818802,-0.0751161723743454,1.68904885915323e-168
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,24922,-0.14513115013787,0.00520758887156388,-0.155338024326135,-0.134924275949605,2.41487278168065e-168
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",24240,-0.114444901472296,0.00411746265651939,-0.122515128279074,-0.106374674665518,2.10768379038819e-167
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GRP,Gastrin-releasing peptide,24240,-0.107768983771367,0.00387830678595441,-0.115370465071838,-0.100167502470897,2.57103638648447e-167
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MEP1A,Meprin A subunit alpha,24805,-0.143552266891252,0.00517283530938871,-0.153691024097654,-0.13341350968485,6.0053322804353e-167
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,29163,-0.143443332604409,0.00521305831442789,-0.153660926900688,-0.133225738308131,1.43124730383592e-164
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MET,Hepatocyte growth factor receptor,29507,0.0390399159155526,0.00142050453490815,0.0362557270271326,0.0418241048039726,3.28568495020676e-164
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KHK,Ketohexokinase,24240,-0.126596697070768,0.00460629845468442,-0.135625042041949,-0.117568352099586,9.00940434931165e-164
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",29566,-0.0686747053961853,0.00250247747568127,-0.0735795612485205,-0.06376984954385,9.62913246413367e-164
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NCS1,Neuronal calcium sensor 1,29725,-0.0561402076001307,0.00205099043431681,-0.0601601488513917,-0.0521202663488698,6.18977182450452e-163
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BPIFB1,BPI fold-containing family B member 1,29333,0.123398977296551,0.00451965300871431,0.114540457399471,0.132257497193631,4.2056620521092e-162
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CHI3L1,Chitinase-3-like protein 1,28935,-0.154148373492058,0.00565301014333986,-0.165228273373004,-0.143068473611112,1.11956264477095e-161
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",28916,-0.178952793211196,0.00658586313242395,-0.191861084950746,-0.166044501471645,1.44420347341159e-160
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SELE,E-selectin,29820,-0.0980614013440277,0.00361260872403255,-0.105142114443131,-0.0909806882449239,2.64672486728724e-160
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,29218,-0.109381050005753,0.00403084299372825,-0.117281502273461,-0.101480597738046,3.6014770711542e-160
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CXCL6,C-X-C motif chemokine 6,29786,-0.149359097966855,0.00551107523767826,-0.160160805432705,-0.138557390501006,8.22350050580879e-160
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,24365,-0.0921461151525408,0.00339860446200712,-0.0988073798980748,-0.0854848504070068,1.61937599083264e-159
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,29786,-0.075409130591743,0.00278682686558888,-0.0808713112482972,-0.0699469499351888,2.53167162074003e-159
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KYNU,Kynureninase,29786,-0.0875138434506634,0.00325471913411173,-0.0938930929535224,-0.0811345939478044,2.28926386030235e-157
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DPY30,Protein dpy-30 homolog,29604,-0.11478722577882,0.00428608864006241,-0.123187959513342,-0.106386492044298,3.88629924509748e-156
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,UMOD,Uromodulin,29750,0.103511773629802,0.0038744720660552,0.0959178083803338,0.11110573887927,2.08360265943634e-155
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,29694,-0.0998405291316452,0.00374407743430771,-0.107178920902888,-0.0925021373604021,7.76513851813795e-155
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,29349,-0.132298942543717,0.00496227757108341,-0.14202500658304,-0.122572878504393,9.36634187433752e-155
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CXCL13,C-X-C motif chemokine 13,29694,-0.116149742855089,0.00436239784656159,-0.124700042634349,-0.107599443075828,2.26328116069372e-154
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,29349,-0.0750872527982818,0.00284325530396991,-0.0806600331940628,-0.0695144724025008,6.48454948731727e-152
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,24793,-0.0994611355531101,0.00376951289363951,-0.106849380824644,-0.0920728902815766,2.46647092702747e-151
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,24922,-0.125097886358372,0.00474195829856691,-0.134392124623563,-0.115803648093181,2.70982036648349e-151
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,29786,-0.0716131124291289,0.00272818481643788,-0.0769603546693471,-0.0662658701889107,3.7283920515176e-150
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,24111,-0.128299201870185,0.00490008829007445,-0.137903374918731,-0.118695028821639,5.03521070681618e-149
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,24951,-0.0417775743041861,0.00160064253098896,-0.0449148336649244,-0.0386403149434477,3.5192762705567e-148
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,29478,0.0507250343885277,0.0019499828450504,0.0469030680122289,0.0545470007648265,1.63622888523333e-147
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,24938,-0.0615658249023153,0.0023644526619932,-0.066200152119822,-0.0569314976848086,1.72335089289163e-147
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,29594,0.0710909245678671,0.00273901618849841,0.0657224528384102,0.076459396297324,7.07893133447082e-147
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,28931,-0.0811186081999271,0.00315155577810171,-0.0872956575250065,-0.0749415588748478,1.80762045448177e-144
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CPA2,Carboxypeptidase A2,29577,-0.120275805229588,0.00468757121751846,-0.129463444815924,-0.111088165643251,1.27418709841937e-143
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HAO1,Hydroxyacid oxidase 1,29725,-0.235767736560705,0.00919270771322842,-0.253785443678633,-0.217750029442778,1.65835606255177e-143
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,28643,-0.101515850892974,0.0039577453509871,-0.109273031780908,-0.0937586700050388,1.77345550783813e-143
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,29725,-0.0680366317466652,0.00265329892893328,-0.0732370976473744,-0.062836165845956,1.87931266875632e-143
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINA5,Plasma serine protease inhibitor,24644,-0.0587652089933603,0.00229126123136273,-0.0632560810068312,-0.0542743369798893,3.41535468580653e-143
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD2AP,CD2-associated protein,29478,-0.116800949864745,0.00456339149557091,-0.125745197196064,-0.107856702533426,6.30949677212433e-143
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,29694,-0.0636506366112579,0.00249148261040887,-0.0685339425276593,-0.0587673306948565,2.04272960540481e-142
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINA4,Kallistatin,24557,-0.0439171210873235,0.00171877009087404,-0.0472859104654366,-0.0405483317092104,3.81703213390949e-142
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,29674,-0.0768005557261369,0.00302646641687941,-0.0827324299032205,-0.0708686815490532,1.45993612038022e-140
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LEP,Leptin,29478,-0.122507403963278,0.00482781440958393,-0.131969920206063,-0.113044887720494,1.53016084795832e-140
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GDF15,Growth/differentiation factor 15,29820,-0.0809411438256609,0.00319541926404791,-0.0872041655831948,-0.074678122068127,4.49842455066782e-140
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AGRN,Agrin,29581,-0.0623911087462114,0.00247457761289319,-0.067241280867482,-0.0575409366249407,8.50287623551894e-139
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,29434,-0.0502476572329549,0.00199540900308838,-0.0541586588790081,-0.0463366555869017,1.86859353107364e-138
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SORD,Sorbitol dehydrogenase,29595,-0.122955316771112,0.00489027092535061,-0.1325402477848,-0.113370385757425,4.77853260921503e-138
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SEMA3F,Semaphorin-3F,29478,-0.0474823756966734,0.00189388497965027,-0.0511943902567879,-0.0437703611365588,2.81007956282295e-137
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FETUB,Fetuin-B,29545,-0.059383560768702,0.00237386978931422,-0.0640363455557579,-0.0547307759816461,1.1011409323216e-136
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HEG1,Protein HEG homolog 1,24381,-0.0491970296825089,0.00196492793193566,-0.0530482884291028,-0.045345770935915,1.27184023689265e-136
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CFI,Complement factor I,24966,-0.035912950776665,0.00143460111028249,-0.0387247689528187,-0.0331011326005113,1.2849862941394e-136
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MENT,Protein MENT,24381,0.0407150460559757,0.00163574049968872,0.0375089946765858,0.0439210974353656,4.54487613712403e-135
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,29390,-0.0897939129695578,0.00361234311320509,-0.0968741054714398,-0.0827137204676758,5.33818637702671e-135
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL15,C-C motif chemokine 15,29820,-0.0786984415530784,0.00316666852123949,-0.0849051118547078,-0.072491771251449,5.81748640092114e-135
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,29594,-0.0758592134653405,0.00305674755383012,-0.0818504386708476,-0.0698679882598335,1.40317958483362e-134
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CST3,Cystatin-C,29530,-0.0505054410211092,0.00203905638040201,-0.0545019915266972,-0.0465088905155213,4.53507499088805e-134
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,24888,0.0868593899530565,0.00352641061814941,0.0799476251414837,0.0937711547646294,2.2625167802372e-132
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,29301,-0.0452914062375312,0.001858748688631,-0.048934553667248,-0.0416482588078144,7.60375365024799e-130
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,29218,-0.128090119818654,0.00529208086553483,-0.138462598315102,-0.117717641322205,3.69352292265912e-128
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CPB1,Carboxypeptidase B,29820,-0.102625627157877,0.00424698750845993,-0.110949722674459,-0.0943015316412958,8.96803914863527e-128
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTBS,Di-N-acetylchitobiase,24653,-0.0475852509833393,0.00196748178931663,-0.0514415152903999,-0.0437289866762787,9.67140617663e-128
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,28797,-0.117890379344125,0.00488008506205013,-0.127455346065743,-0.108325412622506,1.16635755348202e-127
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LSP1,Lymphocyte-specific protein 1,29434,-0.0697715049451113,0.00288938666545737,-0.0754347028094078,-0.0641083070808149,1.38660689711684e-127
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MLN,Promotilin,29434,-0.154481082352049,0.00640075650448582,-0.167026565100841,-0.141935599603257,1.87377793425544e-127
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GH1,Somatotropin,29433,0.307847329297041,0.0127641795217438,0.282829537434424,0.332865121159659,2.78711035460055e-127
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,POSTN,Periostin,24938,0.0659023595046555,0.00273136645156808,0.060548881259582,0.0712558377497289,3.65693700610913e-127
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OMD,Osteomodulin,29581,0.0746612770213534,0.00310692496468408,0.0685717040905726,0.0807508499521342,2.17508539118459e-126
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NCAM2,Neural cell adhesion molecule 2,29443,0.0464958088842269,0.0019403027594355,0.0426928154757333,0.0502988022927205,1.08026919386666e-125
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,29434,0.0674575793281694,0.00281706226650831,0.0619361372858131,0.0729790213705257,1.61689230208447e-125
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,28797,-0.189249787788083,0.0079281436496097,-0.204788949341318,-0.173710626234848,1.01009989382832e-124
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CHMP6,Charged multivesicular body protein 6,24922,-0.0969562367473971,0.00407412220032962,-0.104941516260043,-0.0889709572347511,8.43151873455485e-124
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,29434,-0.064582696917538,0.00272152569389911,-0.0699168872775803,-0.0592485065574958,2.53376638817194e-123
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IDUA,Alpha-L-iduronidase,29725,-0.0786264751913675,0.00331592574163459,-0.0851256896449712,-0.0721272607377637,3.80617800846144e-123
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,29581,-0.0495682289009192,0.00209140823262893,-0.0536673890368719,-0.0454690687649665,4.9679068272937e-123
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ENO3,Beta-enolase,24240,-0.102719992909704,0.00434393323849688,-0.111234102057158,-0.0942058837622499,3.09225290820662e-122
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,24805,-0.0468892426992961,0.00198513267379128,-0.050780102739927,-0.0429983826586652,5.32474691545346e-122
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,29760,-0.0649729207124832,0.00275661815067826,-0.0703758922878126,-0.0595699491371538,1.02926631467474e-121
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,29497,-0.0518476513788816,0.00219978420549942,-0.0561592284216604,-0.0475360743361027,1.06185075978561e-121
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD5,T-cell surface glycoprotein CD5,29683,-0.0582022350247448,0.00247516311785406,-0.0630535547357387,-0.0533509153137508,3.72654392900107e-121
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NUMB,Protein numb homolog,24229,-0.141905175289871,0.00602962493555656,-0.153723240163562,-0.13008711041618,4.12766725176424e-121
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,29370,-0.0341838554210581,0.00145607147205127,-0.0370377555062786,-0.0313299553358376,9.15387950291607e-121
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NECTIN2,Nectin-2,29433,-0.0503339569998367,0.0021470619615621,-0.0545421984444984,-0.046125715555175,1.97616172966982e-120
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDHR2,Cadherin-related family member 2,29349,-0.122226505471539,0.00521881921705118,-0.13245539113696,-0.111997619806119,3.36924423239376e-120
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,24793,-0.117205547248696,0.0050008120952112,-0.12700713895531,-0.107403955542082,3.61716240762164e-120
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PSME1,Proteasome activator complex subunit 1,29192,-0.0623446474711535,0.00266749010506109,-0.0675729280770732,-0.0571163668652338,1.03781566168285e-119
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",29820,-0.0837652917457752,0.00359589736936311,-0.0908132505897269,-0.0767173329018235,5.81174690220889e-119
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,24793,-0.0957396312280051,0.00411121979871024,-0.103797622033477,-0.0876816404225331,1.11998566025899e-118
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ELN,Elastin,24922,-0.0589846460249074,0.00253457065106942,-0.0639524045010034,-0.0540168875488113,1.56650952391298e-118
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTSZ,Cathepsin Z,29487,-0.052839295816807,0.00227464169366929,-0.0572975935363988,-0.0483809980972151,2.64126281447744e-118
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL16,Pro-interleukin-16,29786,-0.0690591273205348,0.00297396900881779,-0.0748881065778176,-0.0632301480632519,3.13223216374115e-118
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTSB,Cathepsin B,29480,0.0875769264222636,0.00377909179358386,0.0801699065068393,0.094983946337688,9.41522899308953e-118
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",28797,-0.13756399052079,0.00594696807218852,-0.14922004794228,-0.125907933099301,2.61025204368937e-117
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,29434,-0.106193785532592,0.0045916990057243,-0.115193515583812,-0.0971940554813727,2.73975474726351e-117
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRSS2,Trypsin-2,29594,-0.0891013083907603,0.00385497855393522,-0.0966570663564734,-0.0815455504250473,3.72191492546448e-117
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,29736,-0.0340924099835093,0.00147506151605121,-0.0369835305549697,-0.0312012894120489,3.74548680337758e-117
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,29454,-0.0462205836076049,0.00200362051012569,-0.0501476798074512,-0.0422934874077585,1.04115601714958e-116
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,29443,0.0668402381411463,0.00289797986015799,0.0611601976152367,0.072520278667056,1.14390006302425e-116
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OCLN,Occludin,24867,-0.0731191784120225,0.00317105794702046,-0.0793344519881826,-0.0669039048358624,2.02596208971494e-116
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,24229,-0.141832745130064,0.0061592781065406,-0.153904930218883,-0.129760560041244,4.37036425767899e-116
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LAT2,Linker for activation of T-cells family member 2,29349,-0.205068344827739,0.00893347189983945,-0.222577949751424,-0.187558739904053,1.37162514371284e-115
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FAM3B,Protein FAM3B,29349,-0.0589150729671536,0.00256897329098576,-0.0639502606174857,-0.0538798853168215,2.24108081153675e-115
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,24240,0.100645566687165,0.00439607235743008,0.0920292648666024,0.109261868507728,8.73092624690792e-115
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FUOM,Fucose mutarotase,24381,-0.105222005249664,0.00460172315689507,-0.114241382637178,-0.0962026278621498,1.63416258318274e-114
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITGA11,Integrin alpha-11,29434,0.0563482589165487,0.00246963692624185,0.0515077705411147,0.0611887472919827,3.09581912035138e-114
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RNASET2,Ribonuclease T2,29697,-0.0434981558702562,0.00191398745616146,-0.0472495712843327,-0.0397467404561798,2.28092185692796e-113
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,29349,-0.11070818467634,0.00487418782306666,-0.12026159280955,-0.101154776543129,3.15286441454405e-113
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,29349,-0.058719973673529,0.0025854773350468,-0.0637875092502207,-0.0536524380968373,3.27444191208139e-113
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MYH9,Myosin-9,24938,-0.184872460980028,0.00813904827950512,-0.200824995607858,-0.168919926352198,4.55659593582058e-113
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SNAPIN,SNARE-associated protein Snapin,24867,-0.0948215886841611,0.00418026806406846,-0.103014914089735,-0.0866282632785869,9.18432368297273e-113
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LBR,Delta(14)-sterol reductase LBR,29694,-0.10850252742071,0.00480129006556377,-0.117913055949215,-0.0990919988922051,3.95748368467134e-112
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,28595,-0.0317403745908444,0.00141185886514322,-0.0345076179665251,-0.0289731312151637,5.8120042180856e-111
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,29349,-0.0706630230748593,0.00314491472174274,-0.0768270559294751,-0.0644989902202436,7.21089670310365e-111
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",29349,-0.071261553787094,0.00317400057376379,-0.077482594911671,-0.0650405126625169,1.05799282881271e-110
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SNAP29,Synaptosomal-associated protein 29,29566,-0.147284154189118,0.00657340006459289,-0.16016801831572,-0.134400290062516,2.85100117204037e-110
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NUCB2,Nucleobindin-2,29652,-0.0600258185582486,0.00268281149861909,-0.065284129095542,-0.0547675080209552,5.72322247819197e-110
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PXN,Paxillin,28774,-0.0829590829292693,0.00371171600407115,-0.0902340462972487,-0.0756841195612898,1.02583413228452e-109
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VEGFA,Vascular endothelial growth factor A,29683,-0.0926789544147916,0.00415679760080812,-0.100826277712376,-0.0845316311172077,3.21142594007593e-109
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PAXX,Protein PAXX,24381,-0.0737209167238858,0.0033097195954972,-0.0802079671310603,-0.0672338663167113,8.04666191663649e-109
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ERMAP,Erythroid membrane-associated protein,24229,-0.0718579194063516,0.00322733156209153,-0.078183489268051,-0.0655323495446522,9.87152897418157e-109
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BECN1,Beclin-1,24240,-0.0969408401371199,0.00435461194030562,-0.105475879540119,-0.0884058007341209,1.07098039471003e-108
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DTYMK,Thymidylate kinase,24922,-0.109871091315625,0.00494285223655744,-0.119559081699277,-0.100183100931972,2.07522404183037e-108
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,YES1,Tyrosine-protein kinase Yes,29349,-0.181896755529817,0.00819193618239665,-0.197952950447314,-0.165840560612319,2.43793098042196e-108
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FAM3C,Protein FAM3C,29433,-0.0479473342212559,0.00216323246381881,-0.0521872698503408,-0.043707398592171,5.77334686804087e-108
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,29434,0.0558494467591087,0.00252018192081113,0.0509098901943189,0.0607890033238985,6.27136722427554e-108
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,24381,-0.12118604269053,0.00546435905413804,-0.131896186436641,-0.11047589894442,6.61720196720216e-108
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TXLNA,Alpha-taxilin,29218,-0.141256111584209,0.00637648164255947,-0.153754015603625,-0.128758207564792,7.61455691298738e-108
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,29349,-0.0949608088453829,0.00428770837503645,-0.103364717260454,-0.0865569004303114,8.50041418222994e-108
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,29434,-0.0817229841225767,0.0036966580589973,-0.0889684339182115,-0.074477534326942,2.02006831925496e-107
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BCHE,Cholinesterase,24528,-0.0448225456466444,0.00202899977200158,-0.0487993851997675,-0.0408457060935213,4.28563967638859e-107
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EGLN1,Egl nine homolog 1,29434,-0.0863707107619776,0.0039133365681628,-0.0940408504355766,-0.0787005710883785,4.46223236828092e-107
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LGALS9,Galectin-9,29453,-0.0507254854926817,0.00229851176289774,-0.0552305685479613,-0.0462204024374022,4.65705368519316e-107
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EFNA4,Ephrin-A4,29169,-0.0488481318200055,0.00221540707045817,-0.0531903296781035,-0.0445059339619074,7.26363856079432e-107
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CFH,Complement factor H,23693,-0.0372711070993668,0.00169224550796461,-0.0405879082949774,-0.0339543059037561,1.95927582787113e-106
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,24845,-0.0749618789785527,0.00341415343317123,-0.0816536197075683,-0.0682701382495371,7.6830312344148e-106
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EEF1D,Elongation factor 1-delta,24922,-0.144424461757516,0.0065946413718249,-0.157349958846293,-0.13149896466874,2.5477706399587e-105
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FYB1,FYN-binding protein 1,29400,-0.144782618742499,0.00661623766456288,-0.157750444565043,-0.131814792919956,2.62393319973164e-105
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,29478,-0.0531182137513444,0.00244625859327636,-0.057912880594166,-0.0483235469085227,9.84604853628051e-104
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SARG,Specifically androgen-regulated gene protein,24820,-0.17113294325968,0.00788744740565356,-0.186592340174761,-0.1556735463446,2.01174768590668e-103
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CES3,Carboxylesterase 3,29349,-0.108588086113651,0.0050278726252891,-0.118442716459217,-0.0987334557680839,1.20415751908519e-102
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDH2,Cadherin-2,29478,-0.055061072947895,0.00255205576709288,-0.0600631022513971,-0.050059043644393,1.91004515802807e-102
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,29218,-0.0604473214753007,0.00280505739097802,-0.0659452339616176,-0.0549494089889838,3.35856190691207e-102
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADM,Pro-adrenomedullin,29725,-0.0411773234314348,0.00191565625604833,-0.0449320096932895,-0.0374226371695801,1.03061435029911e-101
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGF23,Fibroblast growth factor 23,29693,-0.0880427654228341,0.00409625421398618,-0.0960714236822471,-0.0800141071634212,1.06982768998724e-101
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,29443,-0.0821916510832678,0.00383450053705001,-0.0897072721358858,-0.0746760300306498,3.76556869925638e-101
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,24240,-0.130965025972677,0.00611150656693488,-0.14294357884387,-0.118986473101485,6.17384146818422e-101
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD209,CD209 antigen,29527,0.0600686431689242,0.00280699144205416,0.054566939942498,0.0655703463953504,7.8707810023518e-101
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",29307,-0.161336175363141,0.00755312987004706,-0.176140309908434,-0.146532040817849,1.8341493254561e-100
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RNASE4,Ribonuclease 4,24194,-0.0425828204351129,0.00199349340608652,-0.0464900675110424,-0.0386755733591833,2.61196747623138e-100
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",29349,-0.14971081565817,0.00701637459912475,-0.163462909872454,-0.135958721443885,2.95952901177129e-100
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,24609,-0.0491752670202112,0.00230434367309816,-0.0536917806194836,-0.0446587534209388,3.89007573882165e-100
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AGR2,Anterior gradient protein 2 homolog,28553,-0.155238184427808,0.00728407006308523,-0.169514961751455,-0.140961407104161,5.29334298017664e-100
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,29169,-0.137059078076462,0.00643656898182596,-0.149674753280841,-0.124443402872083,7.47470035704277e-100
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,24111,-0.0958838553830937,0.00450739662299093,-0.104718352764156,-0.0870493580020314,1.67735530490861e-99
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CPA1,Carboxypeptidase A1,29820,-0.092777815114434,0.00438409656895375,-0.101370644389583,-0.0841849858392846,1.13142347035342e-98
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TFF3,Trefoil factor 3,29426,-0.0707476039393936,0.0033448870336634,-0.0773035825253739,-0.0641916253534134,1.46740024562581e-98
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DCTN1,Dynactin subunit 1,29725,-0.0987579867226584,0.00467579775993197,-0.107922550332125,-0.0895934231131918,2.69128783945013e-98
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,29433,-0.173615146807434,0.00823274096539058,-0.1897513190996,-0.157478974515269,5.40966840688909e-98
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STC1,Stanniocalcin-1,29694,-0.0659983361527242,0.00313125207455589,-0.0721355902188538,-0.0598610820865947,6.71446304448693e-98
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,29820,-0.0599244973358498,0.00284682866891552,-0.0655042815269243,-0.0543447131447754,1.18733440266429e-97
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TOP2B,DNA topoisomerase 2-beta,24229,-0.121130869437912,0.00575399641515412,-0.132408702411614,-0.10985303646421,1.6536571200013e-97
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,F10,Coagulation factor X,24951,-0.0418756721551385,0.00199270447605447,-0.0457813729282052,-0.0379699713820717,3.36746783386708e-97
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITGAV,Integrin alpha-V,29725,0.0251529341414559,0.00119787742817677,0.0228050943822294,0.0275007739006824,3.48723549152095e-97
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,REN,Renin,29478,-0.115237852225161,0.00548874222543127,-0.125995786987007,-0.104479917463316,3.73107769164184e-97
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,29820,-0.101200597587147,0.0048299563203873,-0.110667311975106,-0.0917338831991883,8.85436967251933e-97
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,29478,-0.0544149687268065,0.00260377118126213,-0.0595183602420802,-0.0493115772115327,2.76306023996742e-96
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARF6,ADP-ribosylation factor 6,24805,-0.161446067130977,0.00772430462716892,-0.176585704200228,-0.146306430061726,3.54059867073777e-96
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SULT2A1,Bile salt sulfotransferase,29434,-0.0840049486636077,0.00403830578430245,-0.0919200280008405,-0.0760898693263749,2.0204275305616e-95
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,YTHDF3,YTH domain-containing family protein 3,28931,-0.127543915608512,0.00613756056718671,-0.139573534320198,-0.115514296896826,3.20517493324269e-95
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL32,Interleukin-32,29434,0.0651848809551415,0.0031424635218949,0.0590256524522275,0.0713441094580555,6.75018102095712e-95
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,24805,-0.121549959483034,0.00587850438654101,-0.133071828080654,-0.110028090885413,3.48052135293929e-94
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EZR,Ezrin,29694,-0.0357150869046769,0.0017317031812199,-0.0391092251398679,-0.0323209486694859,7.57749878658961e-94
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,24793,-0.118616809637635,0.00575094240316949,-0.129888656747847,-0.107344962527423,9.91286581962041e-94
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,29542,0.0460057453393284,0.00223379194840834,0.0416275131204481,0.0503839775582088,1.3754845655061e-93
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,28774,-0.0414775543282139,0.00201841097705368,-0.0454336398432391,-0.0375214688131887,3.62778792560934e-93
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCARB2,Lysosome membrane protein 2,28762,-0.0471218343167157,0.00229411997595733,-0.0516183094695921,-0.0426253591638393,4.3879488386141e-93
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,24805,-0.088000985766673,0.00430900868673032,-0.0964466427926644,-0.0795553287406816,6.02356930844067e-92
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,28797,-0.0750263959504841,0.00368073945505294,-0.0822406452823879,-0.0678121466185804,1.0416942974741e-91
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NPL,N-acetylneuraminate lyase,24922,-0.0659781449841469,0.00324511319551051,-0.0723385668473475,-0.0596177231209463,3.71986395618113e-91
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GZMA,Granzyme A,29786,-0.0507820694614138,0.00250064339125553,-0.0556833305082746,-0.0458808084145529,4.56606091236704e-91
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEP85,Centrosomal protein of 85 kDa,28797,-0.0936690024676081,0.00461486042419404,-0.102714128899028,-0.0846238760361877,5.89807683651639e-91
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DCXR,L-xylulose reductase,29566,-0.0784047028127298,0.00386670602443153,-0.0859834466206156,-0.070825959004844,8.54740663724088e-91
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,28774,-0.0755686808585677,0.0037289606711748,-0.0828774437740703,-0.0682599179430651,1.11938532314581e-90
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTGR1,Prostaglandin reductase 1,24922,-0.119602500779826,0.00590598829584878,-0.131178237839689,-0.108026763719962,1.861766521215e-90
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,28797,-0.104369633232791,0.00515755769332739,-0.114478446311713,-0.0942608201538692,2.00163381820655e-90
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,28797,-0.0522249552829937,0.002586515902356,-0.0572945264516115,-0.047155384114376,4.92006278178024e-90
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANG,Angiogenin,29435,-0.0491043137982361,0.00243286096500793,-0.0538727212896516,-0.0443359063068206,5.53681251570896e-90
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AREG,Amphiregulin,29349,-0.0664638714268043,0.00329949495906346,-0.0729308815465687,-0.0599968613070399,1.237185329546e-89
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PIGR,Polymeric immunoglobulin receptor,29115,-0.0525722570990051,0.0026101681448223,-0.0576881866628568,-0.0474563275351534,1.31019648328107e-89
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NAA80,N-alpha-acetyltransferase 80,24195,-0.176184934020734,0.00874972404080056,-0.193334393140703,-0.159035474900765,1.93121009139574e-89
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,24805,-0.203404461365562,0.0101162679682329,-0.223232346583299,-0.183576576147825,3.32093526970355e-89
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LAT,Linker for activation of T-cells family member 1,29786,-0.109105346854239,0.00545578982156096,-0.119798694904499,-0.0984119988039799,2.18074317633455e-88
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,29349,-0.121877641734361,0.00609813524874988,-0.13382998682191,-0.109925296646811,2.8217354191414e-88
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,29443,-0.0413383039095078,0.00207108305611576,-0.0453976266994947,-0.0372789811195209,4.7237423716933e-88
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,29443,-0.0430194275246439,0.00215548693079187,-0.047244181908996,-0.0387946731402918,4.88015509055329e-88
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,29604,-0.083293844396784,0.00417736229581029,-0.0914814744965721,-0.0751062142969958,7.01590541630302e-88
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BACH1,Transcription regulator protein BACH1,29434,-0.105877513608247,0.00531242085820329,-0.116289858490325,-0.0954651687261682,8.46863624644104e-88
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,XCL1,Lymphotactin,29725,-0.0796621500679038,0.00400342283907026,-0.0875088588324815,-0.0718154413033261,1.56016749153939e-87
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,28797,-0.0710033722517938,0.00357175574549747,-0.0780040135129688,-0.0640027309906188,2.38236874208359e-87
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,S100P,Protein S100-P,28916,-0.0768064986490174,0.00386817073672822,-0.0843881132930047,-0.0692248840050301,3.73006542482299e-87
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",29434,-0.139518236013346,0.00702999362732756,-0.153297023522908,-0.125739448503784,4.4246946320861e-87
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FABP1,"Fatty acid-binding protein, liver",29454,-0.134638881000051,0.00679117183063013,-0.147949577788086,-0.121328184212016,6.61864266297104e-87
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL12A_IL12B,Interleukin-12,29349,-0.110929159152542,0.00560672931012427,-0.121918348600386,-0.0999399697046986,1.47235733119771e-86
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CXCL17,C-X-C motif chemokine 17,29786,-0.0598518430280097,0.00302902841880556,-0.0657887387288686,-0.0539149473271509,2.38333826004155e-86
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GAST,Gastrin,24845,-0.18623476465022,0.0094240029422861,-0.204705810417101,-0.167763718883339,2.92787611759827e-86
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,28931,-0.100022713541422,0.00506483854504195,-0.109949797089705,-0.0900956299931402,3.06552334919741e-86
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDH1,Cadherin-1,28477,-0.0572281068441967,0.00289828508771728,-0.0629087456161226,-0.0515474680722709,3.31488335757343e-86
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",24867,-0.0894015742377559,0.00452786228397659,-0.09827618431435,-0.0805269641611617,4.07170768114018e-86
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEP20,Centrosomal protein 20,28797,-0.105825064660708,0.00536698913463402,-0.11634436336459,-0.095305765956825,5.61310161949646e-86
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,29434,-0.0812642554951921,0.00412194555845591,-0.0893432687897657,-0.0731852422006185,5.75823056326566e-86
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,24805,-0.0426907011155665,0.00216877813701625,-0.0469415062641184,-0.0384398959670147,1.3277320562993e-85
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,THOP1,Thimet oligopeptidase,29343,-0.0437891139050746,0.00222632986577525,-0.0481527204419941,-0.0394255073681551,1.42435591825086e-85
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,29632,-0.102753645950627,0.00523807816549884,-0.113020279155005,-0.0924870127462495,3.87203495657561e-85
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,29694,-0.135489770957412,0.00691587170935705,-0.149044879507752,-0.121934662407072,6.33863311322554e-85
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,24111,-0.105433516958717,0.00538036088866071,-0.115979024300492,-0.0948880096169424,7.66161708949359e-85
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,29704,-0.11547532450331,0.00590182983533202,-0.127042910980561,-0.10390773802606,1.03081067080277e-84
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD63,CD63 antigen,29169,-0.0724067221920276,0.00370059982116292,-0.0796598978415069,-0.0651535465425482,1.05022811317866e-84
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD248,Endosialin,24938,0.0568852207236159,0.00291039621771365,0.0511808441368971,0.0625895973103347,1.9327657251847e-84
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CXCL10,C-X-C motif chemokine 10,29581,-0.0941394849089756,0.00482272712222809,-0.103592030068543,-0.0846869397494085,2.52499476565059e-84
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ELOA,Elongin-A,29349,-0.0735981464904043,0.00377298537459444,-0.0809931978246094,-0.0662030951561992,3.29988070242306e-84
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,APOC1,Apolipoprotein C-I,24914,0.0528712360152506,0.00271068948902318,0.0475582846167651,0.058184187413736,4.25082805236836e-84
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MTSS2,Protein MTSS 2,24793,-0.139836737359794,0.00717996980559907,-0.153909478178769,-0.12576399654082,7.44679573213618e-84
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PVR,Poliovirus receptor,29694,-0.0519794114770819,0.00267292354193483,-0.0572183416192742,-0.0467404813348897,1.03372792096065e-83
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",24240,-0.0975736503508671,0.00502265924193281,-0.107418062465055,-0.0877292382366788,1.98127325081971e-83
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,29173,-0.0397999090878804,0.00205037468994584,-0.0438186434801742,-0.0357811746955865,2.094356928302e-83
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,29434,-0.148566002128079,0.00765611595780348,-0.163571989405374,-0.133560014850784,2.33261075430189e-83
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SNAP23,Synaptosomal-associated protein 23,29478,-0.121707035530824,0.00627204499608675,-0.134000243723154,-0.109413827338494,2.33730729259881e-83
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,24240,-0.101888309139155,0.00525254449834667,-0.112183296355914,-0.0915933219223951,3.44052030105714e-83
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HEPH,Hephaestin,24922,-0.0370992725196099,0.00191361101620343,-0.0408499501113686,-0.0333485949278512,4.07125256181446e-83
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,24229,-0.062594167932551,0.00323586621784042,-0.0689364657195182,-0.0562518701455837,9.67557218110366e-83
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLXNB2,Plexin-B2,29701,-0.0333092819769246,0.00172344726149155,-0.0366872386094481,-0.0299313253444012,1.02492022775123e-82
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ISM1,Isthmin-1,29434,-0.054793172321383,0.00283665141504212,-0.0603530090948655,-0.0492333355479004,1.27788756863854e-82
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TGFA,Protransforming growth factor alpha,29434,-0.0650812085109928,0.00337494923869061,-0.0716961090188264,-0.0584663080031592,2.37959377614203e-82
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,29453,-0.0692717662294811,0.00360460760120142,-0.0763367971278359,-0.0622067353311264,8.37496522006863e-82
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DKK1,Dickkopf-related protein 1,29694,-0.0820330721975673,0.0042785987992986,-0.0904191258441926,-0.0736470185509421,1.9401072856014e-81
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL12B,Interleukin-12 subunit beta,29786,-0.0753676073919632,0.00393232595200179,-0.0830749662578867,-0.0676602485260397,2.19638672514698e-81
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,24381,-0.115240579307594,0.00601406818010115,-0.127028152940593,-0.103453005674596,3.05553998434009e-81
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",24740,-0.150878860537779,0.00789425209105779,-0.166351594636252,-0.135406126439305,7.61490302239528e-81
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL3,C-C motif chemokine 3,29434,-0.083372619840832,0.00436796506873522,-0.0919338313755531,-0.074811408306111,9.91793888316021e-81
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TJAP1,Tight junction-associated protein 1,29566,-0.113585394133377,0.00597324242420244,-0.125292949284814,-0.101877838981941,3.81067939874557e-80
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,APOA1,Apolipoprotein A-I,24966,0.0378499146184514,0.00199020422884384,0.0339491143299175,0.0417507149069854,4.45515271941846e-80
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,REG4,Regenerating islet-derived protein 4,29497,-0.0682378482177099,0.00359371033483642,-0.0752815204739893,-0.0611941759614306,6.41934548289806e-80
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STAB2,Stabilin-2,24938,-0.0387176376474855,0.0020381630553426,-0.042712437235957,-0.034722838059014,6.71564374146677e-80
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,S100A4,Protein S100-A4,29566,-0.0779305051402144,0.00411123661253966,-0.0859885289007921,-0.0698724813796367,1.18259209111185e-79
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",24845,-0.0548868136507913,0.00289771417483908,-0.0605663334334759,-0.0492072938681067,1.88976225605891e-79
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,29443,-0.0585000010007905,0.00309086436384759,-0.0645580951539318,-0.0524419068476493,2.03730557190579e-79
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,29491,-0.0542703529970636,0.00287448792651662,-0.0599043493330362,-0.0486363566610911,4.88034280401249e-79
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AXIN1,Axin-1,29434,-0.129530330353547,0.00686452713123965,-0.142984803530776,-0.116075857176317,5.95010421142029e-79
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RBKS,Ribokinase,28795,-0.0677886909390908,0.00359338902454862,-0.0748317334272061,-0.0607456484509755,6.65007214176433e-79
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FUS,RNA-binding protein FUS,28765,-0.0538404403880743,0.00285787573699921,-0.0594418768325928,-0.0482390039435559,1.07209298248293e-78
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,24951,0.0361352036088522,0.00191848643500335,0.0323749701962456,0.0398954370214587,1.36433991615911e-78
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SIAE,Sialate O-acetylesterase,29495,-0.0632563966129515,0.00336322533747305,-0.0698483182743986,-0.0566644749515043,1.86313652472692e-78
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,24111,-0.0766024663324799,0.00407250441955831,-0.0845845749948142,-0.0686203576701457,2.29377415360005e-78
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,24867,-0.132915591297185,0.00706795136592312,-0.146768775974394,-0.119062406619976,2.38881788620171e-78
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,29291,-0.0413959704917851,0.00220373720307824,-0.0457152954098185,-0.0370766455737518,2.92441453501826e-78
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,28797,-0.0868745654174919,0.0046275792776888,-0.0959446208017619,-0.0778045100332218,3.66889693796192e-78
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GSN,Gelsolin,24845,0.0259357853079254,0.00138340794973061,0.0232243057264534,0.0286472648893974,6.97322165888332e-78
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FABP5,Fatty acid-binding protein 5,29624,-0.0917596336571014,0.00490659763278511,-0.10137656501736,-0.0821427022968426,1.35460580395023e-77
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IKBKG,NF-kappa-B essential modulator,29434,-0.123621455623378,0.0066137595587224,-0.136584424358474,-0.110658486888282,1.63266430264691e-77
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,24138,-0.0679356966021206,0.00363644911490939,-0.0750631368673429,-0.0608082563368981,2.44500405425495e-77
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AMN,Protein amnionless,28931,-0.0639440044568917,0.00342583836515128,-0.0706586476525883,-0.0572293612611952,2.70641369071106e-77
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDCD5,Programmed cell death protein 5,29694,-0.0779286666083163,0.00417600799132028,-0.0861136422713041,-0.0697436909453285,2.84641471355774e-77
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,24445,-0.152485194423085,0.0081664853634008,-0.168491505735351,-0.13647888311082,2.88488470975174e-77
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MTDH,Protein LYRIC,24229,-0.125791992026486,0.0067421734926166,-0.139006652072014,-0.112577331980957,3.81754381014135e-77
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,24805,-0.068982671116068,0.00370204557848823,-0.076238680449905,-0.0617266617822311,5.75559194003729e-77
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,29434,-0.0757762115774294,0.00406992100434299,-0.0837532567459417,-0.0677991664089171,6.29168853926537e-77
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,29443,-0.0314938185555948,0.00169334456525784,-0.0348127739035001,-0.0281748632076894,9.09700569249304e-77
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SNCG,Gamma-synuclein,29218,-0.0896820638259727,0.00482257558145235,-0.0991343119656193,-0.0802298156863261,9.56274171778105e-77
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,24845,-0.0931767538728417,0.00501448385038499,-0.103005142219596,-0.0833483655260872,1.49966250887933e-76
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,24230,-0.0523184243924237,0.00282283880359071,-0.0578511884474614,-0.0467856603373859,3.69831201446174e-76
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ASAH2,Neutral ceramidase,29218,-0.0706894377619539,0.00382037880680575,-0.0781773802232931,-0.0632014953006146,5.29157095587028e-76
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,28774,-0.105488288487757,0.00570730714382145,-0.116674610489647,-0.0943019664858669,7.78549115891166e-76
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDC27,Cell division cycle protein 27 homolog,28797,-0.0812182594853082,0.00439636665517001,-0.0898351381294415,-0.072601380841175,9.18546091166665e-76
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,29434,-0.0572151611262777,0.00309950778104562,-0.0632901963771271,-0.0511401258754282,1.17245899017075e-75
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,29820,-0.0466300277634823,0.00252929453661314,-0.051587445055244,-0.0416726104717205,1.7779528127399e-75
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CPE,Carboxypeptidase E,29468,0.0514381457099065,0.00279060984480573,0.0459685504140872,0.0569077410057257,1.91375263372118e-75
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LEPR,Leptin receptor,29478,0.0413760179941504,0.00224524844471083,0.0369753310425172,0.0457767049457836,2.07042715577204e-75
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NFX1,Transcriptional repressor NF-X1,24111,-0.0902924552172236,0.00490006899557535,-0.0998965904485513,-0.080688319985896,2.63894887620238e-75
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLA2G15,Phospholipase A2 group XV,29566,-0.0352806656236928,0.00191685102489497,-0.0390376936324869,-0.0315236376148986,3.12630256859487e-75
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,29218,-0.0708410140745173,0.00385961751245182,-0.0784058643989229,-0.0632761637501117,8.02764527239123e-75
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,29820,0.0326087934405162,0.00178061615689175,0.0291187857730084,0.036098801108024,1.66545868981689e-74
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ESM1,Endothelial cell-specific molecule 1,29454,0.0453585701782001,0.00247677362743497,0.0405040938684276,0.0502130464879727,1.67384089489737e-74
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,INSL5,Insulin-like peptide INSL5,24805,-0.129671381550818,0.00708104917838722,-0.143550237940457,-0.115792525161179,2.03934186385488e-74
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GLB1,Beta-galactosidase,29218,-0.0552791170027827,0.00302108567515076,-0.0612004449260782,-0.0493577890794872,2.24716822037304e-74
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,29349,-0.0368782552872966,0.00201884621204658,-0.0408351938629079,-0.0329213167116853,3.90900708981468e-74
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,29478,-0.0561801229007587,0.00307911236183603,-0.0622151831299573,-0.0501450626715601,5.7391959356368e-74
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINH1,Serpin H1,24445,-0.170048130978258,0.00932516498345151,-0.188325454345823,-0.151770807610693,8.35045008904985e-74
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FSTL3,Follistatin-related protein 3,29351,-0.0420594681465713,0.00230802489568017,-0.0465831969421044,-0.0375357393510382,8.64256190062613e-74
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,29434,-0.0809590619308164,0.00444409147657267,-0.0896694812248988,-0.072248642636734,9.59099387993879e-74
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PSME2,Proteasome activator complex subunit 2,29081,-0.0475211543124823,0.00261515396870316,-0.0526468560911405,-0.042395452533824,2.21562648856916e-73
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CNTN1,Contactin-1,29820,0.0357990691189482,0.00197126753059006,0.0319353847589917,0.0396627534789047,2.64099207355252e-73
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GFRA1,GDNF family receptor alpha-1,29674,-0.0370911910404616,0.00204305086957384,-0.0410955707448263,-0.0330868113360969,2.93569893531895e-73
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",29497,0.0442866104836488,0.00243983666698996,0.0395045306163484,0.0490686903509491,3.13472188199366e-73
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPP1R9B,Neurabin-2,29786,-0.12331948909093,0.00680598718681303,-0.136659223977083,-0.109979754204776,5.54557959803905e-73
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",24922,-0.0985587601090528,0.00543850192363352,-0.109218223879375,-0.0878992963387311,6.24381333818018e-73
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RNASE6,Ribonuclease K6,24828,-0.0404059034689965,0.00223049198872223,-0.044777667766892,-0.0360341391711009,7.12919230988963e-73
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CALCA,Calcitonin,29163,-0.0810685861585377,0.00448506563709762,-0.089859314807249,-0.0722778575098263,1.24617563335202e-72
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,29426,-0.0799012528400369,0.00442474253225423,-0.0885737482032552,-0.0712287574768186,1.68838597237939e-72
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEP43,Centrosomal protein 43,28705,-0.0907270242730294,0.00502940504329035,-0.100584658157879,-0.0808693903881804,2.40541531957593e-72
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL18,Interleukin-18,29335,-0.0598920883370536,0.00332159795945678,-0.0664024203375889,-0.0533817563365183,2.73172516576758e-72
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ERBIN,Erbin,29349,-0.133176956819687,0.00739663976525191,-0.14767437075958,-0.118679542879793,4.34955930860075e-72
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TREH,Trehalase,24938,-0.0977081851909555,0.0054246365030951,-0.108340472737022,-0.0870758976448891,4.50203485133313e-72
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,28774,-0.0796016410818357,0.00442542432025973,-0.0882754727495448,-0.0709278094141267,6.07421363798358e-72
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",29378,-0.088159852996694,0.00490292621854255,-0.0977695883850374,-0.0785501176083506,6.66928205098094e-72
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,29536,-0.0675422460031663,0.00375840836337459,-0.0749087263953805,-0.0601757656109521,7.94783563286622e-72
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,28797,-0.0866367500443666,0.00482192807190864,-0.0960877290653076,-0.0771857710234257,8.68709429548884e-72
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,24922,-0.100248633742406,0.00557973208433398,-0.111184908627701,-0.0893123588571118,1.01075572043774e-71
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,29786,-0.127953842640808,0.00714325120502272,-0.141954615002652,-0.113953070278963,2.23249548179628e-71
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLSCR3,Phospholipid scramblase 3,24804,-0.0763022328747841,0.00426112378031635,-0.0846540354842041,-0.0679504302653641,2.94692253982389e-71
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BCR,Breakpoint cluster region protein,29434,-0.11836262176165,0.00661345607462262,-0.13132499566791,-0.105400247855389,2.96048973033069e-71
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,APLP1,Amyloid-like protein 1,29478,0.0665739743890472,0.00372038051185014,0.0592820285858209,0.0738659201922735,3.10974147935957e-71
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",28774,-0.0659087946013817,0.00368385453448199,-0.0731291494889664,-0.058688439713797,3.35820259218154e-71
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SELP,P-selectin,29594,-0.0733103969461607,0.004104071527903,-0.0813543771408506,-0.0652664167514709,5.42486111372359e-71
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SNCA,Alpha-synuclein,24381,-0.150138327275694,0.00840198117001434,-0.166606210368922,-0.133670444182465,5.79768740345058e-71
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,28595,-0.111567654800979,0.00625305098993015,-0.123823634741242,-0.0993116748607154,8.06857672106368e-71
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,29349,0.0254832539752552,0.00142896503637411,0.022682482503962,0.0282840254465485,9.20993243704685e-71
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,24845,-0.11164323153742,0.00625929527554109,-0.12391145027748,-0.0993750127973593,1.01931927705101e-70
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,28916,-0.123387444740731,0.00692506976465812,-0.136960581479461,-0.109814308002001,1.23498114097701e-70
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL1R2,Interleukin-1 receptor type 2,29404,-0.0256375631408405,0.00143904680422364,-0.0284580948771188,-0.0228170314045621,1.25776362075617e-70
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AGXT,Serine--pyruvate aminotransferase,29478,-0.0992334678956492,0.00557325954103502,-0.110157056596078,-0.0883098791952205,1.50763526543531e-70
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,24845,-0.0524866474127555,0.00294648727972036,-0.0582617624810074,-0.0467115323445035,1.53245046963279e-70
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,24240,-0.0960862556176968,0.00539991776607887,-0.106670094439211,-0.0855024167961822,2.20708496568777e-70
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SRPK2,SRSF protein kinase 2,29434,-0.10760513361148,0.0060531911831592,-0.119469388330472,-0.0957408788924884,2.50514146259118e-70
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,24381,-0.037164722502197,0.00209089574230492,-0.0412628781571147,-0.0330665668472794,3.09180450829375e-70
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TRIM5,Tripartite motif-containing protein 5,29434,-0.110035780256406,0.00620122543683929,-0.122190182112611,-0.0978813784002008,4.43448305389784e-70
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FMNL1,Formin-like protein 1,28774,-0.0787956904352575,0.00444126869023304,-0.0875005770681142,-0.0700908038024007,4.72306956683278e-70
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IMMT,MICOS complex subunit MIC60,24793,-0.0571868574493042,0.0032243324540693,-0.06350654905928,-0.0508671658393284,5.98530308875561e-70
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,29443,0.0671970587102866,0.00379154653228856,0.059765627507001,0.0746284899135722,6.4540716176382e-70
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,29478,-0.0359600562621121,0.00202937656293655,-0.0399376343254677,-0.0319824781987565,6.80992626869717e-70
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,24381,-0.0281036140931887,0.00158614046371115,-0.0312124494020626,-0.0249947787843149,8.31767002438476e-70
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,29566,0.0306398608264956,0.00173107530467235,0.0272469532293378,0.0340327684236534,9.63058387815355e-70
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,29369,-0.0249286762082539,0.00140851581148325,-0.0276893671987611,-0.0221679852177467,9.91790065331234e-70
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SORT1,Sortilin,29433,-0.0475692642284025,0.00268968612414065,-0.0528410490317181,-0.0422974794250868,1.23816818885062e-69
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,29820,0.0406671962646077,0.00230129546567376,0.0361566571518872,0.0451777353773283,1.57633342784891e-69
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C19orf12,Protein C19orf12,28774,-0.0823182449784069,0.0046634131098191,-0.0914585346736523,-0.0731779552831614,2.28533275072542e-69
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,29581,-0.0520521115666834,0.00295009337326298,-0.0578342945782789,-0.046269928555088,2.55654160993001e-69
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HEXIM1,Protein HEXIM1,29434,-0.103348552118284,0.00586554099511479,-0.114845012468709,-0.0918520917678587,3.94931866987573e-69
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,24922,-0.0377117240501276,0.00214069475980395,-0.0419074857793434,-0.0335159623209119,4.82342976136671e-69
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,29434,-0.131964760763136,0.00749614373957601,-0.146657202492705,-0.117272319033567,5.15681280724998e-69
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLA2,Src-like-adapter 2,24867,-0.133646335801912,0.0075900838062439,-0.14852290006215,-0.118769771541674,5.61273786304188e-69
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,24845,-0.0804547688893017,0.00457090747755892,-0.0894137475453172,-0.0714957902332862,6.29538488817132e-69
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FCN1,Ficolin-1,24919,-0.0711766070279415,0.00406666275298449,-0.0791472660237911,-0.0632059480320919,3.5141165486078e-68
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PSMG3,Proteasome assembly chaperone 3,29434,-0.0635240413445534,0.00364228506402211,-0.0706629200700367,-0.0563851626190701,8.88816960959038e-68
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLXNA4,Plexin-A4,29434,-0.102764347360334,0.0058945273004968,-0.114317620869308,-0.0912110738513606,1.00081234830422e-67
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TDRKH,Tudor and KH domain-containing protein,28774,-0.107060718955805,0.00614624615023613,-0.119107361410268,-0.0950140765013419,1.32025745912988e-67
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,24845,-0.13616187863098,0.00782202151012408,-0.151493040790823,-0.120830716471137,1.82155383390368e-67
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EHBP1,EH domain-binding protein 1,24922,-0.0942075136096582,0.00541479043115872,-0.104820502854729,-0.0835945243645871,2.13329868965426e-67
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,24793,-0.143728350369221,0.00826352385608642,-0.15992485712715,-0.127531843611292,2.33950162456552e-67
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",29536,-0.10835148345468,0.00623373493930982,-0.120569603935727,-0.0961333629736329,2.46880377079605e-67
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,29443,-0.0642166699176673,0.00369687322134278,-0.0714625414314992,-0.0569707984038355,2.98874537052271e-67
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",29349,-0.075907872255553,0.00437801621152121,-0.0844887840301345,-0.0673269604809714,5.21153667115449e-67
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PENK,Proenkephalin-A,24381,-0.0389101161488953,0.00224325311585793,-0.0433068922559769,-0.0345133400418138,5.40127824855759e-67
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL11,Eotaxin,29786,-0.047170206517394,0.00272157277550045,-0.0525044891573748,-0.0418359238774131,5.75882190541276e-67
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATG16L1,Autophagy-related protein 16-1,24805,-0.106993230345077,0.00618301184699277,-0.119111933565183,-0.0948745271249711,1.07534031318021e-66
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,24793,-0.0904229359448563,0.0052298380488783,-0.100673418520658,-0.0801724533690548,1.38117390857563e-66
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,24845,-0.10993884656965,0.00640566725810851,-0.122493954395543,-0.0973837387437577,1.20778618384388e-65
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,24845,-0.0990285466185059,0.00577327059510938,-0.11034415698492,-0.0877129362520915,1.42717541368113e-65
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KAZN,Kazrin,24805,-0.129413335923252,0.00755238331341523,-0.144216007217546,-0.114610664628959,1.92460068334093e-65
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EPO,Erythropoietin,29434,-0.0940112846044576,0.00549023704558909,-0.104772149213812,-0.083250419995103,2.06357036043518e-65
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FEN1,Flap endonuclease 1,28797,-0.0780380985197574,0.00455759698498249,-0.0869709886103231,-0.0691052084291918,2.12263511606876e-65
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CNST,Consortin,29478,-0.133766767124813,0.00782772299141356,-0.149109104187984,-0.118424430061642,3.70556739885657e-65
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,29594,-0.0520466941542937,0.00304605978980638,-0.0580169713423142,-0.0460764169662732,3.84125774442766e-65
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,29349,-0.169619504361245,0.00992814394665791,-0.189078666496694,-0.150160342225795,3.98750798360913e-65
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,29349,-0.0946744432124938,0.00554548082363195,-0.105543585626812,-0.0838053007981752,4.91750850930449e-65
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MFAP5,Microfibrillar-associated protein 5,29820,-0.0503850168622333,0.0029524115711198,-0.0561717435416281,-0.0445982901828385,5.44186531643546e-65
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCN2,CCN family member 2,29478,-0.070423404499621,0.00412656091185259,-0.0785114638868521,-0.0623353451123899,5.47120598997514e-65
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DAG1,Dystroglycan,29581,-0.0582841720759933,0.00342834701594822,-0.0650037322272518,-0.0515646119247348,1.64591923797689e-64
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EGFR,Epidermal growth factor receptor,29820,0.020161322305419,0.00118608893793911,0.0178365879870584,0.0224860566237797,1.70754615831133e-64
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,A1BG,Alpha-1B-glycoprotein,24966,-0.0210240052119772,0.00123936644685641,-0.0234531634478158,-0.0185948469761386,3.5038487740413e-64
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",24209,-0.0982051698441758,0.00579108728518231,-0.109555700923133,-0.0868546387652185,3.94532004534561e-64
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COCH,Cochlin,24922,-0.0567428632128523,0.00335500618290263,-0.0633186753313414,-0.0501670510943631,8.21396100866858e-64
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BTD,Biotinidase,24966,-0.0253749842797402,0.00150074934854493,-0.0283164530028883,-0.0224335155565922,8.87278251220864e-64
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GOLM2,Protein GOLM2,29694,-0.0275841250270694,0.0016328032714329,-0.0307844194390779,-0.0243838306150609,9.94238314661261e-64
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,29655,-0.0373677142777252,0.00221269676819722,-0.0417045999433917,-0.0330308286120586,1.09804077228897e-63
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OGFR,Opioid growth factor receptor,29349,-0.0399016171530648,0.00236313480789361,-0.0445333613765363,-0.0352698729295933,1.15955522895083e-63
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,29218,-0.0537606618334061,0.0031841734291866,-0.0600016417546118,-0.0475196819122003,1.18931246668401e-63
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FOXO1,Forkhead box protein O1,29434,-0.104268566761809,0.00617675846611648,-0.116375013355397,-0.0921621201682204,1.2426991615763e-63
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BCAN,Brevican core protein,29218,0.0414854466774477,0.00245940107058347,0.0366650205791041,0.0463058727757913,1.54499292490373e-63
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,29218,-0.070077848115224,0.00415882523912746,-0.0782291455839138,-0.0619265506465342,2.07887644146079e-63
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,29694,0.0557515707511883,0.00331267190572141,0.0492587338159744,0.0622444076864023,2.90299170837528e-63
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,24229,-0.0851194597884114,0.00505529757386777,-0.0950278430331922,-0.0752110765436305,2.96093891305531e-63
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL5,C-C motif chemokine 5,29594,-0.122048621369857,0.00725801608445701,-0.136274332895393,-0.107822909844321,3.68258104418517e-63
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,29454,-0.0473901412278492,0.00281836600682131,-0.0529141386012189,-0.0418661438544794,3.75302091713965e-63
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTSS,Cathepsin S,23389,-0.0298390267099034,0.00177357405787214,-0.0333152318633328,-0.026362821556474,3.81658897772604e-63
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,QDPR,Dihydropteridine reductase,29345,-0.0523210317089277,0.00311662230901099,-0.0584296114345892,-0.0462124519832661,5.90810146454607e-63
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,29218,-0.0701184545205532,0.00417866994381666,-0.0783086476104338,-0.0619282614306725,6.7315945153127e-63
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,24229,-0.0638080315842764,0.00380254442337397,-0.0712610186540894,-0.0563550445144635,7.70062239397959e-63
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,29218,-0.114445821967082,0.00683931247065779,-0.127850874409571,-0.101040769524593,1.46193175200806e-62
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TAX1BP1,Tax1-binding protein 1,24845,-0.0764898055714826,0.00457520422365727,-0.0854572058498509,-0.0675224052931144,2.11553290890411e-62
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NIT2,Omega-amidase NIT2,24813,-0.0902767347778814,0.00540127262752239,-0.100863229127825,-0.0796902404279376,2.27658016315912e-62
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PALM2,Paralemmin-2,24845,-0.045878200792068,0.00274570408410643,-0.0512597807969166,-0.0404966207872194,2.46644132468824e-62
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,28931,-0.0837115530247728,0.00501696387118099,-0.0935448022122875,-0.0738783038372581,3.25676324420073e-62
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",29443,-0.0555410475789189,0.00332880569983467,-0.0620655067505949,-0.049016588407243,3.25803195105498e-62
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCN4,CCN family member 4,29725,-0.0483279231361423,0.00289895346583755,-0.0540098719291839,-0.0426459743431008,4.09478532809898e-62
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,24922,-0.0768931696493248,0.00461933547796942,-0.0859470671861448,-0.0678392721125047,6.99773693770687e-62
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CSTB,Cystatin-B,29030,-0.0511608493976632,0.00307528812022355,-0.0571884141133014,-0.0451332846820251,7.386635775364e-62
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TGFBR2,TGF-beta receptor type-2,29566,-0.0392990490642347,0.00237021917630927,-0.0439446786498009,-0.0346534194786685,1.8334357731389e-61
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,29497,-0.0406512069645884,0.00245317704825527,-0.0454594339791687,-0.0358429799500081,2.14750151297364e-61
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NRP2,Neuropilin-2,29443,0.0343419528920069,0.00207359699411748,0.0302777027835366,0.0384062030004771,2.50612327277786e-61
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SBSN,Suprabasin,24905,0.0413822869438439,0.00249997527240961,0.036482335409921,0.0462822384777667,3.23346350197185e-61
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SEL1L,Protein sel-1 homolog 1,24240,-0.0383918832078984,0.00231960769216317,-0.0429383142845382,-0.0338454521312586,3.41385250034546e-61
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,29594,0.052295625227731,0.00316332494200887,0.0460955083413936,0.0584957421140684,4.07107745528187e-61
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACAN,Aggrecan core protein,29192,0.0338342528268258,0.00204893417490222,0.0298183418440174,0.0378501638096341,5.58832960537063e-61
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLIN1,Perilipin-1,28774,-0.0416437529180922,0.00252292008338825,-0.0465886762815332,-0.0366988295546512,6.31919824023204e-61
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EREG,Proepiregulin,29163,-0.0954744840224489,0.00579346311872484,-0.10682967173515,-0.0841192963097482,9.67273250005249e-61
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HLA_E,,29434,-0.0345815788586809,0.00209924115571405,-0.0386960915238805,-0.0304670661934814,1.06661115527621e-60
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD207,C-type lectin domain family 4 member K,28835,-0.0460063502227755,0.00279732655409308,-0.051489110268798,-0.0405235901767531,1.67617852086579e-60
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DLK1,Protein delta homolog 1,29820,-0.0661486701629169,0.0040286395844471,-0.0740448037484333,-0.0582525365774006,2.54964064952562e-60
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,29566,-0.112770389355312,0.00687291420985267,-0.126241301206623,-0.0992994775040003,3.10043305636803e-60
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PROC,Vitamin K-dependent protein C,29545,-0.030662683520907,0.00187029281017103,-0.0343284574288423,-0.0269969096129718,3.85672951979408e-60
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,29581,-0.148267253808392,0.00904806101480724,-0.166001453397415,-0.13053305421937,4.38768476082699e-60
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AP3B1,AP-3 complex subunit beta-1,24805,-0.090914448326396,0.00555667632481816,-0.10180553392304,-0.0800233627297525,7.44436487366738e-60
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TALDO1,Transaldolase,24888,-0.0527172178153756,0.00322496956518149,-0.0590381581631313,-0.0463962774676199,9.43231496241082e-60
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OSM,Oncostatin-M,29293,-0.0838773729284094,0.00514062579248597,-0.0939529994816819,-0.0738017463751369,1.37946615917633e-59
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CNTN5,Contactin-5,29511,0.0437403195846919,0.00268078179713144,0.0384859872623142,0.0489946519070695,1.38034220276801e-59
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDHR5,Cadherin-related family member 5,29478,-0.0458928340033799,0.00281295384590718,-0.0514062235413579,-0.0403794444654018,1.41382891280839e-59
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DDT,D-dopachrome decarboxylase,24938,-0.048297834289293,0.00295935227319693,-0.054098164744759,-0.042497503833827,1.43999438134975e-59
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IFNGR2,Interferon gamma receptor 2,29218,-0.0614187968578782,0.00376684944183853,-0.0688018217638817,-0.0540357719518746,1.66456823628845e-59
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",29349,0.0497957905555716,0.00305725655872295,0.0438035677004746,0.0557880134106686,2.19917679094055e-59
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DNMBP,Dynamin-binding protein,29218,-0.0719079189437734,0.00441598809534426,-0.0805632556106482,-0.0632525822768987,2.36020597400381e-59
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,28774,-0.0789363558852902,0.00485201929999631,-0.0884463137132829,-0.0694263980572974,3.02586121060344e-59
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,24381,-0.0921520173126089,0.00566733440205838,-0.103259992740643,-0.0810440418845745,3.87511788946288e-59
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SEZ6L2,Seizure 6-like protein 2,29349,0.028200704028027,0.00173650888251846,0.0247971466182908,0.0316042614377632,4.76969361901788e-59
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OTUD7B,OTU domain-containing protein 7B,24867,-0.0741696840196992,0.00458562381419971,-0.0831575066955306,-0.0651818613438678,1.52243232287466e-58
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HNMT,Histamine N-methyltransferase,29082,-0.0550212985002963,0.0034036447896454,-0.0616924422880013,-0.0483501547125913,1.59296372306034e-58
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,24111,-0.042802251251581,0.00264885322286392,-0.0479940035683942,-0.0376104989347677,1.99837503941995e-58
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LYN,Tyrosine-protein kinase Lyn,29349,-0.0984453445149158,0.0061004765065847,-0.110402278467822,-0.0864884105620098,2.48829604735424e-58
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL22,C-C motif chemokine 22,29169,-0.0603029587528084,0.00373726046461173,-0.0676279892634474,-0.0529779282421695,2.56688316483151e-58
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NSFL1C,NSFL1 cofactor p47,29694,-0.0756751383576446,0.00469704360637474,-0.0848813438261391,-0.0664689328891501,3.75683024790648e-58
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,24845,-0.105354603310935,0.00655153594303628,-0.118195613759286,-0.0925135928625841,6.81268458604483e-58
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,29478,-0.0737108438450621,0.00458652989163637,-0.0827004424326694,-0.0647212452574548,7.16586502460268e-58
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADD1,Alpha-adducin,24381,-0.0817586236841318,0.00508510369120905,-0.0917254269189015,-0.0717918204493621,7.21990124698685e-58
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BMPER,BMP-binding endothelial regulator protein,24381,-0.0266673015169683,0.00165953060735575,-0.0299199815073855,-0.023414621526551,8.31977030075773e-58
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,METAP2,Methionine aminopeptidase 2,29674,-0.0665726194626733,0.00415137086647378,-0.074709306360962,-0.0584359325643847,1.24602673890152e-57
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,29434,-0.0759922432932846,0.0047441712535746,-0.0852908189502908,-0.0666936676362784,1.67526720710682e-57
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LGALS8,Galectin-8,29694,-0.0701799583176086,0.00438265166559849,-0.0787699555821816,-0.0615899610530355,1.80241293366797e-57
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTSF,Cathepsin F,29566,-0.046448596666761,0.00290148354520378,-0.0521355044153604,-0.0407616889181616,1.94286573886314e-57
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTRB1,Chymotrypsinogen B,29443,-0.0643060607872389,0.00402556967785873,-0.072196177355842,-0.0564159442186358,3.35438145327753e-57
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,24429,-0.0509878347575046,0.00319341845077778,-0.0572469349210291,-0.0447287345939801,4.25492229730948e-57
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,P4HB,Protein disulfide-isomerase,29313,-0.0446891342380658,0.00280016070853018,-0.0501774492267849,-0.0392008192493466,4.26167175900056e-57
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGR,Tyrosine-protein kinase Fgr,28774,-0.065663868506291,0.00411492623033602,-0.0737291239177496,-0.0575986130948324,4.44527074018488e-57
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,24381,-0.0450649860140571,0.0028239327711607,-0.050599894245532,-0.0395300777825821,4.85993438527628e-57
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,24793,-0.0557871404423135,0.00349627410819831,-0.0626398376943822,-0.0489344431902448,4.96694392377686e-57
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",29301,-0.0872635144355196,0.00547210925857666,-0.0979888485823298,-0.0765381802887093,5.20071943208038e-57
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,29786,-0.0640684810730594,0.00401958729866946,-0.0719468721784516,-0.0561900899676673,5.84202608104772e-57
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,APCS,Serum amyloid P-component,24726,-0.0400714832465933,0.00251725028737722,-0.0450052938098526,-0.0351376726833339,8.99920738319728e-57
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,29349,-0.0622170176113371,0.00391403429271112,-0.0698885248250509,-0.0545455103976233,1.16741756915634e-56
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARSA,Arylsulfatase A,29443,-0.051465380501689,0.00323963527188126,-0.0578150656345763,-0.0451156953688018,1.35896579472718e-56
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,29396,-0.0471714020756305,0.00297020092083584,-0.0529929958804688,-0.0413498082707923,1.46303295029397e-56
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STK11,Serine/threonine-protein kinase STK11,28916,-0.0837702171673791,0.00527576241400478,-0.0941107114988284,-0.0734297228359297,1.55369862036759e-56
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,29382,0.0293353282155088,0.00184817431996751,0.0257129065483725,0.0329577498826451,1.68587436102603e-56
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD72,B-cell differentiation antigen CD72,24381,-0.049417032413059,0.00311209875185668,-0.0555167459666981,-0.0433173188594199,1.70164019207733e-56
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NCK2,Cytoplasmic protein NCK2,29581,-0.121127433004946,0.00763417266156268,-0.136090411421609,-0.106164454588283,1.85028873470472e-56
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL7,C-C motif chemokine 7,29434,-0.0673045814161743,0.00424514316350416,-0.0756250620166425,-0.0589841008157062,2.24178431307569e-56
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CA6,Carbonic anhydrase 6,29372,0.0724836647786988,0.00457422773202302,0.0635181784239337,0.0814491511334639,2.56203677866702e-56
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,29566,0.048499535169886,0.00306092224147432,0.0425001275765963,0.0544989427631756,2.60812347405884e-56
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GASK1A,Golgi-associated kinase 1A,24111,-0.0495200105577807,0.00312489920971954,-0.055644813008831,-0.0433952081067304,2.84236967443423e-56
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BRAP,BRCA1-associated protein,24565,-0.126067951231833,0.00795663896435408,-0.141662963601967,-0.110472938861699,2.92308240307889e-56
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,29163,-0.127648624271821,0.00806644638402707,-0.143458859184514,-0.111838389359128,3.60692157199109e-56
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATP6AP2,Renin receptor,28797,-0.0465021026958212,0.00293879298370838,-0.0522621369438896,-0.0407420684477528,3.69526507490192e-56
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MMP1,Interstitial collagenase,28424,-0.104979339057664,0.00663706303857286,-0.117987982613267,-0.0919706955020611,4.11626994786716e-56
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDGFC,Platelet-derived growth factor C,28797,-0.0331128195164913,0.0020942797254507,-0.0372176077783747,-0.0290080312546079,4.49613456923815e-56
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LGALS3BP,Galectin-3-binding protein,24966,-0.0348381443141116,0.00220333664444806,-0.0391566841372298,-0.0305196044909934,4.84977608953416e-56
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CMIP,C-Maf-inducing protein,24793,-0.0950303633486137,0.00601393503729739,-0.106817676021717,-0.0832430506755108,5.68571816448167e-56
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SYTL4,Synaptotagmin-like protein 4,24922,-0.0835460082773439,0.00529108232563696,-0.0939165296355923,-0.0731754869190955,6.81327771483105e-56
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLK14,Kallikrein-14,29725,0.0525944512865656,0.00333805349080526,0.0460518664445873,0.0591370361285439,1.05009809779144e-55
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DOK2,Docking protein 2,29478,-0.138410799719479,0.00879968107613083,-0.155658174628695,-0.121163424810262,1.60912176712854e-55
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,24793,-0.0679352556503396,0.00431937534163383,-0.0764012313199419,-0.0594692799807373,1.80357664038358e-55
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITGBL1,Integrin beta-like protein 1,24938,-0.0424739432179614,0.00270262686075181,-0.0477710918650349,-0.0371767945708878,2.17563308844702e-55
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",29349,-0.0378067954391187,0.00240813026868824,-0.0425267307657476,-0.0330868601124897,2.55565694263074e-55
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GOLGA3,Golgin subfamily A member 3,24867,-0.0887716743130062,0.00566035274479654,-0.0998659656928075,-0.077677382933205,3.63277533606297e-55
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RAB27B,Ras-related protein Rab-27B,24922,-0.0934489030529382,0.00596044497291644,-0.105131375199854,-0.081766430906022,3.91521228212884e-55
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,24240,-0.0351416861194649,0.00224171884341896,-0.0395354550525661,-0.0307479171863638,4.10525872829718e-55
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,25976,0.0354488604895395,0.00226256904822531,0.0310142251550179,0.0398834958240611,4.51033415259992e-55
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ULBP2,UL16-binding protein 2,29218,-0.0432548385030168,0.00276316858896949,-0.048670648937397,-0.0378390280686366,5.21743167416364e-55
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,29581,-0.0437981727485166,0.00280095639781273,-0.0492880472882296,-0.0383082982088037,6.77887453652976e-55
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,24381,-0.0659998632527552,0.00421978555731518,-0.0742706429450929,-0.0577290835604174,7.12487896742623e-55
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",24867,-0.0878273378307864,0.00562188471816688,-0.0988462318783935,-0.0768084437831793,9.33783693097679e-55
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,28738,-0.065785803286502,0.00422300765591648,-0.0740628982920983,-0.0575087082809057,1.7185486274604e-54
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",29581,-0.0310812692146918,0.00199742090589797,-0.0349962141902518,-0.0271663242391318,2.21305938464785e-54
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,29581,-0.0303960848660168,0.0019562718397534,-0.0342303776719335,-0.0265617920601002,3.15701461748866e-54
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TPP1,Tripeptidyl-peptidase 1,29286,-0.0515722324115048,0.00332413040227381,-0.0580875279999614,-0.0450569368230481,4.54582641247102e-54
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SOST,Sclerostin,29433,-0.0433861009193609,0.0027995827939887,-0.0488732831955787,-0.0378989186431431,5.91049347485094e-54
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CREG1,Protein CREG1,29079,-0.0426248084558992,0.00275055816494596,-0.0480159024591933,-0.0372337144526051,5.99742155245842e-54
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,24805,-0.0531110156097683,0.00342913869909941,-0.0598321274600031,-0.0463899037595334,7.46018179648579e-54
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,29683,-0.0704436382038996,0.00455472749575539,-0.0793709040955801,-0.061516372312219,9.53753173106169e-54
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD6,T-cell differentiation antigen CD6,29760,-0.0588866517829064,0.00380750013332345,-0.0663493520442204,-0.0514239515215925,9.53844970040506e-54
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,29478,-0.0358794027082929,0.00231986962897172,-0.0404263471810775,-0.0313324582355084,9.55771575290406e-54
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,29820,-0.0249156347467969,0.00161164939484866,-0.0280744675607003,-0.0217568019328936,1.04922957880713e-53
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,29443,-0.0309662269866749,0.00200427834702126,-0.0348946125468366,-0.0270378414265133,1.22471484584647e-53
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",28931,-0.0667220673568738,0.00432185984083184,-0.0751929126449042,-0.0582512220688434,1.4807555979188e-53
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,29581,-0.0953966784239,0.00619567484043102,-0.107540201111145,-0.0832531557366552,2.74859744527173e-53
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SH2B3,SH2B adapter protein 3,28797,-0.109219941864258,0.00709618955890686,-0.123128473399715,-0.0953114103288002,3.05035486374087e-53
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL21,C-C motif chemokine 21,29581,-0.0451781071531856,0.00294069385829283,-0.0509418671154395,-0.0394143471909317,4.64359294204864e-53
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,24867,-0.0536414221670098,0.00349063445047577,-0.0604830656899423,-0.0467997786440773,4.76312117947334e-53
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AAMDC,Mth938 domain-containing protein,24240,-0.0595238169037902,0.00387798883654616,-0.0671246750234207,-0.0519229587841598,6.37094975523221e-53
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RASSF2,Ras association domain-containing protein 2,28797,-0.0620734257822583,0.00404775449440579,-0.0700070245912936,-0.0541398269732229,7.19479706019954e-53
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",24805,-0.115082864605848,0.00750347012146218,-0.129789666043914,-0.100376063167782,7.53662223961831e-53
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,24240,-0.114333371026767,0.0074600519441327,-0.128955072837267,-0.0997116692162668,9.05723421177456e-53
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HYAL1,Hyaluronidase-1,29265,-0.0255150329022951,0.00166581875646931,-0.0287800376649749,-0.0222500281396153,9.46475252513475e-53
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,23850,-0.0369309922085448,0.00241241649283263,-0.0416593285344968,-0.0322026558825929,1.19103685290766e-52
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,23906,-0.0594527352550957,0.0038840812375207,-0.0670655344806363,-0.0518399360295552,1.2251622516213e-52
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RFC4,Replication factor C subunit 4,24793,-0.0236085735126514,0.00154360059822769,-0.0266340306851777,-0.0205831163401252,1.44717277261076e-52
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD302,CD302 antigen,29349,-0.0338020916238798,0.00221090504302642,-0.0381354655082115,-0.029468717739548,1.44870449898631e-52
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,29394,-0.0332457414682674,0.00217514045711605,-0.0375090167642149,-0.0289824661723199,1.54781493097507e-52
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DGKA,Diacylglycerol kinase alpha,24229,-0.0606945267174349,0.00397414691631618,-0.0684838546734146,-0.0529051987614552,2.05241387135505e-52
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,24445,-0.0589050778613356,0.00386953064695053,-0.0664893579293587,-0.0513207977933126,4.33002472606955e-52
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OGA,Protein O-GlcNAcase,24805,-0.0781034294679456,0.00513093713234515,-0.0881600662473421,-0.0680467926885492,4.34397925370733e-52
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,24396,-0.0718875604249343,0.0047243175506878,-0.0811472228242824,-0.0626278980255863,4.76866109465739e-52
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NIT1,Deaminated glutathione amidase,24240,-0.052284171593959,0.00343722291832502,-0.059021128513876,-0.0455472146740419,5.18747732850871e-52
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,24805,-0.0918766920711918,0.00604080982336747,-0.103716679324992,-0.0800367048173915,5.26694806117129e-52
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTSE,Cathepsin E,24381,-0.0577620661984971,0.00379853076295004,-0.0652071864938791,-0.050316945903115,5.55577726934061e-52
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SHISA5,Protein shisa-5,24938,-0.0279122171351146,0.00183743609711119,-0.0315135918854525,-0.0243108423847766,6.94582804304319e-52
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PCBP2,Poly(rC)-binding protein 2,24867,-0.0797883812412965,0.00525245044641453,-0.090083184116269,-0.0694935783663241,6.97260004734395e-52
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,24805,-0.044145790882822,0.00290802736623462,-0.0498455245206419,-0.0384460572450022,8.12459823204271e-52
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,JAM3,Junctional adhesion molecule C,24381,-0.0559029575991917,0.00368281471935322,-0.063121274449124,-0.0486846407492594,8.35725269796991e-52
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ICAM4,Intercellular adhesion molecule 4,29434,0.0577535578994973,0.00381047796386989,0.0502850210903123,0.0652220947086823,1.0761195972186e-51
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,29349,-0.0490634696060662,0.00323764443431963,-0.0554092526973326,-0.0427176865147997,1.11811859473638e-51
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ASPN,Asporin,24922,0.0302931657641369,0.00200045282371199,0.0263722782296615,0.0342140532986124,1.42728836367985e-51
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",24867,-0.0879037563068877,0.00580988931872678,-0.0992911393715922,-0.0765163732421833,1.74150004550612e-51
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,24195,-0.075674423516101,0.00501367354834124,-0.0855012236708498,-0.0658476233613522,3.0552116841856e-51
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATXN3,Ataxin-3,24845,-0.0675860304441008,0.00448106561010015,-0.0763689190398971,-0.0588031418483045,3.55534598809032e-51
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DAB2,Disabled homolog 2,29725,-0.120269639945388,0.00798956965479164,-0.135929196468779,-0.104610083421996,5.06505913325163e-51
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AZI2,5-azacytidine-induced protein 2,24867,-0.0603471393897124,0.00401359685657882,-0.0682137892286069,-0.0524804895508179,7.17790794160454e-51
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,24111,-0.0679237371860948,0.00451916825041433,-0.0767813069569069,-0.0590661674152827,7.92374407422257e-51
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARSB,Arylsulfatase B,29349,-0.0599024490700558,0.00399101003823005,-0.0677248287449867,-0.0520800693951249,9.84424024497981e-51
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,29386,-0.0702912287101618,0.00468380359445096,-0.0794714837552856,-0.0611109736650379,1.01451779813253e-50
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PQBP1,Polyglutamine-binding protein 1,28797,-0.06058554763399,0.004038018285493,-0.0685000634735563,-0.0526710317944238,1.07873142851222e-50
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DTNB,Dystrobrevin beta,24752,-0.0473434605989073,0.0031552046588636,-0.0535276617302799,-0.0411592594675346,1.14022447296317e-50
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GLO1,Lactoylglutathione lyase,28916,-0.0628925597786545,0.00419372521405292,-0.0711122611981982,-0.0546728583591108,1.19482662500495e-50
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NCAN,Neurocan core protein,29694,0.0405491248177018,0.00270578507439818,0.0352457860718814,0.0458524635635223,1.38685725470223e-50
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,24805,-0.118027962264958,0.00787550275198045,-0.133463947658839,-0.102591976871076,1.493545259412e-50
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BID,BH3-interacting domain death agonist,29434,-0.0721978268499159,0.00482154943990018,-0.0816480637521203,-0.0627475899477116,1.66764783477742e-50
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,24845,-0.0341312630952536,0.00228036124179245,-0.0386007711291668,-0.0296617550613403,1.98810100921728e-50
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,WASHC3,WASH complex subunit 3,24845,-0.0818443514074954,0.00546893071045,-0.0925634555999774,-0.0711252472150135,2.05284547815918e-50
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COLEC12,Collectin-12,29454,-0.0284881187273823,0.00191027420255261,-0.0322322561643854,-0.0247439812903792,4.12930632111716e-50
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,24805,-0.110966579132663,0.00744260820358854,-0.125554091211696,-0.096379067053629,4.70302182051862e-50
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STAMBP,STAM-binding protein,29163,-0.0687268615852569,0.00461934584277647,-0.0777807794370988,-0.059672943733415,6.97836290355111e-50
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GMPR,GMP reductase 1,29786,-0.0533850774790179,0.00359047973826946,-0.060422417766026,-0.0463477371920097,7.96885965750908e-50
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,29736,-0.0350660874019786,0.00236127472733279,-0.0396941858675508,-0.0304379889364063,1.04143752023946e-49
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,29820,-0.0342433543207551,0.00230588717460098,-0.038762893182973,-0.0297238154585372,1.04158049410627e-49
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VNN1,Pantetheinase,24951,-0.0785118495866904,0.00528881800118249,-0.0888779328690081,-0.0681457663043727,1.22379419399818e-49
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,24229,-0.0533655872766773,0.00359580892418916,-0.0604133727680881,-0.0463178017852666,1.31381792116562e-49
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,29443,-0.0392604932526404,0.00264652744321803,-0.0444476870413478,-0.0340732994639331,1.32055410321044e-49
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VEGFC,Vascular endothelial growth factor C,29566,-0.0596418231890186,0.00402399047842579,-0.0675288445267331,-0.051754801851304,1.60140858332824e-49
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RNASE1,Ribonuclease pancreatic,24951,-0.0262438846040736,0.00177366691693397,-0.0297202717612641,-0.022767497446883,2.5026550877344e-49
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,24381,-0.0722922521154496,0.00488898852339803,-0.0818746696213097,-0.0627098346095894,2.91731580240513e-49
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,WIF1,Wnt inhibitory factor 1,29725,0.0364136529187265,0.00246724838699589,0.0315778460802145,0.0412494597572384,4.03168353268191e-49
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SUSD2,Sushi domain-containing protein 2,29443,0.0305343082394562,0.00206888316707015,0.0264792972319987,0.0345893192469137,4.04561971663353e-49
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDH15,Cadherin-15,29639,-0.0617361483067411,0.00418381883164319,-0.0699364332167618,-0.0535358633967205,4.21101977081683e-49
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RAB6A,Ras-related protein Rab-6A,29434,0.049472764339954,0.00335374950291915,0.0428994153142325,0.0560461133656755,4.50872947967106e-49
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COMMD1,COMM domain-containing protein 1,24240,-0.0655411549509641,0.00445233638730467,-0.0742677342700813,-0.0568145756318469,7.72822563076871e-49
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,29536,0.0873052714258932,0.00593480631259567,0.0756730510532056,0.0989374917985807,8.19392535284755e-49
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,28916,-0.0518637078110865,0.00352632061336454,-0.058775296213281,-0.044952119408892,8.65096411489613e-49
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,29608,-0.109238155770679,0.00745007178109743,-0.12384029646163,-0.0946360150797276,1.65405441279878e-48
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,29581,-0.110494788567516,0.00753934357294713,-0.125271901970492,-0.0957176751645393,1.83138232863333e-48
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,29566,-0.0356061413655162,0.00243016885168519,-0.0403692723148192,-0.0308430104162132,1.94321946130846e-48
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,29694,-0.0718203872128752,0.00490388374714732,-0.0814319993572839,-0.0622087750684665,2.12083206444545e-48
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SEC31A,Protein transport protein Sec31A,24240,-0.0816449766367227,0.00558717220802267,-0.0925958341644471,-0.0706941191089982,3.72484582121626e-48
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL4,C-C motif chemokine 4,29498,-0.068959211287874,0.00472364970391766,-0.0782175647075526,-0.0597008578681954,4.21384970463615e-48
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,29434,-0.11856880565381,0.00812298569631697,-0.134489857618592,-0.102647753689029,4.34272723650254e-48
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,28931,-0.0630381855069107,0.00433082645009631,-0.0715266053490995,-0.054549765664722,7.93562652179219e-48
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FCN2,Ficolin-2,29381,-0.043219112119047,0.00297079822729034,-0.0490418766445361,-0.0373963475935579,8.82330301521732e-48
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MYDGF,Myeloid-derived growth factor,24922,-0.105549185213629,0.00725376804894669,-0.119766570589564,-0.0913317998376933,9.04849594758063e-48
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,24229,-0.095218617385752,0.00654908064369794,-0.1080548154474,-0.082382419324104,1.08602536134976e-47
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD274,Programmed cell death 1 ligand 1,29218,-0.0360164167575255,0.00247859838058075,-0.0408744695834638,-0.0311583639315872,1.13173518890857e-47
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,28916,-0.0396191027793696,0.00272900959947612,-0.0449679615943428,-0.0342702439643964,1.37575271349841e-47
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,28916,-0.0981688604145284,0.00676444475979542,-0.111427172143727,-0.0849105486853294,1.48504297801572e-47
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATRN,"Attractin, Isoform 2",24966,-0.0174667630916699,0.00120688825231274,-0.0198322640662029,-0.015101262117137,2.80812375543843e-47
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CES2,Cocaine esterase,29349,-0.0572501181244875,0.00395757392014745,-0.0650069630079765,-0.0494932732409985,2.89251113625787e-47
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MDK,Midkine,29455,-0.0531666894910327,0.00367971814050332,-0.0603789370464192,-0.0459544419356462,3.71193264706646e-47
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FAM13A,Protein FAM13A,24805,-0.0708310817291369,0.00490517254876414,-0.0804452199247147,-0.0612169435335592,4.49606066232214e-47
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,29349,0.0277744731486968,0.00192523316002882,0.0240010161550403,0.0315479301423533,5.10465232794559e-47
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,29566,-0.0264842447956634,0.00183604141613205,-0.0300828859712822,-0.0228856036200446,5.23240771874532e-47
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,24240,-0.0802698203114657,0.00556615259924061,-0.0911794794059773,-0.0693601612169542,5.97048472459448e-47
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,24867,-0.0795343600976017,0.00552210428037849,-0.0903576844871435,-0.0687110357080598,7.66190947624702e-47
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,USO1,General vesicular transport factor p115,29349,-0.0936042201404663,0.00650186843831953,-0.106347882279573,-0.08086055800136,7.86225150429673e-47
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NCAM1,Neural cell adhesion molecule 1,29594,0.0315182901327923,0.00218996193261246,0.0272259647448719,0.0358106155207127,8.34348405488233e-47
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HPSE,Heparanase,24688,-0.0979985238378757,0.00681613023199952,-0.111358139092595,-0.0846389085831567,1.10732417964445e-46
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SH3GLB2,Endophilin-B2,24845,-0.0693188680675802,0.00482550376233921,-0.078776855441765,-0.0598608806933953,1.31772516151914e-46
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SFRP4,Secreted frizzled-related protein 4,24381,-0.0432199973177138,0.00300954595151114,-0.0491187073826756,-0.0373212872527519,1.40950984880265e-46
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BOC,Brother of CDO,28916,0.0243863690288725,0.00169869759422328,0.0210569217441949,0.0277158163135501,1.41500334617236e-46
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,28797,-0.0809282139820455,0.00563884775875505,-0.0919803555892054,-0.0698760723748856,1.5010273144011e-46
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IMPACT,Protein IMPACT,24845,-0.0579751259002138,0.00404358325589899,-0.0659005490817758,-0.0500497027186518,1.95388128466619e-46
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,29443,0.0455121999264255,0.00317579672059333,0.0392876383540626,0.0517367614987885,2.00948763793553e-46
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CFC1,Cryptic protein,28797,-0.048898324757646,0.00341215469136223,-0.0555861479527159,-0.042210501562576,2.03516730625196e-46
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD36,Platelet glycoprotein 4,24229,-0.04716501152825,0.00329136039542796,-0.0536160779032888,-0.0407139451532112,2.20211391640917e-46
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ESYT2,Extended synaptotagmin-2,24845,-0.085464958753091,0.00597317013004352,-0.0971723722079763,-0.0737575452982057,2.97362057972853e-46
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,24938,0.0274730357812407,0.00192149347950307,0.0237069085614147,0.0312391630010667,3.44289109383976e-46
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STAT2,Signal transducer and activator of transcription 2,24229,-0.0805353130748602,0.00563293056557246,-0.0915758569833822,-0.0694947691663382,3.51124659918558e-46
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,29536,-0.0732808239894129,0.00513163037546374,-0.0833388195253219,-0.063222828453504,4.14125724449201e-46
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,24867,-0.0873163759421031,0.00611399149809085,-0.0992997992783612,-0.075332952605845,4.35070785951559e-46
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,28797,-0.0591804758910013,0.00414709495193184,-0.0673087819967877,-0.0510521697852149,4.81020161858117e-46
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,24867,-0.0682543662726811,0.00478191355447838,-0.0776269168394587,-0.0588818157059034,4.87256896467712e-46
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANGPT1,Angiopoietin-1,29322,-0.0869027624162967,0.00609905835155046,-0.0988569167853356,-0.0749486080472578,6.51673694183189e-46
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',24845,-0.043149574145273,0.00302862768670047,-0.049085684411206,-0.0372134638793401,7.07427343365491e-46
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CFHR4,Complement factor H-related protein 4,24892,0.0757643741552343,0.00532378883263034,0.0653297480432789,0.0861990002671898,8.86430034336684e-46
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TCTN3,Tectonic-3,24922,-0.0307930991495918,0.00216417966801626,-0.0350348912989037,-0.02655130700028,9.21319241245382e-46
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,24938,0.0340985321960608,0.00239844894577234,0.029397572262347,0.0387994921297746,1.08605960185054e-45
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,29786,-0.0692104151718297,0.00487508715484854,-0.0787655859953328,-0.0596552443483266,1.35207923963169e-45
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NCF2,Neutrophil cytosol factor 2,29395,-0.0853518328073049,0.00601205190394118,-0.0971354545390296,-0.0735682110755802,1.35756923348371e-45
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL18BP,Interleukin-18-binding protein,29594,-0.0317649477229071,0.00223810390726758,-0.0361516313811516,-0.0273782640646627,1.43328774576021e-45
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD83,CD83 antigen,29434,-0.0349036946033035,0.00246308065204065,-0.0397313326813032,-0.0300760565253038,1.96187079071402e-45
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VSNL1,Visinin-like protein 1,24845,-0.03927377326479,0.00277251672363227,-0.0447079060431093,-0.0338396404864708,2.25451660434169e-45
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPARCL1,SPARC-like protein 1,29489,0.0281777891166697,0.00199163087586656,0.0242741925999712,0.0320813856333681,2.70031998870857e-45
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,28797,-0.0456262097523039,0.003228607321995,-0.0519542801034141,-0.0392981394011937,3.42387762948561e-45
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,28797,-0.064751562422039,0.00458472519274803,-0.0737376237998252,-0.0557655010442529,3.86146700625821e-45
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,24867,-0.0540867034327059,0.00382888912726564,-0.0615913261221465,-0.0465820807432652,3.93024277328754e-45
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,28916,-0.042269292752204,0.00299417311584217,-0.0481378720592546,-0.0364007134451533,4.20453970310879e-45
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEMIP2,Cell surface hyaluronidase,24229,-0.0339794264850613,0.00240738745820726,-0.0386979059031475,-0.029260947066975,4.65686330591935e-45
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,24229,-0.099613817578428,0.00707010966541335,-0.113471232522638,-0.0857564026342178,6.63807140996443e-45
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLC16A1,Monocarboxylate transporter 1,28774,-0.0590303022091512,0.00419172294264851,-0.0672460791767423,-0.0508145252415601,6.85338402342574e-45
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATG4A,Cysteine protease ATG4A,28797,-0.0600783286370476,0.00426727596895612,-0.0684421895362016,-0.0517144677378936,7.22118286816278e-45
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL14,C-C motif chemokine 14,29435,-0.0403476026727297,0.00286953472306592,-0.0459718907299389,-0.0347233146155205,9.25183671552077e-45
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CASP10,Caspase-10,28774,-0.0727614448823942,0.00518216913297176,-0.0829184963830188,-0.0626043933817695,1.23321172600797e-44
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",24240,-0.0992222245837002,0.00706662230750016,-0.113072804306401,-0.0853716448609999,1.30935287457832e-44
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,24195,-0.0737590736307748,0.00525754321494081,-0.0840638583320588,-0.0634542889294908,1.54509222718199e-44
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITGA5,Integrin alpha-5,29443,-0.0254010088255552,0.00181168368947114,-0.0289519088569186,-0.0218501087941917,1.62096999541963e-44
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,24922,-0.0605220837951518,0.00432308663066635,-0.0689953335912579,-0.0520488339990458,2.30476886629712e-44
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNXB,Tenascin-X,29443,0.0261780293687314,0.001870910718132,0.0225110443611926,0.0298450143762701,2.41577246726268e-44
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANXA2,Annexin A2,23907,-0.0722509259191417,0.00516440957424311,-0.0823731686846582,-0.0621286831536252,2.67770952986676e-44
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AP2B1,AP-2 complex subunit beta,24195,-0.0495995516094453,0.00354638162569839,-0.0565504595958142,-0.0426486436230765,2.82579565853195e-44
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TADA3,Transcriptional adapter 3,24793,-0.0402012761777314,0.0028748169189444,-0.0458359173388625,-0.0345666350166004,2.87880394477877e-44
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,28916,0.0217343955264825,0.00155498829778493,0.018686618462824,0.024782172590141,2.9930979147843e-44
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,24381,-0.0728591850191713,0.00521182383916882,-0.0830743597439422,-0.0626440102944004,3.07872353718898e-44
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,24867,-0.061640176645015,0.00440981640768997,-0.0702834168040873,-0.0529969364859426,3.12625311917237e-44
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,28916,-0.0578327309605179,0.00414739455426258,-0.0659616242868726,-0.0497038376341633,4.7315224546121e-44
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,29694,-0.0659722410951121,0.0047338730941227,-0.0752506323595926,-0.0566938498306316,5.25420998349766e-44
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DNM3,Dynamin-3,24867,-0.0556083673244896,0.00398961824094264,-0.0634280190767372,-0.047788715572242,5.43117617868178e-44
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,APP,Amyloid-beta precursor protein,29395,-0.0671047803008275,0.0048172304488302,-0.0765465519805347,-0.0576630086211203,5.73417061214481e-44
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,WDR46,WD repeat-containing protein 46,24793,-0.0364563947908501,0.0026173156788181,-0.0415863335213336,-0.0313264560603666,6.1910761591694e-44
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,29820,-0.0723448332816413,0.00519776437859884,-0.082532451463695,-0.0621572150995876,6.71697514017335e-44
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINA9,Serpin A9,29227,-0.072954754097603,0.00524297156217519,-0.0832309783594663,-0.0626785298357396,7.11475514952546e-44
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DDHD2,Phospholipase DDHD2,24867,-0.0669738750975204,0.00481593247980728,-0.0764131027579426,-0.0575346474370981,8.41537313512311e-44
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RPL14,60S ribosomal protein L14,24240,-0.0406999650825339,0.00292836668992745,-0.0464395637947918,-0.0349603663702761,9.52204839662338e-44
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,23721,-0.0501300352110991,0.00360683628162443,-0.057199434323083,-0.0430606360991152,9.58985196501454e-44
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD27,CD27 antigen,29566,-0.0418643909614409,0.00301414394417968,-0.047772113092033,-0.0359566688308487,1.00936686052159e-43
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NBN,Nibrin,28931,-0.0527770524415478,0.00380036889802853,-0.0602257754816837,-0.0453283294014119,1.04444031487986e-43
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CXCL5,C-X-C motif chemokine 5,29384,-0.114328310736877,0.00823344372784803,-0.130465860443459,-0.0981907610302952,1.0612025427809e-43
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MITD1,MIT domain-containing protein 1,29218,-0.0969538996266835,0.00698548246021068,-0.110645445248696,-0.0832623540046705,1.16338192923713e-43
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GMPR2,GMP reductase 2,24381,-0.0678286189881375,0.00488722436007619,-0.0774075787338868,-0.0582496592423881,1.24916351803151e-43
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLRD1,Natural killer cells antigen CD94,29786,-0.0465018280163011,0.00335958269451859,-0.0530866100975575,-0.0399170459350446,1.95113754671107e-43
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CXCL9,C-X-C motif chemokine 9,29581,-0.0666305081488298,0.00481717165127938,-0.0760721645853373,-0.0571888517123222,2.23503556504205e-43
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,29434,-0.0724553541913105,0.00523880095289447,-0.0827234040589837,-0.0621873043236374,2.28066281121793e-43
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SNX15,Sorting nexin-15,24381,-0.0544148499125374,0.00393326872737067,-0.0621240566181839,-0.0467056432068909,2.30244454975158e-43
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NADK,NAD kinase,29478,-0.0541388192609459,0.00391704738262564,-0.0618162321308921,-0.0464614063909996,2.58798002567153e-43
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TFPI,Tissue factor pathway inhibitor,29435,0.0315873408637673,0.00229256319897459,0.0270939169937771,0.0360807647337575,4.69328653490489e-43
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FKBPL,FK506-binding protein-like,24805,-0.059187347557086,0.00429773607487154,-0.0676109102638342,-0.0507637848503378,5.42869761447804e-43
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,29218,-0.0707949836536586,0.00515140734025485,-0.0808917420405581,-0.0606982252667591,7.64469259378337e-43
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,24195,-0.0799711947372848,0.00583271990507114,-0.0914033257512242,-0.0685390637233453,1.26340409421898e-42
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,29434,-0.10017140087268,0.00731315826362727,-0.11450519106939,-0.0858376106759708,1.42146120004234e-42
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EPPK1,Epiplakin,24240,-0.0734665472048794,0.00536215563516835,-0.0839763722498094,-0.0629567221599495,1.44463737440478e-42
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OPHN1,Oligophrenin-1,24845,-0.106857219024054,0.00780363025330008,-0.122152334320522,-0.0915621037275857,1.59001544409401e-42
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPBP,Platelet basic protein,24816,-0.0839866418517535,0.00614370536738736,-0.0960283043718328,-0.0719449793316743,2.17484925053678e-42
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDCP1,CUB domain-containing protein 1,29218,-0.0514854104604464,0.00376852258803272,-0.0588717147329906,-0.0440991061879023,2.31272198688488e-42
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL25,C-C motif chemokine 25,29786,-0.0486459149693591,0.00356091393059929,-0.0556253062733337,-0.0416665236653845,2.32753906554104e-42
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRKL,Crk-like protein,29491,-0.104827492045868,0.0076781866674281,-0.119876737914027,-0.0897782461777085,2.61923133986009e-42
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CETN2,Centrin-2,28774,-0.066765468737866,0.00489548144788947,-0.0763606123757293,-0.0571703251000026,3.21314099795221e-42
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINE2,Glia-derived nexin,24922,-0.0638165987408996,0.00467978283486822,-0.0729889730972413,-0.0546442243845579,3.43688417979679e-42
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TCOF1,Treacle protein,24922,-0.0309323253707731,0.00227460113070941,-0.0353905435869635,-0.0264741071545826,5.73258659574774e-42
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,29760,-0.0375067434174687,0.00275899066452075,-0.0429143651199294,-0.032099121715008,5.77345630978386e-42
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNF,Tumor necrosis factor,28868,-0.0376583149945611,0.0027710953777612,-0.0430896619349731,-0.0322269680541492,6.20767833048067e-42
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,29433,-0.0731839598257085,0.00539900692386138,-0.0837660133964768,-0.0626019062549402,9.86892267733205e-42
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CBS,Cystathionine beta-synthase,24240,-0.0504823241169481,0.00372637034933904,-0.0577860100016526,-0.0431786382322436,1.1657113406912e-41
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,24922,-0.105580622271517,0.00779508061581582,-0.120858980278516,-0.0903022642645183,1.19917992333064e-41
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,29443,-0.0414585524819441,0.00306433631143214,-0.0474646516523511,-0.0354524533115371,1.39724890714124e-41
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,29434,-0.0368066631416735,0.00272245823533376,-0.0421426812829277,-0.0314706450004193,1.59376189080724e-41
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,29434,-0.0752180567211911,0.00556367758384739,-0.086122864785532,-0.0643132486568502,1.59716080404487e-41
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TRAF2,TNF receptor-associated factor 2,29434,-0.06886396217115,0.00509490873015801,-0.0788499832822597,-0.0588779410600403,1.66893463792501e-41
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,UROD,Uroporphyrinogen decarboxylase,24381,-0.0680466364447699,0.00503422322876157,-0.0779137139731425,-0.0581795589163972,1.75645170419125e-41
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,29218,-0.0764489212180291,0.00567137602212866,-0.0875648182214012,-0.0653330242146569,2.73425178106044e-41
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLF4,Krueppel-like factor 4,24101,-0.0390246593979818,0.0028946825564181,-0.0446982372085613,-0.0333510815874023,2.83753089789418e-41
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TF,Serotransferrin,24966,-0.0211708119537779,0.00157068468666699,-0.0242493539396452,-0.0180922699679106,2.91097196647837e-41
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LARP1,La-related protein 1,24793,-0.0615231248712567,0.00456478303613102,-0.0704700996220735,-0.0525761501204399,2.95480415117215e-41
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,29566,-0.0262873636246153,0.00195314829764261,-0.0301155342879949,-0.0224591929612358,3.60629040220659e-41
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CXCL11,C-X-C motif chemokine 11,29694,-0.0767345399135104,0.00570254992226027,-0.0879115377611405,-0.0655575420658802,3.73965324201853e-41
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,24845,-0.0310832355528485,0.00231046887732284,-0.0356117545524012,-0.0265547165532957,4.10765812472749e-41
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,29566,-0.024139027037393,0.00179498991539377,-0.0276572072715648,-0.0206208468032212,4.17929602529011e-41
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,24805,-0.0745399417345824,0.00554997241855318,-0.0854178876749467,-0.0636619957942182,5.56038996717506e-41
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,28916,-0.0735233019084293,0.00548242991543682,-0.0842688645426854,-0.0627777392741731,6.93615797114148e-41
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,24170,-0.082629913306382,0.00616942549350528,-0.0947219872736523,-0.0705378393391116,9.23236955713018e-41
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,24229,-0.11983306278127,0.00894785537226784,-0.137370859310915,-0.102295266251625,9.35843386429595e-41
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KITLG,Kit ligand,29478,0.0361943658545319,0.00270359216243623,0.0308953252161568,0.0414934064929069,9.41345827361652e-41
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,24805,-0.0628415559905087,0.00469730305351783,-0.0720482699754036,-0.0536348420056137,1.12204093867847e-40
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,S100A14,Protein S100-A14,24867,-0.0514534346189648,0.00384774380583355,-0.0589950124783986,-0.0439118567595311,1.21231443608876e-40
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PAMR1,Inactive serine protease PAMR1,29443,-0.0266826293834076,0.00199661093893537,-0.0305959868237209,-0.0227692719430942,1.29006909998256e-40
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL2,C-C motif chemokine 2,29169,-0.05075186347027,0.00379899018407554,-0.058197884231058,-0.0433058427094819,1.37634935338974e-40
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",24805,-0.142036549636868,0.0106572489197878,-0.162924757519652,-0.121148341754084,2.20059731278349e-40
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PF4,Platelet factor 4,24822,-0.094112313368539,0.00706214244487444,-0.107954112560493,-0.0802705141765851,2.24094163140982e-40
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,24867,-0.0654116984011282,0.00490883788345052,-0.0750330206526913,-0.0557903761495652,2.27024941085739e-40
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SYAP1,Synapse-associated protein 1,24381,-0.0557249202412448,0.00418373909121451,-0.0639250488600252,-0.0475247916224643,2.4707110763846e-40
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RILP,Rab-interacting lysosomal protein,29632,-0.0572940832612136,0.00430440188069342,-0.0657307109473727,-0.0488574555750545,2.62373989815169e-40
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,28797,-0.0382319948601251,0.00287283672536094,-0.0438627548418326,-0.0326012348784177,2.7327518696258e-40
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DKK4,Dickkopf-related protein 4,29169,-0.0442094420834152,0.00332279448625013,-0.0507221192764655,-0.0376967648903649,2.84166732618345e-40
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,28931,-0.0364683179442862,0.00274149695832044,-0.0418416519825942,-0.0310949839059781,2.94661205550146e-40
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL13,C-C motif chemokine 13,29732,-0.0664560151868183,0.00499654568402931,-0.0762492447275158,-0.0566627856461209,3.00178817084041e-40
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,24922,-0.024427134103182,0.00183893799155049,-0.028031452566621,-0.0208228156397431,3.96395793451546e-40
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,THBS2,Thrombospondin-2,29443,-0.0360036805331729,0.00271184143918697,-0.0413188897539794,-0.0306884713123665,4.13531430526851e-40
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TMSB10,Thymosin beta-10,29443,-0.0728389169908579,0.00549400990868179,-0.0836071764118742,-0.0620706575698416,5.29161475086659e-40
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HSPB6,Heat shock protein beta-6,29725,-0.03685370395736,0.00278455008168432,-0.0423114221174613,-0.0313959857972587,7.14013195937691e-40
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,27939,-0.0382921466849102,0.00289841954855893,-0.0439730490000857,-0.0326112443697347,9.92643349320221e-40
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,29478,-0.0763561306414511,0.0057842747704291,-0.0876933091914921,-0.06501895209141,1.12775510333164e-39
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,24381,-0.051394055179876,0.00389870209722729,-0.0590355112904415,-0.0437525990693105,1.51467071998001e-39
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,29443,-0.0546430228789948,0.00415019484762327,-0.0627774047803364,-0.0465086409776532,1.77211208512471e-39
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,29581,-0.025245755636757,0.0019179816875675,-0.0290049997443894,-0.0214865115291247,1.85851365678089e-39
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,B2M,Beta-2-microglobulin,24966,-0.0297686441722162,0.00226127094547356,-0.0342007352253443,-0.025336553119088,1.90016262525007e-39
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,F12,Coagulation factor XII,24966,-0.0397272854292208,0.00302041210839822,-0.0456472931616813,-0.0338072776967603,2.21390735790026e-39
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TBCC,Tubulin-specific chaperone C,29218,-0.0768526445187962,0.00584902149754799,-0.0883167266539903,-0.0653885623836022,2.53159516493846e-39
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ZNRD2,Protein ZNRD2,24805,-0.0656400136263105,0.00499529718098423,-0.0754307961010396,-0.0558492311515814,2.6164091889172e-39
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",24101,-0.069528352802023,0.00530228897028224,-0.0799208391837762,-0.0591358664202699,3.78356349295096e-39
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",29443,-0.036340368719637,0.00277232130103087,-0.0417741184696575,-0.0309066189696165,3.80099411600807e-39
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,24793,-0.0361573251669113,0.00275808260648378,-0.0415631670756195,-0.0307514832582031,3.91720409130809e-39
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPARC,SPARC,29566,-0.0666850359341662,0.00509153888418685,-0.0766644521471724,-0.0567056197211599,4.38884866602827e-39
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,29725,-0.0305859232393866,0.00233563867227599,-0.0351637750370476,-0.0260080714417257,4.49408750547935e-39
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,29786,0.0246662349857783,0.00188407196728384,0.020973453929902,0.0283590160416546,4.69218840278405e-39
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,24951,-0.0256010112467566,0.00195690827422203,-0.0294365514642317,-0.0217654710292814,5.58141873669989e-39
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,24922,-0.0860093165087315,0.00658201417631265,-0.0989100642943043,-0.0731085687231587,6.79629246990685e-39
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATXN2L,Ataxin-2-like protein,24867,-0.045724602149378,0.0035002618112033,-0.0525851152993364,-0.0388640889994195,7.177321002714e-39
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINB8,Serpin B8,29786,-0.0532770328547949,0.00407983503550359,-0.0612735095243819,-0.0452805561852078,7.25774855908146e-39
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",24329,-0.081378944551282,0.00623768845677898,-0.0936048139265688,-0.0691530751759952,9.00086462229808e-39
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD69,Early activation antigen CD69,29344,-0.0828527193982418,0.00635476730282475,-0.0953080633117784,-0.0703973754847053,9.54853761044185e-39
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ING1,Inhibitor of growth protein 1,28719,-0.0434669554964454,0.00333495627339101,-0.0500034697922918,-0.036930441200599,1.01327987514271e-38
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,29444,-0.0535231282944134,0.00410940187593733,-0.0615775559712506,-0.0454687006175763,1.13504618421381e-38
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,24229,-0.0422263275485297,0.00324594239572068,-0.0485883746441422,-0.0358642804529171,1.46561225638831e-38
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCARF1,Scavenger receptor class F member 1,29820,-0.0398848542349578,0.0030700708513212,-0.0459021931035474,-0.0338675153663683,1.7393266710862e-38
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CASC3,Protein CASC3,24195,-0.0396391108480348,0.00305307692415018,-0.0456231416193692,-0.0336550800767005,2.04490937078622e-38
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HS1BP3,HCLS1-binding protein 3,24240,-0.0851928085673558,0.00656236374602156,-0.098055041509558,-0.0723305756251535,2.07856656491412e-38
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,29434,-0.0980803717161353,0.00755808784857852,-0.112894223899349,-0.0832665195329214,2.10995922848164e-38
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITGB1,Integrin beta-1,29474,0.0204048804213179,0.00157515681541668,0.0173175730631012,0.0234921877795346,2.83072775481936e-38
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,24209,-0.0535952969462949,0.00413754248023669,-0.0617048802075588,-0.045485713685031,3.01248900740431e-38
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RRAS,Ras-related protein R-Ras,24195,-0.123234614441594,0.00951413793968318,-0.141882324803373,-0.104586904079815,3.03745602889734e-38
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,29581,-0.121837097137665,0.00941090798934132,-0.140282476796774,-0.103391717478556,3.1297601347047e-38
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TSC22D1,TSC22 domain family protein 1,24867,-0.062683776571341,0.004847245765567,-0.0721843782718523,-0.0531831748708297,3.95153201480613e-38
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,24867,-0.107138630788483,0.00829119526338649,-0.123389373504721,-0.0908878880722458,4.48807753187113e-38
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,29163,-0.0220568076646376,0.00170900790089213,-0.0254064631503861,-0.018707152178889,5.27852103158688e-38
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,29409,-0.0431895630449452,0.00334800197123066,-0.0497516469085573,-0.0366274791813331,5.6998518140787e-38
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BGN,Biglycan,28750,0.111919520624348,0.00869243320882788,0.0948823515350453,0.128956689713651,7.86817098231404e-38
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TFF1,Trefoil factor 1,29319,-0.0736317816990315,0.00572306542651263,-0.0848489899349962,-0.0624145734630667,8.87524310827828e-38
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,YJU2,Splicing factor YJU2,24793,-0.0303641512895815,0.00235972881505983,-0.0349892197670987,-0.0257390828120642,9.04609732312572e-38
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,REG1B,Lithostathine-1-beta,29820,-0.0525704599316883,0.0040868359792244,-0.0605806584509681,-0.0445602614124084,9.12110732485366e-38
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,28787,-0.073165049539801,0.00568967005395387,-0.0843168028455506,-0.0620132962340515,9.69333195701853e-38
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FOXJ3,Forkhead box protein J3,24229,-0.0414334927853199,0.00322497626270137,-0.0477544462602146,-0.0351125393104252,1.17653146667191e-37
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD226,CD226 antigen,24229,-0.0393115419067674,0.00306417446577099,-0.0453173238596785,-0.0333057599538562,1.48749911904706e-37
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STX8,Syntaxin-8,29434,-0.0449159050077483,0.00350207135845789,-0.0517799648703258,-0.0380518451451708,1.48770903725092e-37
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,24793,-0.0328368916881455,0.00256046685585705,-0.0378554067256253,-0.0278183766506657,1.57253848424527e-37
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ST13,Hsc70-interacting protein,24381,-0.0520599871094888,0.00406344734207559,-0.0600243438999569,-0.0440956303190206,1.86114559219014e-37
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GPI,Glucose-6-phosphate isomerase,24951,-0.0440205353888133,0.00343960917028952,-0.0507621693625807,-0.0372789014150458,2.20259677716285e-37
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,24867,-0.0869405117730797,0.00679398781899705,-0.100256727898314,-0.0736242956478454,2.2455245989087e-37
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RGCC,Regulator of cell cycle RGCC,24867,-0.0703325222429928,0.00549751687795031,-0.0811076553237754,-0.0595573891622102,2.33860997565304e-37
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NUB1,NEDD8 ultimate buster 1,29434,-0.0775451146910971,0.00606407700252632,-0.0894307056160487,-0.0656595237661455,2.41787091839414e-37
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,28931,-0.0506104983756123,0.00396254126306544,-0.0583770792512206,-0.0428439175000041,2.95527799445575e-37
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLAU,Urokinase-type plasminogen activator,29443,0.0269363853487057,0.00210909844459207,0.0228025523973053,0.0310702183001062,2.97047559312655e-37
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NGRN,Neugrin,24845,-0.0205747616725361,0.00161100504670625,-0.0237323315640804,-0.0174171917809919,3.10326665571648e-37
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,29694,-0.045574238293633,0.00358136417665538,-0.0525937120798776,-0.0385547645073885,5.34016665390332e-37
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LPP,Lipoma-preferred partner,24111,-0.0615207036005279,0.00483806415517282,-0.0710033093446666,-0.0520380978563891,6.33617112572906e-37
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MINK1,Misshapen-like kinase 1,24845,-0.0854159392008616,0.0067418927528757,-0.098630048996498,-0.0722018294052252,1.13452759544973e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RWDD1,RWD domain-containing protein 1,29694,-0.0581669607962286,0.00459441883946244,-0.067172021721575,-0.0491618998708822,1.21981958954586e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,24229,-0.0532385639659993,0.00420518403790487,-0.0614807246802929,-0.0449964032517058,1.28325973372351e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,28916,-0.0318241531955248,0.00251483989799762,-0.0367532393956001,-0.0268950669954495,1.3206388103213e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FOXO3,Forkhead box protein O3,28797,-0.0884674800564301,0.0069932708798443,-0.102174290980925,-0.0747606691319353,1.39355367255436e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,24867,-0.098372690038645,0.00778565607728501,-0.113632575950124,-0.0831128041271664,1.75064573113567e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,24922,-0.0436377016986791,0.00345806630514372,-0.0504155116567608,-0.0368598917405974,2.14166650228495e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DBI,Acyl-CoA-binding protein,29329,-0.0715659462964601,0.00567811037229985,-0.0826950426261678,-0.0604368499667524,2.49906567959136e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,28797,-0.0305879557980329,0.00242925530807609,-0.035349296201862,-0.0258266153942037,2.93127514358832e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,29408,-0.0323324263044905,0.00256797201477034,-0.0373656514534403,-0.0272992011555406,2.9493177787868e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,24845,0.033710393632168,0.00267894425705252,0.0284596628883451,0.038961124375991,3.35833071583283e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATOX1,Copper transport protein ATOX1,29566,-0.0650033336788124,0.00516992072571283,-0.0751363783012095,-0.0548702890564152,3.66182937731826e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,24805,-0.0828611422970268,0.00659050424937637,-0.0957785306258045,-0.0699437539682491,3.84144266524811e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,29426,-0.0887299789132994,0.00705915037128422,-0.102565913641016,-0.0748940441855823,3.84859321747736e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DBNL,Drebrin-like protein,29581,-0.0841416121758568,0.00669850948486198,-0.0972706907661863,-0.0710125335855273,4.26483079658361e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OPLAH,5-oxoprolinase,24240,-0.0626929518438098,0.00499294921423628,-0.0724791323037129,-0.0529067713839067,4.75476438915409e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,APOA2,Apolipoprotein A-II,24951,0.0441836612275462,0.00352054693385537,0.0372833892371897,0.0510839332179027,5.09368526673129e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,29604,-0.0297856839250161,0.00237468305584289,-0.0344400627144681,-0.025131305135564,5.361653584395e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,24240,-0.0541282484891641,0.00431433362341131,-0.0625843423910503,-0.0456721545872779,5.40083537951907e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,REEP4,Receptor expression-enhancing protein 4,24867,-0.0566786432814761,0.00452177628440764,-0.065541324798915,-0.0478159617640371,6.20197043884246e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL17,C-C motif chemokine 17,29414,-0.0825326621989898,0.00658842362403878,-0.0954459725021058,-0.0696193518958738,6.57024686294466e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COL1A1,Collagen alpha-1(I) chain,29820,0.0227137042278701,0.001813556711488,0.0191591330733536,0.0262682753823866,6.76207811418725e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,24793,-0.0785073334348849,0.0062804761060595,-0.0908170666027615,-0.0661976002670082,9.54399952566195e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RAB33A,Ras-related protein Rab-33A,24111,-0.0604240577689881,0.00483489947301104,-0.0699004607360897,-0.0509476548018864,9.9458999138511e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,24951,-0.0574283544650667,0.00459819432754757,-0.06644081534706,-0.0484158935830735,1.09184610931475e-35
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COL3A1,Collagen alpha-1(III) chain,24938,-0.0211560904280688,0.00169402986077494,-0.0244763889551877,-0.0178357919009499,1.10171539500793e-35
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",24240,-0.0338206430127134,0.00270952390083592,-0.0391313098583518,-0.028509976167075,1.2030422393629e-35
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IFNLR1,Interferon lambda receptor 1,29434,-0.0334560354849204,0.00268497005142901,-0.0387185767857213,-0.0281934941841196,1.50782412673877e-35
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,29694,-0.0421245788491158,0.00338733057853507,-0.0487637467830445,-0.035485410915187,2.04420314223721e-35
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",24852,-0.0362371304992026,0.00291666723030312,-0.0419537982705967,-0.0305204627278085,2.46146293954319e-35
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MMP7,Matrilysin,28870,-0.0449803723021742,0.00362224549376128,-0.0520799734699463,-0.0378807711344021,2.57551144904492e-35
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,28797,-0.0587680413812954,0.00473985174258256,-0.0680581507967572,-0.0494779319658336,3.26706567919106e-35
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,24240,-0.0392913722521148,0.00317097346896015,-0.0455064802512767,-0.0330762642529529,3.73924732516821e-35
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,28797,-0.0822923431893041,0.00665133169279773,-0.0953289533071877,-0.0692557330714206,4.53218414893835e-35
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,24229,-0.0794140310523996,0.00641787674941943,-0.0919930694812616,-0.0668349926235375,4.61998306137538e-35
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,29349,-0.0791477315848285,0.00639911651888223,-0.0916899999618376,-0.0666054632078193,4.73058984890272e-35
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,POF1B,Protein POF1B,24229,-0.0413297012358787,0.00334124717198882,-0.0478785456929768,-0.0347808567787806,4.87461234861177e-35
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STX4,Syntaxin-4,29349,-0.0531682535009589,0.00430035726286684,-0.0615969537361779,-0.0447395532657399,5.02383454104431e-35
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",24240,-0.0576015710141638,0.00465835717002315,-0.0667319510674092,-0.0484711909609184,5.14235581524048e-35
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,28797,-0.0535902248052078,0.00433551733356934,-0.0620878387790037,-0.0450926108314119,5.22990986714776e-35
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,29434,-0.0329439673955055,0.00266866192529283,-0.0381745447690794,-0.0277133900219315,6.34583875953717e-35
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,24867,-0.106208610280422,0.0086105662245505,-0.123085320080541,-0.0893319004803032,7.45241416659657e-35
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BMP10,Bone morphogenetic protein 10,24381,0.0256281323924802,0.00207887877461285,0.021553529994239,0.0297027347907214,8.14443409058257e-35
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GTPBP2,GTP-binding protein 2,24195,-0.0725342188238249,0.00588402811722467,-0.0840669139335853,-0.0610015237140645,8.21551396196849e-35
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,24805,-0.0797257106838793,0.00646904797761527,-0.0924050447200052,-0.0670463766477533,8.48818841969448e-35
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,24240,-0.0489218691070749,0.00397424824428242,-0.0567113956658685,-0.0411323425482814,1.01992607029041e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TP53,Cellular tumor antigen p53,28797,-0.038976352576792,0.00316762744947572,-0.0451849023777644,-0.0327678027758196,1.04623719361813e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,24867,-0.0344780696858891,0.00280228159284987,-0.0399705416078749,-0.0289855977639034,1.09350586593191e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,24111,-0.0595822501536905,0.00484926636304036,-0.0690868122252496,-0.0500776880821314,1.35281436259956e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TFF2,Trefoil factor 2,29536,-0.051388829279391,0.00418499434720162,-0.0595914181999062,-0.0431862403588758,1.42103577122737e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,28797,-0.0403482107830994,0.00328614037954106,-0.0467890459269999,-0.0339073756391989,1.44594441734441e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TSNAX,Translin-associated protein X,24111,-0.0351559220555776,0.00286411975293771,-0.0407695967713355,-0.0295422473398196,1.57268492061214e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DCTN2,Dynactin subunit 2,29349,-0.0838718403573607,0.00683779893607554,-0.0972739262720688,-0.0704697544426527,1.67739331005265e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,29443,-0.0312415779184849,0.00255073028935082,-0.0362410092856125,-0.0262421465513573,2.08624548077173e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,24229,-0.0388353366346308,0.00317469004567008,-0.0450577291241441,-0.0326129441451174,2.62232412761233e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CHAD,Chondroadherin,24381,0.0461587771759793,0.00377548366411901,0.0387588291943061,0.0535587251576526,2.84821133969242e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CETN3,Centrin-3,24805,-0.0689176364791317,0.00563955101816989,-0.0799711564747446,-0.0578641164835187,3.03486499489029e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TPD52L2,Tumor protein D54,24381,-0.0962820747195002,0.00788412827355575,-0.11173496613567,-0.080829183303331,3.3709930441378e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,24445,-0.0591193064025782,0.00484338965373976,-0.0686123501239081,-0.0496262626812482,3.62318522361849e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",29434,-0.0848534822422065,0.00695769800007759,-0.0984905703223586,-0.0712163941620544,3.96548199880217e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,29218,-0.0700202303650213,0.00574383055267375,-0.0812781382482619,-0.0587623224817808,4.22698120555188e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAP2,Microtubule-associated protein 2,24845,-0.0409313576057665,0.00335964457710123,-0.047516260976885,-0.0343464542346481,4.77621421405929e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,28862,-0.0463093310107036,0.00380464748064605,-0.0537664400727698,-0.0388522219486373,5.32466044504493e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,YWHAQ,14-3-3 protein theta,24381,-0.0654893265378831,0.00538068355742916,-0.0760354663104442,-0.0549431867653219,5.55505277174695e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLXNB3,Plexin-B3,29383,-0.0416754531198809,0.00343131986110057,-0.048400840047638,-0.0349500661921238,7.29895587725663e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EGF,Pro-epidermal growth factor,29379,-0.0908753132131454,0.00748679637327099,-0.105549434104757,-0.0762011923215343,7.99886644407981e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TPR,Nucleoprotein TPR,24111,-0.0421188777875582,0.00347335712241225,-0.0489266577474862,-0.0353110978276302,9.61418440491802e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VEGFD,Vascular endothelial growth factor D,29732,0.0314558827182814,0.00259587535055024,0.0263679670312029,0.0365437984053599,1.02306254123594e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,24240,0.0310390426050958,0.00256134734918408,0.026018801800695,0.0360592834094966,1.05844430057791e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,29218,-0.0366653100858665,0.00302906280563401,-0.0426022731849091,-0.0307283469868238,1.2036344633567e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,24805,-0.0565107163677665,0.00466980195944184,-0.0656635282082726,-0.0473579045272605,1.29303836666059e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD164,Sialomucin core protein 24,29443,-0.0234586568903755,0.00194078258028492,-0.027262590747734,-0.0196547230330171,1.4820858524073e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CNTN4,Contactin-4,29443,0.0210919941845805,0.00174571636360044,0.0176703901119236,0.0245135982572374,1.57595400644538e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,29443,-0.0263102961359668,0.00218061217875251,-0.0305842960063218,-0.0220362962656119,1.92610500988705e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,29278,-0.0240572663345725,0.0019957162823034,-0.0279688702478872,-0.0201456624212579,2.20486101851473e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COMT,Catechol O-methyltransferase,28591,-0.0737105096701789,0.00611573305619224,-0.0856973464603157,-0.0617236728800421,2.26447581238365e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ICA1,Islet cell autoantigen 1,28931,-0.069387943651126,0.00576381620844986,-0.0806850234196877,-0.0580908638825642,2.67739537414187e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TWF2,Twinfilin-2,24938,-0.0732705194448999,0.00609069894075293,-0.0852082893687757,-0.0613327495210242,3.05930771636638e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",24381,-0.0912138583122312,0.00758230292940922,-0.106075172053873,-0.0763525445705892,3.07662607925445e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,28797,-0.0410685785376641,0.00341585589848564,-0.047763656098696,-0.0343735009766323,3.23463737577771e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,29760,-0.0446826220570299,0.00372265040051857,-0.0519790168420463,-0.0373862272720135,4.09170058632222e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,29561,0.0272260195734266,0.00226909490675976,0.0227785935561775,0.0316734455906757,4.31291610429385e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PROS1,Vitamin K-dependent protein S,24966,-0.0222575367958412,0.00185524024351322,-0.0258938076731271,-0.0186212659185553,4.53681718297286e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LGALS1,Galectin-1,29478,-0.0297933879256363,0.00248399775876119,-0.0346620235328082,-0.0249247523184644,4.55472401014521e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C3,Complement C3,23779,-0.0407000668130226,0.00339316373533779,-0.0473506677342847,-0.0340494658917606,4.71799758573868e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DLG4,Disks large homolog 4,24845,-0.0617947096859768,0.00515644671066843,-0.0719013452388869,-0.0516880741330667,5.31775375211998e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RETN,Resistin,29362,-0.0366420474797546,0.00305913644456379,-0.0426379549110996,-0.0306461400484096,5.53832376990839e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTSL,Cathepsin L1,29478,-0.0211446357723446,0.00176535857010684,-0.024604738569754,-0.0176845329749352,5.55945657669559e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IDS,Iduronate 2-sulfatase,29786,0.00772091821821596,0.000644721303929477,0.00645726446251419,0.00898457197391774,5.68006195753071e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,29536,-0.066217661202128,0.00553400370370348,-0.0770643084613868,-0.0553710139428692,6.41280478058649e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,24111,-0.0587074331360003,0.00491088730748588,-0.0683327722586726,-0.049082094013328,7.61356305581464e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,29536,0.039133238606407,0.00327763353977348,0.032709076868451,0.0455574003443631,8.76805428722891e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STK24,Serine/threonine-protein kinase 24,28774,-0.0535849505129127,0.00449032548405456,-0.0623859884616596,-0.0447839125641657,9.47021045910112e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,24229,0.0281451504781874,0.00235888058027937,0.0235217445408398,0.032768556415535,1.00099448119743e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PSAP,Prosaposin,24761,-0.0246277183685947,0.00206709101800017,-0.0286792167638751,-0.0205762199733144,1.22620440504903e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,UBXN1,UBX domain-containing protein 1,24381,-0.0597292105111904,0.00502225491042288,-0.0695728301356192,-0.0498855908867615,1.58529184395168e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL15,Interleukin-15,29434,-0.028281682060784,0.00237914528838018,-0.0329448068260092,-0.0236185572955589,1.63515732896812e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",29566,-0.0526362583212637,0.00443188564569009,-0.0613227541868163,-0.0439497624557111,1.85395785843013e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SH3BP1,SH3 domain-binding protein 1,24805,-0.0413618056124481,0.00348547410928944,-0.0481933348666554,-0.0345302763582408,2.15218118648416e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EPHA2,Ephrin type-A receptor 2,28347,-0.0271301137765763,0.00228702343821678,-0.0316126797154812,-0.0226475478376715,2.20820123326233e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD46,Membrane cofactor protein,29331,-0.0246366819108328,0.0020775504993793,-0.0287086808896163,-0.0205646829320494,2.3050066419609e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,29725,-0.0462463573582787,0.00390373120404682,-0.0538976705182104,-0.0385950441983469,2.64644153737123e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",29443,-0.0661793273870418,0.00558803886060536,-0.0771318835538283,-0.0552267712202553,2.76883811950447e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,29593,0.0208179598463042,0.0017586079010955,0.017371088360157,0.0242648313324514,2.94548148203853e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MIF,Macrophage migration inhibitory factor,29386,-0.0582658323148672,0.00492700068633573,-0.0679227536600853,-0.0486089109696492,3.39701455860328e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CALB2,Calretinin,28774,-0.0261896250561375,0.0022172219769254,-0.0305353801309113,-0.0218438699813637,4.01989960926741e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,28538,-0.104421677293473,0.0088464069570908,-0.121760634929371,-0.087082719657575,4.42830412096804e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PARK7,Parkinson disease protein 7,29443,-0.0446385910675339,0.00378243453412782,-0.0520521627544245,-0.0372250193806434,4.52660594323208e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,29786,-0.0382861517384741,0.00324735721658689,-0.0446509718829844,-0.0319213315939638,5.18267115367661e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDA,Cytidine deaminase,24890,-0.0400437863349677,0.00339813384679729,-0.0467041286746904,-0.033383443995245,5.73745113080913e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPART,Spartin,24381,-0.0663409440519372,0.00563528189159945,-0.0773860965594721,-0.0552957915444023,6.60751708113988e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MBL2,Mannose-binding protein C,24610,0.0924104396601949,0.00786935547359717,0.0769865029319444,0.107834376388445,9.31829259654894e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,24788,-0.0368535470002481,0.00313837716272849,-0.043004766239196,-0.0307023277613003,9.32812781290383e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,24793,-0.0709012410246173,0.00603992734772237,-0.0827394986261532,-0.0590629834230815,9.78967660830366e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADA,Adenosine deaminase,29786,-0.0295806839762078,0.00252318698437692,-0.0345261304655866,-0.024635237486829,1.13352750547985e-31
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANGPT2,Angiopoietin-2,29725,-0.032380791479324,0.00276514179738122,-0.0378004694021912,-0.0269611135564568,1.32385650060749e-31
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TBC1D23,TBC1 domain family member 23,29349,-0.0761580903943029,0.0065060459134177,-0.0889099403846016,-0.0634062404040042,1.40038099984244e-31
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD300C,CMRF35-like molecule 6,29694,-0.0293451217151478,0.00250694770263936,-0.0342587392123209,-0.0244315042179746,1.40142329667118e-31
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,24229,-0.0416115269457966,0.00355697612444983,-0.0485832001497183,-0.034639853741875,1.57602722310928e-31
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DOK1,Docking protein 1,24845,-0.116092185802857,0.00992844970786179,-0.135551947230266,-0.0966324243754474,1.67647942137891e-31
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FIS1,Mitochondrial fission 1 protein,29453,-0.0652490654007962,0.00558540163643342,-0.0761964526082057,-0.0543016781933867,1.84718826362895e-31
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,29349,-0.0982579378252566,0.00842992692187998,-0.114780594592141,-0.0817352810583719,2.51190999155946e-31
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DPP4,Dipeptidyl peptidase 4,28990,0.025307277890744,0.0021754817079011,0.0210433337432579,0.0295712220382302,3.28798326279687e-31
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GRAP2,GRB2-related adapter protein 2,29478,-0.107706939258828,0.0092666533233184,-0.125869579772532,-0.0895442987451237,3.67994513232221e-31
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,28774,-0.0432580971596131,0.00372446177990966,-0.050558042248236,-0.0359581520709901,4.07746668894442e-31
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,29478,-0.0484234864052726,0.00417187145332077,-0.0566003544537813,-0.0402466183567639,4.43013106490597e-31
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,24381,-0.0721199137688202,0.00621281871799033,-0.0842970384560813,-0.0599427890815592,4.51787541708729e-31
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SUSD1,Sushi domain-containing protein 1,28916,-0.0411850254590905,0.00354911433846778,-0.0481412895624873,-0.0342287613556936,4.59213871160076e-31
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,24845,-0.0448790512460421,0.00387215135493666,-0.0524684679017179,-0.0372896345903662,5.55165931886646e-31
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GLRX,Glutaredoxin-1,29291,-0.0469959241201747,0.00406915301248749,-0.0549714640246502,-0.0390203842156992,8.67781779446262e-31
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPOCK1,Testican-1,29218,0.0215393886789926,0.00186650006801345,0.0178810485456862,0.0251977288122989,9.67084038142971e-31
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CIT,Citron Rho-interacting kinase,24195,-0.0380914044931261,0.00330187177423269,-0.0445630731706221,-0.03161973581563,1.04173340796715e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,24240,-0.0265443410560403,0.00230400882509079,-0.0310601983532182,-0.0220284837588623,1.24367218039329e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLAMF6,SLAM family member 6,28797,-0.0319746149458637,0.00277670909411792,-0.0374169647703348,-0.0265322651213926,1.28950211637215e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,29673,-0.0353475855157917,0.00307298766477153,-0.0413706413387439,-0.0293245296928395,1.48484817851219e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,29434,-0.0283220923394148,0.00246512501095896,-0.0331537373608943,-0.0234904473179352,1.73837570682203e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,28797,-0.0707356627131558,0.00615862549653269,-0.0828065686863599,-0.0586647567399517,1.81558174226762e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,29218,-0.078329535830775,0.0068217974208044,-0.0917002587755516,-0.0649588128859984,1.88355227102772e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,24922,-0.0515014476883793,0.00448694201638131,-0.0602958540404866,-0.0427070413362719,2.02793971065654e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SEPTIN8,Septin-8,24801,-0.0268127735133968,0.00233973073372398,-0.0313986457514958,-0.0222269012752978,2.50493051168585e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",29378,-0.0542480140502727,0.00473773374518328,-0.0635339721908319,-0.0449620559097135,2.72051305295921e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACYP1,Acylphosphatase-1,24297,-0.0547300554424869,0.00478174679593405,-0.0641022791625176,-0.0453578317224562,2.95732913747238e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAX,Protein max,28774,-0.0872008183480135,0.00763186765582942,-0.102159278953439,-0.0722423577425879,3.60721464324227e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],28826,-0.0399149594954331,0.00350112200452638,-0.0467771586243048,-0.0330527603665614,4.81562547711159e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STX7,Syntaxin-7,24229,-0.041212343343049,0.00361560677350734,-0.0482989326191234,-0.0341257540669746,5.07651234865541e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,29434,-0.0504752900548971,0.00443049252557324,-0.0591590554050207,-0.0417915247047735,5.25564094784021e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPRY2,Protein sprouty homolog 2,28931,-0.0762566689548418,0.00669481002812259,-0.0893784966099621,-0.0631348412997215,5.40845866844348e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,29478,-0.0558047034229194,0.00489974620127268,-0.0654082059774139,-0.046201200868425,5.46262024482819e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,F2R,Proteinase-activated receptor 1,29536,-0.0473199528528295,0.00415832554804551,-0.0554702709269987,-0.0391696347786603,6.10334194535181e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,29375,-0.0305776814696858,0.0026872160591892,-0.0358446249456967,-0.025310737993675,6.15187192486619e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AGT,Angiotensinogen,24951,-0.0191493568808377,0.00168325107197093,-0.0224485289819008,-0.0158501847797747,6.49604044445233e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,28586,-0.0317023566577348,0.002787194695685,-0.0371652582612774,-0.0262394550541922,6.51340985244562e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,28797,-0.0494354569599037,0.00435008546517504,-0.0579616244716468,-0.0409092894481606,7.29559320198781e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",29581,-0.0905346087503952,0.00797110384046202,-0.106157972277701,-0.0749112452230897,7.81719067135137e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,24966,0.0215168825936437,0.00189472682207104,0.0178032180223844,0.0252305471649029,8.17814591914792e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NUDC,Nuclear migration protein nudC,29786,-0.0520571094047688,0.00458949555441666,-0.0610525206914254,-0.0430616981181121,9.28391346272013e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,24240,0.0173509269888973,0.00153000298769873,0.0143521211330078,0.0203497328447868,9.83092220480326e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLIN3,Perilipin-3,29478,-0.0349734675860895,0.00308846902256164,-0.0410268668703103,-0.0289200683018687,1.1510837570109e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,29349,-0.0282587624931034,0.00249561196385614,-0.0331501619422614,-0.0233673630439454,1.15842285032519e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NME3,Nucleoside diphosphate kinase 3,29497,0.0196238579704307,0.00173529288475159,0.0162226839163176,0.0230250320245438,1.36798707138658e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",29163,-0.0786972415376442,0.0069597081994523,-0.0923382696085707,-0.0650562134667177,1.38775196775222e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,24240,-0.039480009977549,0.00349574077480467,-0.0463316618961662,-0.0326283580589319,1.66995042856884e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LGALS3,Galectin-3,29544,-0.0243703094119952,0.00215944355339472,-0.0286028187766488,-0.0201378000473415,1.77936058414598e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NEXN,Nexilin,24951,-0.0565858733860498,0.00501707567912219,-0.0664193417171293,-0.0467524050549703,1.97134917607712e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDH5,Cadherin-5,29820,0.0248160007916407,0.00220340105466587,0.0204973347244956,0.0291346668587858,2.30179136768166e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,THTPA,Thiamine-triphosphatase,24755,-0.0721555140177733,0.0064116341855886,-0.0847223170215269,-0.0595887110140196,2.61253103120784e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,APOBR,Apolipoprotein B receptor,24240,0.0349014397344506,0.00310254620808028,0.0288204491666132,0.0409824303022879,2.75975986117796e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,29400,-0.0688270124592284,0.00612249453382249,-0.0808271017455205,-0.0568269231729363,2.92100294959855e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNC,Tenascin,29594,0.0387918672277835,0.00346273462002454,0.0320049073725354,0.0455788270830316,4.52749939900802e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,24326,-0.0442942590179446,0.00395610598751139,-0.0520482267534669,-0.0365402912824223,4.99958890332298e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TSPAN8,Tetraspanin-8,24805,-0.0815898893603085,0.00728975678866048,-0.0958778126660831,-0.067301966054534,5.21431165489033e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",24445,-0.040355835365299,0.00360591064230311,-0.0474234202242131,-0.0332882505063849,5.27507411624907e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD80,T-lymphocyte activation antigen CD80,24922,-0.0278399569062342,0.002489294389821,-0.0327189739102833,-0.022960939902185,5.73352727425641e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ASAH1,Acid ceramidase,24732,-0.0378763081642223,0.00338924188126203,-0.0445192222514959,-0.0312333940769487,6.30904156949001e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,24805,-0.0430671685610619,0.00385430277757535,-0.0506216020051096,-0.0355127351170142,6.42462053009164e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CACYBP,Calcyclin-binding protein,24329,-0.0837538798916377,0.00749802998574903,-0.0984500186637058,-0.0690577411195696,6.7152088464001e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VWC2,Brorin,29114,-0.0322781081596604,0.00289034426293757,-0.037943182915018,-0.0266130334043028,6.72892151027468e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TMED8,Protein TMED8,24805,-0.0835242943264007,0.00748191537812118,-0.0981888484675182,-0.0688597401852832,7.21013816020509e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PKD2,Polycystin-2,24111,-0.0479465392908867,0.00429615027406531,-0.0563669938280547,-0.0395260847537187,7.50220991543718e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LMNB2,Lamin-B2,24845,-0.0227152677543802,0.00203677600281648,-0.0267073487199005,-0.0187231867888599,8.14615100434995e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,24922,-0.0324130196786673,0.0029149441151292,-0.0381263101443205,-0.026699729213014,1.17654214947185e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RTBDN,Retbindin,29349,-0.0238829973132335,0.00214991836393112,-0.0280968373065385,-0.0196691573199285,1.29665004376427e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,24240,-0.0743710055338618,0.00670216172855397,-0.0875072425218276,-0.061234768545896,1.52733202966003e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GET3,ATPase GET3,24922,-0.0445087687884436,0.00401122069518207,-0.0523707613510004,-0.0366467762258867,1.52929599987772e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRSS22,Brain-specific serine protease 4,24229,-0.0282708394434577,0.00254784696003391,-0.0332646194851241,-0.0232770594017912,1.53763098378476e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GAS6,Growth arrest-specific protein 6,29639,0.0204588545726894,0.00184612156967978,0.016840456296117,0.0240772528492618,1.74385211711229e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,24793,-0.0413570025341493,0.00373250976884477,-0.0486727216810851,-0.0340412833872136,1.82562036420457e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DPEP1,Dipeptidase 1,29163,0.0389866821851292,0.00352077019326663,0.0320859726063266,0.0458873917639318,1.92575754619089e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,29354,-0.0715272353908608,0.00646271857502983,-0.0841941637979192,-0.0588603069838023,2.04924905133499e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MMP9,Matrix metalloproteinase-9,29411,-0.0485547032714153,0.00438957108315459,-0.0571582625943983,-0.0399511439484323,2.19704221361087e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TBCB,Tubulin-folding cofactor B,29218,-0.0804506292199134,0.00728212556653402,-0.0947235953303201,-0.0661776631095067,2.55975408394136e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GBP1,Guanylate-binding protein 1,24816,-0.0518224209555409,0.00469749534417064,-0.0610295118301153,-0.0426153300809664,3.11833433309872e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,29349,-0.0260629707546718,0.00236305319360476,-0.0306945550141372,-0.0214313864952065,3.13420851117644e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,24229,-0.0448949918833583,0.0040771005259804,-0.0528861089142799,-0.0369038748524367,3.92267999069244e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,28774,-0.05370740576901,0.00488056540206478,-0.0632733139570569,-0.044141497580963,4.14396563460855e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CPXM1,Probable carboxypeptidase X1,29566,-0.0547449907471204,0.00497643134024638,-0.0644987961740033,-0.0449911853202375,4.29189411011952e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,24445,-0.0847536660269524,0.0077035338641372,-0.0998525924006613,-0.0696547396532435,4.3544174986835e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VASN,Vasorin,29065,0.0219610665817551,0.00199748695802126,0.0180459921440334,0.0258761410194768,4.62147493142552e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CA2,Carbonic anhydrase 2,29368,-0.0546553169841418,0.00497697875039953,-0.0644101953349249,-0.0449004386333587,5.31087806759586e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDH3,Cadherin-3,29694,-0.0288274863701536,0.00262597682609267,-0.0339744009492952,-0.023680571791012,5.53115826909572e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MGLL,Monoglyceride lipase,29536,-0.0688456735653506,0.00628992431552675,-0.081173925223783,-0.0565174219069182,7.90853995722151e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD300E,CMRF35-like molecule 2,29642,-0.0323014303276,0.00295480070433398,-0.0380928397080946,-0.0265100209471054,9.17292710038927e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL19,C-C motif chemokine 19,29694,-0.0973948764024483,0.0089106524217228,-0.114859755149025,-0.0799299976558716,9.34218959777876e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,24195,-0.0344343339054376,0.00315480860271589,-0.0406177587667608,-0.0282509090441145,1.13557401381032e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ASS1,Argininosuccinate synthase,24111,-0.0630166372222159,0.00577392203031395,-0.0743335244016313,-0.0516997500428006,1.14695554943066e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,24701,-0.0240913056417261,0.0022099549495693,-0.028422817342882,-0.0197597939405703,1.31394804289468e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CHCHD6,MICOS complex subunit MIC25,24793,-0.0229984857162599,0.00211087238524829,-0.0271357955913466,-0.0188611758411733,1.40251719345071e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRTAC1,Cartilage acidic protein 1,29820,0.0237722981853179,0.0021826933259124,0.0194942192665296,0.0280503771041062,1.42990666837257e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BSG,Basigin,29760,-0.0162161892136675,0.00148975961879788,-0.0191361180665114,-0.0132962603608237,1.52996978521096e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CXCL8,Interleukin-8,29218,-0.05351084465126,0.00491933623211212,-0.0631527436661997,-0.0438689456363202,1.66339804343121e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FABP3,"Fatty acid-binding protein, heart",24922,-0.0401145645684325,0.00368831645847945,-0.0473436648270522,-0.0328854643098127,1.72727144479741e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,24229,-0.0716872107497356,0.00660087688325326,-0.0846249294409119,-0.0587494920585592,2.06181970682115e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,29478,-0.0654651444060977,0.00603634784177973,-0.0772963861759859,-0.0536339026362094,2.36857345406532e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,24938,0.0169528842534555,0.00156770500299462,0.013880182447586,0.0200255860593249,3.4024284944183e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,24845,-0.0234154250367718,0.00216652724526967,-0.0276618184375004,-0.0191690316360433,3.63351963009405e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TMPRSS5,Transmembrane protease serine 5,29079,0.029843526380308,0.00276383743103156,0.0244264050154861,0.0352606477451298,3.96692373640289e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,28797,-0.0769340117343931,0.00712880228165117,-0.0909064642064294,-0.0629615592623568,4.23213336543391e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TTF2,Transcription termination factor 2,24195,-0.0385772375571695,0.00357677339195096,-0.0455877134053933,-0.0315667617089456,4.64542112411892e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,24805,-0.0458070505835044,0.00424991641338599,-0.054136886753741,-0.0374772144132679,5.00139751204048e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MMP12,Macrophage metalloelastase,29466,-0.0414717515183614,0.0038512623964029,-0.0490202258153111,-0.0339232772214117,5.4522815726801e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,24229,-0.0281091377062567,0.00261369214316849,-0.0332319743068669,-0.0229863011056464,6.48735954423073e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,29566,-0.0563530236705837,0.00524248836868716,-0.0666283008732105,-0.0460777464679568,6.6971262367473e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,24229,-0.0708192487014071,0.00658781608314522,-0.0837313682243717,-0.0579071291784424,6.81289319586081e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,24381,-0.064626886834092,0.00601678310273396,-0.0764197817154506,-0.0528339919527335,7.49533085821674e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EFNA1,Ephrin-A1,29390,-0.0219916352019639,0.00204988630142486,-0.0260094123527567,-0.0179738580511712,8.41180763181145e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IST1,IST1 homolog,24636,-0.0775339113020832,0.0072271588295798,-0.0916991426080597,-0.0633686799961068,8.60743795442163e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,24381,-0.032936668369785,0.00307044908568044,-0.0389547485777187,-0.0269185881618514,8.72656890084925e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD160,CD160 antigen,29786,-0.036470429216007,0.00340300436240013,-0.0431403177663113,-0.0298005406657028,9.46541225927147e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,24681,-0.047156406467125,0.00440277808532274,-0.0557858515143575,-0.0385269614198924,1.03917047186568e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLG,Plasminogen,24421,-0.0172796724146129,0.00161348424953797,-0.0204421015437074,-0.0141172432855185,1.05263353394568e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CIAPIN1,Anamorsin,29566,-0.0485710238420226,0.00454064189054785,-0.0574706819474963,-0.0396713657365488,1.17695145122168e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AIF1,Allograft inflammatory factor 1,28797,-0.0407208541270271,0.00380944830437829,-0.0481873728036085,-0.0332543354504456,1.27973318320983e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,28774,-0.0497350998195505,0.00465284283406571,-0.0588546717743193,-0.0406155278647817,1.28330013235586e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BIN2,Bridging integrator 2,29443,-0.0696891080686531,0.00652297078138755,-0.0824741308001727,-0.0569040853371335,1.35839473382963e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDH17,Cadherin-17,29478,-0.0526596357633406,0.00493273404637367,-0.062327794494233,-0.0429914770324482,1.48151611976122e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BCL2L15,Bcl-2-like protein 15,24229,-0.0438455352848118,0.00410964419824291,-0.0519004379133678,-0.0357906326562557,1.62914792897477e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL20,C-C motif chemokine 20,29786,-0.0678829731425365,0.00636423730269008,-0.080356878255809,-0.0554090680292639,1.63375139978567e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CASP7,Caspase-7,24845,-0.0651633524872426,0.00610959256562068,-0.0771381539158592,-0.0531885510586261,1.68017247254181e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LEFTY2,Left-right determination factor 2,29674,-0.0400487003855022,0.00376079577625567,-0.0474198601069633,-0.0326775406640411,1.96753312195164e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,24178,-0.0215053728829627,0.00201997120773711,-0.0254645164501275,-0.017546229315798,2.07453589237207e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,24922,-0.0220691120552196,0.00207383904685322,-0.0261338365870519,-0.0180043875233873,2.17278897694559e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,29349,-0.0422208910521729,0.00397399784512081,-0.0500099268286097,-0.0344318552757361,2.56534367304164e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,29218,0.08842060844428,0.00832263633175276,0.0721082412340445,0.104732975654515,2.57143039878147e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITGAM,Integrin alpha-M,29443,0.0243849809123553,0.00229558285619944,0.0198856385142044,0.0288843233105062,2.61196720740828e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",29349,-0.0266519171885143,0.00250963704609796,-0.0315708057988663,-0.0217330285781623,2.69033116259339e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,29454,-0.0400677013061798,0.00377464340983896,-0.0474660023894642,-0.0326694002228955,2.83258389872499e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BAP18,Chromatin complexes subunit BAP18,24845,-0.0511074833586749,0.00482420909504973,-0.0605629331849724,-0.0416520335323774,3.6150063208119e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BST2,Bone marrow stromal antigen 2,29694,-0.0402893100048326,0.00380613025848611,-0.0477493253114654,-0.0328292946981998,3.87875773180804e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,24867,-0.0609626940778123,0.00576380099885651,-0.0722597440355711,-0.0496656441200535,4.33698533692423e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,29581,-0.020664381928856,0.00195511640235415,-0.0244964100774701,-0.0168323537802418,4.59909995237319e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RBM17,Splicing factor 45,24867,-0.05867743956888,0.00556792288949011,-0.0695905684322806,-0.0477643107054793,6.51253813626007e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",24845,-0.074805919208762,0.00709866295893303,-0.0887192986082707,-0.0608925398092532,6.54434232983809e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TBCA,Tubulin-specific chaperone A,24381,-0.0657285485465225,0.00624322688799042,-0.0779652732469837,-0.0534918238460612,7.2960284262472e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",28916,-0.0708181071995653,0.00673714249337477,-0.0840229064865799,-0.0576133079125508,8.50385735753521e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,24867,-0.0449955999781175,0.00428097914071563,-0.0533863190939201,-0.0366048808623148,8.74586457283615e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,24867,-0.065234594131183,0.00620859810034492,-0.0774034464078591,-0.053065741854507,9.07009266964748e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,24867,-0.0512510551188903,0.00488476070228002,-0.0608251860953591,-0.0416769241424214,1.06367379713206e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,29581,0.0155801628644321,0.00148613222246311,0.0126673437084045,0.0184929820204598,1.13868681019108e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,24805,-0.0581997808406331,0.00555323818392143,-0.0690841276811191,-0.0473154340001471,1.20352019839094e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,24904,-0.0365443912004273,0.0034888515389096,-0.0433825402166901,-0.0297062421841645,1.27748005901967e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BPIFA2,BPI fold-containing family A member 2,23405,0.0844783226353874,0.00806998981144063,0.0686611426049638,0.100295502665811,1.377351929182e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCRG1,Scrapie-responsive protein 1,24922,-0.0209384380463236,0.00200217139042825,-0.0248626939715629,-0.0170141821210842,1.52341187391062e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FN1,Fibronectin,24966,-0.020346169729196,0.00194729133684256,-0.0241628607494074,-0.0165294787089846,1.68142376044379e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,L1CAM,Neural cell adhesion molecule L1,29566,0.0219377407160815,0.00210089807657472,0.0178199804859951,0.026055500946168,1.76419539701349e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,24805,-0.0624880604904353,0.00598610614066312,-0.074220828526135,-0.0507552924547356,1.86100468020115e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,JAM2,Junctional adhesion molecule B,29694,-0.0202049972153463,0.00193747220573454,-0.024002442738586,-0.0164075516921066,2.03262302432282e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINB6,Serpin B6,29623,-0.0447056918519996,0.0042882231499272,-0.0531106092258569,-0.0363007744781422,2.10489946141651e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,24922,-0.0743387663720515,0.00713532168019127,-0.0883239968652264,-0.0603535358788766,2.30390332242932e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NT5E,5'-nucleotidase,29566,-0.0423655613085813,0.00406855396207571,-0.0503399270742497,-0.0343911955429129,2.39472670892839e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ICAM1,Intercellular adhesion molecule 1,29391,-0.0217629096737298,0.00209217978388528,-0.025863582050145,-0.0176622372973147,2.68569386482537e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD244,Natural killer cell receptor 2B4,29786,-0.0203917643827235,0.00196219567514986,-0.0242376679060173,-0.0165458608594298,2.96855092243837e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,29725,-0.0471642285317786,0.00454160662166364,-0.0560657775102394,-0.0382626795533179,3.20768952055485e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTGES2,Prostaglandin E synthase 2,24037,-0.0416554619416561,0.00401067796320162,-0.0495163907495312,-0.0337945331337809,3.24240204765672e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,28774,-0.0288480441295424,0.0027816626776177,-0.0343001029776731,-0.0233959852814117,3.72942438760321e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD300A,CMRF35-like molecule 8,24381,-0.022655458887014,0.00218606506432156,-0.0269401464130842,-0.0183707713609437,4.09489543012448e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,29573,-0.0839504179387908,0.00810476237903396,-0.0998357522016974,-0.0680650836758843,4.24247979370083e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NID2,Nidogen-2,29443,-0.0550582620928079,0.0053163029350527,-0.0654782158455112,-0.0446383083401046,4.3185472992684e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,24190,-0.0270638157774423,0.00261274072400899,-0.0321847875964999,-0.0219428439583846,4.32578799799875e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,24445,-0.0423973093887504,0.0040933760611301,-0.0504203264685654,-0.0343742923089354,4.359194422807e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CASP2,Caspase-2,29434,-0.0509400380640266,0.00492154079573588,-0.060586258023669,-0.0412938181043843,4.60037089636826e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CX3CL1,Fractalkine,29218,0.0253323466933618,0.00245054988708499,0.0205292689146752,0.0301354244720484,5.27088960977227e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTSC,Dipeptidyl peptidase 1,29446,-0.0325181325204074,0.00314701574127071,-0.038686283373298,-0.0263499816675168,5.51368486772488e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,24111,-0.0210570753158544,0.00203978544819405,-0.0250550547943147,-0.0170590958373941,6.23954322314862e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FAM3D,Protein FAM3D,24805,-0.0635474544755221,0.00615727321675572,-0.0756157099803633,-0.0514791989706809,6.37996395083303e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,29536,-0.0381952564381087,0.00370293505130939,-0.0454530091386751,-0.0309375037375423,6.65466685927634e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RALY,RNA-binding protein Raly,24793,-0.0361019452442626,0.00350352209973471,-0.0429688485597427,-0.0292350419287826,7.54992652258552e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,24111,-0.0499174604537779,0.00484930881321354,-0.0594221057276764,-0.0404128151798793,8.46549488475638e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,28797,-0.0425211320998779,0.00413260641077639,-0.0506210406649997,-0.0344212235347562,8.70444201604001e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,24805,-0.0656189107278036,0.0063798421268027,-0.0781234012963369,-0.0531144201592703,9.20103978071994e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TREML2,Trem-like transcript 2 protein,29443,-0.0252197749124717,0.00246052156351909,-0.0300423971769691,-0.0203971526479743,1.30491102968761e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",29478,-0.0544026088918239,0.00531233131029314,-0.0648147782599984,-0.0439904395236493,1.43084197264468e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LACTB2,Endoribonuclease LACTB2,29478,-0.0489614461640987,0.00478396888664125,-0.0583380251819155,-0.0395848671462818,1.52726816066783e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD58,Lymphocyte function-associated antigen 3,29409,0.0131029306591937,0.00128095212867094,0.0105922644869986,0.0156135968313887,1.6153482588784e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MMP8,Neutrophil collagenase,29640,-0.0537427789007222,0.00525443238761168,-0.0640414663804411,-0.0434440914210033,1.63036699936853e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,29349,-0.0417751768002035,0.00409223288556143,-0.0497959532559039,-0.0337544003445031,1.9976676842468e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DENR,Density-regulated protein,24229,-0.0426682624719005,0.00418353321865261,-0.0508679875804596,-0.0344685373633414,2.24183195495619e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,24381,-0.0883065462337898,0.00866484898293699,-0.105289650240346,-0.0713234422272333,2.4252527450858e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GIMAP7,GTPase IMAP family member 7,24381,0.0240106567731732,0.00235679045946211,0.0193913474726274,0.0286299660737189,2.51356415876438e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,APOA4,Apolipoprotein A-IV,24966,-0.0264974462470541,0.00260337768770216,-0.0316000665149503,-0.0213948259791578,2.77036792160665e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MICALL2,MICAL-like protein 2,24195,-0.0506794898951961,0.00498195637200782,-0.0604441243843314,-0.0409148554060608,2.94072598366107e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CST7,Cystatin-F,29498,-0.0686469178326896,0.00674987807642358,-0.0818766788624798,-0.0554171568028994,2.95693780600774e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,29542,-0.0378611814442008,0.00372487151901577,-0.0451619296214717,-0.0305604332669299,3.13310074769207e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COMP,Cartilage oligomeric matrix protein,29214,0.0248348316999802,0.00244367213617883,0.0200452343130697,0.0296244290868907,3.18516854661214e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LAP3,Cytosol aminopeptidase,28931,-0.0358001289531672,0.00352661824483485,-0.0427123007130435,-0.0288879571932909,3.58591846879786e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VCAN,Versican core protein,29694,0.022114391832195,0.00218032119150561,0.0178409622968441,0.026387821367546,3.90889779056505e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,29218,-0.0218773603133479,0.00215880711492025,-0.0261086222585916,-0.0176460983681042,4.27868464252081e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,24867,-0.0359723732763525,0.00354957440111333,-0.0429295391025346,-0.0290152074501703,4.33572323410482e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,24922,-0.0660497347252059,0.00652167168416714,-0.0788322112261735,-0.0532672582242383,4.63362414813958e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",24240,-0.0642205337571099,0.00634215362342754,-0.0766511548590279,-0.0517899126551919,4.73109044700798e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BAG6,Large proline-rich protein BAG6,28916,-0.0266980034903683,0.00264084457520528,-0.0318740588577706,-0.0215219481229659,5.48839293066699e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TMEM106A,Transmembrane protein 106A,24793,-0.0520373541021923,0.00514677181551356,-0.0621250268605988,-0.0419496813437857,5.51455172138432e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,24229,-0.0258564647780858,0.00256071039162287,-0.0308754571456666,-0.0208374724105049,6.32792758308486e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,29640,-0.0212281916189599,0.00210426945997102,-0.0253525597605031,-0.0171038234774167,6.81270202494848e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,24229,-0.0587494786465609,0.00583005703277449,-0.0701763904307989,-0.0473225668623229,7.78088177363772e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BOLA1,BolA-like protein 1,24101,-0.0401102773278896,0.00398453127310967,-0.0479199586231846,-0.0323005960325947,8.65881821414478e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AZU1,Azurocidin,28534,-0.0557910100026661,0.0055490579219658,-0.066667163529719,-0.0449148564756131,9.64900124087771e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LAMB1,Laminin subunit beta-1,24240,-0.0222772073450067,0.0022165108079337,-0.0266215685285567,-0.0179328461614566,1.01655789771697e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCRIB,Protein scribble homolog,24240,-0.0662066572179158,0.00659067273917065,-0.0791243757866903,-0.0532889386491413,1.06994933955768e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DXO,Decapping and exoribonuclease protein,24845,-0.0332940181815554,0.00331510449609992,-0.0397916229939112,-0.0267964133691995,1.09314511619609e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,24867,0.0328375209896992,0.00327118210579733,0.0264260040623364,0.039249037917062,1.14618506799029e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGF2,Fibroblast growth factor 2,29434,-0.0491067998218728,0.00489402413522546,-0.0586990871269147,-0.0395145125168309,1.17906295527175e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,24571,-0.0409396433639626,0.00408006132734975,-0.0489365635655681,-0.032942723162357,1.19913495317079e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LAYN,Layilin,29163,-0.0254325408477793,0.00253567933030858,-0.0304024723351841,-0.0204626093603744,1.23063611686316e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANXA3,Annexin A3,29640,-0.0506221032870941,0.00505254623606148,-0.0605250939097746,-0.0407191126644136,1.36959448998402e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,29678,-0.0197441614619213,0.0019717631810062,-0.0236088172966934,-0.0158795056271491,1.45002750359585e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,29089,-0.0845095837461675,0.0084588653169367,-0.101088959767363,-0.0679302077249715,1.82730378658382e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD200,OX-2 membrane glycoprotein,29434,0.0192390614697642,0.00192599530001473,0.0154641106817353,0.0230140122577931,1.8531718021768e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OPTC,Opticin,29349,0.0327478833378006,0.00327917397210297,0.0263207023524787,0.0391750643231224,1.90132227724479e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",29349,-0.0501900941560268,0.00503280472777311,-0.0600543914224621,-0.0403257968895915,2.18918623129482e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTF1,Cardiotrophin-1,28916,-0.0609720986938272,0.00612735784059971,-0.0729817200614026,-0.0489624773262517,2.72723204552454e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL8,C-C motif chemokine 8,29683,-0.0436437394030852,0.00438673596791963,-0.0522417419002077,-0.0350457369059627,2.76995086724141e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MYO9B,Unconventional myosin-IXb,28931,-0.0476649567192666,0.00479147110632102,-0.0570562400876558,-0.0382736733508774,2.80809888049184e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,29478,0.0285649831694138,0.00287548774186308,0.0229290271953622,0.0342009391434655,3.22243403621562e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CAPG,Macrophage-capping protein,29174,-0.0420617084395531,0.00423429371020954,-0.0503609241115638,-0.0337624927675424,3.2374652075689e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,29349,0.0473720572358775,0.00477055706347324,0.0380217653914699,0.056722349080285,3.35084694163994e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCARA5,Scavenger receptor class A member 5,29694,-0.0216354542260827,0.00218176005794325,-0.0259117039396515,-0.0173592045125139,3.83372532471125e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,29694,-0.0407674797162089,0.00411322395624396,-0.0488293986704471,-0.0327055607619708,4.03767966933019e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BCL2L1,Bcl-2-like protein 1,24845,-0.0718498000153498,0.00724844701708504,-0.0860567561688365,-0.0576428438618631,4.05769861085485e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,28797,-0.0371313320206421,0.00375133546560293,-0.0444839495332239,-0.0297787145080604,4.61546073331346e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RAB10,Ras-related protein Rab-10,24922,-0.038567042636055,0.00389643790490956,-0.0462040609296777,-0.0309300243424323,4.68307094052864e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CFP,Properdin,24966,-0.0165949325399605,0.00167681735022809,-0.0198814945464076,-0.0133083705335135,4.7452075026751e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,24867,0.0188678489328368,0.00191036281017958,0.0151235378248848,0.0226121600407888,5.79798106351104e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,24256,-0.0202684599317518,0.00205260640053683,-0.024291568476804,-0.0162453513866996,5.93354090257168e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLKB1,Plasma kallikrein,24454,-0.0180540170582677,0.00182984020172229,-0.0216405038536434,-0.014467530262892,6.42243128511318e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,29725,-0.0240586941271384,0.00244015186528258,-0.0288413917830923,-0.0192759964711845,6.7613531691931e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPME1,Protein phosphatase methylesterase 1,29349,-0.0427847688207717,0.00433965434003957,-0.0512904913272493,-0.0342790463142942,6.80068240394202e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NRGN,Neurogranin,24951,-0.0654142646309309,0.00665359132628374,-0.078455303630447,-0.0523732256314147,9.06940258601226e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,29694,-0.0327055081083597,0.00332988390444247,-0.039232080561067,-0.0261789356556525,9.82316705644003e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,29820,0.0205832119212466,0.00209571440029348,0.0164756116966714,0.0246908121458218,9.84352087836475e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EHD3,EH domain-containing protein 3,24240,-0.0839686130081518,0.00855483863306285,-0.100736096728955,-0.0672011292873486,1.06620601010209e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,29786,-0.0195605193245155,0.00199767070708094,-0.0234759539103941,-0.0156450847386369,1.32268694072418e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FOLR1,Folate receptor alpha,29383,-0.0205136610513356,0.00209554283757319,-0.024620925012979,-0.0164063970896921,1.35683426954604e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,24793,-0.07679502926653,0.00784607975588233,-0.0921733455880593,-0.0614167129450006,1.39734189100584e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,24240,-0.0523379405194512,0.00534922720641631,-0.0628224258440272,-0.0418534551948752,1.44928124603794e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C2,Complement C2,29545,-0.0165757955084035,0.00169481901472832,-0.019897640777271,-0.013253950239536,1.4807261474973e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",29434,-0.0307468299929468,0.00314629276566505,-0.0369135638136503,-0.0245800961722434,1.60056592417052e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CXCL16,C-X-C motif chemokine 16,29786,-0.0166899825674246,0.00170865289130412,-0.0200389422343806,-0.0133410229004685,1.67115051051778e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BDNF,Brain-derived neurotrophic factor,24938,-0.0590289969001912,0.00604567712823858,-0.0708785240715388,-0.0471794697288436,1.76606445767656e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,24240,-0.0364525008707559,0.00373354739077666,-0.0437702537566782,-0.0291347479848337,1.77657750360861e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,24445,-0.0315290576418654,0.00322955179002931,-0.0378589791503228,-0.025199136133408,1.78969468730078e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OGN,Mimecan,29443,-0.0298248821225951,0.00305666704242293,-0.0358159495257441,-0.0238338147194462,1.85633475027807e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,29517,-0.019045636659478,0.00195304010993793,-0.0228735952749564,-0.0152176780439997,1.95960754557793e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GIMAP8,GTPase IMAP family member 8,24016,-0.036190836426231,0.0037124504142027,-0.0434672392380683,-0.0289144336143937,2.06026190426823e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLSTN2,Calsyntenin-2,29786,0.0280027203970368,0.00287357039644459,0.0223705224200054,0.0336349183740682,2.09480805250898e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPAG1,Sperm-associated antigen 1,24867,-0.0410959558502446,0.00421741596156462,-0.0493620911349112,-0.0328298205655779,2.13903839738774e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KIFBP,KIF-binding protein,29349,-0.0581113935298721,0.00597675791339946,-0.0698258390401351,-0.0463969480196092,2.60266153017429e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,24793,-0.0667708570699865,0.00687042188242981,-0.0802368839595489,-0.0533048301804241,2.75338679284128e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MPO,Myeloperoxidase,29443,-0.0323632352141549,0.00333120266906874,-0.0388923924455297,-0.0258340779827802,2.80613050977706e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CENPF,Centromere protein F,24445,-0.0384322897083968,0.00395595115081567,-0.0461859539639955,-0.0306786254527981,2.85408575979108e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLIT2,Slit homolog 2 protein,28774,-0.0366349991611531,0.00378173916730712,-0.044047207929075,-0.0292227903932311,3.68986580131037e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,24101,-0.0700457607608799,0.0072388892114328,-0.0842339836152882,-0.0558575379064717,4.17100043532639e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,24805,-0.0212778003157443,0.00219922762645638,-0.0255882864635988,-0.0169673141678898,4.2085328555955e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,28916,-0.0778639044168964,0.00805717727036619,-0.0936559718668142,-0.0620718369669787,4.6342442038525e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,28797,-0.0534963931270484,0.00553904145018277,-0.0643529143694066,-0.0426398718846902,4.90767848568916e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,24240,-0.0323160199798272,0.00334642178328521,-0.0388750066750662,-0.0257570332845882,5.03615920885723e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,28797,-0.0594003029642084,0.0061573828603849,-0.0714687733705628,-0.047331832557854,5.46454810510397e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,24845,-0.044184673277335,0.00458304750689231,-0.0531674463908439,-0.035201900163826,5.86962150147887e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PCDH9,Protocadherin-9,24805,-0.0237577460508241,0.00246513589781803,-0.0285894124105475,-0.0189260796911008,6.06703575570873e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PCDH17,Protocadherin-17,29478,-0.0252104063164634,0.00261747243546805,-0.0303406522899808,-0.020080160342946,6.33602993366129e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITGAL,Integrin alpha-L,24229,-0.0305270194212099,0.00317649721351577,-0.0367529539597008,-0.024301084882719,7.91466570095512e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,24111,-0.0483904076559756,0.00504257289967396,-0.0582738505393366,-0.0385069647726147,9.05749965695845e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,24883,0.0103556026834937,0.00107930852508383,0.00824015797432935,0.012471047392658,9.18271677298634e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,28774,-0.0514572059617579,0.0053652554898925,-0.0619731067219472,-0.0409413052015686,9.41909298865766e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,29218,-0.0247394660271648,0.00257983611507496,-0.0297959448127117,-0.0196829872416178,9.52469925277304e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCN3,CCN family member 3,29795,-0.0235462133502142,0.00245703200997623,-0.0283619960897676,-0.0187304306106608,1.01132973268975e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,29274,-0.0181870892136558,0.00189857716388422,-0.0219083004548689,-0.0144658779724427,1.05115015403548e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,24846,-0.0139363470421379,0.0014564823002986,-0.0167910523507232,-0.0110816417335527,1.18213959985515e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DHPS,Deoxyhypusine synthase,24793,-0.0283787588187084,0.00296714338182943,-0.0341943598470941,-0.0225631577903228,1.23070653565183e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COL5A1,Collagen alpha-1(V) chain,24381,-0.0281425743073217,0.00294673380584184,-0.0339181725667717,-0.0223669760478717,1.40899697867313e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,24381,-0.0419962621131233,0.00440132642579823,-0.0506228619076878,-0.0333696623185588,1.53191745026639e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CASP3,Caspase-3,29820,-0.0608233927850021,0.00638036202985013,-0.0733289023635084,-0.0483178832064959,1.64135457177317e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ERI1,3'-5' exoribonuclease 1,24445,-0.0235782610800792,0.00247345196832544,-0.028426226937997,-0.0187302952221613,1.67299223896261e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRADD,Death domain-containing protein CRADD,29163,-0.0522725796500969,0.00548860757945463,-0.063030250505828,-0.0415149087943658,1.79360702795586e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",24922,-0.0509894050437807,0.00535669731330366,-0.0614885317778558,-0.0404902783097055,1.9051801126234e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FCRLB,Fc receptor-like B,28797,-0.0423524981199251,0.00445021335036616,-0.0510749162866428,-0.0336300799532074,1.91761049549253e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,29594,-0.020530484640473,0.00216142514421754,-0.0247668779231394,-0.0162940913578066,2.28223971462933e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDIA4,Protein disulfide-isomerase A4,24938,-0.0419801291991606,0.00441948785969803,-0.0506423254041688,-0.0333179329941525,2.30608573252611e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,29566,-0.0575354496422971,0.00606234504401863,-0.0694176459285736,-0.0456532533560206,2.46304350320204e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,24445,-0.0509145287123442,0.00536451678265839,-0.0614289816063547,-0.0404000758183338,2.49088971566098e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,24229,-0.0232827679528657,0.00245823234211411,-0.0281009033434093,-0.018464632562322,3.00685467873712e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CNPY4,Protein canopy homolog 4,29349,-0.0514468491305298,0.00543595582451314,-0.0621013225465755,-0.040792375714484,3.17256021723383e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DMD,Dystrophin,24240,-0.0356104395292871,0.00376618669204831,-0.0429921654457018,-0.0282287136128724,3.50348400982576e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OLFM4,Olfactomedin-4,23498,-0.0849139471006314,0.00899625859824187,-0.102546613953185,-0.0672812802480773,4.10978041484145e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SMTN,Smoothelin,24776,-0.0647979219689037,0.0068761080454595,-0.0782750937380043,-0.0513207501998031,4.72606453262787e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LGMN,Legumain,29581,-0.0245007872870634,0.00260155460229468,-0.0295998343075609,-0.0194017402665658,4.9322931195425e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPRR3,Small proline-rich protein 3,24845,-0.0465392823423646,0.00494571509264609,-0.056232883923951,-0.0368456807607783,5.37634313055283e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,29725,-0.0267135210236966,0.00283962428847941,-0.0322791846291162,-0.0211478574182769,5.43866762757464e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",24867,-0.028974135030495,0.00307990991178579,-0.0350107584575951,-0.0229375116033948,5.50795991355538e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GMFG,Glia maturation factor gamma,24922,-0.0491502413875266,0.00522490627421373,-0.0593910576849855,-0.0389094250900677,5.53567953641619e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,24793,-0.0468092400078181,0.00497970235403338,-0.0565694566217235,-0.0370490233939127,5.9124197767143e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANXA11,Annexin A11,29373,-0.0454711646328882,0.00484275027660905,-0.0549629551750419,-0.0359793740907345,6.44781818417656e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HSPB1,Heat shock protein beta-1,29039,-0.0468180032506873,0.00498902166313278,-0.0565964857104275,-0.037039520790947,6.78648352938372e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PGA4,Pepsin A-4,24951,-0.0486562510066357,0.00518751356377096,-0.0588237775916268,-0.0384887244216446,7.17511473477464e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GRSF1,G-rich sequence factor 1,23862,-0.0551140933398243,0.00588175568288548,-0.0666423344782799,-0.0435858522013688,7.85074410666042e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,24845,-0.0253021439666406,0.00270169394749632,-0.0305974641037334,-0.0200068238295478,8.20791375589685e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HMOX2,Heme oxygenase 2,28774,-0.0317316678870931,0.00338982975713418,-0.0383757342110761,-0.0250876015631101,8.46785373056671e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SNX9,Sorting nexin-9,29478,-0.0462426183049959,0.00495647432540922,-0.055957307982798,-0.0365279286271939,1.13329437465978e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLB,Beta-klotho,28774,0.050204475780678,0.00538349840222636,0.0396528189123144,0.0607561326490417,1.17992739489132e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GNAS,Neuroendocrine secretory protein 55,24867,-0.0600717582944787,0.0064443888006982,-0.0727027603438471,-0.0474407562451102,1.23880882248153e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,28931,0.0267148532126852,0.00286675642520588,0.0210960106192816,0.0323336958060887,1.25710572216194e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,24111,-0.0463822071535416,0.00497841047113812,-0.0561398916769724,-0.0366245226301109,1.30017266108172e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NID1,Nidogen-1,29518,-0.0255373203706629,0.00275397324944109,-0.0309351079395675,-0.0201395328017584,1.93119181787415e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CFB,Complement factor B,24538,-0.0221798585149751,0.00239274589338386,-0.0268696404660074,-0.0174900765639427,2.01718106425668e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,28916,-0.0358972698134311,0.00387344403869858,-0.0434892201292803,-0.0283053194975819,2.03326982465613e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,24805,-0.0646289639385049,0.00697494629407888,-0.0782998586748995,-0.0509580692021103,2.08742517229863e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD99L2,CD99 antigen-like protein 2,29443,-0.0162307983642342,0.001756001840878,-0.0196725619723551,-0.0127890347561133,2.5525036826651e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,24805,-0.0793369344944187,0.00858365300474536,-0.0961608943837196,-0.0625129746051178,2.58882901032339e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD59,CD59 glycoprotein,28277,-0.0154736014796868,0.00167456894999105,-0.0187557566216692,-0.0121914463377043,2.6242026990722e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MYOC,Myocilin,29443,0.0306281074718151,0.00331594338948789,0.0241288584284188,0.0371273565152113,2.70992544797772e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,UNC79,Protein unc-79 homolog,24016,-0.0377535821089112,0.00408757359482046,-0.0457652263547593,-0.0297419378630631,2.75997227061632e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AMPD3,AMP deaminase 3,24845,-0.047614863243257,0.00515961053344544,-0.0577276998888101,-0.0375020265977039,2.9601489652142e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SOD3,Extracellular superoxide dismutase,24951,0.0403032402474089,0.00436959198864,0.0317388399496745,0.0488676405451433,3.09467097762267e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,29349,-0.0242338482268072,0.00263120318363235,-0.0293910064667266,-0.0190766899868877,3.46633742748093e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,29786,-0.0226443014392568,0.00246451794078277,-0.027474756603191,-0.0178138462753226,4.24948147313768e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD86,T-lymphocyte activation antigen CD86,24805,0.020011614007652,0.00218145633493258,0.0157359595911841,0.0242872684241198,4.92501162336032e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTN,Pleiotrophin,28916,-0.0333117728444814,0.00363251146287638,-0.0404314953117191,-0.0261920503772437,5.0141895766032e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,S100A12,Protein S100-A12,29023,-0.0499853211833578,0.00545238388190078,-0.0606719935918833,-0.0392986487748322,5.14663071480768e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINB9,Serpin B9,29218,-0.0220177736268054,0.00240686270151556,-0.0267352245217759,-0.0173003227318349,6.17101316182339e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCN5,CCN family member 5,29443,-0.0257721609128833,0.00282389586913728,-0.0313069968163924,-0.0202373250093743,7.51724134187429e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,24195,-0.045253135953877,0.00496418037220553,-0.0549829294833998,-0.0355233424243541,8.389791820994e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRLF1,Cytokine receptor-like factor 1,29581,-0.0170751009671101,0.00187401485866483,-0.0207481700900932,-0.0134020318441271,8.62310040611782e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDCD6,Programmed cell death protein 6,29478,0.0463393169914135,0.00508744859475701,0.0363679177456898,0.0563107162371373,8.86199295169215e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GAL,Galanin peptides,29581,0.0426635421877315,0.00468443095152437,0.0334820575227438,0.0518450268527193,8.94512672273588e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCGN,Secretagogin,28931,-0.0291665916511355,0.0032031950828581,-0.0354448540135374,-0.0228883292887336,9.12738449765614e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PI3,Elafin,29014,-0.0363634683616422,0.00399882688740497,-0.044201169060956,-0.0285257676623285,1.01825081687002e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COL2A1,Collagen alpha-1(II) chain,24240,-0.0534868981773564,0.00588467314536048,-0.0650208575422629,-0.0419529388124499,1.07227119521098e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,29361,-0.017775636276706,0.00195919627845915,-0.0216156609824859,-0.0139356115709261,1.22909615838178e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,24111,-0.0241456963055996,0.00266097310164306,-0.02936120358482,-0.0189301890263792,1.23263993574141e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",24867,-0.0313795632623259,0.00346124654436332,-0.038163606489278,-0.0245955200353738,1.32379889202884e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BLNK,B-cell linker protein,24229,-0.0263384143011111,0.0029060194043483,-0.0320342123336338,-0.0206426162685884,1.35777391910267e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SELL,L-selectin,24966,0.0153113181282703,0.00169048188601976,0.0119979736316716,0.0186246626248691,1.43168893454066e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GFRAL,GDNF family receptor alpha-like,24025,0.0413327254158931,0.0045708297128446,0.0323738991787177,0.0502915516530685,1.64093111019386e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",24922,-0.0581486584351758,0.00644565543281959,-0.0707821430835022,-0.0455151737868494,1.98809130008499e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HMBS,Porphobilinogen deaminase,29725,-0.0281875665775211,0.00312708907466673,-0.0343166611638679,-0.0220584719911743,2.10296504903662e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CERT,Ceramide transfer protein,28774,-0.0401683454719287,0.00446055638446843,-0.0489110359854869,-0.0314256549583706,2.28165834965494e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,28931,-0.0256743395259345,0.00285283705099408,-0.0312659001458829,-0.0200827789059861,2.40109240394945e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,29518,0.0232639401827147,0.00258513290804389,0.0181970796829487,0.0283308006824808,2.40824248320568e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD7,T-cell antigen CD7,24177,-0.0286100819737719,0.00318210339973413,-0.0348470046372508,-0.022373159310293,2.6268118347377e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,29327,-0.0288194805995576,0.00320627425848063,-0.0351037781461797,-0.0225351830529356,2.65398377384559e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,THY1,Thy-1 membrane glycoprotein,29694,-0.0186273978238764,0.00207274797870348,-0.0226899838621352,-0.0145648117856176,2.69214625714207e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",24867,-0.0309043115083125,0.00344470425087725,-0.037655931840032,-0.0241526911765931,3.12536921674633e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",28931,-0.0468818924011769,0.00522726714323189,-0.0571273360019114,-0.0366364488004423,3.17645805999503e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",24922,-0.0196714285589203,0.00219349607020082,-0.0239706808565139,-0.0153721762613267,3.22464507924698e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,24240,-0.0345651409811885,0.00385884545974423,-0.0421284780822872,-0.0270018038800898,3.55858281612188e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,28797,-0.0438859819023916,0.00490216591485349,-0.0534942270955044,-0.0342777367092787,3.68378447858847e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TBC1D5,TBC1 domain family member 5,29434,-0.0506895965192205,0.0056660480599722,-0.061795050716766,-0.0395841423216749,3.89000671243371e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C1RL,Complement C1r subcomponent-like protein,24925,-0.012704975561273,0.00142015197547026,-0.0154884734331947,-0.00992147768935126,3.92901314469153e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IFNG,Interferon gamma,28931,-0.073879885079591,0.00825938994036042,-0.0900682893626974,-0.0576914807964845,3.9377146381004e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,24845,-0.0249768184596545,0.00279463966926703,-0.0304543122114179,-0.0194993247078911,4.25480839814136e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PCDH7,Protocadherin-7,24805,-0.022660799039746,0.00253642351281996,-0.0276321891248731,-0.0176894089546188,4.38170395452501e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STX16,Syntaxin-16,28797,-0.0376300442782556,0.00421957643825265,-0.0459004140972308,-0.0293596744592804,5.02384126275857e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CAT,Catalase,24587,-0.0347568408711841,0.00390319249568102,-0.0424070981627189,-0.0271065835796493,5.71394776791657e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BLVRB,Flavin reductase,29443,-0.0420541326839207,0.00472522148199765,-0.0513155667886361,-0.0327926985792053,5.90151622231647e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ALPP,"Alkaline phosphatase, placental type",29349,-0.0668963592239235,0.00751790895287924,-0.0816314607715668,-0.0521612576762801,5.99132512382964e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,APRT,Adenine phosphoribosyltransferase,29192,-0.0308193445816614,0.00346466079301178,-0.0376100797359645,-0.0240286094273583,6.15258188634678e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",29478,0.0506731004112294,0.00569811385398211,0.0395047972574245,0.0618414035650343,6.28227287362845e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRYBB1,Beta-crystallin B1,24922,-0.0422701981440233,0.0047569693342432,-0.05159385803914,-0.0329465382489066,6.75660264856233e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,28797,-0.0373921673078076,0.00420864940395597,-0.0456411201395613,-0.0291432144760539,6.78041161355236e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,24922,-0.0209178461905639,0.00235450592440377,-0.0255326778023953,-0.0163030145787325,6.86498984476223e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SMS,Spermine synthase,24101,-0.0414198564749741,0.0046692123066339,-0.0505715125959766,-0.0322682003539716,7.75268930619067e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MESD,LRP chaperone MESD,29443,-0.0779887655450748,0.00879868057816849,-0.0952341794782851,-0.0607433516118646,8.16775829422774e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,24793,-0.0281544407725247,0.00317653666706833,-0.0343804526399786,-0.0219284289050708,8.28264745553085e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL18,C-C motif chemokine 18,29166,-0.0451481989775444,0.0051021685690048,-0.0551484493727938,-0.035147948582295,9.33356154055084e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BAX,Apoptosis regulator BAX,28722,-0.0580298561755985,0.00656526730114011,-0.0708977800858331,-0.0451619322653639,1.02054717662142e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,29497,-0.0218078032253398,0.00246853649832292,-0.0266461347620527,-0.0169694716886268,1.06191579614455e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,24805,-0.0303132840819135,0.00343273271776205,-0.0370414402087271,-0.0235851279550999,1.10802695739157e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,REG1A,Lithostathine-1-alpha,29353,-0.0315752221226655,0.00357617869479951,-0.0385845323644725,-0.0245659118808584,1.11048704643921e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,29478,-0.0225721325552355,0.00255711953709957,-0.0275840868479506,-0.0175601782625203,1.13169797285906e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,24867,-0.0639226922502058,0.00724225817309325,-0.0781175182694686,-0.049727866230943,1.15121512797622e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",29218,-0.0372880059938105,0.00422521267294089,-0.0455694228327746,-0.0290065891548463,1.15312798647784e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,24805,-0.0325809299010773,0.00369257242935048,-0.0398183718626043,-0.0253434879395504,1.18235582711936e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",29820,-0.0186192415943722,0.00211408712943375,-0.0227628523680623,-0.014475630820682,1.35084242830833e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,24111,-0.0229891254212869,0.00261282686045597,-0.0281102660677806,-0.0178679847747932,1.47682861278458e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,24240,-0.0361271060429359,0.00411715366496762,-0.0441967272262725,-0.0280574848595994,1.82309931466068e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,24922,0.0209256829351588,0.00238499646419805,0.0162510898653306,0.025600276004987,1.83443465535151e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPP1,Osteopontin,29757,0.0293347376759829,0.00334763229408286,0.0227733783795805,0.0358960969723853,2.00320032368718e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINI2,Serpin I2,24805,-0.0362390557694805,0.00413598770731506,-0.044345591675818,-0.028132519863143,2.0405545736613e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DCTN6,Dynactin subunit 6,28774,-0.0453717421548994,0.00518330251953507,-0.0555310150931881,-0.0352124692166106,2.1804457450781e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,29434,-0.051898536945448,0.00593106001517451,-0.06352341457519,-0.0402736593157059,2.23931107016987e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CXCL1,Growth-regulated alpha protein,29420,-0.0604477183558977,0.00691098979121549,-0.0739932583466801,-0.0469021783651154,2.31357217835396e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,24922,-0.0450618364772688,0.00516172330241462,-0.0551788141500015,-0.0349448588045362,2.70342829103703e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL19,Interleukin-19,28654,-0.0446749558453122,0.00511985594651497,-0.0547098735004816,-0.0346400381901429,2.78310871437703e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD40LG,CD40 ligand,29786,-0.049194818903146,0.00563814100933583,-0.0602455752814442,-0.0381440625248478,2.78895449208393e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,29478,-0.0421458416785887,0.00485675589701912,-0.0516650832367462,-0.0326266001204312,4.23977527434003e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,24240,-0.0331537513510051,0.00382035764048147,-0.0406416523263488,-0.0256658503756614,4.26998846753921e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,24195,-0.0386658568906011,0.00445679060352036,-0.0474011664735011,-0.0299305473077012,4.3636019868729e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PKN3,Serine/threonine-protein kinase N3,24445,-0.0477460924933369,0.00550370384542476,-0.0585333520303695,-0.0369588329563044,4.37823537795674e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GRN,Progranulin,29313,-0.0155272365030782,0.00179037048211293,-0.0190363626480196,-0.0120181103581369,4.43629203750195e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,29454,0.0249180365701121,0.00287789870321448,0.0192773551118117,0.0305587180284125,5.02354606845808e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,24445,-0.0427247144664806,0.00493426797389005,-0.0523958796953051,-0.0330535492376561,5.05806546986164e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,29467,-0.0595303271918362,0.00687816769008069,-0.0730115358643944,-0.0460491185192781,5.17709288443088e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SWAP70,Switch-associated protein 70,24805,-0.0225578522983122,0.0026096295611267,-0.0276727262381205,-0.0174429783585039,5.74603026109489e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DKK3,Dickkopf-related protein 3,29820,0.0184264328792001,0.00213754535242361,0.0142368439884498,0.0226160217699503,6.99827984857246e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,28774,-0.0696377512228292,0.0081274824120742,-0.0855676167504947,-0.0537078856951638,1.10304684541557e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SIGLEC1,Sialoadhesin,29581,-0.026424256644031,0.00308471083721268,-0.0324702898849679,-0.0203782234030942,1.1206561964184e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LPA,Apolipoprotein(a),24484,0.111479723490489,0.013016337072397,0.0859677028285911,0.136991744152387,1.1473803133623e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEP170,Centrosomal protein of 170 kDa,24240,-0.0481561744891149,0.00562361428733662,-0.0591784584922947,-0.0371338904859351,1.16194965869463e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ZBP1,Z-DNA-binding protein 1,24229,-0.0253338113942026,0.00296575038264999,-0.0311466821441965,-0.0195209406442086,1.39414738574516e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SEMA4D,Semaphorin-4D,29694,-0.0185450820488144,0.00217261789409609,-0.0228034131212428,-0.0142867509763861,1.45691759357967e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DCTD,Deoxycytidylate deaminase,24381,-0.05908472634213,0.00692425866906471,-0.0726562733334968,-0.0455131793507632,1.50774040023819e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,24381,-0.0780462365256299,0.00915669238159334,-0.0959933535935529,-0.060099119457707,1.63768984975024e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,24381,-0.0542130923837304,0.00636424919182504,-0.0666870207997075,-0.0417391639677533,1.71016030133639e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EDF1,Endothelial differentiation-related factor 1,24867,-0.0422470400506694,0.00495975231890597,-0.0519681545957251,-0.0325259255056137,1.71429498293112e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,29434,-0.0205026752920408,0.0024128516092218,-0.0252318644461155,-0.015773486137966,2.03109262943059e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINF2,Alpha-2-antiplasmin,24515,-0.00842909930603796,0.00099195620646778,-0.0103733334707148,-0.00648486514136111,2.04666190710859e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C4BPB,C4b-binding protein beta chain,29566,0.0247098018100099,0.00291019028702858,0.0190058288474339,0.0304137747725859,2.14715082932096e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BMP6,Bone morphogenetic protein 6,28884,-0.0254163448956834,0.00299493556302331,-0.0312864185992091,-0.0195462711921577,2.23108503807102e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ELOB,Elongin-B,24111,-0.0244945292250747,0.002889241804403,-0.0301574431617046,-0.0188316152884448,2.42376854007708e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,29374,-0.0201718016061879,0.00238158367600658,-0.0248397056111607,-0.015503897601215,2.56875070120306e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LTA,Lymphotoxin-alpha,29434,-0.0246471642053992,0.00291093817825026,-0.0303526030347697,-0.0189417253760287,2.6313999379721e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPP3R1,Calcineurin subunit B type 1,29218,-0.0251280149431684,0.0029691114772964,-0.0309474734386694,-0.0193085564476675,2.72262573369923e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD84,SLAM family member 5,29434,-0.0191768386282332,0.00226846428489558,-0.0236230286266285,-0.0147306486298378,2.95152903308015e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CXCL3,C-X-C motif chemokine 3,29453,-0.0576676135150025,0.00682737187499305,-0.0710492623899889,-0.0442859646400162,3.13694955271875e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD93,Complement component C1q receptor,28353,0.0193090388297037,0.00228890024515663,0.0148227943491967,0.0237952833102107,3.43948184498867e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,24109,-0.025384250360267,0.00300946757641256,-0.0312828068100356,-0.0194856939104983,3.50142528487279e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNR,Tenascin-R,29218,0.0258339838659269,0.0030636833756772,0.0198291644495995,0.0318388032822542,3.54245490987807e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL6,Interleukin-6,29349,-0.0451450947878671,0.0053570474823023,-0.0556449078531796,-0.0346452817225546,3.69893564901298e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,24523,-0.0342628224732628,0.0040657032039901,-0.0422316007530834,-0.0262940441934422,3.72967046423656e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,24229,-0.0529476982487067,0.00629452631436194,-0.0652849698248561,-0.0406104266725573,4.26103863201961e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,29349,-0.0574574683590317,0.00683292627474854,-0.0708500038575388,-0.0440649328605246,4.32337211266574e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CHRDL2,Chordin-like protein 2,29478,-0.0326162348414096,0.00387903583015474,-0.0402191450685129,-0.0250133246143063,4.34374761235467e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,29525,-0.0727267264036062,0.00866353710362988,-0.0897072591267208,-0.0557461936804916,4.88210947641443e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,29169,-0.0151614642307307,0.00180657282653247,-0.0187023469707343,-0.011620581490727,4.97618712781122e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KIF22,Kinesin-like protein KIF22,24111,-0.075090282964305,0.00895746292515518,-0.0926469102976091,-0.0575336556310008,5.43877574966866e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,29398,-0.0148471532873363,0.00177339450488581,-0.0183230065169125,-0.0113713000577601,5.90492975859669e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PMVK,Phosphomevalonate kinase,28757,-0.0666298679611358,0.00797230114809356,-0.0822555782113992,-0.0510041577108724,6.681772308771e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GP6,Platelet glycoprotein VI,29400,-0.0532704132579961,0.00637995515144827,-0.0657751253548347,-0.0407657011611574,7.14333481337814e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,24793,-0.0334213450476337,0.00401437831729948,-0.0412895265495406,-0.0255531635457267,8.83256251966008e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAGED1,Melanoma-associated antigen D1,28797,-0.0291702854814326,0.00351466514530867,-0.0360590291662376,-0.0222815417966276,1.08987475792182e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LGALS7_LGALS7B,Galectin-7,29320,-0.0252149257925813,0.00304499231795655,-0.0311831107357761,-0.0192467408493864,1.27514311350224e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PARD3,Partitioning defective 3 homolog,24445,-0.0444664108711866,0.00540585046490094,-0.0550618777823924,-0.0338709439599807,2.037781538425e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HDGF,Hepatoma-derived growth factor,29688,-0.0557818122655399,0.00678424195528088,-0.0690789264978904,-0.0424846980331893,2.07763211839536e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CSDE1,Cold shock domain-containing protein E1,24111,-0.0709194961868911,0.00862953810069992,-0.087833390864263,-0.0540056015095193,2.16826451919376e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,29443,-0.0302395768033979,0.00368290377627657,-0.0374580682049,-0.0230210854018958,2.28620158385172e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,24111,-0.0369526936090375,0.00450163634584885,-0.0457759008469013,-0.0281294863711738,2.34637350720176e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,29019,-0.0133273403120818,0.00162391842167366,-0.0165102204185622,-0.0101444602056015,2.3627568997905e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,29434,-0.0593998366360297,0.00725243440035137,-0.0736146080607184,-0.045185065211341,2.70954288346178e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,28774,-0.0380018178712919,0.00464193649645887,-0.0471000134043513,-0.0289036223382325,2.79644769057915e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDZD2,PDZ domain-containing protein 2,24111,-0.0358855249695734,0.00438675976592774,-0.0444835741107918,-0.027287475828355,2.96697645901679e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RSPO3,R-spondin-3,29725,-0.0168351090928168,0.00205918792511037,-0.0208711174260331,-0.0127991007596005,3.05983931010571e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EPHB4,Ephrin type-B receptor 4,29820,-0.0148088701154443,0.00181203754209095,-0.0183604636979426,-0.0112572765329461,3.13920650685957e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,29725,0.0341656186710073,0.00418212630945301,0.0259686511044794,0.0423625862375352,3.22004373034026e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINA12,Serpin A12,28628,-0.0663963915386574,0.00813455151301746,-0.0823401125041716,-0.0504526705731432,3.42166327568786e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,24240,-0.025124948796372,0.00307853899298088,-0.0311588852226145,-0.0190910123701294,3.47344967690289e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,24805,-0.0291095000738733,0.00357095612325844,-0.0361085740754598,-0.0221104260722868,3.75533863438472e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TLR3,Toll-like receptor 3,29786,-0.0361036441902141,0.00443527760501682,-0.0447967882960471,-0.0274105000843812,4.10183490365261e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SEMA7A,Semaphorin-7A,29736,-0.0163283890428841,0.00200744121505662,-0.0202629738243951,-0.0123938042613732,4.31627202088111e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,24240,-0.0605068519973303,0.00745191041656184,-0.0751125964137915,-0.0459011075808691,4.89627276536751e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,24240,-0.0362167351315352,0.0044800509376699,-0.0449976349693682,-0.0274358352937022,6.55824759650442e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,24867,-0.0231791201338426,0.0028716280566421,-0.0288075111248611,-0.0175507291428241,7.23978584469392e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRYM,Ketimine reductase mu-crystallin,24101,-0.0448763179874306,0.00557071160005605,-0.0557949127235404,-0.0339577232513207,8.26191325705768e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SNX5,Sorting nexin-5,24240,-0.0175065906251461,0.00217685685222928,-0.0217732300555155,-0.0132399511947767,9.22912196132608e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLTA,Clathrin light chain A,28916,-0.0274693669827549,0.00341777782877283,-0.0341682115271496,-0.0207705224383601,9.53926039478877e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,24195,-0.0362461994297129,0.00451832002327189,-0.0451021066753258,-0.0273902921841,1.0867723192199e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,24445,-0.0413096047091607,0.00515063953006897,-0.0514048581880959,-0.0312143512302255,1.10197233786296e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,29218,-0.0608565645569474,0.00759214049613707,-0.0757371599293761,-0.0459759691845188,1.13539177924354e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCN4B,Sodium channel subunit beta-4,24240,-0.0249578973678821,0.00311373033443117,-0.0310608088233672,-0.018854985912397,1.14667486174424e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,S100G,Protein S100-G,24867,0.0271449225848368,0.00338846997151055,0.0205035214406761,0.0337863237289974,1.18767139414372e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FRMD4B,FERM domain-containing protein 4B,24111,-0.0409939321213921,0.00512073485271432,-0.0510305724327122,-0.030957291810072,1.24338135760106e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PADI4,Protein-arginine deiminase type-4,28722,-0.0412516981232903,0.00516679431291909,-0.0513786149766117,-0.0311247812699689,1.46919818632311e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,28719,-0.0384299784230813,0.00481704123700358,-0.0478713792476083,-0.0289885775985543,1.54323341760975e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AMOTL2,Angiomotin-like protein 2,24711,-0.0281155252032296,0.00352390101993897,-0.03502237120231,-0.0212086792041493,1.54482224905191e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",24845,-0.061527738075212,0.00772441344893901,-0.0766675884351325,-0.0463878877152916,1.71762436927646e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,29566,0.0261725155558543,0.00328627295716452,0.0197314205598119,0.0326136105518968,1.72236492498488e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,28931,-0.0379295242602234,0.00476457469101288,-0.0472680906546087,-0.0285909578658382,1.77243950089494e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,24867,-0.0733596873507739,0.00921764430379104,-0.0914262701862044,-0.0552931045153435,1.81356093345683e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,28931,-0.0245145319190239,0.00309369091045628,-0.0305781661035182,-0.0184508977345296,2.38131274455288e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MPI,Mannose-6-phosphate isomerase,29349,-0.0491891780936215,0.00620798650429281,-0.0613568316420354,-0.0370215245452076,2.3898647510027e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,XRCC4,DNA repair protein XRCC4,28774,-0.0212733621055724,0.00269251903518895,-0.0265506994145427,-0.015996024796602,2.86698468126241e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PZP,Pregnancy zone protein,24966,-0.0306979852892414,0.0038870904148177,-0.0383166825022841,-0.0230792880761987,2.96400139579345e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,24322,0.0280871212035523,0.00356077481811128,0.0211080025600542,0.0350662398470504,3.20119047766412e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,28797,-0.029648846007082,0.00375994737113672,-0.03701834285451,-0.022279349159654,3.2446069972883e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,24867,-0.0205397882316539,0.00260541066093511,-0.0256463931270867,-0.0154331833362211,3.31303637754388e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FCRL6,Fc receptor-like protein 6,29434,-0.0388453526565404,0.00493425842622261,-0.0485164991719367,-0.0291742061411441,3.59281875539957e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,29218,0.0206810311013101,0.002629503464705,0.0155272043104883,0.0258348578921319,3.81786822057527e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SUGT1,Protein SGT1 homolog,28797,-0.0460392233737852,0.00585866720353393,-0.0575222110927117,-0.0345562356548587,4.0287207955208e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGF19,Fibroblast growth factor 19,29581,-0.0439171573636159,0.00559331291363276,-0.0548800506743361,-0.0329542640528957,4.24172779472773e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACRBP,Acrosin-binding protein,24793,-0.0221709867008115,0.0028241581309034,-0.0277063366373822,-0.0166356367642409,4.31154845481215e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,28797,-0.0208178007673783,0.00265386776718873,-0.0260193815910682,-0.0156162199436884,4.50298579040148e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NXPH3,Neurexophilin-3,24229,0.0172867256784869,0.00220660303034169,0.0129617837390172,0.0216116676179566,4.91563744501014e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C8B,Complement component C8 beta chain,24966,0.0173531249038648,0.00221575939963318,0.0130102364805838,0.0216960133271459,5.00452091624478e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,24445,-0.0199183545480982,0.00255165144303403,-0.0249195913764449,-0.0149171177197515,6.1358472987075e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,24845,0.0387089532017909,0.00495975988320917,0.028987823830701,0.0484300825728809,6.20329765680134e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GAS2,Growth arrest-specific protein 2,24445,-0.0300117362099193,0.00385651176490415,-0.0375704992691314,-0.0224529731507072,7.41485078230965e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MMP3,Stromelysin-1,29443,0.0276126152635793,0.00356125456807681,0.0206325563101487,0.0345926742170098,9.21832718046053e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DBN1,Drebrin,24229,-0.0289464924954921,0.00374095673408516,-0.036278767694299,-0.0216142172966852,1.05150220983258e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CA4,Carbonic anhydrase 4,29820,0.0133536997110412,0.0017269542633911,0.00996886935479463,0.0167385300672877,1.08755858486096e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CPQ,Carboxypeptidase Q,24920,-0.020750663551196,0.00268495576527268,-0.0260131768511304,-0.0154881502512615,1.12922141444651e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLGN,Calmegin,24195,-0.0253300817374215,0.0032792965423255,-0.0317575029603795,-0.0189026605144635,1.16874547976711e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MSTN,Growth/differentiation factor 8,28916,-0.0294820008706287,0.00382025901860304,-0.0369697085470907,-0.0219942931941667,1.22663004531302e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,29581,-0.0489998602575581,0.00635359541688134,-0.0614529072746456,-0.0365468132404707,1.27597315617469e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,24764,-0.0394622989589589,0.00511683634359824,-0.0494912981924114,-0.0294332997255063,1.28265731993893e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINA7,Thyroxine-binding globulin,24966,-0.0104050829834041,0.00134956600682601,-0.0130502323567831,-0.00775993361002517,1.30552305966362e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DNPEP,Aspartyl aminopeptidase,24845,-0.0327340332739273,0.00424581352420924,-0.0410558277813774,-0.0244122387664772,1.30807903213912e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RAB44,Ras-related protein Rab-44,24793,-0.0236648266247775,0.00307012816809632,-0.0296822778342463,-0.0176473754153087,1.32494370692396e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",29163,-0.0408998381757366,0.00530742290348931,-0.0513023870665757,-0.0304972892848976,1.33773575505326e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,24867,-0.0371969405189826,0.00482786104191668,-0.0466595481611393,-0.0277343328768259,1.36098425278889e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,24764,-0.0230079039148967,0.00298759819731776,-0.0288635963816395,-0.0171522114481539,1.39896248856883e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,24793,-0.0190968437943758,0.00248242630908922,-0.0239623993601907,-0.0142312882285609,1.49278684240967e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,24445,-0.0213646412663589,0.00277936384645625,-0.0268121944054132,-0.0159170881273047,1.5642654549985e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,29349,0.022810833853283,0.00296892161298558,0.0169917474918313,0.0286299202147348,1.59986894906939e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TST,Thiosulfate sulfurtransferase,28706,-0.0422154311558237,0.00549812442000176,-0.0529917550190272,-0.0314391072926203,1.66525996186631e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LYZL2,Lysozyme-like protein 2,24016,-0.0201616604655514,0.00262709900070055,-0.0253107745069245,-0.0150125464241784,1.72380010280403e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STX6,Syntaxin-6,28797,-0.0375201111450719,0.00488980253679598,-0.047104124117192,-0.0279360981729518,1.73142544124105e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,24445,-0.0419915522315377,0.00547207923844161,-0.0527168275388833,-0.0312662769241922,1.73224753788824e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HEPACAM2,HEPACAM family member 2,24845,0.0234760868443311,0.00306107215802316,0.0174763854146057,0.0294757882740565,1.79356125956145e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GRK5,G protein-coupled receptor kinase 5,28916,-0.0289198338080764,0.00377804836505018,-0.0363248086035747,-0.021514859012578,1.99794545253303e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MATN3,Matrilin-3,29169,0.0178385370876928,0.0023343883599494,0.0132631359021919,0.0224139382731936,2.21060093116483e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,24845,-0.0265528823168471,0.00347746700244277,-0.0333687176416349,-0.0197370469920593,2.32681252697544e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,29581,-0.0660828717223124,0.00866928869143667,-0.0830746775575282,-0.0490910658870965,2.55975080466331e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AK1,Adenylate kinase isoenzyme 1,29478,-0.0347640664258454,0.00456646616851055,-0.0437143401161261,-0.0258137927355647,2.76012678934131e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HPCAL1,Hippocalcin-like protein 1,29786,-0.0405269130228495,0.00532563065093701,-0.050965149098686,-0.0300886769470129,2.82651845933733e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BPIFB2,BPI fold-containing family B member 2,24852,-0.0359828114329817,0.00472820433157812,-0.0452500919228748,-0.0267155309430886,2.83274809561249e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,28797,-0.0417494549621271,0.00548917673181181,-0.0525082413564783,-0.030990668567776,2.91828226510069e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,24793,-0.0269581898252666,0.00354850574749239,-0.0339132610903517,-0.0200031185601815,3.13648026008435e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,29218,-0.0128365432265731,0.00169207690354693,-0.0161530139575251,-0.00952007249562112,3.39047304732737e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",24229,-0.0199828045755101,0.00263463345820636,-0.0251466861535945,-0.0148189229974256,3.45328707046127e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GFAP,Glial fibrillary acidic protein,28753,0.0254946252837916,0.00336199972167186,0.0189051058293148,0.0320841447382685,3.473767122472e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MMP10,Stromelysin-2,29439,0.032490451675054,0.00428931069829556,0.0240834027063946,0.0408975006437133,3.70373581658342e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,24195,-0.034505374510572,0.00455843550601209,-0.0434399081023557,-0.0255708409187883,3.87839071791065e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,29434,-0.0262237838494913,0.00346798287535974,-0.0330210302851964,-0.0194265374137862,4.09478985608755e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,24111,-0.0211765770790553,0.0028011631779943,-0.0266668569079242,-0.0156862972501865,4.17678884023346e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LACRT,Extracellular glycoprotein lacritin,24732,-0.0274231897108936,0.00362806942709768,-0.0345342057880051,-0.0203121736337822,4.21510028568919e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL7,Interleukin-7,29434,-0.0353396410831524,0.00467593661006733,-0.0445044768388844,-0.0261748053274205,4.21964967970748e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TBC1D17,TBC1 domain family member 17,28774,-0.0244940753352659,0.00324487400371809,-0.0308540283825534,-0.0181341222879785,4.53177112356149e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RILPL2,RILP-like protein 2,24922,-0.0537865324275135,0.00713127142303583,-0.0677638244166637,-0.0398092404383633,4.77338344670667e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPM1F,Protein phosphatase 1F,24922,-0.028911242790982,0.00384165656672505,-0.0364408896617631,-0.0213815959202009,5.42032875746583e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CA1,Carbonic anhydrase 1,28867,-0.0325797850159298,0.0043434515178483,-0.0410929499909125,-0.0240666200409471,6.52055093100107e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRSS27,Serine protease 27,29395,-0.0218710468360915,0.00292424152325542,-0.0276025602216721,-0.0161395334505109,7.68520853426152e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,24805,0.0382117539760235,0.00513850078745166,0.0281402924326182,0.0482832155194287,1.06850156824476e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,28774,-0.0394031835300602,0.00532695455664231,-0.0498440144610792,-0.0289623525990413,1.43158712171557e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,28774,-0.0206648754473809,0.00279431409136412,-0.0261417310664545,-0.0151880198283072,1.44904654797297e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANXA10,Annexin A10,28774,-0.0440848676169985,0.005972097669415,-0.0557901790490519,-0.0323795561849451,1.60384667843984e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,24845,-0.0249647907146068,0.00338601694802651,-0.0316013839327388,-0.0183281974964749,1.72166576496727e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,24845,-0.0250078509411999,0.00339828588518916,-0.0316684912761706,-0.0183472106062291,1.9110059270933e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,29349,-0.0289457826216018,0.00393503176693779,-0.0366584448847998,-0.0212331203584037,1.94577776353158e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRDX1,Peroxiredoxin-1,28669,0.0481015983298188,0.00654517008844969,0.0352730649564574,0.0609301317031802,2.04759837014886e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CSNK1D,Casein kinase I isoform delta,24229,-0.034201929843081,0.00465789060666534,-0.0433313954321451,-0.025072464254017,2.15782300733993e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,F13B,Coagulation factor XIII B chain,24833,-0.0138126706854347,0.00188286697581982,-0.0175030899580415,-0.0101222514128278,2.26858128560115e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GGH,Gamma-glutamyl hydrolase,28984,-0.0181467865951197,0.00247515853662803,-0.0229980973269107,-0.0132954758633288,2.33430254154723e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RCOR1,REST corepressor 1,28916,-0.0237725762598444,0.00324515686566444,-0.0301330837165467,-0.0174120688031421,2.44129188164171e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,F3,Tissue factor,29541,0.0145443860569278,0.00198551327051032,0.0106527800467276,0.0184359920671281,2.44546738449894e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",29434,-0.0438535821244442,0.00598726140136148,-0.0555886144711127,-0.0321185497777757,2.45977703380896e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TXN,Thioredoxin,24647,-0.023378407953433,0.00319698732384741,-0.029644503108174,-0.0171123127986921,2.69942265433494e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,24805,-0.0151020012440475,0.00206579689631399,-0.0191509631608229,-0.0110530393272721,2.74215710972963e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,24229,-0.0215755056676757,0.0029533194336971,-0.0273640117577221,-0.0157869995776294,2.84758239661544e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,29349,-0.0206415498700587,0.00282628836990644,-0.0261810750750753,-0.0151020246650421,2.87695799374644e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLAMF8,SLAM family member 8,28797,-0.0283975537272753,0.00389722175386181,-0.0360361083648445,-0.0207589990897061,3.26006476906162e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,24867,-0.0203720827810502,0.0027965792735556,-0.0258533781572191,-0.0148907874048812,3.32126565243769e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD48,CD48 antigen,29536,-0.015861454398972,0.00217784053330428,-0.0201300218442484,-0.0115928869536956,3.34362317751693e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,24793,-0.0314732576498932,0.00432391056810778,-0.0399481223633845,-0.022998392936402,3.46606579827205e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RLN2,Prorelaxin H2,24326,-0.0602063887748601,0.00828995236247484,-0.0764546954053108,-0.0439580821444094,3.91219823494582e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",28916,-0.0464936257872024,0.00640787510798734,-0.0590530609988576,-0.0339341905755472,4.09639731547441e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",24805,-0.0462385320584335,0.00638830621332235,-0.0587596122365453,-0.0337174518803217,4.68615512031384e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TSPAN1,Tetraspanin-1,28916,-0.0298413142846068,0.00412495033199826,-0.0379262169353234,-0.0217564116338903,4.79412232137809e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C7orf50,Uncharacterized protein C7orf50,24845,-0.0117428998740431,0.0016250442933106,-0.0149279866889319,-0.00855781305915434,5.11021994063138e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,24111,-0.0236276754561532,0.0032738565583818,-0.0300444343105816,-0.0172109166017249,5.46894262885586e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CALB1,Calbindin,29349,-0.0227713242835654,0.00317357859956542,-0.0289915383387136,-0.0165511102284172,7.38686305019464e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PSPN,Persephin,29434,-0.0489232777225903,0.00682665668706172,-0.0623035248292313,-0.0355430306159494,7.87458566297369e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EDN1,Endothelin-1,24240,-0.015250307895328,0.00212974830647938,-0.0194246145760276,-0.0110760012146285,8.26080968595718e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,24381,-0.0193045439075942,0.00270397296480529,-0.0246043309186126,-0.0140047568965758,9.64195757929885e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MYL4,Myosin light chain 4,24240,-0.0270990948728727,0.00379791544350093,-0.0345430091421346,-0.0196551806036109,9.93265209461324e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,APPL2,DCC-interacting protein 13-beta,24381,-0.0583414577864356,0.00817741373074807,-0.0743691886987018,-0.0423137268741694,9.9882617179964e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,29628,0.0104805538892464,0.0014713080443554,0.00759679012230983,0.013364317656183,1.07785081082372e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,28931,-0.0223294840365938,0.00313495095124987,-0.0284739879010435,-0.016184980172144,1.08263383350791e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,28774,-0.0255309883564927,0.00358767109014879,-0.0325628236931843,-0.018499153019801,1.13447810504973e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",29365,-0.0344838203485506,0.00485283156989711,-0.043995370225549,-0.0249722704715523,1.22251084882873e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,24805,-0.0507417104524711,0.00715599818884515,-0.0647674669026076,-0.0367159540023346,1.3692034477987e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,24769,-0.0450795397082578,0.00637519561377456,-0.0575749231112559,-0.0325841563052597,1.5781184701582e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLK13,Kallikrein-13,28845,-0.0226358221490715,0.00320496478841816,-0.0289175531343711,-0.0163540911637719,1.66954520797783e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,29349,-0.0107485182269175,0.00152408231425232,-0.013735719562852,-0.00776131689098289,1.79683290740244e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,28797,-0.0240605357865936,0.0034127984491637,-0.0307496207469544,-0.0173714508262327,1.82832190757366e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ABHD14B,Protein ABHD14B,29121,-0.0292643897575595,0.00415875656431518,-0.0374155526236172,-0.0211132268915017,2.01037934254447e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STK4,Serine/threonine-protein kinase 4,29478,-0.0441805789831605,0.00628467522486743,-0.0564985424239006,-0.0318626155424203,2.11194020480648e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CST5,Cystatin-D,28890,-0.0283499216705835,0.00403373118727253,-0.0362560347976377,-0.0204438085435293,2.13837544638525e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,24195,-0.024762456519742,0.0035278400946045,-0.0316770231051668,-0.0178478899343172,2.29109908707773e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CASP1,Caspase-1,28774,-0.0344738514151321,0.0049402811011158,-0.044156802373319,-0.0247909004569451,3.0564518654408e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL17C,Interleukin-17C,28931,-0.0356456109358786,0.00511757519784208,-0.0456760583236491,-0.0256151635481081,3.34635584804107e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,28916,-0.0272379538553116,0.00393035849567887,-0.0349414565068422,-0.019534451203781,4.29225493255652e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD101,Immunoglobulin superfamily member 2,24805,-0.0216207874135157,0.0031223902073286,-0.0277406722198797,-0.0155009026071516,4.48401850230429e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",24938,-0.0210747918404225,0.00304612318729577,-0.0270451932875223,-0.0151043903933228,4.67288689775032e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCARF2,Scavenger receptor class F member 2,29694,0.0146511613354421,0.00211810841761138,0.0104996688369238,0.0188026538339605,4.70333572991177e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DAPK2,Death-associated protein kinase 2,24229,-0.0270215503924478,0.00391245520666692,-0.034689962597515,-0.0193531381873807,5.08881190042874e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GP5,Platelet glycoprotein V,24381,-0.018190874650452,0.00263981147948195,-0.0233649051502366,-0.0130168441506674,5.67612003054096e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,29349,-0.0267726323055675,0.0038883209847905,-0.0343937414357569,-0.0191515231753782,5.87869915220449e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DPEP2,Dipeptidase 2,29349,0.0146176071757457,0.00212971994411067,0.0104433560852888,0.0187918582662026,6.84677544524244e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLC51B,Organic solute transporter subunit beta,24111,-0.0382545151204402,0.00557605750791931,-0.049183587835962,-0.0273254424049183,7.02835044347466e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DSC2,Desmocollin-2,29135,-0.0171050192552062,0.00249693551188981,-0.0219990128585102,-0.0122110256519022,7.51051289299817e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TPMT,Thiopurine S-methyltransferase,28797,-0.036204733962077,0.00529173926079121,-0.0465765429132278,-0.0258329250109263,7.97996548617917e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",24240,-0.0247297364668054,0.00361533232096062,-0.0318157878158882,-0.0176436851177226,8.09426936204604e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NAA10,N-alpha-acetyltransferase 10,24111,-0.0253755241264047,0.00371360615823873,-0.0326541921965526,-0.0180968560562568,8.50659256485767e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AKAP12,A-kinase anchor protein 12,24381,0.0107396096615502,0.00157318276088809,0.0076561714502096,0.0138230478728909,8.89442767880662e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATXN10,Ataxin-10,28774,-0.0361167852632763,0.00529107384933772,-0.0464872900079782,-0.0257462805185744,8.90578833884428e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,UROS,Uroporphyrinogen-III synthase,24195,-0.0340114573297433,0.00498253812128188,-0.0437772320474558,-0.0242456826120309,8.92982498704475e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,28662,-0.0285704067610274,0.00418784731434967,-0.0367785874971528,-0.0203622260249021,9.14279595594459e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITGA6,Integrin alpha-6,29434,-0.0258016715956133,0.00378341559607723,-0.0332171661639246,-0.0183861770273019,9.30091367539905e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,28797,-0.0148523697038859,0.00218223371987976,-0.0191295477948503,-0.0105751916129216,1.02288589716048e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,29594,-0.0226800586895985,0.00333767893728864,-0.0292219094066842,-0.0161382079725127,1.10243558261599e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,29434,-0.0597216443108443,0.00880743057506513,-0.0769842082379719,-0.0424590803837166,1.2174959354341e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,24951,-0.0358741203570007,0.00529562197604336,-0.0462535394300457,-0.0254947012839557,1.27792415154936e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COMMD9,COMM domain-containing protein 9,24793,-0.0194472634109132,0.0028774489183635,-0.0250870632909057,-0.0138074635309208,1.42511532998879e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCRN1,Secernin-1,29434,-0.0273878406978607,0.00405449710641089,-0.035334655026426,-0.0194410263692953,1.45564908270251e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANPEP,Aminopeptidase N,29531,0.0137476654687212,0.00204032486025978,0.00974862874261199,0.0177467021948303,1.63555042045164e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PER3,Period circadian protein homolog 3,24229,-0.0589660432612504,0.00875128735232905,-0.0761185664718153,-0.0418135200506854,1.64200197467621e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD22,B-cell receptor CD22,29786,-0.0204579188473583,0.00303703308804967,-0.0264105036999356,-0.0145053339947809,1.65593569239674e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,24240,-0.0118033182834132,0.00175249833848714,-0.015238215026848,-0.00836842153997841,1.67439856315153e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,28719,-0.0207499875580148,0.00308178453525762,-0.0267902852471198,-0.0147096898689099,1.6920540633317e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,24381,-0.0335908561322647,0.00500192457593801,-0.0433946283011032,-0.0237870839634262,1.91431679572613e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,29434,-0.0584440431718854,0.00873299783177803,-0.0755607189221704,-0.0413273674216005,2.2359591143424e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,24793,-0.0264567068079455,0.0039549670988672,-0.0342084423217252,-0.0187049712941658,2.28721415628311e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPL,Periplakin,24229,-0.0159505658681914,0.00238522111324108,-0.0206255992501439,-0.0112755324862389,2.32356098647936e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,24922,0.017241420173252,0.00258584152753736,0.0121731707792788,0.0223096695672253,2.65413816805771e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",28719,-0.0227414718612324,0.00341424832246759,-0.0294333985732689,-0.016049545149196,2.77341760592199e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SUSD5,Sushi domain-containing protein 5,24273,0.0166821847925879,0.00250544408843577,0.0117715143792538,0.021592855205922,2.82786696496317e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KIF1C,Kinesin-like protein KIF1C,24111,-0.0176220416786559,0.00264901947049371,-0.0228141198408236,-0.0124299635164882,2.94753645521236e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANXA1,Annexin A1,24281,-0.0207697789981752,0.00312297255048,-0.026890805197116,-0.0146487527992344,2.98015573105967e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CORO1A,Coronin-1A,28847,-0.0430613589965091,0.00647697087887529,-0.0557562219191047,-0.0303664960739135,3.01624110176802e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLK11,Kallikrein-11,29296,-0.014891166072077,0.00224006178489932,-0.0192816871704797,-0.0105006449736744,3.03019806123781e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GZMH,Granzyme H,28916,-0.0369262817720032,0.00555590388653341,-0.0478158533896087,-0.0260367101543977,3.05865245034373e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RAB37,Ras-related protein Rab-37,28931,-0.0396359700314393,0.0059754719995709,-0.0513478951505982,-0.0279240449122803,3.3447733540363e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,24381,-0.0306748649957479,0.00463187006770051,-0.0397533303284409,-0.0215963996630549,3.60364787945635e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STXBP1,Syntaxin-binding protein 1,24867,-0.0374330668620256,0.0056546762455058,-0.048516232303217,-0.0263499014208343,3.66906844357494e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HRG,Histidine-rich glycoprotein,24833,-0.015142724401882,0.00228756557088136,-0.0196263529208095,-0.0106590958829546,3.67567055926597e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FADD,FAS-associated death domain protein,29478,-0.0366402972030951,0.00554089710938352,-0.0475004555374868,-0.0257801388687034,3.83817639546088e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRG3,Proteoglycan 3,24938,0.0239765004966111,0.00363678420463574,0.0168484034555251,0.0311045975376972,4.40308240782181e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTRC,Chymotrypsin-C,29456,0.0304892178853668,0.00464472978866769,0.0213855474995781,0.0395928882711555,5.31602095069526e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,29349,-0.00967744631675038,0.00147603696186925,-0.0125704787620141,-0.00678441387148665,5.60476990188419e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FCRL2,Fc receptor-like protein 2,29645,-0.0234590762589728,0.00358171981109027,-0.0304792470887097,-0.0164389054292359,5.86084734448086e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LIF,Leukemia inhibitory factor,28774,-0.0244329885433064,0.00373933130787789,-0.031762077906747,-0.0171038991798657,6.50824255326472e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,29820,-0.0109687335335499,0.00168183655251002,-0.0142651331764695,-0.00767233389063022,7.05427158243846e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RP2,Protein XRP2,29349,-0.0198339112623158,0.00304119052545702,-0.0257946446922115,-0.01387317783242,7.06168742115483e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BCAM,Basal cell adhesion molecule,29443,0.0113851464785538,0.00174889963712759,0.00795730318978377,0.0148129897673239,7.64146965741405e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DLL1,Delta-like protein 1,29566,-0.0141092933923707,0.00217186511458234,-0.0183661490169521,-0.00985243776778932,8.3574334829177e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RBP2,Retinol-binding protein 2,29349,0.0362694759730466,0.00558419651494241,0.0253244508037595,0.0472145011423337,8.43490719231475e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",24922,-0.0252741090229707,0.0038910703757143,-0.0329006069593708,-0.0176476110865707,8.43676027798008e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,29223,-0.0190785351808526,0.0029383845766352,-0.0248377689510576,-0.0133193014106476,8.55697011404511e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CPB2,Carboxypeptidase B2,24914,-0.010684161603376,0.00164667057810091,-0.0139116359364538,-0.00745668727029824,8.84164331334976e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTSV,Cathepsin L2,29618,0.0194808733650807,0.00300897225394682,0.0135832877473449,0.0253784589828165,9.67673122129547e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,28797,-0.0277212825404395,0.0042868327685449,-0.0361234747667875,-0.0193190903140915,1.01830335410941e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DPP7,Dipeptidyl peptidase 2,29279,-0.0282712260343416,0.00437529765125236,-0.0368468094307962,-0.019695642637887,1.05260095450873e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",29402,0.0261291722492666,0.00404384141898963,0.0182032430680469,0.0340551014304862,1.05310139057364e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLA2G1B,Phospholipase A2,29787,0.0202083835986439,0.00313185332625017,0.0140699510791935,0.0263468161180942,1.116852130403e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SNX2,Sorting nexin-2,24793,-0.0382555780736032,0.00592887851550192,-0.049876179963987,-0.0266349761832194,1.12115443624486e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,29194,-0.0459231082739718,0.00711887785780701,-0.0598761088752735,-0.03197010767267,1.12934210267844e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SF3B4,Splicing factor 3B subunit 4,29349,-0.0341050881684339,0.00529425342429569,-0.0444818248800535,-0.0237283514568144,1.19807999576319e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DGCR6,Protein DGCR6,24101,-0.0206044367344153,0.00319923038405086,-0.026874928287155,-0.0143339451816756,1.21378545457803e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",29395,-0.0511435208343934,0.00794834584773632,-0.0667222786959566,-0.0355647629728302,1.25798002254619e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,28797,-0.0245513521714475,0.00382201122700153,-0.0320424941763705,-0.0170602101665245,1.35100142540833e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,28797,-0.0246749493620833,0.00384381712190404,-0.0322088309210152,-0.0171410678031513,1.38953695853134e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD70,CD70 antigen,29434,0.0199311626570616,0.00310576232718346,0.013843868495782,0.0260184568183412,1.4065685183229e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,24938,-0.0106348947890393,0.00166013612302856,-0.0138887615901753,-0.00738102798790337,1.52015080554043e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SEMA4C,Semaphorin-4C,29349,0.0131004805298503,0.00204625268752102,0.00908982526230911,0.0171111357973915,1.55486855825245e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MIA,Melanoma-derived growth regulatory protein,29566,-0.0171627241489545,0.00268120109892402,-0.0224178783028456,-0.0119075699950634,1.56539798008749e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLEC3B,Tetranectin,24381,0.00998902684926064,0.00156173528722968,0.00692802568629046,0.0130500280122308,1.62279834579152e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLMP,CXADR-like membrane protein,29725,-0.00983060938413301,0.00153859576620868,-0.012846257085902,-0.00681496168236399,1.69070198248992e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NPTX2,Neuronal pentraxin-2,24938,0.0155152390539114,0.00242968000711661,0.0107530662399628,0.0202774118678599,1.73607250504753e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,THBD,Thrombomodulin,29478,-0.0132892622190636,0.00208230466586134,-0.0173705793641518,-0.00920794507397537,1.77390031921793e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SIL1,Nucleotide exchange factor SIL1,24240,-0.0150479334672864,0.00235805019260181,-0.0196697118447859,-0.0104261550897868,1.78515737378382e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,29216,-0.0270408185010601,0.00424057550727834,-0.0353523464953256,-0.0187292905067945,1.83664654271068e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,24177,-0.0271775382095638,0.0042644860346625,-0.0355359308375023,-0.0188191455816253,1.88718919483028e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C2orf69,UPF0565 protein C2orf69,24195,-0.0276545122488871,0.00434990019697975,-0.0361803166349674,-0.0191287078628068,2.08718185555986e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SAA4,Serum amyloid A-4 protein,24966,-0.0151580918226145,0.00238680208693933,-0.0198362239130156,-0.0104799597322134,2.17894451912475e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STXBP3,Syntaxin-binding protein 3,28797,-0.0202141286275537,0.00318477435091978,-0.0264562863553564,-0.0139719708997509,2.22655971154201e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,29673,-0.0139968026081692,0.00221094121740757,-0.0183302473942881,-0.00966335782205041,2.47542632680954e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,29434,-0.068918933100241,0.0108993674753423,-0.090281693351912,-0.0475561728485701,2.59868733358558e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",24845,0.0275626004844938,0.00437237672504904,0.0189927421033977,0.0361324588655899,2.95312894474274e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,24845,-0.0169454550274634,0.00269606841064738,-0.0222297491123323,-0.0116611609425945,3.32773312383917e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,24805,-0.0520759292704682,0.00828939704029884,-0.0683231474694539,-0.0358287110714825,3.39287535955348e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EPHB6,Ephrin type-B receptor 6,29163,-0.0145293628544301,0.00231597934715772,-0.0190686823748592,-0.00999004333400096,3.5791077113367e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDCD1,Programmed cell death protein 1,29661,-0.0195250258404459,0.00311808150089073,-0.0256364655821917,-0.0134135860987,3.85595692437642e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BTC,Probetacellulin,28797,-0.0338617318344859,0.00540782081320267,-0.0444610606283631,-0.0232624030406087,3.86369255398783e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,29478,0.0117078477356921,0.00187061954190849,0.0080414334335515,0.0153742620378328,3.9327002216492e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,28774,-0.0186993824575269,0.00299533511890174,-0.0245702392905743,-0.0128285256244795,4.35708315556935e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,24111,-0.0452546822906264,0.00725463033580745,-0.059473757748809,-0.0310356068324438,4.50451734646679e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,24445,-0.0315993910793373,0.00508166605015846,-0.0415594565376479,-0.0216393256210267,5.10666572572496e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BCL2,Apoptosis regulator Bcl-2,24805,-0.024297148553116,0.00391398780911913,-0.0319685646589895,-0.0166257324472425,5.45925832921477e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,24111,-0.0206378361134988,0.00333471219219484,-0.0271738720102007,-0.0141018002167969,6.1604640724775e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,29114,-0.0149159251473533,0.00241670444743746,-0.0196526658643307,-0.0101791844303759,6.83163386952736e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AOC3,Membrane primary amine oxidase,29594,0.013534004529902,0.00219510185192226,0.00923160490013435,0.0178364041596696,7.11472651289215e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HMOX1,Heme oxygenase 1,29165,0.0215291854391739,0.00349190734953335,0.0146850470340886,0.0283733238442593,7.12037823922594e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OBP2B,Odorant-binding protein 2b,29137,0.0280139799385274,0.00454863711945536,0.0190986511843948,0.0369293086926599,7.42732299675627e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",24240,-0.0409383281043807,0.00667627795962137,-0.0540238329052386,-0.0278528233035228,8.81732105026018e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GPA33,Cell surface A33 antigen,29349,-0.0601072635427794,0.00981133261935438,-0.079337475476714,-0.0408770516088448,9.10834380787389e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GBP4,Guanylate-binding protein 4,28774,-0.0218717803903234,0.00357316224389039,-0.0288751783883485,-0.0148683823922982,9.41161276675129e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,29623,-0.0365486893280651,0.0059759766736839,-0.0482616036084855,-0.0248357750476447,9.71923937204955e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRDX6,Peroxiredoxin-6,29725,0.0264499651404316,0.0043441212595583,0.0179354874716973,0.0349644428091659,1.15239355690259e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL1R1,Interleukin-1 receptor type 1,29390,-0.0101725475068392,0.00167182264690579,-0.0134493198947746,-0.00689577511890388,1.18147853686448e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ENO2,Gamma-enolase,29694,-0.0289074586017901,0.00475339728893723,-0.0382241172881071,-0.0195907999154731,1.20567818728046e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PMM2,Phosphomannomutase 2,24111,-0.0266651181143941,0.00438507519527117,-0.0352598654971256,-0.0180703707316626,1.21322150734385e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SNX18,Sorting nexin-18,24805,-0.0197486370926032,0.00325408995104074,-0.026126653396643,-0.0133706207885633,1.30684660479211e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SEZ6L,Seizure 6-like protein,29566,0.0120878802394311,0.0019975337788725,0.00817271403284098,0.0160030464460212,1.45316267887737e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,29786,-0.0258166554132258,0.00428030561848342,-0.0342060544254534,-0.0174272564009983,1.64359640579906e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,24381,0.0123959916541228,0.00205773881421645,0.00836282357825857,0.016429159729987,1.72507975267364e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,29349,-0.00950486570362904,0.00158125626708011,-0.0126041279871061,-0.00640560342015202,1.86604872427834e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CASP9,Caspase-9,24229,-0.0275656530505404,0.00459341907732789,-0.0365687544421031,-0.0185625516589777,1.98747610731182e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CFHR2,Complement factor H-related protein 2,24789,-0.0249479269099766,0.00415754026040034,-0.0330967058203612,-0.0167991479995919,1.99262866512547e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,29594,-0.0187061785591893,0.00311996707216398,-0.0248213140206307,-0.0125910430977479,2.05041016905763e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRG2,Bone marrow proteoglycan,24938,0.0225517333725781,0.00377541563589722,0.0151519187262195,0.0299515480189366,2.35636992587261e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,S100A11,Protein S100-A11,29208,-0.0197372749871736,0.00330665157809341,-0.0262183120802367,-0.0132562378941105,2.4152194312456e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,24111,-0.0242307416053375,0.00406426051476374,-0.0321966922142745,-0.0162647909964006,2.52781826254792e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,24016,-0.029013882439598,0.00486907907178874,-0.0385572774203039,-0.019470487458892,2.57635918327318e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RGS10,Regulator of G-protein signaling 10,24867,-0.0258871171592922,0.00435196236563455,-0.0344169633959359,-0.0173572709226484,2.74434376938821e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,24381,-0.01602722975962,0.00269447181733976,-0.0213083945216059,-0.010746064997634,2.74822310240655e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,24805,-0.0171677491763804,0.00289435116079719,-0.0228406774515429,-0.0114948209012179,3.04220143598051e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,24445,-0.0376666224338762,0.00635358080992633,-0.0501196408213318,-0.0252136040464206,3.09992157552637e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,29349,-0.0134471860738877,0.00227447188653944,-0.017905150971505,-0.00898922117627045,3.41250942129232e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,29725,0.0251834522335856,0.0042596136169192,0.016834609544424,0.0335322949227473,3.41366495828452e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,24738,0.011707409281839,0.00198024937808466,0.00782612050079306,0.0155886980628849,3.42230929037442e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",24793,-0.0223046280013582,0.00378601363013326,-0.0297252147164194,-0.014884041286297,3.88065199815717e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,24240,-0.0269328184822006,0.0045803321779258,-0.0359102695509352,-0.017955367413466,4.15392090855089e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PROCR,Endothelial protein C receptor,24111,0.0153811545506306,0.00261630741728732,0.0102531920127474,0.0205091170885137,4.1830331762754e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",28797,-0.0216233298349284,0.00367867520210533,-0.0288335332310548,-0.0144131264388019,4.19773247247151e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",24381,-0.0381509232153154,0.00649293722504611,-0.0508770801764058,-0.025424766254225,4.26386940382039e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RBP7,Retinoid-binding protein 7,24805,-0.025793426618912,0.00439025116303649,-0.0343983188984636,-0.0171885343393605,4.27831422515087e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,28931,-0.0285443966122468,0.00486341337493077,-0.0380766868271111,-0.0190121063973825,4.42647345614017e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,24805,0.0215469191439555,0.00367369000951716,0.0143464867253019,0.0287473515626091,4.54288832071495e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,28931,-0.025352620797783,0.00432609499312014,-0.0338317669842985,-0.0168734746112675,4.66773357111822e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LIPF,Gastric triacylglycerol lipase,24240,-0.0260813040787176,0.00445625855774571,-0.0348155708518992,-0.017347037305536,4.89778856491754e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SDHB,Succinate dehydrogenase,24805,-0.0293131362498998,0.0050145371932302,-0.039141629148631,-0.0194846433511686,5.10969923477633e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IFNL1,Interferon lambda-1,28774,-0.0192069515222115,0.00329845294272492,-0.0256719192899523,-0.0127419837544707,5.84082886228128e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,29462,-0.0245311226925837,0.00422335946354323,-0.0328089072411284,-0.016253338144039,6.37061304195749e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",24867,-0.0387161199555671,0.00667531128081882,-0.051799730065972,-0.0256325098451622,6.71593275574579e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD300LF,CMRF35-like molecule 1,29725,-0.025368879982082,0.0043822176074081,-0.0339580264926019,-0.0167797334715621,7.14967449758068e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,24801,-0.0157276901900041,0.00271996695031345,-0.0210588254126184,-0.0103965549673897,7.45664304287891e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STC2,Stanniocalcin-2,29396,-0.0109026454100541,0.00188588291563619,-0.014598975924701,-0.00720631489540714,7.49244120603943e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,29132,-0.0126018459641578,0.00218329429715112,-0.016881102786574,-0.00832258914174159,7.91579883201362e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PREB,Prolactin regulatory element-binding protein,28931,-0.0121561447948573,0.00210871414955108,-0.0162892245279774,-0.0080230650617372,8.2624885880377e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NRCAM,Neuronal cell adhesion molecule,29478,-0.0118425219839843,0.00205957583130775,-0.0158792906133474,-0.00780575335462106,9.01344233233771e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,24793,-0.0167093139831169,0.00291543913708766,-0.0224235746918088,-0.0109950532744251,1.00807917239153e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C1S,Complement C1s subcomponent,24966,-0.00872111348060812,0.0015243524590597,-0.0117088443003651,-0.00573338266085111,1.06988961201631e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,YAP1,Transcriptional coactivator YAP1,24845,-0.0112578248757292,0.00197066875673525,-0.0151203356389303,-0.00739531411252814,1.12473125374033e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTX3,Pentraxin-related protein PTX3,29434,0.0205124370512632,0.00359142255191018,0.0134732488495192,0.0275516252530071,1.1305802313249e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AHCY,Adenosylhomocysteinase,29478,-0.0280274581190393,0.0049076161733853,-0.0376463858188745,-0.0184085304192041,1.13385341757803e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",24938,-0.025937935194343,0.00454659618654044,-0.0348492637199622,-0.0170266066687237,1.17720696025772e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,24729,-0.0183639295034985,0.00322906237405875,-0.0246928917566536,-0.0120349672503433,1.30689315350174e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,29478,0.0131587053808552,0.00231534881686108,0.00862062169980748,0.0176967890619029,1.33405464516863e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,29478,-0.0202349916659413,0.00356119598203496,-0.0272149357907298,-0.0132550475411527,1.34322218664368e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CFHR5,Complement factor H-related protein 5,24623,0.017320197585986,0.00305059062975794,0.0113410399516604,0.0232993552203115,1.3809184950439e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,24195,-0.0222686276617871,0.00392642681573257,-0.0299644242206229,-0.0145728311029513,1.43189181828944e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",24793,-0.0153201313411748,0.00270432827791891,-0.0206206147658959,-0.0100196479164537,1.48618129040933e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CGA,Glycoprotein hormones alpha chain,29443,0.03300503859921,0.00582677552572569,0.0215845585687877,0.0444255186296324,1.48937122538469e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,24867,-0.0124294741484952,0.00219685641492698,-0.0167353127217521,-0.00812363557523831,1.54970332980224e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CXCL12,Stromal cell-derived factor 1,28931,0.0164473138919959,0.0029108822048202,0.0107419847705483,0.0221526430134435,1.61686852396153e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CA13,Carbonic anhydrase 13,29114,-0.0428408151315791,0.00758578978189348,-0.0577089631040903,-0.0279726671590679,1.64306121369775e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,28931,-0.0144135964013227,0.00255699663542219,-0.0194253098067502,-0.00940188299589522,1.74725486686153e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,29434,0.0191751486461882,0.00340294920449092,0.012505368205386,0.0258449290869904,1.76799152187459e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",24111,-0.0258133785497605,0.00458372963749621,-0.0347974886392531,-0.016829268460268,1.80614477620793e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL10,Interleukin-10,28931,-0.0334938433897683,0.0059490977804189,-0.0451540750393894,-0.0218336117401473,1.81804075566972e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,28916,-0.025274775628049,0.00449303181106735,-0.034081117977741,-0.0164684332783569,1.86866781948119e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,24381,0.010456824581846,0.00186470378306959,0.00680200516702961,0.0141116439966624,2.07173650501207e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",29786,-0.0276051238657892,0.00492795232635961,-0.037263910425454,-0.0179463373061243,2.14078633335892e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCS,Copper chaperone for superoxide dismutase,29218,-0.0192765554272939,0.00344322981964733,-0.0260252858738027,-0.0125278249807851,2.18288456300733e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDK1,Cyclin-dependent kinase 1,24016,-0.0148866530625247,0.0026629382911682,-0.0201060121132144,-0.00966729401183503,2.29126008163603e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCT,Secretin,24195,-0.0191352477471775,0.00342517208208886,-0.0258485850280716,-0.0124219104662833,2.33977662907542e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACHE,Acetylcholinesterase,24381,-0.0134763691112583,0.00241313995079396,-0.0182061234148144,-0.0087466148077021,2.36764857576393e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NPTX1,Neuronal pentraxin-1,29443,0.0164941127186578,0.00295472878933477,0.0107028442915617,0.022285381145754,2.39480798283081e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LXN,Latexin,29117,0.0272387484895438,0.00488641837428664,0.017661368475942,0.0368161285031456,2.50613774174284e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,29434,-0.0371072740255494,0.00665982270141358,-0.0501605265203201,-0.0240540215307788,2.54308802169767e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,29341,-0.0140929118888756,0.00253466306012406,-0.0190608514867187,-0.00912497229103241,2.72007435505121e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,24915,-0.0100803459188334,0.00181305567071289,-0.0136339350334307,-0.00652675680423615,2.72749788258897e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARFIP1,Arfaptin-1,24867,-0.0278921665959474,0.00502176742463641,-0.0377348307482348,-0.0180495024436601,2.81653545255885e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SATB1,DNA-binding protein SATB1,24867,-0.012025064924835,0.00216699374559067,-0.0162723726661927,-0.00777775718347728,2.89917863742993e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,28931,-0.0171212254061207,0.00308718549113597,-0.0231721089687472,-0.0110703418434942,2.94998708000777e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,24793,-0.0181985235902331,0.00328132316743287,-0.0246299169984015,-0.0117671301820646,2.95103579740206e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MYOM3,Myomesin-3,24381,0.0377879291556858,0.00681936889044604,0.0244219661304115,0.05115389218096,3.03399608214908e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PI16,Peptidase inhibitor 16,24951,0.00992573040757217,0.00179230947149961,0.00641280384343294,0.0134386569717114,3.09107073931165e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CASP8,Caspase-8,29632,-0.02473728813938,0.00446975112523912,-0.0334980003448486,-0.0159765759339113,3.1497846455518e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PEPD,Xaa-Pro dipeptidase,24951,0.0105551164404163,0.0019118679438043,0.00680785527055985,0.0143023776102727,3.40743162319397e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RAB2B,Ras-related protein Rab-2B,24793,-0.0248558284913964,0.00450279475633102,-0.0336813062138052,-0.0160303507689876,3.42221592610976e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,24229,-0.0123521546373557,0.00224839998690733,-0.0167590186116941,-0.00794529066301738,3.9743929352459e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLK10,Kallikrein-10,29466,-0.0159380864007293,0.00290332868349631,-0.021628610620382,-0.0102475621810765,4.06186398623692e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RNASE3,Eosinophil cationic protein,29343,-0.0432734410034663,0.00789347188933008,-0.0587446459065533,-0.0278022361003794,4.23573159958277e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD99,CD99 antigen,29443,0.00780847359742222,0.00142943197123893,0.00500678693379392,0.0106101602610505,4.72898783087792e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,29433,-0.0127249368267309,0.00233130605472681,-0.0172942966939955,-0.00815557695946638,4.84630414553605e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGA,Fibrinogen alpha chain,24407,0.012258616786072,0.00225554317233585,0.00783775216829379,0.0166794814038503,5.53570657383038e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PSMG4,Proteasome assembly chaperone 4,24229,-0.0222577582151169,0.00409592699887512,-0.0302857751329121,-0.0142297412973216,5.55985678607156e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GDF2,Growth/differentiation factor 2,29478,0.0140307859063495,0.00259012733824511,0.00895413632338913,0.01910743548931,6.10727476325352e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,29652,-0.0110478325802013,0.00204351306059651,-0.0150531181789704,-0.00704254698143214,6.48386504396309e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TK1,"Thymidine kinase, cytosolic",24445,-0.0180466571392206,0.00334467926096521,-0.0246022284907125,-0.0114910857877288,6.89177112724925e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,24445,-0.028504313238055,0.00528468620980396,-0.0388622982092708,-0.0181463282668392,6.96401042872335e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NPTXR,Neuronal pentraxin receptor,29478,0.013337106413102,0.00247533561795232,0.00848544860191545,0.0181887642242885,7.17921839179392e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCGB2A2,Mammaglobin-A,24111,0.0124108161172652,0.00230519454519072,0.00789263480869135,0.016928997425839,7.35916621590227e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VEGFB,Vascular endothelial growth factor B,24229,-0.0113453292925415,0.00211080801451248,-0.0154825130009859,-0.00720814558409701,7.73439415376331e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RGMB,RGM domain family member B,29694,-0.0105118870124099,0.00195595751970253,-0.0143455637510268,-0.0066782102737929,7.74631005756056e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LY96,Lymphocyte antigen 96,29218,-0.0138869279764714,0.00258421405172096,-0.0189519875178445,-0.00882186843509835,7.7704439639689e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,29349,-0.0174629912105652,0.00326581710562422,-0.0238639927375886,-0.0110619896835417,8.99905127522637e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TPSAB1,Tryptase alpha/beta-1,29753,-0.0203270674694376,0.00380447646178388,-0.027783841334534,-0.0128702936043412,9.21258091575959e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",29632,-0.0275700129928414,0.00517143035486252,-0.0377060164883719,-0.0174340094973109,9.82707314978224e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FCRL1,Fc receptor-like protein 1,29478,-0.017543660890468,0.00330134911355143,-0.0240143051530288,-0.0110730166279072,1.07970904315268e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDHR1,Cadherin-related family member 1,28774,-0.0165413543968129,0.00311274257784882,-0.0226423298493966,-0.0104403789442292,1.07996617785415e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,28797,-0.0207502843542835,0.00391069994814482,-0.0284152562526473,-0.0130853124559196,1.12867517366009e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRDX2,Peroxiredoxin-2,24556,-0.0238363596658146,0.00449930860970831,-0.0326550045408429,-0.0150177147907863,1.18227550741396e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,24845,-0.0270419333799309,0.00511577450028316,-0.0370688514004859,-0.0170150153593759,1.26082453444596e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,24951,-0.0100549642890521,0.00190378087416694,-0.0137863748024193,-0.00632355377568493,1.29150453448279e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRH,Corticoliberin,28751,-0.0332951111589962,0.00631762187796283,-0.0456776500398033,-0.020912572278189,1.37259940524006e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CILP,Cartilage intermediate layer protein 1,24938,-0.0209070157920068,0.00396776218807461,-0.028683829680633,-0.0131302019033805,1.38142421150367e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,28719,-0.0182999255724245,0.00348645749202788,-0.0251333822567991,-0.0114664688880498,1.54131019452703e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,23623,-0.0413535848219668,0.00789911704050312,-0.0568358542213529,-0.0258713154225807,1.66201966086123e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,29581,0.0162016140998719,0.00309652052002408,0.0101324338806247,0.0222707943191191,1.68645609409517e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,THPO,Thrombopoietin,28916,-0.0146411621681086,0.00280276176299561,-0.02013457522358,-0.00914774911263723,1.7646978157507e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SNU13,NHP2-like protein 1,24111,-0.023822956920322,0.00456564031159069,-0.0327716119310397,-0.0148743019096043,1.82481715800039e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,24845,-0.0910512176999671,0.0174540215510083,-0.125261099939943,-0.0568413354599909,1.83666900926135e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,24016,-0.0291347330656221,0.00559287166518012,-0.0400967615293751,-0.018172704601869,1.91158486766486e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TEK,Angiopoietin-1 receptor,29566,-0.00825527341916048,0.00158692801540025,-0.011365652329345,-0.00514489450897599,1.98419460536504e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,29349,0.0126795746566748,0.0024379227573754,0.00790124605221906,0.0174579032611306,1.99576024940403e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,29497,-0.0100932525223571,0.00194145471546859,-0.0138985037646756,-0.00628800128003868,2.01905955331791e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,29326,-0.0107594016674369,0.00207014361670892,-0.0148168831561864,-0.00670192017868742,2.03428777228743e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SEPTIN9,Septin-9,29349,-0.0107273106682071,0.0020640548845102,-0.0147728582418471,-0.00668176309456714,2.03663647790899e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,28797,-0.0165436498827264,0.0031862028846977,-0.0227886075367339,-0.0102986922287189,2.09148196889897e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,UNC5D,Netrin receptor UNC5D,24229,0.0100065385595252,0.00192798558540826,0.00622768681212497,0.0137853903069253,2.11817228694517e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SEZ6,Seizure protein 6 homolog,24195,0.0118356289518674,0.0022823594907904,0.00736220434991816,0.0163090535538165,2.16938953840234e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FXN,"Frataxin, mitochondrial",29725,-0.0275801240962244,0.00532386189864571,-0.03801489341757,-0.0171453547748788,2.22767351184245e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PMS1,PMS1 protein homolog 1,24195,-0.0192036492484302,0.00370817218383614,-0.026471666728749,-0.0119356317681113,2.25182072511884e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRYGD,Gamma-crystallin D,24845,-0.0364603099080143,0.00705373121287535,-0.05028562308525,-0.0226349967307786,2.37248686307422e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SAFB2,Scaffold attachment factor B2,24867,-0.010338700965537,0.00200301373220493,-0.0142646078806586,-0.00641279405041533,2.46767464351459e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,29725,-0.01439185208028,0.00278946879726184,-0.0198592109229132,-0.00892449323764676,2.49396730803807e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDIA3,Protein disulfide-isomerase A3,24381,-0.00941955878578066,0.00183092159009494,-0.0130081651023667,-0.00583095246919459,2.70011554742131e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SDC1,Syndecan-1,29478,-0.0150212245051446,0.00292279698777227,-0.0207499066011783,-0.00929254240911098,2.774750789107e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDIA5,Protein disulfide-isomerase A5,24016,-0.0229811308175428,0.00447803485518806,-0.0317580791337114,-0.0142041825013742,2.8896216656334e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINC1,Antithrombin-III,24914,-0.0054982619195948,0.00107769087414932,-0.00761053603292747,-0.00338598780626214,3.3874353186704e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NOS1,"Nitric oxide synthase, brain",28774,-0.0200898791171987,0.00394097664047677,-0.0278141933325332,-0.0123655649018643,3.45999280551301e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,29508,0.0182212293872703,0.00358166720716353,0.0112011616612297,0.0252412971133108,3.65306774812864e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,29820,0.0116734324443014,0.00230153315775613,0.00716242745509943,0.0161844374335035,3.95963719318308e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GC,Vitamin D-binding protein,24966,-0.00956092434792567,0.00188716217344775,-0.0132597622078833,-0.00586208648796807,4.08519888166282e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,29349,-0.0088959556217628,0.00175730862933343,-0.0123402805352563,-0.00545163070826928,4.1681561803581e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,24111,-0.0149076755119026,0.00295422685877773,-0.0206979601551069,-0.00911739086869824,4.53914742471127e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLK8,Kallikrein-8,28443,-0.0131105580425255,0.00261089143861497,-0.0182279052622108,-0.00799321082284014,5.15827401582286e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MANSC1,MANSC domain-containing protein 1,29566,0.0100527963168339,0.00200308363614743,0.0061267523899849,0.0139788402436828,5.23348547546714e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,24381,-0.0117830198879234,0.00235219598026235,-0.0163933240092376,-0.00717271576660922,5.49900771261153e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LUZP2,Leucine zipper protein 2,24793,-0.0163424798679513,0.00326607005519508,-0.0227439771761337,-0.00994098255976896,5.66209299863482e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,24111,0.00746318731889123,0.00149199408316191,0.00453887891589388,0.0103874957218886,5.7091006733787e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,28916,-0.0128132167669479,0.00256729155532183,-0.0178451082153787,-0.0077813253185171,6.04326932809511e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FABP6,Gastrotropin,28872,-0.0202042946549644,0.00408999805765311,-0.0282206908479645,-0.0121878984619643,7.85882323475781e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COPB2,Coatomer subunit beta',24111,-0.0155095663434999,0.00313968279989601,-0.0216633446312961,-0.00935578805570376,7.87055143384695e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HSBP1,Heat shock factor-binding protein 1,24240,-0.0344733499160005,0.00698348527011401,-0.048160981045424,-0.0207857187865771,8.01019485366955e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DGKZ,Diacylglycerol kinase zeta,28931,-0.0126949655431991,0.00257972378452977,-0.0177512241608774,-0.00763870692552071,8.6551389472901e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VGF,Neurosecretory protein VGF,24867,-0.0108771269791838,0.00221480432692493,-0.0152181434599567,-0.00653611049841096,9.11412584490668e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,24101,0.0103649859049763,0.00211271698278835,0.00622406061871111,0.0145059111912415,9.35595248791751e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,24922,-0.00984424708713246,0.00200823728209307,-0.0137803921600349,-0.00590810201423004,9.54941161242814e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITGB7,Integrin beta-7,29725,0.0162863699700134,0.00333111126967367,0.009757391881453,0.0228153480585738,1.01789975310608e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KEL,Kell blood group glycoprotein,28774,-0.0127712097783146,0.0026124035908411,-0.0178915208163632,-0.00765089874026604,1.02060149715993e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,29694,-0.00826746959454419,0.00169352486977597,-0.0115867783393051,-0.00494816084978329,1.05661134979156e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,29378,-0.0144426022884753,0.00296152300198858,-0.020247187372373,-0.00863801720457771,1.08412415499974e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LPO,Lactoperoxidase,28452,-0.0213345085273364,0.00438075750268494,-0.0299207932325989,-0.012748223822074,1.12168748887094e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,24938,-0.0217446205650491,0.00447020564685505,-0.030506223632885,-0.0129830174972132,1.15536965549906e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ICAM3,Intercellular adhesion molecule 3,29820,0.00921632987896244,0.00189612664811941,0.00549992164864841,0.0129327381092765,1.17620023428635e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,24845,0.0109081640765016,0.00224639189919904,0.00650523595407148,0.0153110921989317,1.20594244155451e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ENAH,Protein enabled homolog,28931,-0.0168171506281587,0.00346348783778761,-0.0236055867902224,-0.010028714466095,1.2067728389985e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,28931,-0.0111540269660969,0.00229927168084509,-0.0156605994605532,-0.0066474544716405,1.23408815895432e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,29087,0.0209470921623219,0.00432103315369774,0.0124778671810743,0.0294163171435694,1.25542340827279e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL22,Interleukin-22,24793,-0.0238585166790393,0.0049348429629402,-0.0335308088864021,-0.0141862244716765,1.34141129315137e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,29454,-0.103565932015515,0.0214715285867613,-0.145650128045567,-0.0614817359854629,1.41831170573602e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",24240,-0.00917883220113868,0.00190420562075688,-0.0129110752178222,-0.00544658918445519,1.44214671321802e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",28797,-0.0277982912067718,0.00577097903775799,-0.0391094101207775,-0.0164871722927662,1.46538903217818e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TYMP,Thymidine phosphorylase,29301,-0.0232458468039847,0.00483479682297791,-0.0327220485770214,-0.013769645030948,1.53181114138413e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,29427,-0.0257288389848573,0.00535603803154878,-0.0362266735266929,-0.0152310044430217,1.56521011418685e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FSHB,Follitropin subunit beta,24240,0.0226838214349195,0.00472305796005917,0.0134266278332036,0.0319410150366355,1.57410274446443e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,29434,-0.0296166470630557,0.00617862189655225,-0.0417267459802981,-0.0175065481458133,1.64772953764472e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,29349,-0.0160164590997035,0.00334194014046858,-0.0225666617750219,-0.00946625642438503,1.65469239838343e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SELENOP,Selenoprotein P,24966,0.00790706749028765,0.00165050888940063,0.0046720700670624,0.0111420649135129,1.67167791313912e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NECTIN4,Nectin-4,29566,-0.0110967493892584,0.00232283872888873,-0.0156495132978803,-0.00654398548063645,1.78573113858938e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,24805,-0.0174533577736459,0.00365338592289069,-0.0246139941825116,-0.0102927213647801,1.78671523624802e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PKLR,Pyruvate kinase PKLR,29491,-0.0223636844234822,0.00469349549191002,-0.0315629355876258,-0.0131644332593385,1.89917285033279e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,24101,0.0115608474448113,0.00242705812268689,0.00680381352434497,0.0163178813652776,1.91544522483668e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GM2A,Ganglioside GM2 activator,24421,-0.0133417172938427,0.00280195875918926,-0.0188335564618536,-0.00784987812583171,1.93196200189772e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NFIC,Nuclear factor 1 C-type,24867,-0.015466694005207,0.00324882170244084,-0.021834384541991,-0.00909900346842293,1.93999992613972e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,24805,-0.0148595622470149,0.00312367317367046,-0.020981961667409,-0.00873716282662075,1.97518595120058e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STX3,Syntaxin-3,24845,-0.0133067374070083,0.00279808773243599,-0.0187909893625829,-0.00782248545143379,1.9891460924128e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,29674,-0.0230512670044245,0.00485173943195635,-0.0325606762910589,-0.0135418577177901,2.0322467356325e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LY6D,Lymphocyte antigen 6D,29283,-0.0132290173016021,0.00279223554835099,-0.01870179897637,-0.00775623562683413,2.17077947687457e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRUNE2,Protein prune homolog 2,24445,-0.0101159168303707,0.00213555529784399,-0.014301605214145,-0.00593022844659653,2.18228444726477e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MST1,Hepatocyte growth factor-like protein,24615,-0.0221703069514351,0.00468682541451358,-0.0313564847638818,-0.0129841291389885,2.25380645169266e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GZMB,Granzyme B,29434,-0.0223747759118024,0.00473980943157805,-0.0316648023976954,-0.0130847494259094,2.36224063759916e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,29169,-0.0137318770295014,0.00291019788082984,-0.0194358648759279,-0.00802788918307488,2.38647444150376e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,29566,0.00832956967464012,0.00176547554470813,0.00486923760701219,0.011789901742268,2.39225708786909e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,29478,0.00972886598554221,0.00207111866634468,0.00566947339950663,0.0137882585715778,2.646860652973e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,24111,-0.0151014293757078,0.00321677020188083,-0.0214062989713943,-0.00879655978002139,2.68606512218929e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CABP2,Calcium-binding protein 2,24195,-0.0223476011439912,0.00476908531732305,-0.0316950083659444,-0.013000193922038,2.80208047811419e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ABO,Histo-blood group ABO system transferase,24951,0.0493467119668722,0.0105400501125384,0.028688213746297,0.0700052101874475,2.85822148190684e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DDI2,Protein DDI1 homolog 2,24381,-0.0261876029729322,0.00559780843930008,-0.0371593075139604,-0.0152158984319041,2.90973760965474e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LAMA4,Laminin subunit alpha-4,29581,-0.0113275102073105,0.00242931821230251,-0.0160889739034234,-0.00656604651119755,3.13244327085825e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ROBO1,Roundabout homolog 1,29497,-0.00816271859428748,0.00175196457656247,-0.0115965691643499,-0.00472886802422503,3.18857089665577e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,28797,0.0103707401764802,0.00222671750808435,0.00600637386063487,0.0147351064923255,3.21639437894695e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANXA4,Annexin A4,29341,-0.0242849401302113,0.00523400478039388,-0.0345435894997833,-0.0140262907606392,3.50186427189926e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LMOD1,Leiomodin-1,24867,0.0119561390768662,0.00259049811944352,0.00687876276275686,0.0170335153909755,3.94332493869826e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,24805,-0.00721678816009209,0.00156459836623533,-0.0102834009579133,-0.00415017536227084,3.99746122198954e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PADI2,Protein-arginine deiminase type-2,28931,-0.0189176370396372,0.00410263491298677,-0.0269588014690913,-0.0108764726101831,4.02267630142847e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,24229,-0.0129791360870336,0.00281521980498362,-0.0184969669048015,-0.00746130526926572,4.04052766297979e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CNTN2,Contactin-2,29725,0.014947903187061,0.00324326644741202,0.00859110095013341,0.0213047054239885,4.0647935087366e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL1B,Interleukin-1 beta,28745,-0.0188156745794449,0.00409315260324167,-0.0268382536817985,-0.0107930954770912,4.30717431321383e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,24793,-0.00959722556219949,0.00208785814746198,-0.013689427531225,-0.005505023593174,4.31384002536634e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GHRL,Appetite-regulating hormone,29478,-0.0269652578417665,0.00586707253843517,-0.0384647200170994,-0.0154657956664335,4.32395810649113e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLIC5,Chloride intracellular channel protein 5,24195,0.0106935025741049,0.00232856945062729,0.00612950645087539,0.0152574986973344,4.40583684748528e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GSTP1,Glutathione S-transferase P,28604,0.023320648858595,0.00507940781454037,0.0133650095420958,0.0332762881750941,4.42549911898039e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,24793,-0.0140751765602652,0.0030664558934079,-0.0200854301113446,-0.00806492300918567,4.45320171973213e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,24111,0.0138355018422434,0.00301547765208505,0.00792516564415669,0.0197458380403301,4.49416496696359e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CR2,Complement receptor type 2,29594,-0.0155367284107518,0.00338678501445407,-0.0221748270390818,-0.00889862978242182,4.50518432946149e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,24445,-0.0194881984408698,0.00425441595458109,-0.0278268537118487,-0.0111495431698908,4.6571248494986e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCG3,Secretogranin-3,29497,0.01105617401377,0.00241966468767777,0.00631363122592153,0.0157987168016184,4.91337924486742e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL17A,Interleukin-17A,28879,-0.0141565232394984,0.00310673318316415,-0.0202457202785002,-0.00806732620049668,5.21705292317881e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,24016,-0.0139749054296969,0.00308591082607544,-0.0200232906488048,-0.00792652021058908,5.96568006909564e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,24240,-0.0134204855851791,0.00296925720190676,-0.0192402297009163,-0.00760074146944183,6.21871743308875e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CST1,Cystatin-SN,21656,-0.0347375177341436,0.00768838543918677,-0.0498067531949497,-0.0196682822733376,6.2702955155192e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DPT,Dermatopontin,29820,-0.00863258592913048,0.00191439435699078,-0.0123847988688324,-0.00488037298942855,6.52884008327686e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ROBO2,Roundabout homolog 2,29694,0.00757405588322889,0.00168174834876381,0.00427782911965182,0.010870282646806,6.70410749749882e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ELAVL4,ELAV-like protein 4,24101,-0.0278389904474274,0.00619307527048589,-0.0399774179775798,-0.0157005629172751,6.98347922045568e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,24111,-0.0216119740536978,0.00483162563706628,-0.0310819603023477,-0.0121419878050479,7.74737314600097e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RPS10,40S ribosomal protein S10,24111,0.0136955626492737,0.00306279666479456,0.00769248118627633,0.019698644112271,7.79954549960211e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,29030,-0.00947077857805232,0.00212219372860916,-0.0136302782861263,-0.00531127886997837,8.1226082972114e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GUCA2A,Guanylin,29333,-0.0110989347941661,0.00248872220115701,-0.0159768303084338,-0.00622103927989834,8.23820870499348e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,24445,-0.0143036066345089,0.00320750099674537,-0.0205903085881298,-0.00801690468088795,8.25462800718211e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,24801,-0.012460821213895,0.00280128723605825,-0.0179513441965692,-0.00697029823122083,8.69498389837696e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,24951,-0.00839892554844673,0.00189487185234568,-0.0121128743790443,-0.00468497671784919,9.35653392866932e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,24016,0.00988332153050724,0.00223252698797425,0.00550756863407771,0.0142590744269368,9.59890358659489e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PODXL,Podocalyxin,29349,0.00487443187508956,0.00110210668743539,0.0027143027677162,0.00703456098246292,9.77658845627344e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,24229,-0.0120793324561283,0.00273343203558673,-0.0174368592458783,-0.00672180566637829,9.9539098344365e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IMPA1,Inositol monophosphatase 1,29218,-0.0195311736145606,0.00442739812780518,-0.0282088739450588,-0.0108534732840625,1.03055375130121e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,23970,-0.0282475407585293,0.00640541928826693,-0.0408021625635324,-0.0156929189535261,1.03847374289181e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,24951,-0.0128793371418906,0.00292645228630972,-0.0186151836230577,-0.00714349066072357,1.08196655913749e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITGB2,Integrin beta-2,29274,0.00915321704927727,0.00208870674984648,0.00505935181957817,0.0132470822789764,1.17873100095211e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,24240,-0.00898397905352087,0.00205315127440062,-0.0130081555513461,-0.00495980255569565,1.21547707525767e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TXNL1,Thioredoxin-like protein 1,24069,-0.0312598985414064,0.00717752592252255,-0.0453278493495506,-0.0171919477332622,1.33466232172316e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MSLN,Mesothelin,29293,-0.0177076131174324,0.0040729109399296,-0.0256905185596944,-0.00972470767517039,1.38064557376964e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ENSA,Alpha-endosulfine,24793,-0.0166551499432529,0.00385173304924437,-0.0242045467197718,-0.0091057531667339,1.53776948446118e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LBP,Lipopolysaccharide-binding protein,29594,0.0183210826448869,0.0042433395172625,0.0100041371910524,0.0266380280987214,1.5824088357457e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,28774,-0.0148979479301137,0.00346259880303595,-0.0216846415840642,-0.00811125427616325,1.69413008746123e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SFRP1,Secreted frizzled-related protein 1,29120,-0.0135285120214534,0.00314549680237479,-0.019693685754108,-0.00736333828879877,1.70648495919234e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADA2,Adenosine deaminase 2,29328,-0.0133613721965062,0.00311258463168287,-0.0194620380746047,-0.00726070631840781,1.77084798936181e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",24111,0.0149927749584865,0.00349282052651733,0.0081468467265125,0.0218387031904604,1.77398037701933e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,POMC,Pro-opiomelanocortin,24240,-0.022115438958397,0.00515845593514262,-0.0322260125912766,-0.0120048653255175,1.81621628316911e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,28916,-0.0179169252023896,0.00418243608356073,-0.0261144999261686,-0.00971935047861057,1.84280510173794e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ICAM2,Intercellular adhesion molecule 2,29820,-0.00988568889952765,0.00231465729114292,-0.0144224171901678,-0.00534896060888753,1.95280930934017e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,28931,-0.0180484019146046,0.00423485942516085,-0.0263487263879199,-0.00974807744128938,2.03368754923356e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLC12A2,Solute carrier family 12 member 2,24111,0.00851371073680895,0.00201356953893495,0.00456711444049645,0.0124603070331215,2.36469718977725e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,24445,0.00869001390658557,0.00206406832904926,0.00464443998164901,0.0127355878315221,2.56126499469463e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,24845,-0.0101917488181342,0.00242403570308332,-0.0149428587961776,-0.00544063884009094,2.62628032145153e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EPHA4,Ephrin type-A receptor 4,24381,-0.00878953193485543,0.00209117304437226,-0.0128882311018251,-0.00469083276788581,2.64153699257364e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD109,CD109 antigen,29443,0.010295973560891,0.00245275997876197,0.00548856400251749,0.0151033831192644,2.7041952769858e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLC39A14,Zinc transporter ZIP14,28774,-0.0102411261573608,0.00244024842233339,-0.0150240130651342,-0.00545823924958732,2.71578213226093e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RCC1,Regulator of chromosome condensation,24793,-0.0156889208684641,0.00375615883786611,-0.0230509921906817,-0.00832684954624654,2.96581675902523e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GSR,"Glutathione reductase, mitochondrial",24867,-0.00686546290395704,0.00165433918653841,-0.0101079677095723,-0.00362295809834175,3.33620923680088e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,28774,-0.0436913667446604,0.0105605462376228,-0.0643900373704011,-0.0229926961189196,3.52528633292763e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DCN,Decorin,28916,0.00685764754368452,0.00166479485295581,0.00359464963189112,0.0101206454554779,3.81222904912895e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MRC1,Macrophage mannose receptor 1,24951,-0.00849608620848382,0.00206860828245821,-0.0125505584421019,-0.00444161397486573,4.01846650754793e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VIM,Vimentin,28916,-0.0348287208013955,0.00848067193891195,-0.051450837801663,-0.0182066038011281,4.02220250056813e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,24229,-0.00610857484712316,0.00148885445637443,-0.00902672958161704,-0.00319042011262928,4.09392630250726e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRNN,Cornulin,28580,0.0199409193958051,0.00486129870609206,0.0104127739318647,0.0294690648597456,4.10775233287311e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SDC4,Syndecan-4,29478,-0.013753980411749,0.00336570908053394,-0.0203507702095955,-0.00715719061390244,4.3908268480704e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ENG,Endoglin,29820,0.00510852759552498,0.00125139441741365,0.00265579453739424,0.00756126065365573,4.47145059842998e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,28797,-0.0136781322509697,0.00335788533235077,-0.0202595875023772,-0.00709667699956216,4.64484938191367e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MB,Myoglobin,29820,-0.0155207776903487,0.00381451476664576,-0.0229972266329744,-0.00804432874772298,4.7362578292974e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GPR15L,Protein GPR15L,24805,-0.018143290344795,0.00446069610485793,-0.0268862547103165,-0.00940032597927344,4.76941637417662e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,24867,0.0137606454650498,0.00340339522630001,0.00708999082150181,0.0204313001085979,5.28829971640074e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,24101,0.0101275223164256,0.00250987539179742,0.00520816654850264,0.0150468780843485,5.47545248391223e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRTN3,Myeloblastin,28671,-0.0138801590934307,0.00344853223108802,-0.0206392822663632,-0.00712103592049816,5.71345648061968e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",24867,-0.0209500550640733,0.00520592600553335,-0.0311536700349187,-0.0107464400932279,5.73213666324622e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL26,C-C motif chemokine 26,29434,-0.0260393927968221,0.006476034680462,-0.0387324207705277,-0.0133463648231166,5.81243442171406e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TREML1,Trem-like transcript 1 protein,24951,-0.0154919910088016,0.00385347093889695,-0.0230447940490396,-0.00793918796856359,5.83025177282554e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,24111,0.0110453782759563,0.00274986976044309,0.00565563354548785,0.0164351230064248,5.91998606515772e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CA7,Carbonic anhydrase 7,24445,0.0100913636115355,0.00251246669058989,0.00516692889797931,0.0150157983250917,5.92413491866449e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C9orf40,Uncharacterized protein C9orf40,24805,-0.0234983129799009,0.00585256524617026,-0.0349693408623946,-0.0120272850974072,5.96093146924744e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EGFLAM,Pikachurin,24805,-0.00898927359371544,0.00224733923218668,-0.0133940584888013,-0.00458448869862954,6.35361645857104e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,24793,-0.015254596999191,0.00382474883406321,-0.0227511047139549,-0.00775808928442711,6.6713660122962e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STAM,Signal transducing adapter molecule 1,24793,-0.0107013706960758,0.00268824440181529,-0.0159703297236337,-0.00543241166851778,6.88786474188602e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,JUN,Transcription factor AP-1,28931,-0.0144437937306143,0.00364642087607377,-0.0215907786477189,-0.00729680881350972,7.47878138329178e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FBLN2,Fibulin-2,24938,0.00905815445364142,0.00228935206840447,0.00457102439956865,0.0135452845077142,7.62200446413178e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL34,Interleukin-34,28722,-0.0104059100962067,0.00263123351266727,-0.0155631277810346,-0.00524869241137885,7.67937108915701e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IFNW1,Interferon omega-1,24111,0.0104134083514232,0.00263305930395664,0.00525261211566817,0.0155742045871782,7.67950545627142e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FMR1,Synaptic functional regulator FMR1,28797,-0.01019230304391,0.00258584143978476,-0.0152605522658881,-0.00512405382193182,8.11375946893346e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,29218,-0.0174533270188242,0.00442920708702478,-0.0261345729093927,-0.00877208112825559,8.14982955051116e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,28797,-0.0135651025557654,0.00345163897757598,-0.0203303149518143,-0.0067998901597165,8.51277915370138e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,24445,-0.0104606762247018,0.00266369322432837,-0.0156815149443854,-0.00523983750501818,8.62006461472795e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HCG22,Protein PBMUCL2,24111,0.0158818846452567,0.00404993058923568,0.00794402069035479,0.0238197486001587,8.82356811989108e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDH6,Cadherin-6,29478,0.010902314709994,0.00278996673304973,0.00543397991321654,0.0163706495067715,9.33923522673765e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CBX2,Chromobox protein homolog 2,24111,0.0114857701036757,0.00294341732003702,0.00571667215640312,0.0172548680509482,9.55857906581777e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,29443,-0.033572056868728,0.008633911018416,-0.0504945224648233,-0.0166495912726326,0.000101130789039927
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TG,Thyroglobulin,24793,0.031591963748096,0.00814904679382307,0.0156198320322028,0.0475640954639892,0.000106126101277577
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TUBB3,Tubulin beta-3 chain,24101,0.00797151539057638,0.00205799233725516,0.00393785040955625,0.0120051803715965,0.000107592325644769
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,29594,0.00969522264261637,0.00250344877283639,0.00478846304785704,0.0146019822373757,0.000107847178991719
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,28797,-0.0147814512603018,0.00382685098397002,-0.0222820791888831,-0.0072808233317206,0.000112449394859612
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,24195,0.0177802590129989,0.00460657698014327,0.00875136813191808,0.0268091498940797,0.000113795627132449
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,28797,-0.0132999675879079,0.00344842241285263,-0.020058875517099,-0.00654105965871672,0.000115118539242748
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,24111,0.00887855631187919,0.00230223036884436,0.00436618478894424,0.0133909278348141,0.000115320051236332
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,24229,-0.00878393143756336,0.00227817392471113,-0.0132491523299972,-0.00431871054512954,0.000115702107616052
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,28797,-0.0114601519035751,0.00297241488974747,-0.0172860850874801,-0.00563421871967005,0.00011574335558931
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SDK2,Protein sidekick-2,24381,-0.0108951934801841,0.00283122868816828,-0.016444401708994,-0.0053459852513743,0.00011928207288475
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",28774,-0.00774135289088715,0.00201175659873462,-0.011684395824407,-0.0037983099573673,0.000119315739763721
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,28797,-0.0111448932796502,0.00289936166825384,-0.0168276421494278,-0.00546214440987272,0.000121348286840658
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,29478,0.0290965912533071,0.0075886259057418,0.0142228844780532,0.043970298028561,0.000126216496881918
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRSS53,Serine protease 53,24845,0.0104356662173341,0.00272415952994503,0.00509631353864184,0.0157750188960264,0.000128049848699559
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GPC5,Glypican-5,29218,-0.015621367727925,0.00408201590388696,-0.0236221188995434,-0.00762061655630653,0.000130050277139256
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANXA5,Annexin A5,28650,-0.00848264348125284,0.00221784180981192,-0.0128296134284842,-0.00413567353402148,0.000131193602326836
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PALM,Paralemmin-1,24657,-0.00833797034068024,0.00217997538636909,-0.0126107220979637,-0.00406521858339682,0.000131200596475147
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HBQ1,Hemoglobin subunit theta-1,29725,0.0167199971983628,0.00437198264867562,0.00815091120695861,0.025289083189767,0.000131384648486906
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,29349,-0.0105786452886256,0.0027672947325131,-0.0160025429643513,-0.0051547476128999,0.000132250033263239
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CA3,Carbonic anhydrase 3,29761,-0.0166339413000946,0.00436277375083598,-0.0251849778517332,-0.0080829047484561,0.000137734866239782
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,24938,-0.00780378869801073,0.00204688363117915,-0.0118156806151219,-0.00379189678089959,0.000137887044065791
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BLMH,Bleomycin hydrolase,29820,-0.0087974895222494,0.00231029537810941,-0.0133256684633438,-0.00426931058115496,0.000140404190809091
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,24240,-0.0133575172646097,0.00351181938643761,-0.0202406832620274,-0.00647435126719194,0.000142964751920931
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PCDH1,Protocadherin-1,29713,-0.00585224371455623,0.00154210349725813,-0.00887476656918217,-0.00282972085993028,0.000147951547672269
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,29434,0.00972761326552802,0.00256395274513623,0.00470226588506102,0.014752960645995,0.000148541821154752
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINI1,Neuroserpin,24329,0.00848194485383691,0.00223557250266361,0.00410022274861623,0.0128636669590576,0.000148549768680725
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BRDT,Bromodomain testis-specific protein,24111,-0.0101945493403847,0.00268940262113333,-0.0154657784778061,-0.00492332020296341,0.000150627348468929
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLK1,Kallikrein-1,29199,0.0350720982900427,0.00926398439670299,0.0169146888725048,0.0532295077075805,0.000153487748068559
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,24111,0.0161807565437277,0.00428275239410545,0.00778656185128105,0.0245749512361744,0.000158396240600496
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,24111,-0.0235956056612672,0.0062475057758623,-0.0358407169819573,-0.0113504943405771,0.000159235171223515
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRTAP,Cartilage-associated protein,24195,-0.0134514786873814,0.00356224479098657,-0.020433478477715,-0.00646947889704767,0.00015966867280893
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,24867,-0.0133892841119426,0.00356332629028429,-0.0203734036408998,-0.00640516458298543,0.000171994971129316
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD2,T-cell surface antigen CD2,24111,-0.0105454828126948,0.00280713063023816,-0.0160474588479616,-0.00504350677742803,0.000172589971295836
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,24867,-0.00879609434784447,0.00234829144331317,-0.0133987455767383,-0.00419344311895065,0.000180267336179496
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,24845,-0.0152860176724335,0.00408403325432871,-0.0232907228509178,-0.00728131249394922,0.000182338169704436
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,29361,-0.00921037578297666,0.00246424816399177,-0.0140403021844005,-0.00438044938155279,0.000186136963688658
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AHNAK2,Protein AHNAK2,24240,-0.0081171685407381,0.00217229110238479,-0.0123748591014123,-0.00385947798006391,0.000186889948361063
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL28,C-C motif chemokine 28,29327,-0.0160367772501355,0.00430939078709745,-0.0244831831928465,-0.00759037130742445,0.000198525949860419
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C5,Complement C5,24966,-0.00410560149824721,0.00110551204375829,-0.00627240510401346,-0.00193879789248097,0.0002046507202252
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RGMA,Repulsive guidance molecule A,29694,0.00849065985710058,0.00228680690095084,0.00400851833123693,0.0129728013829642,0.000205281635432021
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NEFL,Neurofilament light polypeptide,28674,-0.0121077755631324,0.00326408585842585,-0.0185053838456471,-0.00571016728061777,0.000208149255269252
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",24229,-0.0120604149637856,0.00325517154111041,-0.018440551184362,-0.0056802787432092,0.000211859752450611
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CXCL14,C-X-C motif chemokine 14,28931,-0.0159794015905273,0.00432886830355321,-0.0244639834654916,-0.00749481971556305,0.000223469799424086
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,29581,-0.00757528088461551,0.0020522769733894,-0.0115977437524587,-0.00355281801677228,0.000223635307121245
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,REST,RE1-silencing transcription factor,24016,0.00938999207384199,0.00256125667230947,0.00436992899611543,0.0144100551515685,0.000246745183381683
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GFRA3,GDNF family receptor alpha-3,29157,0.00745113377363201,0.00204758273834818,0.00343787160646958,0.0114643959407944,0.000274181834658086
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NRTN,Neurturin,28931,-0.0130259362015494,0.00359562577824932,-0.0200733627269181,-0.00597850967618076,0.000292023232315595
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",24845,-0.014480751004226,0.00400394257271095,-0.0223284784467394,-0.0066330235617125,0.000299062744834009
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,24229,0.00780525177873462,0.00215841027324027,0.0035747676431837,0.0120357359142856,0.000299561906646899
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARG1,Arginase-1,29216,-0.0135827139284721,0.00376120878892574,-0.0209546831547665,-0.00621074470217764,0.000305219921045713
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C1QL2,Complement C1q-like protein 2,24229,0.0112905591951409,0.00313519921021091,0.00514556874312756,0.0174355496471543,0.000317353975648775
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,24195,0.00967895236817458,0.00269877486783187,0.00438935362722411,0.014968551109125,0.000335903947349432
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,24229,-0.0114905673662306,0.00321048101886819,-0.0177831101632123,-0.00519802456924896,0.000345479960446635
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TPM3,Tropomyosin alpha-3 chain,24111,0.011525447685734,0.00322281561153321,0.00520872908712893,0.0178421662843391,0.000349301329059276
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,XG,Glycoprotein Xg,29693,-0.00831335899246326,0.00233975871718254,-0.012899286078141,-0.00372743190678549,0.000381333527904775
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MKI67,Proliferation marker protein Ki-67,24229,-0.0101208934981552,0.0028494728588047,-0.0157058603014124,-0.00453592669489798,0.000383262552914919
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FCRL5,Fc receptor-like protein 5,29443,-0.0148416889412121,0.00418039290309756,-0.0230352590312833,-0.00664811885114087,0.000385378464403109
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCGB1A1,Uteroglobin,29523,-0.0142725531103581,0.00402081327403801,-0.0221533471274726,-0.0063917590932436,0.000386316433836976
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPING1,Plasma protease C1 inhibitor,24914,0.00486335922996586,0.00137032603419312,0.00217752020294735,0.00754919825698438,0.000387331516146311
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PCDH12,Protocadherin-12,24867,-0.00661740952577939,0.00186545808347644,-0.0102737073693932,-0.00296111168216556,0.000389862085013663
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PROK1,Prokineticin-1,29434,-0.015825423147767,0.00446333301008898,-0.0245735558475414,-0.00707729044799256,0.000392251838230486
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,28774,-0.0217113213269211,0.00612888950802996,-0.0337239447626598,-0.0096986978911824,0.000397046970165985
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,24016,0.00782646389212687,0.00220932148025361,0.00349619379082981,0.0121567339934239,0.000397144313029941
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,INSL4,Early placenta insulin-like peptide,24793,-0.0132686857500407,0.00375247721446272,-0.0206235410903876,-0.00591383040969377,0.000407006146918454
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINA6,Corticosteroid-binding globulin,24966,0.0043435426743293,0.00122903715033174,0.00193462985967909,0.0067524554889795,0.00040990301230187
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLC4A1,Band 3 anion transport protein,24938,-0.0120291589017958,0.00341014562986452,-0.0187130443363303,-0.00534527346726135,0.000420318324433668
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MDM1,Nuclear protein MDM1,24195,-0.00804826794572213,0.00228718264702318,-0.0125311459338876,-0.00356538995755669,0.000434206564219186
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FCRL3,Fc receptor-like protein 3,28931,-0.0138478644568604,0.00393591364026541,-0.0215622551917806,-0.00613347372194024,0.000434929389851085
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,29536,0.0165483883118826,0.00470561311800281,0.00732538660059712,0.0257713900231681,0.000437547347610341
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,24101,0.0161379706715895,0.00459587501202577,0.00713005564801903,0.02514588569516,0.000446562765923087
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,QSOX1,Sulfhydryl oxidase 1,24502,-0.0109080839471589,0.00311024516793962,-0.0170041644763206,-0.00481200341799728,0.000453751600832274
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,24445,-0.0166189030330168,0.00474061604880132,-0.0259105104886674,-0.00732729557736622,0.000456323595468341
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,24195,-0.0096992535075397,0.00278044515071111,-0.0151489260029335,-0.00424958101214592,0.00048681788882849
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,29820,0.00689708271832317,0.00197989322936948,0.00301649198875899,0.0107776734478874,0.00049549648113083
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",24111,-0.0100231744243535,0.00287721377872841,-0.0156625134306612,-0.00438383541804579,0.000495523822268207
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTSH,Pro-cathepsin H,28852,-0.0185670005918267,0.00533164896816118,-0.0290170325694226,-0.0081169686142308,0.000497653572958937
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,24922,-0.0187644447422943,0.00539143678931229,-0.0293316608493464,-0.00819722863524227,0.000501491677297642
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HGFAC,Hepatocyte growth factor activator,24720,0.00712659273456733,0.00205195224803699,0.00310476632841484,0.0111484191407198,0.000515403992323085
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,24101,0.0155912512640786,0.00449111834569681,0.00678865930651287,0.0243938432216444,0.000518322828331174
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,28301,0.00953117907520548,0.00274980829396358,0.00414155481903686,0.0149208033313741,0.000528801196809546
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACTN2,Alpha-actinin-2,24111,0.0149302567425477,0.00432595017160658,0.00645139440619881,0.0234091190788966,0.00055879910989167
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,24111,0.0126905085570063,0.00371086665198679,0.0054172099191122,0.0199638071949004,0.000627656058768432
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,24111,0.00646542178408361,0.00189072840985887,0.00275959410076023,0.010171249467407,0.000628309438499117
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,24016,0.00653764443726049,0.00191346941900943,0.00278724437600201,0.010288044498519,0.000635031215395613
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CBLN1,Cerebellin-1,24101,0.0238543236407244,0.00699040756019169,0.0101531248227487,0.0375555224587001,0.000644907125229861
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,29683,-0.00738715196036448,0.00217805523681797,-0.0116561402245277,-0.00311816369620126,0.000695694741420433
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GUK1,Guanylate kinase,24111,0.00992608210812393,0.00292968761159895,0.00418389438938999,0.0156682698268579,0.000704905555008565
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,APOE,Apolipoprotein E,24966,-0.0179557220551488,0.00530090585471639,-0.028345497530393,-0.00756594657990469,0.000706949010060832
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,28916,-0.00671739542942801,0.00198413972608783,-0.0106063092925602,-0.00282848156629587,0.000711314149783622
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TJP3,Tight junction protein ZO-3,24101,0.0106059547223905,0.00313404623465436,0.00446322410246797,0.0167486853423131,0.000715234055906974
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,24240,0.00616331599242451,0.0018213685247088,0.00259343368399526,0.00973319830085376,0.000715790991189645
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,24805,-0.00639876182702391,0.00190020276189722,-0.0101231592403425,-0.00267436441370535,0.000759931404792436
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DRAXIN,Draxin,29218,-0.0104977103651052,0.00311811876432991,-0.0166092231431918,-0.00438619758701853,0.000761768118596707
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,24229,-0.0146394211415221,0.00435000118326883,-0.023165423460729,-0.00611341882231514,0.000765561153331233
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EVPL,Envoplakin,24445,0.00832068705259097,0.00248187459910592,0.00345621283834338,0.0131851612668386,0.000801831509287666
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PODXL2,Podocalyxin-like protein 2,29566,0.00679594314775412,0.00202815586502486,0.0028207576523054,0.0107711286432028,0.000806795873344982
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DNLZ,DNL-type zinc finger protein,24101,0.0220824600300722,0.00660827827587274,0.00913023460936165,0.0350346854507828,0.000834128897257335
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCND2,G1/S-specific cyclin-D2,24445,0.00898001453995451,0.00269415547148301,0.00369946981584781,0.0142605592640612,0.000859972947981037
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,29694,0.00667855520480962,0.00200580477196171,0.00274717785176466,0.0106099325578546,0.000870724250499697
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",24922,-0.0169436555611335,0.00509691399173813,-0.0269336069849402,-0.00695370413732674,0.00088769630795532
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,24111,-0.011111113230342,0.00334603406842929,-0.0176693400044634,-0.00455288645622062,0.000899313294763713
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LCN15,Lipocalin-15,24867,-0.0150285526133349,0.004548755086136,-0.0239441125821614,-0.0061129926445083,0.00095490516870852
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RYR1,Ryanodine receptor 1,24111,0.00821214619024498,0.00249233138464042,0.00332717667634975,0.0130971157041402,0.000985757629599296
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",24805,-0.0246318470878144,0.00749244563728452,-0.039317040536892,-0.0099466536387367,0.00101201056052785
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,24938,0.00946906603520748,0.00289456946000786,0.00379570989359207,0.0151424221768229,0.00107191716986267
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINA11,Serpin A11,29820,0.00973073731802448,0.0029770741522541,0.00389567197960645,0.0155658026564425,0.00108219699832215
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NEDD9,Enhancer of filamentation 1,24229,-0.00789382978591596,0.00243442665037019,-0.0126653060206415,-0.00312235355119038,0.00118611859185564
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C1R,Complement C1r subcomponent,24966,-0.00458523208610045,0.00141505340384393,-0.00735873675763454,-0.00181172741456635,0.00119550179666421
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLASP1,CLIP-associating protein 1,24016,-0.0172244374541804,0.00532777129930682,-0.0276668692008218,-0.00678200570753908,0.0012268290521992
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,29443,0.00790281195559352,0.00246475039576307,0.0030719011798979,0.0127337227312891,0.00134581652030836
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,29786,-0.00813270118824341,0.00254301012542167,-0.0131170010340699,-0.00314840134241694,0.00138499775179391
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCP2,Non-specific lipid-transfer protein,28797,-0.017671588798876,0.00554510493214188,-0.0285399944658741,-0.00680318313187793,0.00143969591498957
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,29373,-0.0202375103239597,0.00637694354327559,-0.0327363196687799,-0.00773870097913957,0.00150745376443431
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",28774,-0.0124306118249943,0.00392545140269761,-0.0201244965742816,-0.00473672707570699,0.00154355825555739
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CFD,Complement factor D,24966,-0.00448089854931878,0.00142697895022039,-0.00727777729175074,-0.00168401980688681,0.00169070264313341
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,S100A16,Protein S100-A16,28722,-0.0140581376337897,0.00448010315686607,-0.0228391398212472,-0.00527713544633221,0.00170332184719378
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,29454,-0.00672279301319095,0.00214938790955213,-0.0109355933159131,-0.00250999271046878,0.00176309071106263
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ALCAM,CD166 antigen,29820,-0.00444005530864228,0.00142236255774884,-0.00722788592183001,-0.00165222469545455,0.00180039463728831
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MUC16,Mucin-16,29349,-0.0427836933536635,0.0137449822738237,-0.069723858610358,-0.015843528096969,0.00185576808233512
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",29443,-0.00850424031082934,0.00273474783425664,-0.0138643460659724,-0.00314413455568632,0.0018745736659879
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",29443,0.00547887642685746,0.00176561028311952,0.0020182802719432,0.00893947258177171,0.00191682193414416
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINA1,Alpha-1-antitrypsin,24548,0.00183940096640364,0.000593161222534877,0.000676804970235283,0.003001996962572,0.00193078051472007
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",24867,0.00954669308224878,0.00308503848956494,0.00350001764270149,0.0155933685217961,0.00197354848828072
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AFAP1,Actin filament-associated protein 1,24381,-0.0189806208908033,0.00614426577670204,-0.0310233818131392,-0.00693785996846726,0.00200949055497239
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLK6,Kallikrein-6,29519,-0.00687303801712197,0.00222498147143513,-0.0112340017011348,-0.00251207433310911,0.00200996649310142
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLNS1A,Methylosome subunit pICln,24195,-0.00756056004593298,0.00245098017647359,-0.0123644811918212,-0.00275663890004475,0.00203981347317268
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",24240,-0.0101892373833977,0.00331482339263615,-0.0166862912329645,-0.00369218353383083,0.00211557425856252
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,29218,0.00638052803686879,0.00207669027278077,0.00231021510221848,0.0104508409715191,0.00212504428583976
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,29662,-0.0141981660182602,0.00462999838171017,-0.0232729628464121,-0.00512336919010825,0.00216732536765555
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MYH4,Myosin-4,24111,0.0104451277134246,0.00341109930499813,0.00375937307562829,0.017130882351221,0.00220032025531363
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,24016,-0.00655949173108873,0.00214216171292994,-0.0107581286884314,-0.00236085477374604,0.00220040525286182
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FOSB,Protein fosB,28774,-0.00862724393148601,0.00282075467060583,-0.0141559230858734,-0.00309856477709859,0.00222661525016232
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CSF3,Granulocyte colony-stimulating factor,28931,-0.0107460784523145,0.00352029351504078,-0.0176458537417945,-0.00384630316283462,0.00227067480537928
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,29820,-0.0137395352509913,0.00450214121146522,-0.0225637320254632,-0.0049153384765195,0.00227690432749901
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,29694,-0.0100891845667498,0.00330808310186753,-0.0165730274464102,-0.00360534168708943,0.00229151171766289
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NLGN2,Neuroligin-2,24101,0.0105747077850959,0.00347738289373529,0.00375903731337479,0.0173903782568171,0.00236050265800297
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",24195,-0.00864926262913444,0.00284805057316866,-0.014231441752545,-0.00306708350572387,0.00239274351687472
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,29478,0.00626325089171524,0.00206247600345742,0.00222079792493869,0.0103057038584918,0.00239342351429201
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BGLAP,Osteocalcin,24938,-0.0195776849077385,0.00645673841762437,-0.0322328922062823,-0.00692247760919474,0.00243082262800375
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TRIM26,Tripartite motif-containing protein 26,24016,-0.0123934968769279,0.00408959340552701,-0.0204090999517609,-0.00437789380209498,0.00244412309361545
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ERVV_1,,24111,0.0101928264921273,0.00337191156326952,0.00358387982811899,0.0168017731561355,0.00250658755596818
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTNNA1,Catenin alpha-1,24101,0.00774959318167478,0.00257045013290639,0.00271151092117826,0.0127876754421713,0.00257350435375424
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HMCN2,Hemicentin-2,24343,-0.0126203519434417,0.00421405396784051,-0.0208798977204091,-0.00436080616647433,0.00274879068691935
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD82,CD82 antigen,24445,0.00909905573636261,0.00304182191564926,0.00313708478169006,0.0150610266910352,0.00278053426522641
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,28916,0.00687436591319589,0.00231309668441753,0.00234069641173753,0.0114080354146543,0.00296175957299663
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SNAP25,Synaptosomal-associated protein 25,24101,-0.0102814251368547,0.00345946950833295,-0.0170619853731873,-0.00350086490052214,0.00296192005052221
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,24229,0.00941288457289874,0.00317176550509704,0.00319622418290853,0.0156295449628889,0.00300319267234109
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PFDN2,Prefoldin subunit 2,28774,-0.0120136609720907,0.00404903956243672,-0.0199497785144666,-0.00407754342971472,0.00300929492090312
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLU,Clusterin,24966,0.00685545862309177,0.00231583958682772,0.00231641303290945,0.0113945042132741,0.00307680880203906
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,24793,-0.01023432790371,0.00346147295159383,-0.0170188148888339,-0.00344984091858612,0.00311304591725395
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,24922,-0.00592141907663213,0.00200829473059356,-0.00985767674859551,-0.00198516140466875,0.00319636102898127
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DNM1,Dynamin-1,24805,-0.0245659427698421,0.00833923353177754,-0.0409108404921261,-0.00822104504755811,0.0032239148972876
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDH22,Cadherin-22,24445,0.00614492998489228,0.00208991912447173,0.0020486885009277,0.0102411714688569,0.00328231823605235
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,24229,-0.0138318034145771,0.0047048104786873,-0.0230532319528042,-0.00461037487634997,0.00328598849799673
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLC,Galectin-10,29426,0.0141765104238121,0.00482378151686614,0.00472189865075446,0.0236311221968697,0.00329657492719476
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDH23,Cadherin-23,24845,0.00568525556399874,0.00193537457961847,0.00189192138794653,0.00947858974005094,0.00331122964653748
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,24793,-0.010498383530181,0.00360227389021667,-0.0175588403550057,-0.00343792670535635,0.00356718220521743
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,24229,0.00899275525104716,0.00308574755602395,0.00294469004124023,0.0150408204608541,0.00356827806135803
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,24195,-0.0111280866374216,0.00381984664852701,-0.0186149860685346,-0.00364118720630868,0.00358040005254014
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,24111,-0.010242448727452,0.00352747794718164,-0.017156305503928,-0.00332859195097595,0.00369212615517346
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,24229,-0.00775083997168099,0.00267111398190763,-0.0129862233762199,-0.00251545656714204,0.00371447752788326
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,24016,0.00992281784181592,0.0034202286389599,0.00321916970945452,0.0166264659741773,0.0037205668100942
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STX5,Syntaxin-5,24229,-0.00864990938073501,0.00298330191373008,-0.014497181131646,-0.00280263762982406,0.00374163943442756
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,29786,0.00602477402812662,0.00208024618503438,0.00194749150545923,0.010102056550794,0.00378006707835691
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACE,Angiotensin-converting enzyme,24951,-0.00553674018192432,0.0019136567801766,-0.00928750747107046,-0.00178597289277818,0.00381574284560192
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACRV1,Acrosomal protein SP-10,24229,-0.0162266690798813,0.00560893597859634,-0.0272201835979301,-0.00523315456183243,0.00381917607222727
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,24195,-0.0162636545382101,0.00562412263395691,-0.0272869349007657,-0.00524037417565459,0.00383422779899527
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,24793,-0.0140931648480791,0.00487849305115675,-0.0236550112283463,-0.00453131846781187,0.00387006053609579
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GBP2,Guanylate-binding protein 2,28931,-0.0125699863947032,0.00435862723625311,-0.0211128957777593,-0.00402707701164706,0.00393032789218245
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,29288,0.00469936314903903,0.00163513277547219,0.00149450290911355,0.00790422338896452,0.00405607310930884
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MMP13,Collagenase 3,28774,0.00683989206995853,0.00238441064532688,0.00216644720511784,0.0115133369347992,0.00412608318088921
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,24111,0.00803786615202594,0.00280845184490095,0.00253330053602008,0.0135424317680318,0.00421303047642966
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,29388,0.010005098327626,0.00349863017489799,0.00314778318482589,0.016862413470426,0.00424315564780359
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,24381,0.0085555604820195,0.00299340933846068,0.00268847817863657,0.0144226427854024,0.00426503592815263
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CBLN4,Cerebellin-4,29725,-0.00658520702385646,0.00230728903154443,-0.0111074935256836,-0.00206292052202937,0.0043190355880197
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATXN2,Ataxin-2,24101,-0.0231394374276149,0.00810984790702033,-0.0390347393253748,-0.00724413552985505,0.00433112032887886
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GAD1,Glutamate decarboxylase 1,24016,0.00540093372731231,0.00190108634361754,0.00167480449382192,0.00912706296080269,0.00450140766360237
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CHGA,Chromogranin-A,24938,-0.0181751839402125,0.00640105330045017,-0.0307212484090949,-0.00562911947133019,0.00452342943744607
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,24111,0.00768517733989399,0.00271247414458738,0.00236872801650272,0.0130016266632853,0.00461124052608232
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANK2,Ankyrin-2,24111,0.0149197580157552,0.005271614136825,0.00458739430757824,0.0252521217239322,0.00465564059776391
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NDRG1,Protein NDRG1,28774,-0.0138568556709782,0.0049105269328698,-0.0234814884594029,-0.00423222288255335,0.00477776555155978
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL17RA,Interleukin-17 receptor A,29443,-0.00901002403155052,0.00320322112222887,-0.0152883374311191,-0.00273171063198194,0.00491445397846488
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,24240,-0.00680630390637955,0.00242170890014018,-0.0115528533506543,-0.00205975446210479,0.00494984881518958
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITGA2,Integrin alpha-2,24381,-0.00701896260652113,0.00250622833129651,-0.0119311701358623,-0.00210675507717996,0.00510466345877832
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,28797,-0.0157692129920096,0.00563099649136578,-0.0268059661150865,-0.00473245986893267,0.00510685463943592
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",28774,-0.00612768142811975,0.00219904477728813,-0.0104378091916045,-0.00181755366463501,0.00533122960510398
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GBA,Lysosomal acid glucosylceramidase,24195,-0.0109642218875233,0.00394023902208784,-0.0186870903708155,-0.00324135340423116,0.00539622923165884
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,29340,0.00692497359873481,0.00249824078470961,0.00202842166070397,0.0118215255367657,0.00557584352720367
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,28916,0.00689179978280984,0.00249414466775847,0.00200327623400325,0.0117803233316164,0.0057275344222469
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,24845,-0.00566622147450459,0.00205134554768293,-0.00968685874796313,-0.00164558420104605,0.00574559548393185
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NPTN,Neuroplastin,28797,0.0164064327544099,0.00594277081320877,0.00475860196052076,0.0280542635482991,0.00577074432421413
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DCLRE1C,Protein artemis,24016,0.00627026906468422,0.00227261345826385,0.00181594668648707,0.0107245914428814,0.00580124134793187
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,24445,-0.00917378275673403,0.00332610089451723,-0.0156929405099878,-0.00265462500348026,0.00581782056242628
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TEX33,Testis-expressed protein 33,24445,0.00785452596876296,0.00285206953464921,0.00226446968085051,0.0134445822566754,0.00589199325806218
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,24101,0.0118953399556749,0.00431954511945058,0.00342903152155174,0.020361648389798,0.00589445547909245
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CGN,Cingulin,24195,-0.00803561801929615,0.00291821759818885,-0.0137553245117463,-0.00231591152684601,0.00589868986837897
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,24381,-0.0106381719302945,0.00386845711599633,-0.0182203478776474,-0.00305599598294175,0.00596432142177146
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EPCAM,Epithelial cell adhesion molecule,29457,-0.0193818313350063,0.00704894731675468,-0.0331977680758455,-0.00556589459416718,0.00597032631607091
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,24101,0.00642499558001891,0.00233784937958417,0.00184281079603394,0.0110071803640039,0.00599588180444227
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TLR1,Toll-like receptor 1,24229,-0.0052958093788459,0.00192734443025797,-0.00907340446215151,-0.00151821429554028,0.00600550090299279
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,28498,0.0170476356017545,0.0062274618050547,0.0048418104638473,0.0292534607396617,0.00619477792416005
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLK4,Kallikrein-4,29725,0.0124945224701728,0.00457335499717514,0.00353074667570953,0.0214582982646361,0.00629834482764791
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,29218,0.0137963761842221,0.00507541766955335,0.00384855755189752,0.0237441948165467,0.00656621834294032
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,F2,Prothrombin,24966,-0.00293182439415298,0.0010800216905177,-0.00504866690756768,-0.000814981880738282,0.00664019344476725
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CADPS,Calcium-dependent secretion activator 1,24195,0.00854861205384598,0.00315120707367394,0.00237224618944506,0.0147249779182469,0.00667634491928243
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",24445,-0.013926793643312,0.00515071353355526,-0.0240221921690803,-0.0038313951175437,0.00685871820402661
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LEG1,Protein LEG1 homolog,23603,0.0137400041206399,0.00511581456092253,0.0037130075812318,0.0237670006600481,0.00724091638498469
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BMP4,Bone morphogenetic protein 4,29169,0.00901319671032639,0.00336063314879528,0.00242635573868764,0.0156000376819651,0.00732260781017639
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NXPH1,Neurexophilin-1,28774,-0.00745898673665744,0.0027812673580331,-0.0129102707584023,-0.00200770271491256,0.00732545506429721
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,24805,-0.00500642991145445,0.00186984639942646,-0.00867132885433031,-0.00134153096857859,0.00742326273519301
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNN,Tenascin-N,24938,-0.00847658824814304,0.00317078932324084,-0.0146913353216951,-0.00226184117459098,0.00751496933104052
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SAT1,Diamine acetyltransferase 1,24111,0.00984550426842341,0.00368346305920974,0.00262591667237232,0.0170650918644745,0.00752507664834612
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNNI3,"Troponin I, cardiac muscle",28916,-0.0162833816416882,0.00612773002607102,-0.0282937324927874,-0.00427303079058903,0.00788063356233371
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RLN1,Prorelaxin H1,24867,-0.013284909282624,0.00503020124119699,-0.0231441037153701,-0.00342571484987795,0.00827062463574404
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,24101,0.00732221157024359,0.0027737697967706,0.00188562276857322,0.012758800371914,0.00830071701207728
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ERC2,ERC protein 2,24195,-0.0145386538557373,0.00550904632771119,-0.0253363846580512,-0.00374092305342336,0.00831917898305111
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",24111,-0.0076429742958049,0.00290686991119807,-0.0133404393217531,-0.00194550926985669,0.00856202549551028
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,24111,0.0100585672031365,0.00383569558474936,0.00254060385702779,0.0175765305492453,0.008737855745812
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",24229,-0.0118452869676011,0.00452408183954064,-0.0207124873731008,-0.00297808656210148,0.00884307531400869
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DLL4,Delta-like protein 4,24240,-0.0163927006308533,0.00627667777656834,-0.0286949890729272,-0.00409041218877934,0.0090152969305272
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLHL41,Kelch-like protein 41,24867,-0.00945738313631802,0.003632426168003,-0.0165769384256039,-0.00233782784703214,0.00923053072659885
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RBM25,RNA-binding protein 25,24016,0.00881447458614291,0.00339407984999239,0.00216207808015782,0.015466871092128,0.00940953140535085
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,UPK3A,Uroplakin-3a,24101,0.00934747086812345,0.00360430185339305,0.00228303923547308,0.0164119025007738,0.00950839379551799
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LY75,Lymphocyte antigen 75,29434,-0.007306066292424,0.00282433498823281,-0.0128417628693603,-0.00177036971548768,0.00969117155542546
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",24101,-0.00607779900387954,0.00235060799731663,-0.0106849906786201,-0.00147060732913896,0.00972598005453893
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLC13A1,Solute carrier family 13 member 1,24793,-0.0115147606385537,0.00445642678580026,-0.0202493571387222,-0.00278016413838521,0.00977595529093194
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEP164,Centrosomal protein of 164 kDa,28931,-0.011844323308916,0.00458750936178783,-0.0208358416580202,-0.00285280495981187,0.00983171496972437
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,29116,-0.00552008403348332,0.00214297505711713,-0.0097203151454329,-0.00131985292153374,0.0100029144558318
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C7,Complement component C7,24374,0.00607363039623823,0.00237103693888942,0.00142639799601497,0.0107208627964615,0.0104253133961897
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PALLD,Palladin,24229,0.00745451899132089,0.00291714388916033,0.00173691696856665,0.0131721210140751,0.0106121210837689
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,28797,0.00701447442722856,0.00274820078136951,0.00162800089574432,0.0124009479587128,0.01070384988696
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPM1A,Protein phosphatase 1A,28797,-0.00575660041062599,0.0022661700248745,-0.01019829365938,-0.00131490716187198,0.0110830659072009
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,24195,-0.0192006453968104,0.00756835945243511,-0.0340346299235832,-0.00436666087003753,0.0111881181686767
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITGB5,Integrin beta-5,29566,0.00693853853852518,0.00273932822754794,0.00156945521253121,0.0123076218645191,0.0113163418143798
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,24101,0.00761100817411898,0.00301784460162216,0.00169603275493954,0.0135259835932984,0.0116753178202114
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,INSR,Insulin receptor,24229,-0.00310378345861384,0.00123934048224899,-0.00553289080382186,-0.000674676113405814,0.0122730307044036
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,24966,0.00355226393686314,0.00141855680882142,0.000771892591573153,0.00633263528215312,0.0122812972130022
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SH3GL3,Endophilin-A3,24307,-0.0153255359476259,0.00612654107648559,-0.0273335564575377,-0.00331751543771417,0.0123734073814138
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NUP50,Nuclear pore complex protein Nup50,24111,0.00616340187449394,0.00246868383967098,0.00132478154873881,0.0110020222002491,0.0125444262119747
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GNLY,Granulysin,29443,-0.00944745500609182,0.00379323485502206,-0.0168821953219351,-0.00201271469024859,0.0127580004388562
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,24195,-0.00990007502783825,0.00397936099178698,-0.0176996225717407,-0.00210052748393577,0.0128582774323692
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,24016,-0.0156684425461256,0.00631705318254014,-0.0280498667839043,-0.00328701830834697,0.0131325022067937
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,S100A13,Protein S100-A13,24229,-0.00631698712148764,0.00256679714074424,-0.0113479095173464,-0.00128606472562892,0.013860465853848
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NPHS2,Podocin,24229,0.0185479413931274,0.00754831658232059,0.00375324089177909,0.0333426418944758,0.0140083054498203
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,29443,-0.00565774964056305,0.00230776887319253,-0.0101809766320204,-0.00113452264910569,0.0142276344870715
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,29632,-0.00611966412991883,0.00250361783203703,-0.0110267550807114,-0.00121257317912626,0.0145180001495863
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,29820,-0.00537837040283414,0.0022071732632584,-0.0097044299988206,-0.00105231080684768,0.0148249720466996
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",24111,-0.0100325180594077,0.00411847667989213,-0.0181047323519963,-0.00196030376681913,0.014858788528279
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,24229,-0.015431164923009,0.006350349716845,-0.0278778503680252,-0.00298447947799278,0.0151072531510857
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,28916,0.00551622800229907,0.0022785871218458,0.00105019724348131,0.00998225876111683,0.0154883212425247
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FSTL1,Follistatin-related protein 1,24240,-0.00402236504696512,0.0016683948716837,-0.00729241899546518,-0.000752311098465066,0.0159197731998462
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CST6,Cystatin-M,28830,-0.00855011472823848,0.00355110134564327,-0.0155102733656993,-0.00158995609077768,0.0160580242375277
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,29530,-0.00859634571846091,0.00357751165489139,-0.015608268562048,-0.00158442287487378,0.0162724764406354
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,24922,-0.00520419007735747,0.00216939051272751,-0.00945619548230339,-0.000952184672411541,0.0164508979672839
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LAMA1,Laminin subunit alpha-1,24111,0.00947270943353793,0.00394922762007583,0.0017322232981893,0.0172131955688866,0.0164643870666686
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGF20,Fibroblast growth factor 20,24229,0.00769544841579298,0.00320847512639508,0.00140683716805862,0.0139840596635273,0.0164710030584751
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BEX3,Protein BEX3,24016,0.00825140866485232,0.00345035501562716,0.00148871283422308,0.0150141044954816,0.0167888638675631
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DBH,Dopamine beta-hydroxylase,24919,0.0190321502921905,0.00798513228637882,0.00338129101088797,0.0346830095734929,0.0171587403473269
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CENPJ,Centromere protein J,24445,-0.0124994859811036,0.0052507149605433,-0.0227908873037685,-0.00220808465843876,0.0172953609589478
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EPN1,Epsin-1,24445,-0.00759299877120784,0.00319598652416156,-0.0138571323585645,-0.00132886518385118,0.0175190035402858
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,29218,0.00875352503278088,0.00368985970204699,0.00152140001676879,0.015985650048793,0.0176832525215166
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,29820,0.00599181645654324,0.00252779454446035,0.00103733914940096,0.0109462937636855,0.0177764636012101
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MSLNL,Mesothelin-like protein,24195,0.00652919976820338,0.00275483286521519,0.00112972735238161,0.0119286721840252,0.0177915917070406
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAMDC2,MAM domain-containing protein 2,24922,0.00598458195752759,0.0025292483455197,0.00102725520030898,0.0109419087147462,0.017981750579058
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL36A,Interleukin-36 alpha,24229,0.0100662281117893,0.00425496718080254,0.00172649243741632,0.0184059637861623,0.0180009697383799
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GPC1,Glypican-1,29725,-0.00505877042118293,0.00214066663734488,-0.00925447703037888,-0.000863063811986971,0.0181255012016656
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RAB39B,Ras-related protein Rab-39B,24111,-0.0155865551527013,0.00659769253749049,-0.0285180325261826,-0.00265507777921989,0.0181637057846835
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",24240,-0.0132861257955349,0.00563824664695382,-0.0243370892235644,-0.00223516236750541,0.0184595298341936
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TERF1,Telomeric repeat-binding factor 1,24229,0.00505333326239772,0.00214463953902756,0.000849839765903711,0.00925682675889173,0.0184678002609362
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MEP1B,Meprin A subunit beta,29478,-0.019966742678831,0.00849467949239822,-0.0366163144839315,-0.00331717087373051,0.018754772351043
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL36G,Interleukin-36 gamma,24149,-0.0116776818949641,0.00496895052249892,-0.021416824919062,-0.0019385388708662,0.018774840178486
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,24240,0.00689953775021898,0.00294072205865051,0.00113572251526398,0.012663352985174,0.0189736712821087
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,28797,0.00549076943375828,0.00234144543734461,0.000901536376562845,0.0100800024909537,0.0190320939014602
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FBN2,Fibrillin-2,24195,-0.01035608683835,0.0044183891268925,-0.0190161295270593,-0.00169604414964072,0.0190933710701605
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LTB,Lymphotoxin-beta,24793,-0.00596886272067888,0.00254811978181799,-0.0109631774930421,-0.000974547948315621,0.0191650782271902
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,24195,0.00540459261985506,0.00231933831046494,0.000858689531343783,0.00995049570836634,0.0198021609840559
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,24867,-0.00504570485445813,0.00216602335665784,-0.0092911106335075,-0.000800299075408763,0.0198416995779559
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGL1,Fibrinogen-like protein 1,24951,0.0108511864217116,0.00465845109405843,0.00172062227735705,0.0199817505660661,0.0198482096238412
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MERTK,Tyrosine-protein kinase Mer,29786,-0.00430730201174594,0.00185053770229804,-0.0079343559082501,-0.000680248115241793,0.0199402947705355
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AMIGO2,Amphoterin-induced protein 2,29349,-0.003884232257778,0.0016690216128195,-0.00715551461890422,-0.000612949896651787,0.0199586780273061
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL31,Interleukin-31,24229,0.00961474341964511,0.00415864419037519,0.00146380080650974,0.0177656860327805,0.0207865864537863
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,24966,0.00435445854129084,0.00188842606614257,0.000653143451651401,0.00805577363093028,0.0211262466891508
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,24111,-0.00669892441963921,0.00290904569012809,-0.0124006539722903,-0.000997194866988159,0.0212990784403936
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,24195,0.00632077788491456,0.00275336490426316,0.000924182672558757,0.0117173730972704,0.0217040902598247
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,29725,0.00431878241320101,0.00188168402127208,0.000630681731507736,0.00800688309489429,0.021730388468691
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,29433,-0.00806252858545872,0.00351298032996861,-0.0149479700321972,-0.00117708713872024,0.0217362344235209
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GAD2,Glutamate decarboxylase 2,24229,0.00776484029698029,0.00338567052669868,0.00112892606465088,0.0144007545293097,0.0218310738831887
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,24111,0.00672352617546279,0.00293244938935452,0.000975925372327921,0.0124711269785976,0.0218679731057554
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,29581,0.00474403508996395,0.0020779108444957,0.000671329834752386,0.00881674034517552,0.0224327650962886
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PALM3,Paralemmin-3,24111,-0.0123163613124782,0.00539472196877684,-0.0228900163712808,-0.00174270625367563,0.0224367310797668
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GKN1,Gastrokine-1,28114,-0.00467098889458418,0.00204604192944842,-0.00868123107630309,-0.000660746712865276,0.0224413956449331
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DLGAP5,Disks large-associated protein 5,24867,0.00862605590201348,0.00377943717332126,0.00121835904230381,0.0160337527617232,0.0224761975397316
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,24016,0.00420944568671183,0.00185773979534262,0.000568275687840288,0.00785061568558336,0.0234666013474868
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TGFBR1,TGF-beta receptor type-1,24229,-0.00357748298626102,0.00158456441473835,-0.00668322923914818,-0.000471736733373859,0.0239727672515703
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,29038,0.0281731537696385,0.0124894395293989,0.00369385229201654,0.0526524552472604,0.0240932008912072
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,24229,0.00789629678642192,0.0035319352221087,0.000973703751088868,0.014818889821755,0.0253814475619485
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AMBN,Ameloblastin,28931,0.00463443005343455,0.00207956532880766,0.000558482008971544,0.00871037809789756,0.0258510454466867
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PCDHB15,Protocadherin beta-15,24793,-0.00649266592775885,0.00292125896562748,-0.0122183335003887,-0.000766998355128998,0.0262546453970315
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD14,Monocyte differentiation antigen CD14,28954,-0.00669462877036044,0.00301333669806611,-0.01260076869857,-0.000788488842150875,0.0263135664393965
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITM2A,Integral membrane protein 2A,29434,0.00974593939274301,0.00438943783820024,0.00114264122987055,0.0183492375556155,0.0264049090318467
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,24793,0.00842170878534465,0.00380076199622611,0.000972215272741467,0.0158712022979478,0.0267146092935443
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GJA8,Gap junction alpha-8 protein,24016,-0.0100575746394385,0.00454490543927247,-0.0189655893004125,-0.00114955997846443,0.0269115862619528
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,24805,0.00750492754285421,0.00339953346614233,0.00084184194921524,0.0141680131364932,0.0272788815381982
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EVI2B,Protein EVI2B,24016,0.00662143716345351,0.00300194753745734,0.000737619990037124,0.0125052543368699,0.0274134849306208
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CYB5A,Cytochrome b5,24016,-0.0116122731433185,0.0052786604680052,-0.0219584476606087,-0.00126609862602833,0.027826875378374
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,29517,-0.00785663451791264,0.00357170092356792,-0.0148571683281058,-0.000856100707719508,0.0278366293858674
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NGF,Beta-nerve growth factor,29218,0.00193808681348813,0.000884174541926858,0.000205104711311487,0.00367106891566477,0.0283893145375861
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLK3,Prostate-specific antigen,24938,0.014161161074862,0.00648455296317119,0.00145143726704651,0.0268708848826776,0.0289840346213011
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PXDNL,Peroxidasin-like protein,24793,0.00922254167389593,0.00422432062232738,0.00094287325413427,0.0175022100936576,0.0290303494288769
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCN2B,Sodium channel subunit beta-2,24195,0.00461693956052137,0.00211707732904566,0.000467467995591873,0.00876641112545086,0.0292072104653809
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PAEP,Glycodelin,29218,-0.0208708280413403,0.00957334989616573,-0.0396345938378251,-0.00210706224485545,0.029258254978024
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RALB,Ras-related protein Ral-B,24229,-0.00469345951023447,0.00215946318556103,-0.0089260073539341,-0.000460911666534853,0.0297570195771456
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACTA2,"Actin, aortic smooth muscle",28916,-0.00688658139074537,0.00316993837471585,-0.0130996606051884,-0.000673502176302312,0.0298286769393519
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CNTF,Ciliary neurotrophic factor,24101,0.00542152188729877,0.00249695263399532,0.000527494724667931,0.0103155490499296,0.0299216011156045
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GLI2,Zinc finger protein GLI2,24229,0.00526960913934597,0.00243787457484737,0.000491374972645117,0.0100478433060468,0.0306619701418697
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,28774,-0.0123473486506439,0.00571625368523761,-0.0235512058737096,-0.00114349142757821,0.0307776451453815
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TPSD1,Tryptase delta,24867,-0.00589685535544309,0.00273228417276881,-0.0112521323340699,-0.000541578376816229,0.0309207034813445
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RTKN2,Rhotekin-2,24111,0.00813926436033927,0.00378316174595155,0.000724267338274237,0.0155542613824043,0.0314510012716585
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,24016,0.00892728357637786,0.00415045144910935,0.000792398736123533,0.0170621684166322,0.031492569836943
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,24111,0.0114285171297923,0.00532420484999235,0.000993075623807269,0.0218639586357773,0.0318413933114222
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",24111,0.00678710065493967,0.0031674185908122,0.000578960216947746,0.0129952410929316,0.0321402610534241
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,24793,-0.00547583106324674,0.00256551419552515,-0.010504238886476,-0.000447423240017444,0.0328199145276819
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MATN2,Matrilin-2,29497,-0.0046153353379067,0.00216321176348504,-0.00885523039433738,-0.000375440281476016,0.032887301213909
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",24240,-0.0108688331490985,0.00509726327370765,-0.0208594691655655,-0.000878197132631495,0.0329932081582898
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL17D,Interleukin-17D,28931,-0.00528796268539309,0.00248297986559152,-0.0101546032219525,-0.000421322148833712,0.0332061247752144
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",24016,-0.00887981362979705,0.00418653335143876,-0.017085418998617,-0.000674208260977076,0.0339284794960922
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OTOA,Otoancorin,24101,0.00833165573564308,0.003930465395113,0.000627943561221611,0.0160353679100646,0.0340362216961101
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,24101,0.0113623110497934,0.0053645977668207,0.000847699426824791,0.0218769226727619,0.0341838133562158
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD276,CD276 antigen,29454,0.005536199414377,0.00261557763804487,0.000409667243809055,0.010662731584945,0.0342999753361537
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEP290,Centrosomal protein of 290 kDa,24445,-0.0081514825958824,0.00388117917330315,-0.0157585937755566,-0.000544371416208215,0.0357162635271562
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,24229,-0.00451179270906844,0.00214885822124611,-0.00872355482271082,-0.000300030595426053,0.035772316325445
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,24101,0.00503439077701719,0.00239861829779703,0.000333098913335023,0.00973568264069936,0.0358386424927952
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLC1A4,Neutral amino acid transporter A,24195,-0.00790456536692574,0.00377747864780862,-0.0153084235166306,-0.00050070721722084,0.0363996843976157
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,24805,-0.00833893220225777,0.00400055073404398,-0.016180011640984,-0.000497852763531573,0.0371298225607265
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPON2,Spondin-2,29311,-0.00527436792382491,0.00253420455602461,-0.0102414088536332,-0.000307326994016669,0.037417717380048
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,24240,0.00557607212599061,0.00269491067785676,0.00029404719739135,0.0108580970545899,0.0385461539969549
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DSG4,Desmoglein-4,29242,0.00745380514933209,0.00360707968379573,0.000383928969092449,0.0145236813295717,0.0387959648659102
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,24016,0.00626757827811492,0.00303425143257931,0.000320445470259479,0.0122147110859704,0.0388760846004212
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,24445,-0.00802833101297469,0.0039055514948445,-0.0156832119428699,-0.000373450083079469,0.0398297312569862
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,24922,0.00591302823886646,0.00287688027475346,0.000274342900349682,0.0115517135773832,0.0398545279859866
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,24101,0.00886286149567067,0.00431346522836283,0.000408469648079531,0.0173172533432618,0.0399191002982959
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,24101,-0.00926318869607355,0.00451735610226145,-0.018117206656506,-0.000409170735641106,0.040318908635545
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CYTL1,Cytokine-like protein 1,24938,0.00360675165762495,0.0017603328739502,0.000156499224682555,0.00705700409056734,0.0404820297294558
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RPA2,Replication protein A 32 kDa subunit,24229,-0.00474288375081638,0.00232332610378489,-0.00929660291423478,-0.000189164587397993,0.0412199409796831
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TSPAN15,Tetraspanin-15,24111,0.00752470900326628,0.0036964005513231,0.000279763922672996,0.0147696540838596,0.0417928624517577
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GBP6,Guanylate-binding protein 6,24111,0.00684348130685259,0.00337116019887627,0.000236007317055112,0.0134509552966501,0.042366715107569
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRND,Prion-like protein doppel,24845,-0.00763008681519745,0.0037600580196512,-0.0149998005337138,-0.000260373096681103,0.042443773719444
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EDNRB,Endothelin receptor type B,24229,-0.00675562141098995,0.00333900627512181,-0.0133000737102287,-0.000211169111751211,0.0430590541123949
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PVALB,Parvalbumin alpha,29599,-0.0164707894920615,0.00815768011737963,-0.0324598425221256,-0.000481736461997468,0.0434907002454772
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,24229,0.00613945296842185,0.00304310733647116,0.000174962588938378,0.0121039433479053,0.0436549222900385
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TOP1,DNA topoisomerase 1,24805,-0.0165258705836301,0.00826788174805934,-0.0327309188098264,-0.000320822357433775,0.0456405226392277
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGF16,Fibroblast growth factor 16,24229,-0.00695827044363836,0.00349660967633943,-0.0138116254092636,-0.000104915478013081,0.0466016199123319
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RBP1,Retinol-binding protein 1,24195,-0.0100503670779501,0.00507382929548537,-0.0199950724971014,-0.000105661658798743,0.0476222325535984
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,28797,-0.00729559869314316,0.00368540304040959,-0.0145189886523459,-7.22087339403701e-05,0.0477587719929474
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCN3B,Sodium channel subunit beta-3,24101,0.00668142287107273,0.0033758958357592,6.46670329847053e-05,0.0132981787091608,0.047809868103156
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,UBQLN3,Ubiquilin-3,24111,-0.0072542818664342,0.00367835611760094,-0.014463859856932,-4.47038759363678e-05,0.0486035348650085
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,24111,-0.00855709358626002,0.00434658030815301,-0.0170763909902399,-3.77961822801091e-05,0.0489994981880731
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ESPL1,Separin,24016,0.00790626680221723,0.0040516804564256,-3.50268923769593e-05,0.0158475604968114,0.0510264503531923
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,23970,0.0074608355878524,0.00382593465820615,-3.79963422316573e-05,0.0149596675179365,0.0511795742641591
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLXDC1,Plexin domain-containing protein 1,28797,-0.00470571756450053,0.00241523143341423,-0.00943957117399243,2.81360449913611e-05,0.0513827338416211
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,24445,0.0062476562794055,0.00320873792530134,-4.14700541851339e-05,0.0125367826129961,0.0515370788850906
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINB5,Serpin B5,28916,-0.00689150049082618,0.00354110689586056,-0.0138320700067129,4.9069025060521e-05,0.0516472397338615
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,29527,-0.00808699267787029,0.00416500863904639,-0.0162504096104012,7.64242546606349e-05,0.0521888834289688
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGF9,Fibroblast growth factor 9,23970,0.00576508270363768,0.00298078475357742,-7.72554133740555e-05,0.0116074208206494,0.0531147861012255
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,24101,0.00425142101912569,0.00220134547684575,-6.32161154919767e-05,0.00856605815374336,0.0534597873084561
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,29478,0.00247548689768886,0.00128185897824509,-3.69566996715159e-05,0.00498793049504923,0.0534716812021083
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,24405,0.00746344302501504,0.0038673418195491,-0.000116546941301193,0.0150434329913313,0.0536352965215987
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,24101,0.00808729656825301,0.00419411155475109,-0.000133162079059126,0.0163077552155651,0.0538357487530492
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MN1,Transcriptional activator MN1,24195,0.00832267569146722,0.00432973147082173,-0.000163597991343382,0.0168089493742778,0.0545904191371753
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",24195,0.0109229638296191,0.00568425351250202,-0.000218173054884833,0.0220641007141231,0.0546655823610607
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MSMB,Beta-microseminoprotein,29313,-0.00971185548640523,0.00505576937905336,-0.0196211634693498,0.000197452496539359,0.0547483200176584
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MYH7B,Myosin-7B,24016,0.00621059857489317,0.00324063698491269,-0.0001410499155357,0.012562247065322,0.0553165714548302
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ICOSLG,ICOS ligand,29349,-0.0026576877817364,0.00138942349290035,-0.00538095782782109,6.55822643482818e-05,0.0557835233720843
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",24229,0.00619522012213829,0.00324119839600613,-0.000157528734033728,0.0125479689783103,0.0559652460125855
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,24016,-0.00828474491929513,0.00433479080631252,-0.0167809348996677,0.00021144506107742,0.0559880338478986
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CA12,Carbonic anhydrase 12,29349,-0.00452169575649142,0.00237133278379128,-0.00916950801272232,0.000126116499739481,0.0565541524813977
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,24195,-0.00413212099929622,0.00217306198810984,-0.0083913224959915,0.000127080497399058,0.0572457993793592
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BRK1,Protein BRICK1,28774,-0.00615361106523378,0.00325754657775486,-0.0125384023576333,0.000231180227165752,0.0588975373027742
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,24016,-0.0109831538432951,0.00582752469167351,-0.0224051022389752,0.000438794552384958,0.059482005328234
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SAG,S-arrestin,24101,0.00727955629854578,0.00386398944306425,-0.00029386300986015,0.0148529756069517,0.0595840042468734
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,APOH,Beta-2-glycoprotein 1,29443,-0.00491643361083555,0.00261269937894487,-0.0100373243935675,0.000204457171896406,0.0598805271941731
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NXPE4,NXPE family member 4,24111,0.00472531320813535,0.00251254679572811,-0.000199278511491741,0.00964990492776245,0.0600266063993215
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NME1,Nucleoside diphosphate kinase A,24229,0.00300360344978049,0.00159979649290069,-0.000131997676304855,0.00613920457586583,0.0604628458237425
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPRING1,SREBP regulating gene protein,24016,-0.00814604973200775,0.004349997539217,-0.0166720449088731,0.000379945444857572,0.0611280263612127
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,24111,0.00948623420905003,0.00506829960941709,-0.000447633025407464,0.0194201014435075,0.0612630150877035
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,24101,0.00951824879576601,0.00513294547117026,-0.000542324327727694,0.0195788219192597,0.0637021147774222
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,24867,-0.0156254795101935,0.0084361228467432,-0.0321602802898102,0.000909321269423148,0.0640073797804122
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",24195,-0.0114070403185704,0.00616964748980113,-0.0234995493985806,0.000685468761439795,0.0644849415318855
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,24793,-0.0130609726615718,0.00709148029393083,-0.0269602740376763,0.000838328714532573,0.065518741498731
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SSB,Lupus La protein,28774,-0.00799434658155027,0.00434156911953686,-0.0165038220558425,0.000515128892741972,0.0655806348084981
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CPA4,Carboxypeptidase A4,23902,-0.00590023510240862,0.00320928149244591,-0.0121904268276026,0.000389956622785366,0.066002495820961
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,24938,-0.00354284750638254,0.00192967037706288,-0.00732500144542578,0.000239306432660694,0.0663716545219823
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL33,Interleukin-33,28931,-0.00520356915867424,0.00283477074155802,-0.010759719812128,0.000352581494779482,0.0664237592949558
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,28774,-0.0113648834942064,0.00620073439484206,-0.0235183229080969,0.000788555919683997,0.0668383925732245
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,24195,-0.0104019148032616,0.0056765494233979,-0.0215279516731215,0.000724122066598271,0.0668987453728826
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MUCL3,Mucin-like protein 3,24016,0.00586482523900263,0.00320706905162714,-0.000421030102186558,0.0121506805801918,0.0674542512059095
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARTN,Artemin,28931,-0.00595004511614129,0.00325609160726694,-0.0123319846663845,0.000431894434101907,0.067656257246824
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,24793,-0.00597999151080479,0.00327835385677492,-0.0124055650700836,0.00044558204847406,0.0681514720715968
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GFRA2,GDNF family receptor alpha-2,29349,0.00278736519813489,0.00153087117753862,-0.0002131423098408,0.00578787270611058,0.0686519212960299
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ENPEP,Glutamyl aminopeptidase,24111,0.0059209999436084,0.00325463459254846,-0.000458083857786578,0.0123000837450034,0.0688854226966965
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,24101,0.0086428259782189,0.00475670288257163,-0.000680311671621489,0.0179659636280593,0.0692328554682138
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MARCO,Macrophage receptor MARCO,29478,-0.00346828742934464,0.00191350770480494,-0.00721876253076232,0.000282187672073036,0.0699147333022969
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TSPAN7,Tetraspanin-7,24101,0.0124509137184333,0.00689290400494159,-0.00105917813125221,0.0259610055681188,0.070878051929499
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",24867,-0.00896720257872107,0.00498015480920018,-0.0187283060047534,0.000793900847311277,0.071780101059974
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEP350,Centrosome-associated protein 350,24016,0.00484123367843485,0.00270274753624648,-0.000456151492608259,0.010138618849478,0.0732695105648942
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EP300,Histone acetyltransferase p300,24229,-0.00394517280858768,0.00220569962146663,-0.00826834406666227,0.000377998449486902,0.0736874825473243
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRR4,Proline-rich protein 4,24203,0.00911474184384483,0.00509959556755839,-0.000880465468569612,0.0191099491562593,0.0738940962002539
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GPR101,Probable G-protein coupled receptor 101,24101,0.00803099714297385,0.00451071714525754,-0.000810008461730918,0.0168720027476786,0.0750189051569549
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLXDC2,Plexin domain-containing protein 2,24845,0.00348694550908953,0.00197383659683991,-0.000381774220716697,0.00735566523889576,0.0773104304266306
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NOP56,Nucleolar protein 56,24111,-0.0143164118807205,0.00811062907091131,-0.0302132448597066,0.0015804210982657,0.0775525703840024
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NTF4,Neurotrophin-4,28797,-0.0050670285459486,0.00287271162437873,-0.0106975433297309,0.000563486237833721,0.0777680696236105
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNPO1,Transportin-1,24445,0.00454910225243756,0.00258956058754886,-0.000526436499158211,0.00962464100403333,0.0789800896596915
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,24396,0.00647437523315045,0.0036873750902126,-0.000752879943666252,0.0137016304099671,0.0791313186906597
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,H2AP,Huntingtin-interacting protein M,24016,0.00655774867266451,0.00374309166001307,-0.000778710980961112,0.0138942083262901,0.0797933728296456
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEP112,Centrosomal protein of 112 kDa,24111,-0.00586554201595428,0.00335021317179096,-0.0124319598326646,0.000700875800755997,0.0799936670000419
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",29132,-0.00519796630250259,0.00297224018242117,-0.0110235570600481,0.000627624455042895,0.0803295785956522
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NRXN3,Neurexin-3,24195,-0.00449813310435074,0.00257994993237538,-0.00955483497180649,0.000558568763105009,0.0812596727028959
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,24111,0.00449292250831606,0.00257958551416397,-0.000563065099445327,0.00954891011607745,0.0815697478430564
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,24101,0.00632233424390656,0.00365867220652259,-0.000848663280877714,0.0134933317686908,0.0839937559952105
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,METAP1,Methionine aminopeptidase 1,28774,-0.00375804666486527,0.00217795613639737,-0.00802684069220412,0.00051074736247358,0.0844495220014519
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGF5,Fibroblast growth factor 5,28931,0.00413910333216482,0.00240789606010501,-0.000580372945641006,0.00885857960997064,0.0856303676701239
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,28931,-0.00455109734129784,0.00264851199258573,-0.00974218084676587,0.000639986164170191,0.0857416570276947
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,24111,0.008868111607269,0.00516516834932607,-0.0012556183574101,0.0189918415719481,0.0860090899322998
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,24793,-0.00466509865181665,0.00271719140855727,-0.00999079381258889,0.000660596508955595,0.0860131213668579
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,24101,0.00967842004037984,0.00563811121150688,-0.00137227793417364,0.0207291180149333,0.0860638960572073
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,24111,0.00470466831178553,0.00274117231996013,-0.000668029435336328,0.0100773660589074,0.0861203838835466
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SEMA3G,Semaphorin-3G,24381,-0.00552929614659414,0.00323382080163214,-0.0118675849177931,0.000808992624604846,0.0873093399964904
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,28393,-0.00794808298981368,0.00465745620195022,-0.0170766971456361,0.00118053116600874,0.0879206154816291
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,24938,0.00370538426987438,0.00217346248240074,-0.000554602195631063,0.00796537073537983,0.0882385775525784
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DCUN1D2,DCN1-like protein 2,24016,0.00999116531816639,0.00586206879383226,-0.00149848951774484,0.0214808201540776,0.0883239359606489
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TP73,Tumor protein p73,24195,0.00428470061504635,0.00252886621481756,-0.00067187716599607,0.00924127839608876,0.0902179694400365
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,24016,0.00812112480563359,0.00481485781707812,-0.00131599651583953,0.0175582461271067,0.09167787828624
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RELB,Transcription factor RelB,24229,-0.00607767307835414,0.00360839491357741,-0.0131501271089659,0.000994780952257576,0.0921337277462551
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,29673,-0.00422239027460129,0.00251266380693165,-0.00914721133618733,0.000702430786984743,0.0928815339344575
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MYOM2,Myomesin-2,24111,0.00624629218755041,0.00372624108112237,-0.00105714033144944,0.0135497247065503,0.0936927184555867
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,28931,-0.00550926219903664,0.00329532971965667,-0.0119681084495637,0.000949584051490438,0.0945668062691331
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DAND5,DAN domain family member 5,24229,0.00664846646322031,0.00397711687155279,-0.00114668260502316,0.0144436155314638,0.0946003739462578
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,29789,-0.00699136031007777,0.00418428050700355,-0.0151925501038047,0.00120982948364918,0.0947592116264237
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,24101,-0.00535673902317266,0.00320850666043102,-0.0116454120776175,0.000931934031272149,0.0950228606707154
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TPSG1,Tryptase gamma,24229,0.00325747876118287,0.00195384491397205,-0.00057205727020235,0.00708701479256809,0.0954846726888796
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CPLX2,Complexin-2,24016,0.00374444147597679,0.00224866842617351,-0.00066294863932329,0.00815183159127688,0.0958895651791301
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL20,Interleukin-20,28931,0.00592268321965879,0.00356320169998427,-0.00106119211231038,0.012906558551628,0.0964874927911708
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,24951,0.00523235377092873,0.00315313501767968,-0.00094779086372344,0.0114124984055809,0.0970451391368624
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DEFB116,Beta-defensin 116,24101,0.00936132865661222,0.00564854189355938,-0.00170981345476416,0.0204324707679886,0.0974718540749479
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CNPY2,Protein canopy homolog 2,28916,-0.00733782585602612,0.00443093977719334,-0.0160224678193251,0.00134681610727282,0.0977240101093011
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MYL6B,Myosin light chain 6B,24195,-0.0110960319505659,0.0067106275555332,-0.024248861959411,0.00205679805827916,0.0982418453027887
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLINT1,Clathrin interactor 1,24016,0.00575983082323722,0.00348495684151933,-0.00107068458614068,0.0125903462326151,0.0983908365307954
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ENOPH1,Enolase-phosphatase E1,24793,0.00667442056841314,0.00404650853739147,-0.00125673616487415,0.0146055773017004,0.0990728560659665
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,24111,0.00404771053123912,0.00245984462112978,-0.000773584926175256,0.0088690059886535,0.0998767519444582
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,29434,0.00492246249015936,0.00300975188591626,-0.000976651206236502,0.0108215761865552,0.101954048085541
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,28733,0.00339331557361642,0.00208430730578338,-0.000691926745719,0.00747855789295184,0.103529417639422
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,29536,-0.0105239656402732,0.00647988024560439,-0.0232245309216578,0.00217659964111144,0.104365402904343
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BRD1,Bromodomain-containing protein 1,24445,0.00360741802463375,0.0022433665883872,-0.00078958048860516,0.00800441653787266,0.107839846355002
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRYBB2,Beta-crystallin B2,24845,-0.00807870956879666,0.00504736980130072,-0.0179715543793461,0.00181413524175276,0.109483117404148
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,24445,-0.00813439888008639,0.00509229639498476,-0.0181152998142565,0.00184650205408375,0.110191053077052
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,29434,0.00543448159786505,0.00340939900194679,-0.00124794044595066,0.0121169036416808,0.1109533737306
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FAP,Prolyl endopeptidase FAP,29820,0.00318099197510617,0.00199727613048638,-0.000733669240647132,0.00709565319085947,0.111245946286309
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,24101,0.00500203033519017,0.00314612471747524,-0.00116437411106131,0.0111684347814416,0.111869995348829
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DENND2B,DENN domain-containing protein 2B,24111,0.0058931173495275,0.00371365787997613,-0.00138565209522572,0.0131718867942807,0.112553682302946
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,24229,0.00702833801318165,0.00443702281206879,-0.00166822669847317,0.0157249027248365,0.113201963145187
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,29349,-0.00448721533091402,0.00283796878823289,-0.0100496341558505,0.00107520349402244,0.113857668597967
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RRP15,RRP15-like protein,24101,0.0105105594266467,0.00666197318326289,-0.00254690801254862,0.0235680268658419,0.11464890867495
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,28774,-0.00780622844827244,0.00495854554174892,-0.0175249777101003,0.00191252081355544,0.115429565976422
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CHGB,Secretogranin-1,29590,-0.00470340986686407,0.00299046825497289,-0.0105647276466109,0.0011579079128828,0.115775724213998
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,APOB,Apolipoprotein B-100,24951,0.00257894340600034,0.00164449509156318,-0.000644266973463495,0.00580215378546418,0.116840597830918
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NECTIN1,Nectin-1,24229,-0.00369119459752676,0.00236334961395217,-0.00832335984087301,0.000940970645819486,0.118336696472053
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,28774,-0.00771902119760353,0.00495455987555847,-0.0174299585536981,0.00199191615849107,0.119253011559599
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",24867,0.00476856326368665,0.00306227779732444,-0.00123350121906924,0.0107706277464425,0.11943696004925
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,24059,0.00388654093650432,0.00251549304536443,-0.00104382543240996,0.0088169073054186,0.122349406140306
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",28931,-0.0132224021575814,0.00858250444637595,-0.0300441108724783,0.00359930655731542,0.123419554063861
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TEX101,Testis-expressed protein 101,24195,-0.00570431926364087,0.00370330678701244,-0.0129628005661852,0.00155416203890351,0.123492709220695
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,24016,0.00554727163432448,0.0036107423785026,-0.00152978342754062,0.0126243266961896,0.1244720182675
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,24445,0.00800720192479917,0.00522909055121084,-0.00224181555557407,0.0182562194051724,0.125713147116146
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",24111,0.00680941667589457,0.0044565660738212,-0.00192545282879498,0.0155442861805841,0.126537713426847
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TCN2,Transcobalamin-2,29757,-0.00333074888024314,0.00218127995003415,-0.00760605758231008,0.000944559821823803,0.126779123658022
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FZD10,Frizzled-10,24195,-0.00668328083847822,0.00440403058764342,-0.0153151807902593,0.00194861911330288,0.129144147600293
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PCNA,Proliferating cell nuclear antigen,24016,0.00699961749619538,0.004624213736258,-0.0020638414268703,0.0160630764192611,0.130118121032178
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,29820,0.00452457415671433,0.00299042284996537,-0.0013366546292178,0.0103858029426465,0.130284792605853
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DCC,Netrin receptor DCC,24195,-0.00250472231396205,0.00167195445567889,-0.00578175304709268,0.000772308419168573,0.134125398280202
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL24,C-C motif chemokine 24,29536,-0.00901251676103355,0.00602114961474351,-0.0208139700059308,0.00278893648386373,0.134453402368155
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FOLR2,Folate receptor beta,29694,0.00317268760626011,0.00212805112671383,-0.000998292602098987,0.00734366781461921,0.136001317687377
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TLR4,Toll-like receptor 4,24229,0.00308680205646265,0.00207140653685747,-0.000973154755777997,0.0071467588687033,0.136185691825721
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,24111,0.00519846001310538,0.00349828233777606,-0.0016581733689357,0.0120550933951465,0.137291261423285
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,29169,0.00363049417619426,0.0024439087683692,-0.00115956700980938,0.00842055536219789,0.137414903051727
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATP1B4,Protein ATP1B4,24016,0.0045550045381882,0.00307123800178716,-0.00146462194531463,0.010574631021691,0.138056523084818
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DHODH,Dihydroorotate dehydrogenase,24111,-0.00513327710251207,0.00346269682092846,-0.0119201628715319,0.00165360866650772,0.138233506390952
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,29434,0.00604928751384178,0.00408184714888264,-0.00195113289796819,0.0140497079256518,0.138351654719768
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LIFR,Leukemia inhibitory factor receptor,29434,-0.00260946253015292,0.0017673753634642,-0.00607351824254276,0.000854593182236926,0.13983061738872
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",24101,0.00587131516684614,0.00397686289048862,-0.00192333609851155,0.0136659664322038,0.139858062293602
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SYT1,Synaptotagmin-1,24845,0.00422803666335031,0.00288328762064298,-0.00142320707310993,0.00987928039981055,0.142553549363389
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TSLP,Thymic stromal lymphopoietin,28916,-0.00644874206389855,0.00440177674489933,-0.0150762244839012,0.00217874035610414,0.142923171804563
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EXOSC10,Exosome component 10,24111,0.00647192378777199,0.00443345041024716,-0.00221763901631244,0.0151614865918564,0.14435976641382
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRELP,Prolargin,29454,-0.00245018843143153,0.00169229346715726,-0.00576708362705976,0.000866706764196702,0.147669433879599
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,24229,-0.0111957610012743,0.00774722005160093,-0.0263803123024121,0.00398879029986354,0.14843355683652
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPESP1,Sperm equatorial segment protein 1,24922,-0.00319870341152399,0.00221655336661587,-0.00754314801009109,0.00114574118704311,0.149005482655111
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DSG3,Desmoglein-3,29589,-0.00356610641459851,0.00248566801652923,-0.0084380157269958,0.00130580289779879,0.151392524260154
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MELTF,Melanotransferrin,24922,0.00308550121809451,0.0021619828851094,-0.00115198523671991,0.00732298767290894,0.153545553788247
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,23037,-0.0055373281653498,0.00388344065895818,-0.0131488718569078,0.00207421552620823,0.153915961752946
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,29566,-0.010111723567235,0.00714918363336873,-0.0241241234886377,0.00390067635416772,0.157258381592722
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITGB6,Integrin beta-6,28931,0.0031176173014317,0.0022103251099652,-0.0012146199141001,0.0074498545169635,0.158409029527773
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EPB41L5,Band 4.1-like protein 5,24195,-0.00643025041531997,0.00459933402676757,-0.0154449451077844,0.00258444427714447,0.162100986887016
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,24229,-0.00665130147351816,0.00479371702421693,-0.0160469868409833,0.00274438389394703,0.165300905112323
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,28916,-0.00492560662237286,0.00355182907512385,-0.0118871916096156,0.00203597836486989,0.165519458693667
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PITHD1,PITH domain-containing protein 1,23970,0.00800331297343132,0.00582821270219063,-0.00341998392286231,0.0194266098697249,0.169702429699601
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,29594,0.00275654036265964,0.002008742073539,-0.0011805941014768,0.00669367482679608,0.169989206031994
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,29694,-0.00709441957467033,0.00517150487112839,-0.017230569122082,0.00304172997274131,0.170127093282765
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,24101,0.00560544139511955,0.00410619142913131,-0.00244269380597781,0.0136535765962169,0.17222828947932
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,24195,-0.00499298576250236,0.0036744281044267,-0.0121948648471787,0.00220889332217397,0.174207737204375
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,28797,-0.00545786646708685,0.00404551824395846,-0.0133870822252454,0.00247134929107173,0.17731087212571
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRKCQ,Protein kinase C theta type,28931,-0.00427404877074955,0.00316930007941872,-0.0104858769264102,0.00193777938491115,0.177483071078776
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLSTN3,Calsyntenin-3,24845,-0.00299948168156847,0.00222598734761528,-0.00736241688289442,0.00136345351975748,0.177836792238654
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,28797,0.00347597412256605,0.00257968895743542,-0.00158021623400737,0.00853216447913947,0.177849416957252
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",24016,-0.00908880915517752,0.00675897970523268,-0.0223364093774336,0.00415879106707854,0.178734404274426
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,24016,0.00333254897366973,0.0024858339762133,-0.00153968561970834,0.0082047835670478,0.180057825368255
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ROBO4,Roundabout homolog 4,24240,0.00176234408262805,0.00131519304428711,-0.000815434284174694,0.00434012244943079,0.180261521088408
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL9,Interleukin-9,24445,0.00551603033038795,0.00415308128079256,-0.00262400897996548,0.0136560696407414,0.184131786047421
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,29434,-0.00588666037220406,0.00443660579460357,-0.0145824077296271,0.00280908698521895,0.184572335611579
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MYOM1,Myomesin-1,24101,-0.00462884631064824,0.0034912337660042,-0.0114716644920165,0.00221397187072,0.184902527879818
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EFNB2,Ephrin-B2,24195,-0.0055988821698686,0.00422402259278255,-0.0138779664517224,0.00268020211198519,0.185022582576772
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,24016,-0.0138745980959187,0.0104915646092985,-0.0344380647301437,0.00668886853830634,0.186030046062972
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STEAP4,Metalloreductase STEAP4,24101,0.00714370356949137,0.005421683038258,-0.00348279518549431,0.0177702023244771,0.187644310892195
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,24111,0.00602426652574256,0.00457302766174842,-0.00293886769128434,0.0149874007427695,0.187734698004462
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PSMA1,Proteasome subunit alpha type-1,28797,-0.00444519605136793,0.00337528549251693,-0.0110607556167011,0.00217036351396525,0.187854565690613
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,28931,0.00360310976820139,0.00273965576238207,-0.00176661552606748,0.00897283506247025,0.188463608458407
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLK7,Kallikrein-7,23801,-0.00376390248277514,0.00286374774983278,-0.00937684807244739,0.00184904310689711,0.188748682578996
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCARB1,Scavenger receptor class B member 1,28774,-0.0054951071568356,0.00418820123759991,-0.0137039815825314,0.00271376726886023,0.18951553122283
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ICAM5,Intercellular adhesion molecule 5,29478,-0.00428917718060331,0.00327176230471707,-0.0107018312978488,0.00212347693664213,0.189878637785812
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,24445,-0.00500986088393174,0.00382262040560589,-0.0125021968789193,0.0024824751110558,0.190011044244369
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,24101,0.00509582397223862,0.00389832210202264,-0.00254488734772576,0.012736535292203,0.191162732965417
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,24845,-0.00367830220022597,0.00285621550264372,-0.00927648458540766,0.00191988018495571,0.197819319445814
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,JCHAIN,Immunoglobulin J chain,28931,0.00576744651095759,0.00448035398753959,-0.00301404730462001,0.0145489403265352,0.198008848043608
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RASA1,Ras GTPase-activating protein 1,28774,-0.00304711600385845,0.00236943961791097,-0.00769121765496395,0.00159698564724706,0.19845096184546
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,24016,-0.0024838637865656,0.00193758636672049,-0.00628153306533776,0.00131380549220656,0.199877105486989
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NTF3,Neurotrophin-3,29434,-0.0032268249368573,0.00252399835538499,-0.00817386171341188,0.00172021183969728,0.201098203116416
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLC44A4,Choline transporter-like protein 4,24195,0.00648044964273546,0.00507261798217059,-0.00346188160231891,0.0164227808877898,0.201425514208898
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,29218,0.00546605722464634,0.00428487161360252,-0.0029322911380146,0.0138644055873073,0.202084403196667
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IFNL2,Interferon lambda-2,24101,-0.00577643677403374,0.00453123285445049,-0.0146576531687567,0.00310477962068922,0.202390686553138
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,29372,0.00551224401718546,0.00432818175101032,-0.00297099221479476,0.0139954802491657,0.202825803139651
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,24101,-0.0100709570655993,0.00791892532533827,-0.0255920507032623,0.00545013657206368,0.203471375307534
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BRD3,Bromodomain-containing protein 3,24111,-0.00444437725488528,0.00349805884283015,-0.0113005725868324,0.00241181807706181,0.203909334756892
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NINJ1,Ninjurin-1,28797,0.00511105915706298,0.00402873534784035,-0.0027852621247041,0.0130073804388301,0.204575823305519
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KHDC3L,KH domain-containing protein 3,24016,0.00623659663088218,0.0049382729891142,-0.00344241842778166,0.015915611689546,0.206633627517971
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LRP2BP,LRP2-binding protein,24195,-0.00759637104393737,0.00604685805538797,-0.0194482128324978,0.00425547074462305,0.209037143913532
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD33,Myeloid cell surface antigen CD33,29566,-0.00722815139137327,0.00576293126688615,-0.0185234966744701,0.00406719389172359,0.209761396561927
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDIA2,Protein disulfide-isomerase A2,24016,0.00371974538634324,0.00297989455599642,-0.00212084794340975,0.00956033871609623,0.211940391463461
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,24445,-0.00786225435826122,0.00632018332989354,-0.0202498136848526,0.00452530496833012,0.213514625481632
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,24195,0.00329110902604709,0.00265196557898565,-0.00190674350876478,0.00848896156085896,0.214615037979459
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RAB6B,Ras-related protein Rab-6B,28774,-0.00434111346644558,0.00349988351992242,-0.0112008851654935,0.00251865823260236,0.214852605096431
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,24111,0.00294906616768614,0.00238556378490756,-0.00172663885073268,0.00762477118610495,0.216391261652811
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VIT,Vitrin,24922,-0.00337327745330489,0.00274725253649684,-0.00875789242483869,0.00201133751822891,0.219506216890238
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,24793,0.00399624636642169,0.00325751339274757,-0.00238847988336354,0.0103809726162069,0.219917628604883
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGF7,Fibroblast growth factor 7,24016,0.00709324676557794,0.00580189558339909,-0.00427846857788427,0.0184649621090402,0.221502638138409
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,29820,0.00201408096255884,0.00165342940127233,-0.00122664066393493,0.00525480258905261,0.223186743733582
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,24101,0.00437159675998162,0.003594279977582,-0.0026731919960791,0.0114163855160423,0.223895927085608
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CHIT1,Chitotriosidase-1,29579,-0.0134528087512239,0.0110760690008766,-0.0351619039929421,0.00825628649049422,0.224534751268268
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,24240,-0.00336999180435051,0.00277883878846467,-0.00881651582974127,0.00207653222104025,0.225243427093363
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,24195,0.00418005512015847,0.00346171584192923,-0.00260490793002283,0.0109650181703398,0.227247759807785
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,24111,0.00328456460529347,0.00272443084533355,-0.00205531985156029,0.00862444906214723,0.227984902970903
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,24381,0.00327565820154402,0.00275108756607103,-0.00211647342795519,0.00866778983104323,0.233791793653188
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,28931,-0.00322264510070801,0.00270855807702238,-0.00853141893167188,0.00208612873025585,0.23413438610339
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ZNF830,Zinc finger protein 830,24793,-0.00687638486137495,0.00578542170286414,-0.0182158113989887,0.00446304167623876,0.234619888714816
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LCP1,Plastin-2,24938,-0.00410636096126781,0.0034581225404676,-0.0108842811405843,0.00267155921804868,0.235059962215346
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MLLT1,Protein ENL,24016,0.00599799475457391,0.00505423206701809,-0.00390830009678154,0.0159042896059294,0.235346981547598
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,24805,-0.00480981436567102,0.00405397536553812,-0.0127556060821257,0.00313597735078369,0.235458411367008
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DEFB118,Beta-defensin 118,24101,-0.00498097022170661,0.00421503460826686,-0.0132424380539097,0.00328049761049645,0.237330414440921
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FZD8,Frizzled-8,24101,-0.00380532299923829,0.00322055139450214,-0.0101176037324625,0.00250695773398591,0.23738604527377
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,29820,0.0013445623125252,0.00115243840102598,-0.000914216953485712,0.00360334157853611,0.243336519982364
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,24445,0.00524577057853937,0.00460637106219903,-0.00378271670337073,0.0142742578604495,0.254794558985708
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",24240,-0.00703300999342932,0.00620892847701747,-0.0192025098083836,0.00513648982152491,0.257340865691048
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,24867,-0.00197082521202414,0.00174023392805568,-0.00538168371101328,0.001440033286965,0.257432726058361
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STX1B,Syntaxin-1B,24195,-0.00339208503256644,0.00304442085284805,-0.00935914990414861,0.00257497983901573,0.265205692812168
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,24111,0.00404002743252818,0.00362810278304937,-0.00307105402224857,0.0111511088873049,0.26548888583911
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",24111,0.00405329440654056,0.00364465749097992,-0.00309023427578008,0.0111968230888612,0.266097899102903
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,24101,0.00574840525656811,0.00518280788086332,-0.004409898189924,0.0159067087030602,0.267385381974765
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CR1,Complement receptor type 1,24903,0.002904111450992,0.00262531872068474,-0.0022415132415501,0.0080497361435341,0.2686533114603
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CYTH3,Cytohesin-3,24016,-0.00591802313700544,0.00535871020512116,-0.0164210951390429,0.00458504886503203,0.269441769726428
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NPHS1,Nephrin,24229,0.00274480405925393,0.00248794676638553,-0.0021315716028617,0.00762117972136956,0.269933627350059
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CA9,Carbonic anhydrase 9,29725,-0.0036666634235062,0.00332437302984572,-0.0101824345620038,0.0028491077149914,0.270051778549577
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,29349,-0.00209230083450011,0.00189844901331555,-0.00581326090059859,0.00162865923159838,0.27042262137479
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NENF,Neudesin,24793,-0.00882665915343525,0.00802385313895627,-0.0245534113057895,0.00690009299891903,0.27131996480929
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",24111,0.00409666214325807,0.00374787636302311,-0.00324917552826722,0.0114424998147834,0.274377399345498
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,24101,0.00729662026932928,0.00668025157052364,-0.00579667280889704,0.0203899133475556,0.274726558494555
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPON1,Spondin-1,29497,-0.00260236452851471,0.00238920482027615,-0.00728520597625595,0.00208047691922654,0.276066733656324
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,24240,0.00315659800664479,0.00290122087403227,-0.00252979490645845,0.00884299091974804,0.276595326441275
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,24111,-0.00314435405663368,0.0029188469273248,-0.0088652940341903,0.00257658592092293,0.281375367755633
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",24229,-0.00221029371438968,0.00205184964919038,-0.00623191902680284,0.00181133159802347,0.281392672379475
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HLA_A,,24867,-0.00257204060703465,0.00238836153374466,-0.00725322921317419,0.00210914799910489,0.281532763768662
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL3,Interleukin-3,24016,0.00476256355834236,0.00442486183413139,-0.00391016563655516,0.0134352927532399,0.281795362227652
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BTNL10,Butyrophilin-like protein 10,24016,0.00321301266676418,0.00298817342047072,-0.00264380723735844,0.00906983257088679,0.282276739703205
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HLA_DRA,,29322,0.00282382180047263,0.00262832995197601,-0.00232770490540034,0.0079753485063456,0.282661815866848
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RBM19,Probable RNA-binding protein 19,24111,0.00374603277651729,0.00349600656945644,-0.00310614009961734,0.0105982056526519,0.283947466148079
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,24793,-0.0031548796371644,0.00298037985036194,-0.0089964241438738,0.00268666486954501,0.289815309198219
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,24195,-0.00795203784275725,0.00754234603401449,-0.0227350360694256,0.00683096038391115,0.291747480742397
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLSPN,Claspin,28719,-0.00266484201715941,0.0025284513891603,-0.00762060673991359,0.00229092270559478,0.291918179808071
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LMNB1,Lamin-B1,24756,-0.00452092941950635,0.00429099992758716,-0.0129312892775772,0.00388943043856448,0.292083647443319
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,28916,-0.005986139503291,0.00568332690163869,-0.0171254602305028,0.00515318122392084,0.292221089228723
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RAP1A,Ras-related protein Rap-1A,24229,0.00533144536894477,0.00506414248730231,-0.00459427390616777,0.0152571646440573,0.292450759539681
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NLGN1,Neuroligin-1,24195,0.00526733779988002,0.00500435640145341,-0.00454120074696866,0.0150758763467287,0.29255757458744
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,INSL3,Insulin-like 3,24845,0.00578920361211991,0.00550626006422486,-0.00500306611376082,0.0165814733380006,0.293091669078701
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGLON5,IgLON family member 5,24016,0.00711273395073856,0.00681876023277586,-0.00625203610550214,0.0204775040069792,0.296906703536873
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MYO6,Unconventional myosin-VI,24867,-0.00283017814621606,0.00272944153288913,-0.00817988355067876,0.00251952725824664,0.299789099318585
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FST,Follistatin,29536,0.00380554396372195,0.0036735480567613,-0.00339461022753021,0.0110056981549741,0.30024260942481
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TMOD4,Tropomodulin-4,24016,0.00309486590620267,0.00299383786638663,-0.00277305631191512,0.00896278812432046,0.301265651983217
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,29478,-0.00238855324994145,0.0023110024902466,-0.00691811813082479,0.00214101163094188,0.301351702591856
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,24016,0.0070346557953706,0.00683362168309128,-0.00635924270348831,0.0204285542942295,0.30329348674649
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EXTL1,Exostosin-like 1,24111,-0.00356448807908015,0.00347634856247313,-0.0103781312615275,0.00324915510336719,0.305206453604951
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",24229,0.00264623264945422,0.00258267212753579,-0.00241580472051592,0.00770827001942437,0.30555730382982
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EPHA10,Ephrin type-A receptor 10,28774,0.00487002296944993,0.00476595721131407,-0.00447125316472564,0.0142112991036255,0.306867488412545
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,24195,-0.00626875185266639,0.00613924853095256,-0.0183016789733334,0.00576417526800063,0.30721996550026
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,24966,-0.00138973333755081,0.00136300226673462,-0.00406121778035066,0.00128175110524905,0.307922442299249
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",28774,-0.00371130099880104,0.00364727051554616,-0.0108599512092715,0.00343734921166942,0.308897696355779
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDSN,Corneodesmosin,29676,0.00320525910037009,0.00315442738006423,-0.0029774185645558,0.00938793676529598,0.309583198072105
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NEO1,Neogenin,24867,-0.00162471541353631,0.00160139368420823,-0.00476344703458444,0.00151401620751181,0.310323872294055
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAG,Myelin-associated glycoprotein,24195,0.0035177257374276,0.00346993125703811,-0.0032833395263671,0.0103187910012223,0.310700796249994
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MUC2,Mucin-2,24938,-0.00674962171594871,0.00667208973462166,-0.0198269175958072,0.00632767416390975,0.311729435049148
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACTN4,Alpha-actinin-4,28931,-0.00234590294450044,0.00232818852942562,-0.00690915246217465,0.00221734657317378,0.313650796843286
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,24445,-0.00285758048331607,0.00283609264601764,-0.00841632206951064,0.00270116110287851,0.313667763459241
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,29736,0.00340506919044901,0.00337951997147075,-0.00321878995363365,0.0100289283345317,0.313673935428675
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ENO1,Alpha-enolase,29392,-0.00572194812385418,0.00573180586952939,-0.0169562876281318,0.00551239138042342,0.318151743985204
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLPS,Colipase,29400,0.00514404101846883,0.00515410423006765,-0.00495800327246375,0.0152460853094014,0.31826452740796
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,24229,0.0065608614773927,0.00662891105280546,-0.006431804186106,0.0195535271408914,0.322313832814662
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,29566,0.0019655269669347,0.00198751674743866,-0.00193000585804507,0.00586105979191446,0.322702526606891
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,24845,-0.00264207990236469,0.00267756954671823,-0.00789011621393243,0.00260595640920304,0.323776996155134
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,28797,0.00351022065498406,0.00356589356418287,-0.00347893073081436,0.0104993720407825,0.324933350704562
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CASP4,Caspase-4,24445,0.0120534804141976,0.0123132371065777,-0.0120804643146946,0.0361874251430898,0.327636973922884
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",24229,-0.00207696741937646,0.00212933477495403,-0.00625046357828636,0.00209652873953344,0.32936830224529
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD55,Complement decay-accelerating factor,28490,-0.00185602905157794,0.00191326092041839,-0.00560602045559798,0.00189396235244211,0.332011496728845
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD177,CD177 antigen,29413,-0.0090135604200284,0.00931112228930056,-0.0272633601070575,0.00923623926700069,0.333031198186224
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPM1B,Protein phosphatase 1B,24229,-0.00437804984850463,0.00456605051539534,-0.0133275088586795,0.00457140916167024,0.337655772530321
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AMY2A,Pancreatic alpha-amylase,28334,0.00333922638821212,0.0034853104881458,-0.00349198216855364,0.0101704349449779,0.338027688485854
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCIN,Adseverin,24101,-0.00513617089171135,0.00537671632086798,-0.0156745348806126,0.0054021930971899,0.339454983954904
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,24101,-0.00521028819126528,0.00545693926081307,-0.0159058891424589,0.00548531275992834,0.339688189704893
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",24016,-0.00353905740401063,0.0037319411954146,-0.0108536621470232,0.00377554733900198,0.342978447727817
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,29454,-0.00170948645867387,0.00183349477617533,-0.00530313621997752,0.00188416330262977,0.351155543684771
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",28774,-0.00287321906659991,0.00308748957617767,-0.00892469863590815,0.00317826050270833,0.352068113274564
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,24195,0.0028104354752014,0.00303126380563066,-0.00313084158383469,0.00875171253423749,0.353858043043478
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,24445,-0.00377529930183268,0.00407644618386899,-0.0117651338222159,0.00421453521855055,0.354390097418518
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ECM1,Extracellular matrix protein 1,24349,0.00248375508294825,0.00268474303899578,-0.00277834127348348,0.00774585143937999,0.354903830103325
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,24111,0.00382318665664374,0.00414411380859056,-0.00429927640819376,0.0119456497214812,0.356246663721935
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KCNIP4,Kv channel-interacting protein 4,28774,0.00340996783697032,0.00371908273797852,-0.00387943432946759,0.0106993700034082,0.359211063792493
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,WNT9A,Protein Wnt-9a,28931,-0.00191988625620664,0.00209903331031016,-0.00603399154441455,0.00219421903200127,0.360381666768869
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGF3,Fibroblast growth factor 3,24229,0.00200563188065376,0.00219384119619232,-0.00229429686388318,0.0063055606251907,0.360615536506673
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C1QA,Complement C1q subcomponent subunit A,29646,-0.00149975539606918,0.00164984392406895,-0.00473344948724432,0.00173393869510596,0.36334239587535
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HIP1,Huntingtin-interacting protein 1,24111,-0.00221756660274792,0.00244550882183118,-0.00701076389353703,0.00257563068804118,0.364526135174261
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,24101,-0.00783692789676523,0.00866381764902343,-0.0248180104888512,0.00914415469532069,0.365708498653978
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VCAM1,Vascular cell adhesion protein 1,29545,-0.00179416140470483,0.00198713680919885,-0.00568894955073457,0.00210062674132491,0.366592857980613
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ALMS1,Alstrom syndrome protein 1,24445,0.00292845676808457,0.00326778499564218,-0.00347640182337409,0.00933331535954324,0.370176379713816
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",24111,0.00564778618234948,0.00630696246111401,-0.00671386024143398,0.0180094326061329,0.370537172640565
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,28916,-0.00217460166521316,0.00243666169813798,-0.00695045859356359,0.00260125526313727,0.372158566711386
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,24134,-0.00257258899947275,0.00288646712186624,-0.00823006455833058,0.00308488655938509,0.372799277959432
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,24016,0.00318521573089505,0.0035822260353417,-0.00383594729837468,0.0102063787601648,0.373919463282256
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLSTN1,Calsyntenin-1,28774,0.00333497928626163,0.00376187391311244,-0.00403829358343876,0.010708252155962,0.375344389999681
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KDM3A,Lysine-specific demethylase 3A,24229,0.00585607135727784,0.00662270903160434,-0.00712443834466666,0.0188365810592223,0.376574868521479
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,24404,0.00351109956799626,0.00397489987122135,-0.00427970417959759,0.0113019033155901,0.37707332824374
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NRN1,Neuritin,24867,-0.00230478223639704,0.00261047210762502,-0.00742130756734208,0.002811743094548,0.377299585837362
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,24445,0.00443091984235287,0.00502986511195161,-0.00542761577707229,0.014289455461778,0.378368596354722
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BSND,Barttin,24016,0.00216746206278639,0.00247605137528369,-0.00268559863276964,0.00702052275834242,0.381381164017586
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTTG1,Securin,24445,-0.00264877651747486,0.00302624041221979,-0.00858020772542565,0.00328265469047593,0.381435784889093
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",24101,-0.00291696989651779,0.00333458188989692,-0.00945275040071576,0.00361881060768017,0.381711425630883
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AMY2B,Alpha-amylase 2B,27585,0.0031128248505762,0.00356465406382109,-0.00387389711451313,0.0100995468156655,0.382535855785191
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL21R,Interleukin-21 receptor,24229,0.00350349273239227,0.00402176823088016,-0.00437917300013283,0.0113861584649174,0.383690484847139
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TPT1,Translationally-controlled tumor protein,28931,0.00413567460116773,0.00475018683803312,-0.0051746916013772,0.0134460408037127,0.383961203343104
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,24101,0.00397896657949836,0.00457848920886372,-0.00499487226987453,0.0129528054288712,0.384824795033312
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HBZ,Hemoglobin subunit zeta,24922,0.00671515907949303,0.00773060232779255,-0.00843682148298037,0.0218671396419664,0.385048993287179
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,28774,0.00347741530631323,0.00400612506487727,-0.00437458982084621,0.0113294204334727,0.385388081300191
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TCN1,Transcobalamin-1,24546,0.00216303435982704,0.00249933472793717,-0.00273566170692982,0.0070617304265839,0.386803577506334
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPRR1B,Cornifin-B,24445,-0.00540283438368404,0.0062599576572238,-0.0176723513918427,0.00686668262447461,0.388102822625608
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,24195,0.00231059831120222,0.00267940411893462,-0.00294103376190964,0.00756223038431407,0.388500588873803
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,28774,-0.0029667206827158,0.00345919581820503,-0.00974674448639765,0.00381330312096606,0.391102262417951
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HSP90B1,Endoplasmin,28626,0.00417263916304069,0.0048846091985847,-0.00540119486618531,0.0137464731922667,0.392977973967921
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",24845,0.00159012674258819,0.00187501776384533,-0.00208490807454866,0.00526516155972504,0.396412975434271
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,24016,0.00341983349441884,0.00406993056833483,-0.00455723041951743,0.0113968974083551,0.400766360929998
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SOX2,Transcription factor SOX-2,24826,0.00146079881705103,0.00174147524014717,-0.00195249265363742,0.00487409028773948,0.401573715753531
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGF6,Fibroblast growth factor 6,24229,0.00251127080145308,0.0030091147841733,-0.0033865941755266,0.00840913577843275,0.403976725683966
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MORN4,MORN repeat-containing protein 4,24016,-0.00477158507111476,0.00573302577052283,-0.0160083155813395,0.00646514543910998,0.405249119894105
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PAPPA,Pappalysin-1,28931,0.00279310457300497,0.00343032350085804,-0.0039303294886768,0.00951653863468673,0.415514519290424
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,24445,0.00493966682362541,0.00609840388495858,-0.0070132047908934,0.0168925384381442,0.417951865158747
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDH4,Cadherin-4,24101,0.00283552714328593,0.00352086062416905,-0.00406535968008541,0.00973641396665727,0.420625351717146
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FRMD7,FERM domain-containing protein 7,24195,0.00195790574459759,0.00245248782669391,-0.00284897039572247,0.00676478188491765,0.424684218599665
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,24938,0.0014727645433504,0.00185329375910114,-0.00215969122448783,0.00510522031118862,0.426810670895625
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,23494,0.00290913862986202,0.00366441132703802,-0.00427310757113249,0.0100913848308565,0.427267634357298
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,24101,0.00446979646506002,0.00565416300700265,-0.00661236302866518,0.0155519559587852,0.429224958163086
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEP152,Centrosomal protein of 152 kDa,24016,-0.00240510693224335,0.00304609415069022,-0.00837545146759618,0.00356523760310949,0.42978627866689
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,24195,0.00449633307377429,0.00571831641951465,-0.00671156710847442,0.015704233256023,0.431697319776621
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRL,Prolactin,29694,0.00431335520274405,0.00550745683379323,-0.00648126019149067,0.0151079705969788,0.433524984670447
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL5,Interleukin-5,28931,0.00802958554805095,0.010341099967421,-0.0122389703880942,0.0282981414841961,0.437476071620928
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,24445,-0.00247444950445424,0.00319201368748896,-0.00873079633193259,0.00378189732302411,0.438228899718782
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TAP1,Antigen peptide transporter 1,24445,0.00339439964182842,0.0043927857215228,-0.00521546037235628,0.0120042596560131,0.439694739568817
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MTPN,Myotrophin,28916,-0.00183032353234828,0.00238493553206674,-0.00650479717519909,0.00284415011050253,0.442819093845478
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,24922,0.00148680283730368,0.00194026154313856,-0.0023161097872479,0.00528971546185526,0.443511084444105
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGFL4,Insulin growth factor-like family member 4,24229,-0.00419797152747182,0.00550527117386701,-0.0149883030282512,0.00659235997330753,0.445747152344949
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,24793,0.00426600439012754,0.00559604259263879,-0.00670223909144447,0.0152342478716996,0.445873182626501
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,24793,-0.00307811332134586,0.00406792495351157,-0.0110512462302285,0.00489501958753682,0.449249402718495
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TET2,Methylcytosine dioxygenase TET2,24421,-0.00554452267406534,0.00734315548240594,-0.019937107419581,0.0088480620714503,0.450220292910897
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,24922,-0.0018567460623731,0.00246216303043309,-0.00668258560202195,0.00296909347727575,0.450789253639367
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GH2,Growth hormone variant,28797,0.00908147833288733,0.0120487470322108,-0.0145340658502458,0.0326970225160205,0.451018714291
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TCP11,T-complex protein 11 homolog,24445,0.00325291550640981,0.0043422992732366,-0.00525799106913393,0.0117638220819535,0.453790390319988
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,24867,-0.00206839593662094,0.00276339931932914,-0.00748465860250606,0.00334786672926417,0.454167552775664
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,24793,-0.00470039172029052,0.00634293122172332,-0.0171325369148682,0.00773175347428719,0.458673727654055
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,24805,-0.00184153916424709,0.00249830066781809,-0.00673820847317056,0.00305513014467637,0.461058355170751
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FOS,Proto-oncogene c-Fos,23970,-0.00189551215964521,0.00259283746155626,-0.00697747358429549,0.00318644926500506,0.46475144444151
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,24101,0.00299026107965581,0.00411880983880877,-0.00508260620440938,0.011063128363721,0.467845060073259
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,24101,-0.00304434945157536,0.00423108364519445,-0.0113372733961565,0.00524857449300575,0.471827543222357
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,28797,-0.00302262057494272,0.00420507916401664,-0.0112645757364153,0.00521933458652989,0.472268575421091
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,24240,0.00136795723051609,0.0019100635372899,-0.00237576730257211,0.00511168176360429,0.473884552109798
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,28931,0.00155352025454891,0.00217975143461574,-0.00271879255729794,0.00582583306639576,0.47603392820202
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PGR,Progesterone receptor,24229,0.00529139755153616,0.00743975864529467,-0.00929052939324139,0.0198733244963137,0.476947071952091
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SHC1,SHC-transforming protein 1,24016,0.00606241076965486,0.00852476314951139,-0.0106461250033874,0.0227709465426972,0.476996349208014
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,28722,-0.00276628342407254,0.003906594838654,-0.0104232093078344,0.0048906424596893,0.478885154402606
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,24867,-0.00139236946883068,0.00196826036271726,-0.0052501597797565,0.00246542084209514,0.479317598121022
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDCL2,Phosducin-like protein 2,24016,-0.00265487169366489,0.00387642320920496,-0.0102526611837066,0.00494291779637683,0.493428382860093
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,24016,0.00217200532953038,0.00323345882914312,-0.00416557397559013,0.00850958463465088,0.501763239805292
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,29473,0.0019031846580157,0.00283623426464414,-0.00365583450068682,0.00746220381671822,0.502209738625909
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TLR2,Toll-like receptor 2,24445,-0.00112871487204241,0.00168312637535759,-0.00442764256774329,0.00217021282365847,0.502477812818374
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PCARE,Photoreceptor cilium actin regulator,24101,0.00415620931462242,0.00619882989691075,-0.00799349728332264,0.0163059159125675,0.502556445463195
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,YY1,Transcriptional repressor protein YY1,24229,0.00136254138381327,0.00204115779353627,-0.00263812789151783,0.00536321065914436,0.504437724564341
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLK15,Kallikrein-15,24754,-0.00250849866448585,0.00377747926682584,-0.0099123580274645,0.00489536069849279,0.50665373034064
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IKZF2,Zinc finger protein Helios,28797,0.00438744818008067,0.00665209496474277,-0.00865065795081517,0.0174255543109765,0.509542238468976
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FRZB,Secreted frizzled-related protein 3,29123,-0.0012273241272727,0.00187073031772493,-0.00489395555001357,0.00243930729546817,0.511786304893073
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NEB,Nebulin,24111,-0.00181467796675293,0.00277007090676741,-0.00724401694401705,0.00361466101051119,0.512408575925076
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PMCH,Pro-MCH,24111,0.0039977833620008,0.00611463387652577,-0.0079868990359897,0.0159824657599913,0.513243139842845
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDC123,Cell division cycle protein 123 homolog,24016,-0.00301653231205568,0.00463131836000555,-0.0120939162976666,0.00606085167355521,0.514837531175711
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PKD1,Polycystin-1,24922,-0.00125873881653093,0.00193911500735649,-0.00505940423094965,0.00254192659788778,0.516259973664537
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FABP9,Fatty acid-binding protein 9,29434,-0.00264078368701062,0.00407238372023199,-0.0106226557786653,0.00534108840464408,0.516691623953169
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDC25A,M-phase inducer phosphatase 1,24016,0.00191422431423218,0.00295737654630917,-0.0038822337165338,0.00771068234499816,0.517462704759838
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RUVBL1,RuvB-like 1,28797,-0.00485623855772591,0.00753304743457604,-0.019621011529495,0.00990853441404313,0.519154040520427
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ZNF174,Zinc finger protein 174,24229,0.00178129761707199,0.00276342896828196,-0.00363502316076064,0.00719761839490462,0.519194580779141
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,28774,-0.00187575710409319,0.00291084763582903,-0.00758101847031809,0.00382950426213172,0.519319689938418
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IFNGR1,Interferon gamma receptor 1,29581,-0.00097105355057102,0.00153018386689083,-0.00397021392967705,0.00202810682853501,0.525694720608164
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,24101,-0.00276283599979908,0.00435898242544322,-0.0113064415536678,0.00578076955406963,0.526200460951489
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CHP1,Calcineurin B homologous protein 1,24101,-0.00339228310707885,0.00535969056740399,-0.0138972766191907,0.00711271040503296,0.526788513459733
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EBI3_IL27,Interleukin-27,29674,-0.00142172853749031,0.00224767015907455,-0.00582716204927642,0.00298370497429581,0.527042659413877
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PFDN6,Prefoldin subunit 6,24195,0.00300532770129186,0.00478489775951412,-0.00637307190735582,0.0123837273099395,0.529953479718528
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,24111,-0.00449177033669444,0.00717175089813583,-0.0185484020970407,0.00956486142365178,0.531114723610992
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NMI,N-myc-interactor,24706,0.0032482994115267,0.00525821446612358,-0.00705780094207552,0.0135543997651289,0.536741151974655
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MYL3,Myosin light chain 3,24240,-0.00329145818730238,0.00534075071956292,-0.0137593295976457,0.00717641322304094,0.537708072489456
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,24793,-0.00279175316012558,0.00455174646534555,-0.0117131762322029,0.00612966991195171,0.539659360616149
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,24111,0.0022256340961822,0.00367967442580962,-0.00498652777840465,0.00943779597076906,0.545287429642469
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DUSP29,Dual specificity phosphatase 29,24195,0.00295391137749604,0.00488800505189036,-0.00662657852420907,0.0125344012792011,0.545637647186003
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,24445,0.0035033084679565,0.00581895356423527,-0.00790184051794462,0.0149084574538576,0.547145587547409
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HDAC9,Histone deacetylase 9,24101,0.00285643479707624,0.00474497737802178,-0.00644372086384645,0.0121565904579989,0.547185637317607
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",24229,-0.0021405015963111,0.00357534980683445,-0.00914818721770662,0.00486718402508441,0.549389812245445
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ESR1,Estrogen receptor,24229,0.00250953028569282,0.00420844577796406,-0.00573902343911673,0.0107580840105024,0.550974998176449
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,24195,-0.003096078795541,0.00521394259639313,-0.0133154062844715,0.00712324869338952,0.552646352712742
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,24445,-0.00233287434837335,0.00394992494974418,-0.010074727249872,0.00540897855312525,0.554785669693987
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SUMF1,Formylglycine-generating enzyme,24229,-0.00286764363505321,0.00485689783759052,-0.0123871633967306,0.0066518761266242,0.554909921275868
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,24101,-0.00231739147990675,0.00397388032847234,-0.0101061969237125,0.00547141396389904,0.55979386248622
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ZNF75D,Zinc finger protein 75D,24445,-0.00255080621094375,0.00439883481720714,-0.0111725224526697,0.00607091003078224,0.561999376966695
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDAN1,Codanin-1,24845,0.000953394038918154,0.00164689635048734,-0.00227452280803703,0.00418131088587334,0.562659548646498
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TPBGL,Trophoblast glycoprotein-like,24195,0.00173289737801403,0.00301140872482127,-0.00416946372263565,0.00763525847866371,0.564996341873656
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ISM2,Isthmin-2,24938,0.00184176319804347,0.00320717994245728,-0.0044443094891728,0.00812783588525973,0.565795358218764
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,28774,0.00262555403324386,0.00459966746827406,-0.00638979420457329,0.011640902271061,0.568130273161183
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,24111,0.0020275145143745,0.00355924248458474,-0.00494860075541159,0.00900362978416058,0.568921937441211
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,24445,0.00166469016189274,0.00293592920460795,-0.00408973107913884,0.00741911140292432,0.570715155414025
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,28916,-0.00251846689117416,0.0044441852553308,-0.0112290699916225,0.00619213620927421,0.570930508855072
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCNE1,G1/S-specific cyclin-E1,24229,-0.00381014086761284,0.00675958027507565,-0.0170589182067611,0.00943863647153544,0.572987154333402
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,24951,-0.00131065427418824,0.00234896496676609,-0.00591462560904978,0.00329331706067329,0.57686921278134
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAGEA3,Melanoma-associated antigen 3,24445,-0.00345743340606115,0.00622488296626065,-0.015658204019932,0.00874333720780972,0.578611522696677
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,24229,0.00234455585115404,0.00422159849556552,-0.00592977720015438,0.0106188889024625,0.578645654030251
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,24195,0.00207528380336686,0.00375145592695209,-0.00527756981345924,0.00942813742019297,0.580135526229209
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CA8,Carbonic anhydrase-related protein,24229,-0.00109653241661418,0.00199007407812232,-0.00499707760973392,0.00280401277650556,0.581638207079506
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,24195,0.00170869090154407,0.00310296902631906,-0.00437312839004128,0.00779051019312943,0.581869652255383
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,29425,0.00088814919926682,0.00162032918537886,-0.00228769600407574,0.00406399440260938,0.583607581188195
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HEBP1,Heme-binding protein 1,28916,0.00210492577889147,0.00387679342654343,-0.00549358933713365,0.0097034408949166,0.58716472369318
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,24229,-0.0009228256790882,0.00170492101331881,-0.00426447086519308,0.00241881950701668,0.588325228739262
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FAM171A2,Protein FAM171A2,24867,-0.00622546220401429,0.0115754886468115,-0.0289134199517648,0.0164624955437363,0.590710140995917
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TMEM132A,Transmembrane protein 132A,24240,0.00244735438977023,0.00457914500009257,-0.00652776981041121,0.0114224785899517,0.59303055472047
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,24195,-0.00141650741873472,0.00265184198058981,-0.00661411770069074,0.0037811028632213,0.593235880262153
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,24195,-0.00256649497002027,0.00481256354921653,-0.0119991195264847,0.00686612958644412,0.593837325225409
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL4,Interleukin-4,28931,-0.00355215932925205,0.00667899339768221,-0.0166429863887092,0.00953866773020507,0.594840540835846
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NPPB,Natriuretic peptides B,28916,-0.00514790936814808,0.00974291108136429,-0.0242440150876221,0.0139481963513259,0.597243233429887
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRX,Cone-rod homeobox protein,28916,0.00410997371349554,0.00780921502695009,-0.0111960877393266,0.0194160351663177,0.598685258671804
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,24445,0.00251759004976308,0.00490136618386404,-0.00708908767061044,0.0121242677701366,0.607500888360838
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NOS2,"Nitric oxide synthase, inducible",24111,-0.00148332520784327,0.00289864851578559,-0.00716467629878301,0.00419802588309648,0.608844723893411
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BTLA,B- and T-lymphocyte attenuator,24016,-0.00325804726156864,0.00637704543947652,-0.0157570563229426,0.00924096179980534,0.609424160918307
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL25,Interleukin-25,23913,-0.00128980213297352,0.00252721351747851,-0.0062431406272314,0.00366353636128436,0.609800262682404
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,24445,0.00273622640742563,0.00537315956204368,-0.00779516633417997,0.0132676191490312,0.610588786253549
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GSAP,Gamma-secretase-activating protein,28797,-0.00321892386000684,0.00632795659383015,-0.0156217187839139,0.00918387106390025,0.610978348482051
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL11,Interleukin-11,28931,-0.00229876926447567,0.00454090269422803,-0.0111989385451626,0.00660140001621127,0.612694713716944
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL1A,Interleukin-1 alpha,28931,-0.00203405636070938,0.00404843813985102,-0.00996899511481738,0.00590088239339862,0.615368978534321
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",23975,0.000947571778996111,0.00188635411642822,-0.00274968228920319,0.00464482584719541,0.615440206610151
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TSHB,Thyrotropin subunit beta,29478,0.00280584916403038,0.00559412391200345,-0.00815863370349639,0.0137703320315571,0.615973216505241
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,29345,-0.00652469197568427,0.0134852882107734,-0.0329558568688001,0.0199064729174315,0.628504609166187
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SUSD4,Sushi domain-containing protein 4,24793,-0.00147060811959242,0.0030584997571604,-0.0074652676436268,0.00452405140444197,0.630643969932072
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DKKL1,Dickkopf-like protein 1,29349,0.00300057763718755,0.00624876913367993,-0.00924700986482511,0.0152481651392002,0.631098017923447
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BRD2,Bromodomain-containing protein 2,24101,0.0012114383452651,0.00253963887948148,-0.00376625385851859,0.0061891305490488,0.633357869461209
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,24101,-0.00169109100059196,0.00359668748150796,-0.00874059846434755,0.00535841646316364,0.638230583353839
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RSPO1,R-spondin-1,29218,0.00119729524227382,0.00254822282192972,-0.00379722148870842,0.00619181197325606,0.638462122386354
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,28797,-0.00408963715202009,0.00898081208656606,-0.0216920288416896,0.0135127545376494,0.648842924833209
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRTG,Protogenin,29725,-0.000818563183840263,0.00181164751204986,-0.00436939230745799,0.00273226593977746,0.651392173747734
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SHH,Sonic hedgehog protein,24229,0.00141000279132565,0.00314144557551439,-0.00474723053668256,0.00756723611933385,0.653551933869688
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,28774,-0.00127978824172567,0.00285413673168677,-0.00687389623583174,0.0043143197523804,0.653869605745758
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,24445,0.00115556213886138,0.00259138382788687,-0.00392355016379689,0.00623467444151965,0.655655568184717
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FOLR3,Folate receptor gamma,29461,0.00607262067524871,0.0136347378666502,-0.0206514655433857,0.0327967068938831,0.656049437395981
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,24111,-0.00152414486294101,0.00342386689593895,-0.00823492397898135,0.00518663425309932,0.656213136923191
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,F11,Coagulation factor XI,24606,-0.00100552988880385,0.00226296396685775,-0.00544093926384504,0.00342987948623734,0.656799264760474
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GPR158,Probable G-protein coupled receptor 158,24867,-0.00115989716267412,0.00261980594290423,-0.0062947168107664,0.00397492248541817,0.657956477947819
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",24016,0.00156828316778789,0.00356822655141272,-0.00542544087298103,0.00856200720855681,0.66029357544611
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,29333,-0.00082586184971266,0.001896212968216,-0.00454243926741602,0.0028907155679907,0.663179361062916
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,24805,0.00466715270687194,0.0107525186926437,-0.0164077839307096,0.0257420893444535,0.664254426549595
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,24195,0.00219544909081838,0.00508389872549697,-0.00776899241115568,0.0121598905927924,0.665858944188625
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",24381,-0.00201255893211427,0.00468193099755894,-0.0111891436873298,0.00716402582310125,0.667303759821174
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,24445,0.00154807537149007,0.00360697882247489,-0.00552160312056073,0.00861775386354086,0.667789524918671
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",24111,-0.00121134456645586,0.00286249191366047,-0.00682182871723038,0.00439913958431866,0.672168927762371
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,24867,-0.0023589274535482,0.0055883798100934,-0.0133121518813313,0.00859429697423486,0.672946231739645
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,THBS4,Thrombospondin-4,29518,0.00136870867417551,0.00328969542297566,-0.00507909435485678,0.00781651170320781,0.677369570754098
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,29443,-0.00107864385754878,0.0026138705492202,-0.00620183013402037,0.0040445424189228,0.679857609570767
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PSCA,Prostate stem cell antigen,24805,-0.00781177902612323,0.0189364529199416,-0.0449272267492087,0.0293036686969623,0.679957500847042
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL24,Interleukin-24,28931,-0.00145447756496277,0.0035459328044706,-0.00840450586172514,0.00549555073179959,0.681675533405597
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],29349,-0.00169097040927748,0.00413316603884847,-0.00979197584542048,0.00641003502686551,0.682452896347987
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VWF,von Willebrand factor,29820,0.0021568126769129,0.00527449209143766,-0.00818119182230491,0.0124948171761307,0.682605849161656
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,24016,-0.00161362649590769,0.00395077852731559,-0.00935715240944624,0.00612989941763086,0.682959793796503
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SEPTIN3,Neuronal-specific septin-3,24867,0.00222546173297126,0.00553127029081116,-0.0086158280370186,0.0130667515029611,0.687435891227039
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,24867,-0.000990322297640451,0.00247150627996321,-0.00583447460636835,0.00385383001108745,0.688647514575485
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EFHD1,EF-hand domain-containing protein D1,24867,-0.00102372237798244,0.0025749312424342,-0.00607058761315349,0.0040231428571886,0.690948598590104
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,24195,0.00108692776121211,0.00276388519168712,-0.00433028721449465,0.00650414273691887,0.694130318732316
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LMOD2,Leiomodin-2,24101,-0.00180340519141577,0.00463554649449743,-0.0108890763206307,0.0072822659377992,0.697251243247854
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TP53BP1,TP53-binding protein 1,24229,-0.00245610943866568,0.00638647637527035,-0.0149736031341956,0.0100613842568642,0.700552182487082
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,24016,0.000927724244808389,0.00244400286024778,-0.00386252136127726,0.00571796985089404,0.704251563984123
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,24016,0.0017564824712441,0.00462983141998078,-0.00731798711191824,0.0108309520544064,0.704406325777421
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GAGE2A,G antigen 2A,24016,-0.00174339101515088,0.00464385121920122,-0.0108453394047853,0.00735855737448352,0.707352028411863
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SEMA6C,Semaphorin-6C,24229,-0.000713433759272334,0.00191357396699774,-0.0044640387345879,0.00303717121604323,0.709279801241725
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SOX9,Transcription factor SOX-9,24195,-0.000744041620502129,0.00199710972742255,-0.00465837668625032,0.00317029344524606,0.709479802089129
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,24195,0.00131532927015354,0.00360362330476865,-0.00574777240719301,0.00837843094750009,0.715113197311281
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,24111,-0.00135740767176824,0.00375447480315537,-0.00871617828595276,0.00600136294241629,0.717696021938873
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PFDN4,Prefoldin subunit 4,24016,0.00140319245203739,0.00391144229796099,-0.00626323445196616,0.00906961935604093,0.719792442994187
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CASQ2,Calsequestrin-2,24111,0.00127452378724199,0.00357240510466785,-0.00572739021790699,0.00827643779239097,0.721267787514116
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,24195,-0.00108392310442102,0.00305147804976236,-0.00706482008195524,0.0048969738731132,0.722433509439123
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,29786,0.000947617105742264,0.00267011600650726,-0.00428581026701197,0.0061810444784965,0.722669004646074
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,24229,0.00139951114920716,0.00397879574732226,-0.00639892851554448,0.00919795081395879,0.725034523052322
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,24445,0.00168662203946889,0.00484405413285998,-0.00780772406093667,0.0111809681398745,0.727705019247563
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,24173,0.000979329076559994,0.00281334363434022,-0.00453482444674683,0.00649348259986682,0.727767007512814
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,24016,-0.000922033214837833,0.00269971655408489,-0.00621347766084421,0.00436941123116854,0.732707887302414
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,24111,0.00244871443943467,0.00719868394491118,-0.0116607060925912,0.0165581349714606,0.733737946870046
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,24016,-0.00141143574656464,0.0042152750598817,-0.00967337486393276,0.00685050337080349,0.737749955425285
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,24805,0.00411368112479368,0.0125921365633623,-0.0205669065393965,0.0287942687889839,0.743907763644226
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,24101,0.000958988848368368,0.00293901277376523,-0.00480147618821147,0.00671945388494821,0.744203059594853
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SULT1A1,Sulfotransferase 1A1,29694,0.0028349909023296,0.00932848587950472,-0.0154488414214997,0.0211188232261589,0.76120097763579
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DCUN1D1,DCN1-like protein 1,24101,-0.00166578645401759,0.00548358960140072,-0.012413622072763,0.00908204916472782,0.76130068456133
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OMP,Olfactory marker protein,24101,0.00108702709209645,0.00361275068488039,-0.00599396425026911,0.00816801843446201,0.763503814473277
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OSTN,Osteocrin,24195,0.00091802561606684,0.00305787294345872,-0.00507540535311226,0.00691145658524594,0.76401417589667
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FH,"Fumarate hydratase, mitochondrial",24101,0.00182027465386665,0.00614499284516543,-0.0102239113226576,0.0138644606303909,0.767064024265095
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,24016,0.00179604879254446,0.00613161811016457,-0.0102219227033781,0.013814020288467,0.769588923060511
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ZPR1,Zinc finger protein ZPR1,24101,-0.00206584463980093,0.00707416642783192,-0.0159312108383515,0.0117995215587496,0.77026881517551
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PYDC1,Pyrin domain-containing protein 1,24240,-0.000894483775438825,0.00306692984957915,-0.00690566628061397,0.00511669872973632,0.770553327256874
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",24101,0.00119822209754949,0.00413359593246358,-0.00690362593007913,0.00930007012517811,0.77191510779302
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MILR1,Allergin-1,28931,-0.00105598180087688,0.00366912371692259,-0.00824746428604516,0.0061355006842914,0.773500231777382
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL2,Interleukin-2,28931,0.000619457133814727,0.00229716917912176,-0.00388299445726393,0.00512190872489338,0.787422925384293
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NCLN,Nicalin,28931,-0.00102526467003553,0.00380622725005803,-0.00848547008014928,0.00643494074007821,0.787650684992675
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SEPTIN7,Septin-7,24445,-0.00101954504487321,0.00385518643316595,-0.00857571045387847,0.00653662036413204,0.791427226307944
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,28797,-0.00237701998530987,0.0091059493645759,-0.0202246807398786,0.0154706407692589,0.79406327743113
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RGS8,Regulator of G-protein signaling 8,28931,-0.00121365367864344,0.00474297678650213,-0.0105098881801876,0.00808258082290073,0.798041935546107
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CA11,Carbonic anhydrase-related protein 11,28797,-0.000586095932383106,0.00232186761068851,-0.00513695644933259,0.00396476458456638,0.800714879948318
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL13,Interleukin-13,28931,0.000883706520286874,0.0035047889898053,-0.00598567989973151,0.00775309294030526,0.800932654783846
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARG2,"Arginase-2, mitochondrial",24793,-0.000794145703270951,0.00316457206137231,-0.00699670694356067,0.00540841553701877,0.80185574044486
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TBR1,T-box brain protein 1,24195,0.000874355500202399,0.00353383501932399,-0.00605196113767262,0.00780067213807742,0.804582223768804
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TAGLN3,Transgelin-3,24016,0.00108403391356673,0.00441610874370532,-0.0075715392240957,0.00973960705122917,0.806092581756161
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,29395,0.000510194797002717,0.00212492112864619,-0.00365465061514381,0.00467504020914924,0.810253959068447
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MTR,Methionine synthase,24111,-0.00112894644903889,0.00476751344197696,-0.0104732727953137,0.00821537989723595,0.812814083866953
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COPE,Coatomer subunit epsilon,28774,-0.000815403207089325,0.00345032267754711,-0.00757803565508167,0.00594722924090302,0.813180890156631
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TTN,Titin,24111,-0.0011241622708445,0.0049065673782996,-0.0107410343323117,0.00849270979062271,0.818782416422276
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,29820,0.000455531170448556,0.00199523099536876,-0.00345512158047421,0.00436618392137132,0.819406824224128
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MMP15,Matrix metalloproteinase-15,24922,-0.000819120447722898,0.00359330461187098,-0.00786199748699001,0.00622375659154422,0.819681214278535
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,24445,-0.00106027069738945,0.00472052499479647,-0.0103124996871905,0.00819195829241163,0.822285621546384
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,24229,-0.000760771148185153,0.00344518708392979,-0.00751333783268754,0.00599179553631724,0.825233336283245
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,24445,-0.0010108500467421,0.00461355656820589,-0.0100534209204256,0.00803172082694144,0.826570637576664
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AFP,Alpha-fetoprotein,29132,0.00107500622240419,0.00494117120761433,-0.0086096893445199,0.0107597017893283,0.827772686924562
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HRAS,GTPase Hras,24421,-0.00155570948364858,0.00720848331083891,-0.0156843367728928,0.0125729178055957,0.829132606445536
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,29694,0.000735869076548585,0.00341717906949407,-0.00596180189965979,0.00743354005275696,0.829500591565739
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CORO6,Coronin-6,24101,0.000590009205567226,0.00275020537067195,-0.00480039332094979,0.00598041173208424,0.830133422788285
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,24751,-0.000629203564954495,0.00294579583077352,-0.00640296339327059,0.0051445562633616,0.830865637522911
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLK12,Kallikrein-12,28797,0.00214938595265541,0.0100903791436047,-0.0176277571688097,0.0219265290741206,0.831318020665422
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",24016,-0.000849152793762287,0.00402200455408195,-0.00873228171976291,0.00703397613223834,0.832790151086552
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,24101,0.000919944939076451,0.00439355571448716,-0.00769142426131838,0.00953131413947128,0.834149423253715
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,28916,-0.000457961661946669,0.00224181806473488,-0.00485192506882704,0.0039360017449337,0.838135067225575
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,24240,-0.00390798085417427,0.0192852697767939,-0.0417071096166903,0.0338911479083418,0.83941756598363
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CHRDL1,Chordin-like protein 1,29536,-0.000455446571713416,0.00229197984099336,-0.00494772706006041,0.00403683391663358,0.842488492426229
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,24101,0.00105440674379208,0.00539323661029003,-0.00951633701237637,0.0116251504999605,0.84499897963459
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,24938,-0.000718515361540296,0.00367942388816912,-0.00793018618235178,0.00649315545927119,0.845175884554421
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TEF,Thyrotroph embryonic factor,24111,-0.000607848393749826,0.00313098641045612,-0.00674458175824382,0.00552888497074417,0.846068225523047
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TFRC,Transferrin receptor protein 1,29565,0.00053178439033771,0.00280669057619241,-0.00496932913899941,0.00603289791967483,0.849725564069837
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LHB,Lutropin subunit beta,28797,0.0011811282506441,0.00632957885528721,-0.0112248463057188,0.013587102807007,0.851972009617521
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MANSC4,MANSC domain-containing protein 4,24111,0.000896590558024542,0.00486470937231858,-0.00863823981171987,0.010431420927769,0.853775694666812
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,24111,0.000811715386873334,0.00445594519016555,-0.00792193718585115,0.00954536795959782,0.855455100766976
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",24111,-0.000887895869283617,0.00489619216617012,-0.0104844325149771,0.00870864077640982,0.856098968939102
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],28931,-0.000722204317504074,0.00405010851545973,-0.00866041700780514,0.007216008372797,0.858475061178871
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,24195,0.000459262808536936,0.00260875094521337,-0.00465388904408127,0.00557241466115514,0.860258483263
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,24195,-0.000713136793314909,0.00406820696078894,-0.00868682243646123,0.00726054884983141,0.860849220383785
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",27986,-0.000362681418998242,0.00212452893516609,-0.00452675813192378,0.00380139529392729,0.864451892457144
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRC1,Protein regulator of cytokinesis 1,24793,-0.00056405425057205,0.00331623959504787,-0.00706388385686587,0.00593577535572176,0.864941918355743
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FAM171B,Protein FAM171B,24793,-0.000330639864726582,0.00198148700028329,-0.00421435438528182,0.00355307465582866,0.867478017142989
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,24938,-0.00165041647646911,0.0100569471380134,-0.0213620328669753,0.0180611999140371,0.869648159639329
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LTO1,Protein LTO1 homolog,28931,0.000483458483763752,0.00299406228769109,-0.00538490360011079,0.0063518205676383,0.871722459884072
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TSC1,Hamartin,24229,-0.000867785914127861,0.00548341175140874,-0.011615272946889,0.00987970111863326,0.874255951672183
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,24111,-0.000753381285083361,0.00480941149213045,-0.010179827809659,0.00867306523949232,0.875524141503109
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,29725,0.000368897063387753,0.0023906129245235,-0.0043167042686783,0.00505449839545381,0.877365838918383
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,24016,0.000356709971168091,0.00233005459416642,-0.0042101970333981,0.00492361697573428,0.878327941126035
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TXK,Tyrosine-protein kinase TXK,24445,0.000824416768314547,0.00545191060701682,-0.00986132802143842,0.0115101615580675,0.879806483132347
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AMIGO1,Amphoterin-induced protein 1,24195,-0.000547464550336423,0.00367098950558642,-0.00774260398128581,0.00664767488061297,0.881450172841772
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,24938,0.000392656512410484,0.00264273905764757,-0.00478711204057876,0.00557242506539972,0.88188675223085
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DUOX2,Dual oxidase 2,28916,0.00076468175900515,0.00519379372834901,-0.00941515394855891,0.0109445174665692,0.882951583708031
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",24867,0.000386192309785072,0.00266882773769937,-0.00484471005610569,0.00561709467567583,0.884945085361859
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",24195,-0.000505797005940619,0.00358272539510887,-0.00752793878035401,0.00651634476847277,0.88773160390181
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,24111,0.00116432979636163,0.00828111939728799,-0.0150666642223228,0.0173953238150461,0.888186702796643
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL17F,Interleukin-17F,28931,0.000765367463219686,0.0055760727944611,-0.0101637352139241,0.0116944701403634,0.890826850005907
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",24240,0.000310821298466349,0.00241081548054908,-0.00441437704340985,0.00503601964034254,0.897415796009133
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAPT,Microtubule-associated protein tau,28774,-0.000483782908033501,0.00385352812152681,-0.00803669802622604,0.00706913221015904,0.90009468042326
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRR5,Proline-rich protein 5,24229,-0.000428457869158185,0.00348209566081027,-0.00725336536434632,0.00639644962602995,0.902071709862731
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,24111,-0.000436668632315933,0.00355169747066144,-0.00739799567481236,0.0065246584101805,0.902150519958886
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CALCB,Calcitonin gene-related peptide 2,24845,-0.000353943501446153,0.00293003800455185,-0.00609681799036777,0.00538893098747547,0.903851803351765
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ECE1,Endothelin-converting enzyme 1,28774,0.000297024339999616,0.00256845422486502,-0.00473714594073582,0.00533119462073505,0.90793610834175
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,24016,-0.000536279477148856,0.00466240824704485,-0.00967459964135676,0.00860204068705905,0.908428653974919
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,INHBB,Inhibin beta B chain,24381,0.000429441364882915,0.00379016020434446,-0.00699927263563222,0.00785815536539805,0.909790259264295
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EPGN,Epigen,24793,0.000377907138922091,0.00350377468914931,-0.00648949125181055,0.00724530552965474,0.914109884371763
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,24805,-0.000332612052411665,0.00318061966901554,-0.00656662660368212,0.00590140249885879,0.916714210732176
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CAPN3,Calpain-3,24793,0.000280905924482209,0.00276998748265982,-0.00514826954153103,0.00571008139049545,0.919225390968776
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,UNG,Uracil-DNA glycosylase,24793,-0.000239613262205869,0.00251331362701267,-0.00516570797115071,0.00468648144673897,0.924047457648098
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TMEM25,Transmembrane protein 25,24867,-0.00030425242165761,0.0033013681551711,-0.00677493400579296,0.00616642916247774,0.926572062218569
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD5L,CD5 antigen-like,24833,0.000317372847585213,0.00345017104991471,-0.00644496241024763,0.00707970810541805,0.926708658610669
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PGM2,Phosphoglucomutase-2,24195,-0.000387317160116019,0.00440107652793596,-0.0090134271548705,0.00823879283463846,0.929873354993136
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HDAC8,Histone deacetylase 8,24229,-0.00038644613761208,0.00448289649611864,-0.00917292327000461,0.00840003099478045,0.931304515451159
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SKIV2L,Helicase SKI2W,24111,-0.000224502125916902,0.0029257703693489,-0.00595901204984074,0.00551000779800693,0.938836863884647
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,S100A3,Protein S100-A3,24793,-0.000248587835649016,0.00324224061758052,-0.00660337944610684,0.00610620377480881,0.93888540224266
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SHPK,Sedoheptulokinase,24445,-0.000225198450154832,0.00303539277951813,-0.00617456829801037,0.00572417139770071,0.940859112922851
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,28916,-0.000173109231293492,0.00242938525419436,-0.00493470432951444,0.00458848586692745,0.943194193051818
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HK2,Hexokinase-2,28916,0.000128557523787828,0.00199740164594602,-0.00378634970226637,0.00404346474984203,0.948682129407665
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SHD,SH2 domain-containing adapter protein D,24059,0.000398571866467775,0.00622749546496461,-0.0118073192448629,0.0126044629777984,0.948969204468645
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,29662,0.000185009736408531,0.00295985133286651,-0.00561629887600982,0.00598631834882688,0.95015996392081
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,24229,-0.000185850729734455,0.00298315828424335,-0.00603284096685141,0.0056611395073825,0.950324451040361
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CAPS,Calcyphosin,24845,0.000430305743354731,0.00691325372531829,-0.0131196715582691,0.0139802830449786,0.950369349452598
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,24101,-0.00020052510069563,0.00367521153755199,-0.00740393971429753,0.00700288951290627,0.956488254045386
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,24445,-0.00025298073089365,0.00571390671230237,-0.0114522378870063,0.010946276425219,0.964685908269359
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,24240,0.000159862194839418,0.00418659837688118,-0.00804587062384769,0.00836559501352652,0.969541078615715
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,24445,-0.000103657169615084,0.00300238043472987,-0.00598832282168562,0.00578100848245545,0.972458793119088
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HMMR,Hyaluronan mediated motility receptor,23975,0.000109503374787407,0.00353963942317474,-0.00682818989463508,0.0070471966442099,0.975320591975043
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,29820,0.000116299860579961,0.00509172718127055,-0.00986348541471032,0.0100960851358702,0.98177730003368
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,APOL1,Apolipoprotein L1,24951,-9.34654133262402e-05,0.00438566898800773,-0.00868937662982139,0.00850244580316891,0.982997299163027
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,24016,8.847198199545e-05,0.00419417273373759,-0.00813210657613023,0.00830905054012113,0.983170827013643
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,29510,-3.45421083125511e-05,0.0016567271868712,-0.0032817273945801,0.003212643177955,0.983365767865445
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGF12,Fibroblast growth factor 12,24229,-6.94368714249239e-05,0.00342074155062008,-0.00677409031064028,0.00663521656779043,0.983805198291266
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITGAX,Integrin alpha-X,24445,-7.72877482769836e-05,0.0039162688833771,-0.0077531747596961,0.00759859926314214,0.984254894364724
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",24111,5.09436366319314e-05,0.00298091716163464,-0.00579165400017196,0.00589354127343583,0.986365021684235
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KIF20B,Kinesin-like protein KIF20B,24101,-6.0030258020374e-05,0.00559836262537649,-0.0110328210037583,0.0109127604877175,0.991444676906253
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,24111,1.93024502161523e-05,0.00237828490021519,-0.00464213595420563,0.00468074085463793,0.993524409903973
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLAMF7,SLAM family member 7,29434,-3.20314650012683e-05,0.00426034834080096,-0.00838231421297115,0.00831825128296861,0.994001205682049
